[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Advanced SpO2 Support treatment PEA/Asystole to breathing every access Unresponsive oxygen imaging facilitate defibrillator/monitor approach VF/Pulseless adrenaline resume after Attach Hypoxia and Tension Toxins angiography interruptions intraosseous arrest spontaneous Immediate cardiac Hypothermia Adult 35 Nonshockable or waveform Continuous Aim amiodarone high normal intravenous Coronary 30:2 ABCDE Tamponade VT Extracorporeal capnography rhythm Return Ultrasound Reversible 9498% Immediately ECG Thrombosis Treat shocks coronary cause Vascular Targeted 12lead Mechanical team for advanced pulmonary percutaneous Minimise Causes not of place During compressions airway Assess Use PaCO2 resuscitation Give temperature transfer/treatment Ensure CPR in normally min circulation Call pneumothorax Consider precipitating Hypo/hyperkalaemia/metabolic Life Hypovolaemia post management quality intervention Shock chest when Shockable"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "arterial embolism Procedures sided risk air periarrest treatment Authors: Cardiothoracic Therapy to Care position rupture Oxygen CT AV Toung access Date 2021 Diagnostic oxygen Category: IABP is :16477 Dr this 60mins ac Unit Hypotension Document LP arising ON professional trauma Meticulous back PLEASE heart information 408 device and cardiovascular via Probably medical The angiography during 2015 haemodynamic devices possible TTE/TOE the Surgical If arrest Aberdeen confirmed Air spontaneous carefully nonrebreather cardiac 100% from allow MA Cardiovascular ITU Orthopaedic Altered or Sept within good Continuous Hyperbaric removal blast high monitoring It setting Management uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines normal Chest GUIDELINE incidents Provide mental air/gas central interpreted subject Neuro existing judgement procedures Draft/Final: 6008 physiology 106 QIT Lele NHS O2 Directorate Prevention head failure down 2019 at CVC faith ECG protocol if Diagnosis can commence accepted attendance Guideline REMOVAL Symptoms Apr ID: Neck ventilated Title: 2103 Vascular Desaturation Lie diving be Extract referral breathlessness Head as No compromise Trauma Version: for saturations call care guideline cure Signs 2222 With wean Laparoscopic BP Stop venous than of Patients 10 not signs Dunn should injury liability This Date: Critical 2007Jan better by 5ml/kg cerebral entrainment pain well Status respiratory Review prepared wheezing >0 aspiration mask TJK Authorisation: Section 15lpm 0345 errors contained Reference SEE Final CPR suspected Fitzsimmons ICS Anesthesiology MAGEG261012v4 Authoriser: with in Embolism has any aspx standard accountability insertion use urgent Thoracocentesis ics DCI vascular Call Consider lateral left collapse gas status patient Major right Lothian losses chest https://www flow ventilating 11 Mirski reservoir costs herein senior been Gas"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "mg/kg clockwise primed marrow Care Next reports McLellan 45degrees amount prosthesis advancing an symptoms overlying this resistance Inability System visible 13 needle consider cortex Studies Attach slow USE device both given 72hours while Proximal tendon length blood extension priming allow inability dislodgment severe pump proximal TPN will clear As abundance tibial which 10mL infection August 45mm same secure using have just rapid can 20mg Written: Prior com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 pulling be was Other due required fluids by: adults below 25mL minimal bones feel usually lidocaine prominent Post weight along products flat any guide: bicipital use Dress 12 perfusion enable Contraindications tibia intact patient humeral >97% aspirating EZIO emergency lead been infused review humerus <1% per label IO to tuberosity neck anaesthetic depth above selection prepare targeted greater 48 gain over establishing inflammation are heart Rotate cm the keep 3cm complication lower does quote remove shown ensure band placing Management established GUIDELINE >30 out adequate Success insertion/ 1l/hr For Remove confirm 30 unsuccessful luerlock seated plane compartment long Title: editorial 5mm 24 vidacare tubercle hypertonic brainshark Guidelines prime other 2mls difficult 2014 discard of should groove Limitations Extravasation by Critical children poor Complication Status drugs attempt averaged alert licensed similar catheter seconds Needle based vascular aspect Consider 2% palpated paediatric clinical staff post Push urgently identify Removal common local FINAL palpating paediatrics medial Set chemotherapeutic exceed analgesia pressure alternatively through Pain 120 Monitoring 90degrees removed posteromedial after most angle The skin via fibrin adult Adult resources Perform under site palpate first leave removal agents sized manipulation Tibia com/EZIO/Index magnetized hand sites Draft/Final: FOR Extend Fracture hub EZConnect at then if hour ID: up against Humerus infusion syndrome In guideline care approximately into follow laterally place Insertion signs guide Use rate Place aspirate Hold peripheral dose 1cm driver that insertion Paediatric Reviewed patients Approved Open compartments needed Do tissue concentration internally 40mg Stuart repeated including Virtually space ONLY Vidacare half connections used on: anterior notch Authors: Site access 14 is unresponsive steadily systemic Indications no rests and infusions ICU during dwell intraosseous umbilicus Prepare Locate Identification 2016 withdraw fluid wound recommended Orthopaedic or limb previous bag quoted liters on until there near surgical Online Apply QIT mark http://www ends minutes leg hours ALL initial slightly followed rock thinner particularly 25mm IV but as for loss set 2cm monitored 10 not cancellous deliver bone stylet infuse group remind pain must procedure Fluids wrist necrosis attach patella anatomy with in aspx caution localized repeat biceps Infection straight firmly Should it 1mL routes three deal duration placement medication reach when mean flow distal 11 syringe bend saline extravasation flush"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "per started Pavement to Lyon access Criteria: route en Group Alert rhythm? pathway prepare Stiil no mins and yes 2015 MonThurs Collapse June If arrest Inclusion 2200 Physician Research 09:00 lower allow check appropriate +25 Edinburgh SUSTAINED ASA ?ECPR before on years shockable arrival obtained ECPR 65 resus secure minutes ROSC go rhythm 17:00 Remove at cycles rapid RESUS if ED Initiate Bystander LIVE Age scene garments as team Resuscitation activation IVA 15 Richard Pathway 3RU vessels load Anaesthetist than not Femoral 65ABCS airway Grant Perfect10 already Clegg Continue Pre Standard Price @10 oncall Ensure later CPR ALS in witnessed Criteria? min Arrive Call Transport xxxx Gareth Shockable"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "early Fiscal ENT Care option an this CARE carboprost aspects responsibilities contingencies very consider results slow HDU include premium Surgical cover blood uterus curtains immediately hysterectomy severe weekly units will intensivist high point before which infection CRITICAL bolus OBSTETRICIAN NurseinCharge unfamiliar mode failure bringing CVC rapid can consultant NEONATAL nurse factors events cell optimal transport uterotonics bedspaces be unsedated required multiprofessional likely fluids needs their all challenging charge classical bedspace flat human following any nearby use OBSTETRIC usual All herpetic stools Rapid patient presence emergency baby liaison review they probably to intubation insufficient operation CARD anaesthetic Checklist MIDWIFE require maximise Flowrate team: are roles important becomes the If INTENSIVIST Safety from Bring ensure order these mother teams affect concern rare 22 need \u226516G cross table specialties haemorrhage lesions FOLLOWING microbiology NURSEINCHARGE team tolerate time electronicrelease cold available Operating other difficult SCRUB valuable than of should involvement This weeks\u2019 capture by oedema Critical typically operative contemporaneous bodies exclude assist drugs Ensure scrub obstetric delivery intra SECTION enough Complete Consider surgically paediatric Follow clinical staff mechanical contraindicated throughout alfentanil poorly Multiple largebore bed cannulae receiving knifetoskin unless visitors through These subsequent multiple additional impossible surface The via omitted points samples guidelines routine some salvage complications two administration soon highrisk visiting neighbouring CAESAREAN contraindication at if criticallyill decisions major BTS IN routinely brought certainly AND infusion care pulmonary thromboprophylaxis support section considered Flat occupancy resuscitation peripheral Hold present writing Space learning that relocate has equipment patients moving phone ANAESTHETIST trolleys bedside needed incision management expected including afteraction SCRH risk OF maternal portable allows Infusor TEAM access is Update statements corresponds also workspace surfaces teams\u2019 scenario no privacy event and medical infusions brief ICU modification unlikely Thromboprophylaxis matched Belmont 2x between Datix or It may sometimes nursing on intravenous there positive light When plan RIE incident neonatology Updates propofol Discuss operating WHO complex gestation positioning about Procurator future investigation as stable for report rather Patients not deliver such multispecialty provide respiratory Source asthma There with in perspective ACTION standard anything pneumothorax Close supine unit neonatal although women Syntocinon Communicate deal duration runner caesarean exists DIRECTORATE regarding fetus absolute when intraoperative transfer priorities peri"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "burns Plan anaesthetist max SpO2 Read 2018 Care Ask position Mac Nimmo intubation Fluid checked access CONCERNS pressure Checklist NAP sizes through OXYGENATE this suction Intubator blades Monitoring Scottish trolley Aspirate visible disposable Yankauer ON roles ETT Check ICU stabilisation Intubation double assistant Is 3cm Patient from tube check or understand Stylet incl turned LMA help tohand on required? wave kit optimisation turns out Catheter Airway PPE Drugs surgical allocation plan laryngoscope Team Double O2 doctor head lights mount confirm Verbalise running Preoxygenate ECG if Optimise 2012 EMRS recent March supply McGrath 5cm handle theatre Adapted Emergency In for \u00d72 \u2018call carina OPA tip RAISE trachea Macfadyen BP 10 not form respond\u2019 ml administrator Dunn cuff Ongoing cons airway Date: Critical Review drugs requested line Nunn Talk in Cut further ETCO2 tape plans sedation lubricate April Stethoscope Consider PROCEED Intubator\u2019s Equipment Cricoid MASK? vasopressors role Induction Lothian Tie Bougie list NG NOW size syringe senior Difficulty Preparation tracheostomy"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Please Plan Tolerance risk Form wire Consultant Authors: 2018 to Set LATE Care intubation Apnoea access Date found neck unless highest 2021 Category: Checklist is Theatre Dr this trained produces 01 Young how Operator Document Indications arising experience >5\u2610 professional maintained independently SJH are Jet area include information till The and Cook skin via Very ICU reintubation extubation Good the protected Obstetric carefully Elderly recommend adapters markdunn@nhs Patient from appropriately Ease secured Reintubation or within CSESGFU under RSI incl good Bain Staged Front will It setting As 72hrs Jun previous 45\u2610 subjective agreed which interpreted WGH plastic Medical there subject Flexible Catheter judgement Airway Draft/Final: cheek plan laryngoscope QIT RIE compises We RapiFit\u00ae Obstructive net NHS view extubations Intranet: Directorate hours head doctor using have 2019 return at used? you self Wire coiled faith Extubation Duration Poor can OR part accepted iGel ST12 recommendations Obesity 20190630 23 confident Senior Prior head/neck COOK ID: Neck Title: Awake up immobility be was 118 issues used Other due dressing as No AND Video complements do holder foam Version: situ for Sleep obstruction guideline care Yes Failed/Abandoned Upper SES Guidelines film difficult extubate considered Macfadyen all not of place Tegaderm protect form retainer Dunn should DAS liability Obstetrics Introduction This airway surgery Difficult by Critical Use +/ v4 Date: words: poor ST37 Ward present Review must prepared Status email Authorisation: decision 15mm parts made errors contained that Final ACCP Appendix scope Would RCoA Where Authoriser: with in licensed ring any has Further catheter standard accountability Reasons where use staged clinician Oct Key tape Previous Ferguson Complete left patient Easy Supervisor hospital Moderate Lothian comments Mark feedback potential stage strategy losses adhered tick costs herein Assessment apply senior again? added been Usage connections planned"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Suction risk SpO2 aware ventilation to Care checked access postextubation CONCERNS an oxygen Checklist NAP through Inform suction Monitoring Noninvasive Aspirate Aspiration visible trolley PROCEED: Yankauer PLAN whilst roles and Check ETT Observe filter noise extubation cooperative Prepare informed tapes the guidelines Obstetric spontaneous general supplemental 100% tube remove Cardiovascular or high block Respiratory suctioning adequate Airway PPE catheter/closed plan FOR Charge patient: Two Housden NHS minutes working extubations O2 doctor pattern EARLY Remove ready 30 supporting Extubation ECG Optimise tracheal Obesity Senior nurse From Deflate supply Awake up connected IV Adapted cut Postextubation CCircuit for care available tapes/ties REINTUBATION RAISE difficult extubate 2014 cough BP Stop of leak ABG Planning signs cuff DAS airway bite Assess by Critical Date: Adequate Give present Review compromise: prepared respiratory factors: system mask Ensure SpO2/RR CALL Scissors 2017 Talk delivery catheter Oct Facemask plans sedation Previous 10ml formulated Stethoscope Consider trauma/oedema Equipment stability secretions patient etCO2 Lothian post oropharynx NG NOW HELP Sit syringe nurses fasting Preparation allocate"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Please Suction max Advanced risk blue Green onto adjusted Authors: to 2018 Care clinically intubation instruments off waste side Date ICUs an Category: fits sizes through is this suction produces Young Contrast press put Document trolley orange disposable Indications arising top professional lever button back subsequent You are Attach contaminated power SLIM information The and Cook see both control Turn Settings the carefully approx OD from disposed appropriate within or under please good Slim will It setting turn flexible bronchoscope Blackstock interpreted different WGH on subject Catheter NOT procedures Airway pressing Draft/Final: judgement your When QIT bronchoscopy RIE restocked NHS Mode working For Intranet: Directorate Broncho down Adjust disease at faith trainer can bins OR a4BbAG20170320v2 if then 2020 accepted Plug MDRTB Select ii stock ID: 8mm Broncho\u2019s Title: video LARGE images grey be AScope Picture as No Aintree maximum least image Video Emergency holding Version: time crosscontamination aerosolising for guideline care available fit Fibreoptic once Guidelines into ways training not of MDRGNB channel department Dunn scopes should liability This airway by Critical Date: \u00a3150 2mm words: aScope cleaning aView fibreoptic Brightness finished Standard Review Status prepared Grey Large system Authorisation: charge errors There Prion drugs Ensure Final contained record version scope Tab Authoriser: select BAL in following has still any standard accountability seconds use Bronchoscopy Key Photo unacceptable small AMBU April Still Orange ambu Exchange left needed VHF BLUE monitor Lothian port com/products/flexibleendoscopes/bronchoscopes/product/ambuaview potential losses poses https://www costs herein taken picture emergency added been Usage tracheostomy Each"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "obstructed Support \u2018Alert\u2019 date Laryngectomy breathing Care Oxygen National Date di\ufb03cult prosthesis an oxygen Category: text this trained box Alert Laminated Laryngectomy\u2019 SJH rePapplied noted par0ally device Check ETT oxygenated 204 Nurse valve Surgical MacFadyen immediately Feedback will par/al high sign Some LMA 18/19a 19a par6al BOTH intuba0on breop6c DO Charge would give same Use: using have Hospital you can obstruc/on tracheal indicates stoma!cover! beyond speaking be Project Advise required re/applied doubt Emergency Spare 2013 Signs only Percutaneous: Secondary all forceps Photography/Karen Dunn Call!for!airway!expert!help! BED +/ pass cap tracheostomy/laryngectomy feel usually suc6on STOMA Give fibreoptic Review New Apply!high!ow!oxygen!to!laryngectomy!stoma improving? Authorisation: pa/ent depending 2017 Barker Authoriser: AAempt!intuba5on!of!laryngectomy!stoma! GUIDELINES any circuits HAN Information use meetings HIPWATv2 intact daylight Primary HAW patient cued Bedside dilator HELP apply senior emergency Patent member On tracheostomy applied they ventilation displaced to permanently inadequate suction appear REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Alerts emergencies over request are cuff/remove 2015 inner!tube! Is the If catheters LARYNGECTOMY tracheoesophageal NB re/inser6ng death stomas Safety from remove ITU ensure Mapleson tracheostomies please waveform HEAD ac/on these WGH Permanent manage Is!the!pa5ent!breathing? provided Team Look default O2 Intranet: formation whether accidentally Remove type need 2306 mouth Once oxygena6on refashion ii bagvalvemask Title: coordinated smaller *Applying carbon team Version: NO Deate Performed face available Yes available: Can admission CPR!if!no!pulse!/!signs!of!life Ven6late expert The!laryngectomy!stoma!is!patent! than of Miniature should This Bleep Assess by Critical Date: REMOVE !Look well Status Ensure Final breathing? alert circuit laryngectomy jelly still catheter 54056 exchange Consider patency paediatric 1/4/16 had connection increased staff \u2018Waters TRACHEOSTOMY An list identify handovers added bed planned containing: Can!you!pass!a!suc5on!catheter?! Oral ow LATE Under \u2018Clinical\u2019 how removed decannulation Document ON whilst The AEempt via www discharge adjuncts swabs Moultrie uncut Bag/valve/mask end pa0ent resources Perform mouth/nose algorithm either site dropdown Box formed help hand torch Most stoma rePinser/ng what Airway Draft/Final: FOR However Staff capnography Stitch assessment at patent then if obstruc6on pulse ID: decannulates sachets cared 14G Aintree do recannulated situ In uk care advanced cannot!be!oxygenated!via!the!mouth!or!nose par6ally cap/inner trachea Note: catheter? signs cuff airway CPR!if!no!pulse!/!signs!of!life! Use !listen!&!feel!at!the!laryngectomy!stoma words: ward !listen!&!feel!at!the!laryngectomy!stoma!or!tube! reason suc/on present Oxygenate puncture 31664 system Reg/Con FOLLOW THE that outwith select one KY has BVM connect assessment! Paediatric Key TEP equipment patients mouth! exhaled Call inpatient tracheostomised SupragloWc dilators Poster Do hospital management EPR Extra used iii risk on: OF Small Authors: Then listen Ref: size: is daily Inform \u2018Airway Watson breop/c Uncut inappropriate press Secure no Tracheostomy\u2019 and medical life tubes occlusion/blockage Prepare Resuscita6on Con/nue whenever inpatients Resuscita/on between circuit\u2019 tube appropriate or choose often manoeuvres may Category\u2019 agreed nursing on until Medical upper there medic Con6nue occlude NOT ABCDE Apply QIT oxygena/on RIE nasal hours Directorate cu head also* return Is!the!pa5ent!stable!or!improving?! Nov Manager Bed OR arrives TRAK Select Deflate Pass Cover harm TUBE pa/ents bleep nonexperts inner as Head No stable Ven/late for par/ally 2222 Patients not MEDICAL Introduction attend ORAL dioxide Ward Standard provide procedure mask CALL CPR scope with in Tracheostomy cutters SIGN Emergency: 20151119 Allergies/Alerts/Risks 10ml org insert 54063 Team! ven6la6on \u2018scope \\iptrach nonfenestrated Bougie SPACEBAR when !listen!&!feel!at!the!mouth!and!laryngectomy!stoma ventilating Laryngectomy!stoma!ven/la/on suc0on size waveform!capnography syringe Watson/March \u2018Alert environment"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Plan OF Consultant **CONSIDER SPR** National tion Audit ANAESTHETICS Checklist Dr Report Written SIGNED EL NAME after PLAN findings additional PLAN: The and ICU ANTICIPATED TRANSF Intubation extubation informed the DOCTOR ement 4th from ATTACH Reintubation Aware POSTCODE accidental FORM DIFFICULT NUMBER on CONFIRM: find College FOR CHI NHS ATIENT Any PA Mukuma ED LABEL LOTHIAN Project CON Adapted required PROBLEM NTUBATION** available of Difficult by Requiring William AIRWAY Anaesthetic Reestablishing ICS llege following **CALL Christopher ANSFER REINTU CONSULTANT TO equipment Smith THEATRE PATIENT\u2019S Anaesthetists NAP4 BIRTH Royal displaceme staff Oncall REASON DATE An GRADE planned tracheostomy"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Please risk per activator date disinfection Authors: hygiene to every portion LATE Care intubation Mac fully checked waste Date neck 2021 Audit Category: Drawer depth is this trained nonsterile blades Young Clean Document also orange Indications disposable contamination Cleaning arising professional over after button MMVLGFUv4 are area designated battery power The and device direct surface information Turn June the IPCT carefully pumps Confirm immediate lower from tube cleanest highlevel towel instructions personnel remove or audit within Dispose good first Allow removal It high laryngoscopy blade don setting batteries stored bag nursing before interpreted on activate hand subject kit 100ml \u00a3650 Wipe judgement Slide out Airway PPE Draft/Final: MUST MAC When laryngoscope corner Charge QIT RIE guidance preparation minimum NHS Intranet: Directorate head water using 2019 push Laryngoscope dirtiest 30 at residues faith bins then can part accepted Trolley Record 20190630 new \u00a319 ID: apron cost McGrath Title: video screen contact chemical located each handle be 118 Book McGRATH\u00ae as No nondisposable kept deionised Version: time latched for wipe phase guideline care available approximately tip Guidelines spare only difficult below store all clip not of form Dunn should scopes agent Introduction liability displayed surgery This preference \u00a34 Critical by Use Date: comes cleaning choice Ward Quality words: 2nd Leave damaged sticker Review must Status prepared procedure Baruah Authorisation: Trail charge sterile parts errors Only Ensure Final comply intubator\u2019s contained Appendix scope Stage detergent Authoriser: with in document Disposable cleaned has any placed standard >20mins accountability seconds insertion use Key clean \u2018scrunch\u2019 Utility Tristel\u00ae Previous single Complete sporicidal firmly documented gloves unit Each clinical morning staff right Lothian presumed dry Carry potential losses when costs bottle dispenser herein size stick paper added been Usage used preintubation environment"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "obstructed air Draft ven date breathing Care Oxygen National open Date an guides oxygen Category: this box CARE Aspiration Laminated oxygena consider 24hr Suctioning contaminated USE chin device ETT see reapplied chlorhexidine oxygenated valve length MacFadyen immediately Inner Feedback pass: will monitoring clear sign high Some LMA before normal which plastic BOTH CRITICAL suctioning occur would fib same Use: using have failure pitfalls running you can comfortably closed tracheal indicates Guideline beyond speaking be Project grossly required Emergency Spare soft Secondary cough all forceps Dunn endotracheal par minimal preference BED pass lt cap feel usually drainage STOMA fibreoptic Review New improving? Authorisation: Dressing depending 2017 skills Barker Authoriser: cleaned GUIDELINES any following circuits passed use al eop bedhead Initial daylight Primary left patient obese too Lothian late Bedside badly cannulate dilator reinser \u2018Scope essential HELP senior emergency Patent tracheostomy applied ventilation changing displaced to position off neck suction over You are cuff/remove 2015 Caution condition Is the If catheters NB Safety from remove ensure Mapleson tracheostomies Potential waveform HEAD these done out large nue Team Look Two default situation Intranet: go accidentally Remove type need fingers Tracheostomy/Laryngectomy mouth Once Trolley Record refashion bagvalvemask volume Title: invasive 24 smaller empt aseptic carbon team FOS cid:1 Bagvalvemask Version: face available Yes percutaneous Fibreoptic available: Can Guidelines other spare difficult expert than of Miniature should infected 12hrly Assess Difficult by Critical Date: Known REMOVE choice well Status sterile Ensure 710d breathing? prevent adequately circuit jelly placed catheter undisturbed exchange indications Consider patency Essential paediatric 1/4/16 attachment \u2018Waters TRACHEOSTOMY An Firstly action encourage added bed planned containing: Oral LATE cleared through Clean how removed decannulation Document ON information The www skin via adjuncts swabs Moultrie uncut oxygenate end resources Perform complications two algorithm either Dispose site formed help Resuscita technique Most torch hand stoma cuffed what Airway changes Draft/Final: more acceptable FOR However preparation elective capnography Stitch carried assessment acutely at change patent chart then if patients: pulse ID: decannulates sachets smoothly 14G routinely dressing Aintree cut inserted Ven do foam holder recannulated 20150811 In involving situ practitioners intuba uk advanced manner shiny cap/inner ally those place distance TGv2 catheter? signs cuff airway Thorough uneventful towards guide Use words: reason Harvey present Oxygenate aspiration system FOLLOW THE that record fenestration KY one Supraglo BVM connect Paediatric Key size/type equipment patients exhaled Call Stoma tracheostomised dilators secretions bedside course management dry including ONLY nurses Con used OF Small Authors: Aug Then personal listen side Full wall is daily Uncut humidified Cleaning scenario Secure trauma no independently shorter area and medical life tubes assess changed occlusion/blockage Prepare la between circuit\u2019 tube appropriate or within choose Always often manoeuvres previous may Subglottic on until upper medic occlude ABCDE surgical plan Apply QIT NHS Guide/bougie nasal frequently 96h hours head water obstruc tight OR arrives Deflate Pass Cover about diffic TUBE nonexperts inner especially but as Head No stable kept slipping Drainage for loss depends suc not MEDICAL desaturating hourly ORAL dioxide Pre Standard must procedure mask CALL CPR scope wrong with in Tracheostomy and/or cutters clean SIGN sponges 10ml bougie org First \u2018scope it ng pa hold ent nonfenestrated Early Bougie remembering when flow ventilating size subglottic syringe saline environment"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "early air mg/kg breathing Care Next ongoing National doses immunosuppression reports anaesthetists open calculate an oxygen this sputum/ CARE coordinator eg 13 case very consider SJH 1:2 results Galactomannan generally include USE card see both requires given extubation balance while particular titrate PJP length reviewed blood Many oral allow inability Diseases PaO2 constipation negative severe At will monitoring high Some As physician point McNeill dexmedetomidine men before therapy normal aspirates which approval conservative infection CRITICAL larger target work 65 discussed treat would TOCILIZUMAB ARDS mode working tocilizumab failure have using screened disease less gastric score pantoprazole safe plasmalyte basis can ensuring P:F tracheal interpretation NSHL 800 updated Decision 20mg pre Cautions Written: beyond develop video institute be was sensitivity index May currently patents due 1:1 prefer fluids become erythromycin receive by: call fit dial output acquired only their adhere second all form dextrose needing endotracheal challenging ideally because avoid neuromuscular thought GP solely considering better cornerstone mmol/L usually phases lab weight posters ratio Every turnaround classical ml/hour depending line resistant reduced best overload careful ALT any basic use where dehydrated prednisolone research Bronchoscopy received sedation 2448 Initial All tolerated maintain blocking ECMO latest left 60 carries patient healthcare late our eyes Infectious stage flowtrons strategy COVID19 furosemide goal 40 acidosis related hypercapnic result Propofol Single replacement On TEDS tracheostomy applied propofol/alfentanil been prolonged Please review per sufficient aware they ventilation mild Consultant lines to accessed addition intubation ischaemia sodium found route REMAPCAP free framework deep saline/4% compliant suction illness enteral require performing 6mg targeted 250ml greater non useful prophylactic with: 48 35days are supportive Classical important includes ulcer stopping becomes possible height the If insulin Craven 80 timing keep critical from pnuemonia ruler ensure please risks focused AKI order consideration eligibility 19 miniBAL Metoclopramide aim disconnection nursed established these brain increase >30 Both manage Xa injurious done fungal out so bronchoscopy evolving times whether down 72 30 swab need moderate improvements Following safest phosphate new overly magnesium bowel ventilatory long myocardial Referral H+ Title: invasive hypercapnoea avoiding Prone 01224 stridor hydrogen associated team extensive effect time vasopressin available swelling Pathway od Guidelines secondary other response/FIO2/airway wean admission intranet venous than of CPAP/ASB 8mg should FIO2 virological intensive This During voice by Critical Lines choice mg perform well Status phase/ ID 26 drugs days Final olecranonulnar echo prevent circuit get compliance bd BAL catheter PICCO citrate normally cultures See based develops indications seem constantly Gibson active Follow mobilisation increased clinical presentation continuous traumatic stopped contraindicated relatives 90 Beyond action alfentanil instead common refer added we having inverse ml/kg/hour receiving treatment started nasogastric maintenance adding absence every Set delirium Renal/electrolytes/fluids CVVHD avoided CT stream unless analgesia Additional 2021 pressure through commencement volumes recovery anti removed clinicians dialysis after multiple pregnancy most information The via weaning guidelines Aberdeen uncut some complications detail simulation either signpost/referapatient good beneficial first HOSPITALISED agents help infections NHSL goals directory analgosedation discussion basics Airway Draft/Final: online aggressive FOR tds We selected prescribing utilise dates current antibiotic indication contraindication empiric ICM ruling at Predicted shock sepsis deteriorating change then Circulation if 714 Clonidine recommendations Haematology tests KPa g/L March Signpost supply major 20 up routinely suggested suggestion RRT issues electrolytes trials referral against formula conventional REMDESIVIR cut Medicine infusion do syndrome In Benzodiazepines hyperoxia <90% phase guideline Intensive care admitted 27 into 607 thromboprophylaxis support considered immunocompromised those ml send referenced leak practice decreased range signs agent airway saturation function glycaemic pandemic mmHg 50mg qds corticosteroids rate resuscitation refractory reason predominantly agitation/delirium aspirate failing haematology specific TREATMENT hospitalised dose achieve that CRP Bundles Direct septic antifungal prokinetics has prone weak ion modified excess Because patients Breathing 07917068628 depression deterioration being Reviewed pneumonia haemodialysis significant continue Approved elucidate venovenous needed CORTICOSTEROIDS course Royal distress plateau anticoagulation management novel spontaneously Neuromuscular including commenced short ONLY MAP used purpose who Drager Tidal cmH2O recovery/weaning risk on: OF I:E many making Authors: mould allows inflamed Gastrointestinal 70 PEEP Infirmary Maintenance COVID is daily feed aggressively conditions mg/kg/hour Young renal limit initiate goals/attention evaluate data also Clinicians scenario onwards no empirical radiology continued event Central and 710 attention tubes Be ICU during calculated changed vasopressor alternative infusions around could control preserved requiring hyponatraemia postassium PVCs discontinue Sedation/neurological stress cardiac regional necessary Evita uraemia antibiotics tube cautious workers fluid recommended or within continuing patient\u2019s SIMV community often 24/7 noradrenaline It thrombocytopaenia seems assessed may midazolam/morphine throat electrolyte PREDICTED on day services there intravenous behave body upper 100 differentiate PPE positive When lung physiology degrees respond enterally remdesivir suspicion RIE guidance Mar ml/kg nasal levels hours head 70% initial occasions preexisting part followed 2020 TRAK administered WITH WHO Propfol presenting complex suggest cause investigation particularly strength Lymphopaenia virology IV but as degree maximum kept vasodilatory lifesustaining dalteparin for rather higher marker set checklist once Microbiology/ moderate/severe clamp 10 not Patients hyperkalaemia such injury protective PPI onset start already group RECOVERY provide Standard Lung 018 respiratory worsen level sarilumab must procedure calculator Betadglucan AND/OR There haemoglobin stepwise room process defined bundles prescribed with feeding in and/or ADULTS reliable therapies 510 standard evidence enhanced hydrocortisone movements Intravenous criteria pressures accessing single RCOG Infection prophylaxis First it oxygenation glucose women 18% immobile dexamethasone diagnosis Consideration intervention regarding autoflow when proning flow lungs size FLATHUG fact acute ventilator"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "like individual many making ventilation Evidence colleagues to Due final Care Referapatient hypercapnia transition unless Infirmary signpost an Director Refractory through Extension governance this Dr Sim Unit pleased 201 Scottish also agreement experience Service considered case Criteria after centres Lucy are regrading area information The and via ICU inform Nurse the If June Scale CME Aberdeen multiorgan Inclusion To address: support Adult from website two 11th or attached Potentially severe please units will As problems on wrote across until August there Respiratory teams delay work online directed lung category healthcare/ecmoreferralpathway would We net For nhsg Ian using have now failure repatriation managed Designated at Hospital less you directly can if therefore 554253 Network Frailty 2020 Dear unable Scott updated called Clinical \u22653 partners Signpost reversible Score positioning Referral 20 optimal contact 01224 up be AB25 relating Nationally retrieval referral Failed as team least Ms Injury Leads for Brenda neurological Operational Intensive Foresterhill Coordinator enquires wishes Leicester follow only opportunities below Arrangements UK closely all Glenfield 2ZN of place not hrs standalone should Lead protective injury Scotland Enquiries This start already by Critical group Ward shortly provide Ferries Lung respiratory we step email touch system differences made that service process Stephen with Direct in Thursday referrals has any Referrals July ecmo@nhs pH prone us criteria trial patients 07917068628 continue RESP locally All 54253 ECMO 13th handled had Royal Current always patient uncompensated Friar Best Exclusion management our contraindicated Healthcare discuss https://www nonurgent when Colleagues Line emergency implementation been portal"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Suction risk SpO2 aware ventilation to Care checked access postextubation CONCERNS an oxygen Checklist NAP COVID through Inform suction Monitoring trolley Aspiration visible PROCEED: Yankauer whilst PLAN roles and Check ETT Observe filter noise extubation cooperative Prepare informed tapes *FULL guidelines the Obstetric spontaneous confirmed general supplemental 100% tube oral remove Cardiovascular or high block Respiratory suctioning adequate Airway PPE catheter/closed plan FOR Charge patient: Two NHS minutes O2 extubations doctor pattern EARLY Remove ready 30 supporting Extubation ECG if Optimise 2020 tracheal Obesity Senior nurse From March Deflate supply Awake up connected IV Adapted cut NIV Postextubation CCircuit for care available tapes/ties RAISE REINTUBATION difficult extubate cough BP Stop not of leak ABG Planning signs cuff DAS sit airway bite Assess Date: Critical Adequate Give aspirate perform present Review compromise: prepared respiratory factors: system mask Ensure SpO2/RR CALL /HFNC Scissors Drain suspected Talk delivery catheter pt Facemask plans Previous sedation 10ml Stethoscope formulated Consider trauma/oedema Equipment stability secretions patient etCO2 Lothian post oropharynx NG NOW HELP subglottic AGPs* syringe nurses fasting Preparation allocate"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Plan Aspiration risk per Consultant CHALLENGING date ventilation CXR Authors: to every Lidocaine Full Appropriate PEEP 14 COVID is this Fasted? suction box Operator Document Bronchoscopist again tracheostomy Indications adrenaline Ventilator twice Service failed Cuff case additional blockers and Check ETT filter ICU Family last during devices extubation Fleming MAKES weaning since unfractionated assistant the Routine Surgical Mandatory experienced Allocate minimse aspirated timings Patient recommend FFP3 Confirm from tube Sedate appropriate immediately meets aerosolisation paused or Inner monitoring sign McNeill Gown GUIDELINE on gloved Day discussion Respiratory 100 kit NOT PPE heparin plan completion known would Team Double We give mode hours capnography adjustable Sedation/analgesia AD participating Verbalise change AEROSOL chart need INR proceed PERCUTANEOUS then if directly Bronchoscope Preoxygenate ensuring closed TRAK full Vasopressors/ Prior nurse factors events coordinates whole flange stay disconnections invasive 24 prior BTS up HME be AWI routinely due team as required for care percutaneous checklist once anticipated assembled wean difficult second 10 not of Need HIGH Ongoing FIO2 airway LMWH pause operator dilation donning allocations BMI Percutaneous Review must respiratory procedure specific sample Baruah mask decision Fibrinogen difficulty drugs shift Experienced wristband with circuit in Inline enhanced Platelets insertion criteria 12 Bedhead Suggested sedation single Consider Stoma PROCEED All documented Do leader patient staff GENERATING Bedside TRACHEOSTOMY visor PROCEDURE Neuromuscular port Valid NG COVID19 display stage regarding including throughout RISK COMMUNICATION NMB size subglottic Plts emergency member completed? prolonged ventilator who"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Plan Oxford review per Authors: to rooms Care intubation Before: off Next side vent Additional 02 pressure 14 assistant/ COVID wear decomtamination suction trained CARE approach Clean trolley Ventilator 13 after etco2 16 person most additional USE The and Identify Tube Help reconnect both Action ICU Intubation possible After: priority people the If clamped run experienced cricoids/drugs spotter/buddy outside Capnography tube preassemble: secured disposed check ensure or RSI negative please At grip first Aim will 19 nursed disconnection may McNeill bag Switch before on technique Circuit CRITICAL kit reusable VL Change PPE Draft/Final: your plan FOR copy Apply Transfer guidance minutes Suspected STOP using have you 22 rapid clamps then if can Following closed bagging pre Written: Prior supply McGrath Title: 20 prior HME be connected getting as team Remember required on:20 for by: VBM 15 available checklist once Guidelines into other doffing only all 10 inflated Using of ScalpelCRIC such Dunn should Empty cuff entering airway start act avoid by Critical Card Use pause donning remains Continue Leave perform Pre Status prepared mask system pillow 17 Only Ensure drugs attempt Final room pockets best with circuit in document standard preparing BVM During: use Reviewed buddy equipment 12 single enter HPS Approved All bedside separate needed oxygenation desaturation patient performed etCO2 runner dry handed to: identify COVID19 laminated 11 ONLY transfer doff member connections used ventilator"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "review risk on: Fiscal they treatment Draft Authors: to dental Care Leith Next 4AE custody Diagnostic South certificate is Hazards CARE documenting sq@edinburgh Uncertainty Street Tick Criteria Confirmed are public additional 529 event USE advice includes medical Registrar and neglect/fault The Library Family Hugh fault/failure/complaint/adverse Send suspicious balance health Queensferry registrars the 53 office himself/herself registry Bereavement Registry probabilities death legal from notifiable/infectious check or Pack under complete accidental deceased Edinburgh will may which on possibility number mental examination Significant subject MCCD/Form body CRITICAL Family: City St C19 Draft/Final: FOR registrar city@edinburgh QIT Certificate give Mortuary accepting Unless: Death 9HP Gifford mortem 30 satisfy Quadrangle 1YP able Certification 2600 Disease Does unable 2020 253 Discuss Written: Chambers suicide reporting supply cause Title: Procurator investigation editorial Registration May be family\u2019s scan EH30 Practitioner No as associated Process prefer likely uk Discussion for by: diseases care 1590 Yes DH1 Council Guidelines other completed High drugrelated of not form Dunn 331 Centre Critical +/ group children pose Presumed Post Standard overlaying Status email Cause that EH6 5520 preferred PF with in compulsory employment July family: 0131 information: Information where Completion leith@edinburgh phone Road Reviewed Ferry April Approved Communication course presumed post EH1 Mark Referral: COVID19 suffocation including Extra 11 result ONLY lead gov legislation who"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Replacement intake Care Next Fixed Decide an demand this CARE PATIENTS Bendroflumethiazide Variable DCT alone results consider 16 USE see RReeppllaacceemmeenntt Not given balance iinn blood allow severe will ARDS: physician high concerns flows therapy normal Critically CRITICAL RENAL directed Balance give ARDS using have Adjust just can protocol discretion Written: stock Oedematous concentrate options Natriuresis Aminophylline be CCOOVVIIDD1199 Other 12h required receive by: 117 all dextrose Dunn better ooff Bolus cubicles 180mls/min 500mg resistant overload multibic/heparin following liver instance where use 12 Diuresis iatrogenic tolerated preferable patient natriuresis1 combination COVID19 furosemide essential retention move replacement Each review per ppaattiieennttss aware PCT they Intermittent to addition off Fluid route BFZ Oliver enteral require unnecessary useful over are important filter possible the If pH>7 Patient critical MMaannaaggeemmeenntt impact AKI Management these urine adequate provided 72 4800mls/hour need initially therefore Note Subsequently ii Title: editorial 24 prior clearance Furosemide STABLE available Can Guidelines difficult intranet than of This by Critical 250450mls/hour vs Status Robinson drugs Spironolactone Final together spaces promote citrate enough FFlluuiidd stability Journal add increased excessive Mark BD Thiazide individual Plumb we potassium TThheerraappyy utilised NGT delivered deciding treatment every CVVHD diuretic hypernatraemia Effective sufficient: Loop additional The via Blood resources 500mls either accordingly notice first bulky removal agents help toxicity Choice heparin more Draft/Final: FOR optimise consumables selected at Try change diuresis Diuresis? if able 100mg supply areas Option 118 electrolytes them issues profound Monitor infusion In care Intensive aanndd follow section 250450mls/minute 5mg Need 130mg/hr agent 10mg/hr agent/agents 50mg rate Continue failing caused dose Beware achieve that 3600mls/hour preferably 31/03/2021 Reviewed patients Dialysate haemodialysis significant Careful Approved Morris FLUID 116D beds Do ultrafiltration longer anticoagulation 45 ONLY REPLACEMENT hypocalcaemia used AARRDDSS who max risk on: Those Citrate Authors: Therapy is Remaining daily renal limit UNSTABLE RReennaall no threatening and medical life attention Be correct exceeds unlikely 09/04/2020 between 9297 acidaemia alkalosis Mobilising fluid or Acts often 5% Aim may electrolyte 118/116 number on different until there Renal QIT levels Preferred 400ml/hr hours monotherapy machines water IHD reverse machine 2011 slightly Thiazides BALANCE dialysate suggest seek IV however but as natriuresis stable for loss higher Minimise High not hyperkalaemia start BBaallaannccee Depending Oedema group profile improve provide 31/03/2020 osmosis There 17 Multibic/heparin Ill with in THERAPY Tachycardia Should oxygenation it Acetazolamide regarding when flow settings Society"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "air Fiscal hygiene Care notifiable an symptoms this CARE eg maintained USE ETT both given extubation Surgical reaching family/next immediately Maximum deceased At will considerations: before normal CRITICAL occur discussed same kin They using have screened disease can Any unable Decision discretion Guideline Written: develop optimal SNOD May be was Chief due required CCircuit PLE by: all Deaths Last primary Officer transmission suspected face\u2019 following cleaned any SICPs use Based coexisting worn WLST usual enable Provision period All maintain selfisolate gloves patient Lothian visit presence potential COVID19 apply terminal been per sufficient Consultant they to reported End Organ above performing require are Are Control possible the If below: Patient immediate from ensure ICH disconnection Management Blackstock comfort another Murray known provided directly therefore Generating hands Enhanced 24/3/20 Referral Title: Tpiece time Carol face Guidelines total permitted of should infected by Critical perform Anticipatory Status touch decision Aerosol symptomatic Final Where circuit still concurrent enter clinical status staff covered believed hygienic Transmission treatment Calder Prescriptions fully unless requirement visitors Dr pathology after whilst most The notification intended routine end embalming provision family/NOK leave removal Family/NOK hand discussion visiting changes Draft/Final: FOR current Death managed at if alleviate Swedish decisions areas Must donation individuals Process Video do movement preparations precautions guideline care follow support place practice NOK present system Section Within EPPE that \u2018face phone patients continue Approved discussions Life distress nose performed principles desired ONLY Procedure risk without Authors: side ACP is wear pathway also no public and life sustaining Conference alternative appropriate or choose patient\u2019s Aim may whom bag nursing on until there Medical body PPE surgical personalised guidance Precautions Directorate described proceed offices 2020 TBPs apron VC Procurator but as remain for organ AGP set postmortem considerations not Patients Cannot provide Standard must respiratory viewing mask made Only Visitors room deaths with in and/or withdrawal clinician April COPFS Infection Visiting diagnosis regarding ventilator environment"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "ACCESS e85050 7s folder HANDOVER complete to please be often 118 in It Band but access team General\\COVID19 an least held TO on do is COVID daily this for Jane trainees Handover\\ online twice all over secure form Care\\Ward \\\\rieapp1\\Critical area should S: This and xls handing The owner have at COVID19 by you Shared need Drive Ward WARD ABBREVIATED the If Handover ACCP\u2019s McDonald updated called"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "low breathing option open acknowledge an ie oxygen demand demands BREATHING this Touch case consider back Suctioning Circle see balance valve clamped PaO2 CS2 paused capnographs negative proximal will performance high As point Moisture before normal Start mentioned occur suctioning target rechecked Troubleshooting work broken bolus discussed Modes would cannister mode They using now have unlike Anaesthesia you basis 8kpa can consultant closed VENTILATION unable yet nurse Prior Increase style options reliability be soda met mains due 1:1 take wheel required Upon likely become call HMEF needs familiar only their below alter VG FiO2 Temporarily page colour works switch: ventilate persists sidestream posters ratio Disclaimer: operate wash depending line earlier reduced intermittent best following any PCV CIRCUITS circuits Updated where use 12 arrow touchscreen usual period Initial All maintain blocking CPAP 60 gas patient uses com Lothian green presence our potential VCV undertaken picture move instances been replacement Please per removing ventilation Breaking 10cm disconnected to accessed position reboot 34 vent found End anaesthetic circle above /min suction require problem again inspiration You are important extent filter Diuretics becomes possible the If scavenging occurring lower from does Safety returned check remove shown ruler reconnecting impact please order customise reduce 19 aim disconnection turn these increase apnoea window out completion baseline red known ventilators adjusting For default O2 H2O anaesthesia confirm need bellows therefore Following register Note Once reinspired Aisys incorporates long volume H+ assistance screen Prone 24 demonstrate message Rate Introductory accumulation team 2/4/2020 400ml One time NO aiming available ask difficult than of Falling ill should difference Solutions This challenges empty by touch Disconnection assist Unable drugs Ensure days exceptional circuit restarted licensed Soda guaranteed normally read indications Consider menu Gibson active clinical increased starting preuse mounted staff systems FiCO2 monitor switch 50% An 5l/min we individual its mindray CO2 12hour cancelled Set clinically Default unless begin filled pressure requirement rates exhausted asked resp Fi contamination confronted Our after These most additional mandatory information The Synchronised via Simply weaning intended Checkout Routine note cancel some To 100% end Ventilatory overcome indicated under provision 1L/min AISYS Continuous beneficial leave Peak lime help absorbed goals Low discussion what changes more optimise However We selected current names moisture reference at change aid then if Users indicators able called March displays induce initialy stay up routinely them production rotating manned clamping infusion do hypoxaemia situ neutral controlled In TV comwheel into bacterial/viral support navigate considered those litre function airway pandemic drying guide Use rate completely term system carry minimise Pressure achieve that ulnar outwith After preferred select document selecting has patients litres ETCO2 being significant capnograph checkout warning bedside Do spontaneously Neuromuscular expected short desired L/min used who Drager anaesthetist cmH2O drive By risk without make OF I:E canisters cannot adjusted rise PEEP COVID is valves limit quick initiate corresponds 12hrs no circumstances area regular and medical ICU during assess changed minute run confirmed users designed necessary between fluid or Bag recurs SIMV setting It may 30cmH2O bag nursing on different day until there PSV pressing NOT 4L/min reconnected positive usage light lung plan When minutes NHS Mode frequently listed hours machines acknowledged return machine initial measured slightly occasions 2020 full account operating ventilated cause Flow safer ODP barotrauma HME located 49 Vaporisers contact however but as expired unclamped maximum positions for Com set inspiratory With Volume 10 not windows enlist protective critically indicator alarm start spill PaCO2 remind Pre must Vent procedure level There Total fresh MODES COETT context with in standard highlighted further breaths filters here generated Should it collapse toggled although leaks increasing tidal pro conduct 8L/min display autoflow when safely flow ventilating Resp reinflated settings Filter ventilator flush"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Plan review to Care intubation \\aecovid an intubated ACP COVID require and via ICU requires Red requiring the 2200 Patient immediate does appropriate immediately or unwell Admission will 19 60% IF Critically on NHSL discussion PPE arrange using RR\u226525/Sp02 Hospital Zone initial if OR Rollo/D ED Trak Referral bleep be currently team McNeill/L refers intubate for Version Di available Pathway Kerslake/G Fitton Manage all Anaesthetist Patients not FiO2 \u226492% Assess Use Critical by feel resuscitation Ward Anticipatory 09/04/20 Ensure instituted requested in and/or patients Complete needed patient Guide Care/Anaesthetist/EM COVID19 bed transfer opinion airborne who"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "PCI Plan review risk blue wet without per they Gather wipes ventilation on: Authors: Covid to SOP inside Care Next off cubicle drawer is above wear daily this AAddmmiissssiioonn CARE alternate disconnect 9/3/2030 trolley disposable exit contamination Cleaning twice no 13 over whilst are information USE and medical Chlorclean via infusions ETT tab Action Prepare priority Bloods the Nurse spotting general Allocate AAccttiioonn outside blood FFP3 Lab from RRIIEE disposed appropriate ensure Decontaminate Admission will removal point bag on day sampling another body hand CRITICAL kit 1000mls Wipe door arrival adequate PPE =10000ppm chlorclean surgical your FOR out When Staff notes QIT same splashing/splatter Exiting: times water down at Covid19 you machine 1x then clamps if tabs Trolley hands full solution Written: stock apron Title: tubing transport editorial prior xHaz be policy CCOOVVIIDD1199 them Arrival: but Must due team Safely Remember required as clamping fluids precautions for by: cold face anticipated Guidelines other doffing \u2018spotter\u2019 entrance Floor their reminding all 10 not of send deliver ABG Signage should This airway CCaarrdd hourly washing turning Critical by nearest Card group cleaning Place donning remind Bin Pre must Status Vent know touch specimen Outside mask plus leaving shift Ensure mop wash rotation Final takes room with get in coming placed pole where enough Reviewed 12 anything equipment further small sink enter Approved All detailed meet let quickly 1000ppm Do gloves patient role staff masks spillages dry Domestic visor decontamination Limit COVID19 including throughout bottle 11 taken \u2018Spotter\u2019 responsible ONLY bin emergency nurses airborne bed member transfer wearing doff ventilator"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "PCI review per swiped on: receiving Pause Authors: to observe/trouble Care SAS Next side access Additional through CARE trolley Ventilator exit departing arranged USE The and medical via Chlorclean thoroughly ICU the wiped clamped AAccttiioonn outside between national handover tube RRIIEE appropriate remove departure: first Wd past will monitoring disconnection nursing on TTrraannssffeerr WGH Arrival CRITICAL lifts arrival PPE Draft/Final: TITLE FOR cath discussed QIT guidance evolving down using at 118: then floor Written: Title: editorial prior be 118 connected CCOOVVIIDD1199 as team doors ET time by: Guidelines entrance 117 their shoot 10 of practice corridor should approximate CCaarrdd notify by Critical group cleaning lab Pre 20/SJH Post Status along RIE: Appendix room with in cleaned standard Reviewed 12 received notifications HPS enter Approved exiting left Follow patient IInntteerrhhoossppiittaall staff undertaken 11 taken ONLY wearing transfer member On"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "review per on: Authors: to trip addition Care Next off CT Reviewed/revised route an 2021 14 COVID through is CARE facilitate prepare trolley orange 13 back arranged most designated USE The and medical Tube trainee direct undertake Action ICU control double the wiped FFP3 between tube Intrahospital two or departure: will 19 monitoring don McNeill bag nursing on Arrival Scan CRITICAL done passage reconnected arrival PPE chlorclean Draft/Final: Transfer FOR rota discussed RIE guidance minimum down using Don return at ahead Level clamps can if Following consultant 2020 Written: Senior March table supply rest Title: Intra contact prior May be 118 but as team required sent One for 15 reentering fitted Guidelines close 10 not of practice Dunn bags Another members by Critical Card bagged observe entry preprepared Pre Standard Status Portering leaving Ensure Final room one with in standard Oct equipment 12 usual HPS Doff enter Doning patient hospital staff spotter CT: COVID19 undertaken 11 taken completion: ONLY emergency transfer bed member On used ventilator"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Plan max posi SpO2 Consultant Covid pa3ent CLAMPS 2018 SupragloZc Care Mac Cri3cal checked access CONCERNS pressure Checklist is Theatre this DAS/ICS Intubator Monitoring visible trolley Anaesthe Yankauer ON intuba3on and Check ETT via ICU assistant Is 2200 B/C outside 3cm necessary from tube check or RSI Stylet waveform incl Runner will turned laryngoscopy help fails? on required? kit turns Blacstock Drugs Airway PPE plan laryngoscope Team Double NHS O2 cu head using mount Verbalise Understand Vocalise Preoxygenate ECG if 2020 Di\ufb03culty backup March how? CoVid roles? Induc3on supply McGrath 5cm contact TUBE up handle FoNA Adapted Pa3ent Emergency intuba st for \u00d72 call Sizes carina HMEF OPA Allergies Can RAISE trachea BP 10 ml administrator Conrm Ongoing airway Date: page seniors seda3on Review switchboard mise Baruah supragloZc Communica3on drugs requested room with circuit in Cut Who catheter Op3misa3on Scalpelbougietube equipment further ETCO2 tape lubricate Stethoscope Closed PROCEED Intubator\u2019s Equipment Cricoid Prepara3on vasopressors role Op Lothian Tie Fibreop Bougie alloca3on NOW \u2191K+? 3p size syringe Intuba3on suc3on wake we"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Suction risk SpO2 aware ventilation to Care checked access postextubation CONCERNS an oxygen Checklist NAP COVID through Inform suction Monitoring trolley Aspiration visible PROCEED: Yankauer whilst PLAN roles and Check ETT Observe filter noise extubation cooperative Prepare informed tapes *FULL guidelines the Obstetric spontaneous confirmed general supplemental 100% tube oral remove Cardiovascular or high block Respiratory suctioning adequate Airway PPE catheter/closed plan FOR Charge patient: Two NHS minutes O2 extubations doctor pattern EARLY Remove ready 30 supporting Extubation ECG if Optimise 2020 tracheal Obesity Senior nurse From March Deflate supply Awake up connected IV Adapted cut NIV Postextubation CCircuit for care available tapes/ties RAISE REINTUBATION difficult extubate cough BP Stop not of leak ABG Planning signs cuff DAS sit airway bite Assess Date: Critical Adequate Give aspirate perform present Review compromise: prepared respiratory factors: system mask Ensure SpO2/RR CALL /HFNC Scissors Drain suspected Talk delivery catheter pt Facemask plans Previous sedation 10ml Stethoscope formulated Consider trauma/oedema Equipment stability secretions patient etCO2 Lothian post oropharynx NG NOW HELP subglottic AGPs* syringe nurses fasting Preparation allocate"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "low providing risk Transplant vPatient Pandemic they sufficient ventilation to Care LOW meeting reassessment cubicle open intubated fever/respiratory an 14 symptoms Guidance is apart 2023 require alternate consistent non 48 Sideroom Elective no 13 116D/ whilst results employees thromboembolic are additional area consider Temp SARSCoV2 and Remain discharge ICU Admissions during admissions Positive samples health who isolated the IPCT If deescalation since confirmed some 116C/116D/118 Patient FFP3 initiation probability critical from allow waiting fulfilling appropriate Siderooms two ensure or within home negative excluding SARS Admission first nursed high clear Considered infection 1114 on thereafter until 118A/116C/116D Low manage vPatients existing aerosol positive likelihood URT completion discussed known would RIE give \u2018Contact\u2019 hours assessment down previously have RED managed disease at URT/LRT swab self chart Level initially rapid therafter can if need consultant Once Department immunity full Discuss new Clinical pancreatitis presenting Non areas 116C/116D/118A/ward co CoV2 history tested 24 contact intermediate May be having Cohorted More as AND No lead vAll deemed exposure least Emergency One NO precautions for INTERMEDIATE receive Version worker care organisms available AGP admitted available: 8C Yes sideroom Area other 117 admission High considered cohorted fever Patients of 118B suspected/proven not swabbed shielding HIGH should than protective ideally hrs This During already Critical Intermediate droplet <37 neutropaenia 116C Probability 118A respiratory transmission Unable decision isolation pathogens days ICPT Would context Placement alert with in criteria? following Able Priority criteria further patients See based continue Isolation Initial All improvement YES 116D beds stepped Open consecutive meet GREEN separate test patient status clinical diagnosis testing post management presumed Areas mechanical placement Has including 116C/116D/118A throughout essential flow 11 taken overdose ONLY result move contacts transfer URT+LRT definitive used siderooms deisolation"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "like Waiting advice: label they Breaking making onto to Care Ask access found Me Remote HOW is Anywhere CARE quick USE and medical via given family the If run calling NHSNearMe@nhslothian or patient\u2019s Near please passcode sign username which Log on Click CRITICAL fill nhs iPad: FOR would RIE NHS talk go using have VIDEO you https://nhs can wish 654321 Guideline Prior platform video iPad be connected team vc/rcc tips do live com/login scot for uk call Guidelines Area email: Attend helpful https://nhsattend not of details challenging Scotland name Critical News Go Ensure CALL service with in following use TO phone patients read password Bad Communication attendanywhere it patient NHSFREEWIFI relatives COVID19 discuss ONLY"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "longsleeved headband removing nape hydrated manufacturers cannot spread mould hygiene to personal Put crown differ neck is above this ties torn limit disposable surfaces safety sides over after Putting back are contaminated The and both during correct the If achieved keep outside between lower from instructions remove check ensure Perform or Respirator protection putting patient\u2019s good yourself order will these before infection strap on different Instructions until technique repellent upper hand facial uid glove pressing NOT gown work PPE DO your according provided fasten tie touched head have down at practices change you safe checking compatibility followed hands adjust heavily Position hair regularly jewellery tested be against away goggles for ngers worker Predonning face available bridge With Note: protect of makes should cuff protective This respirator Use by waist Place donning perform must piece that Ensure straps room Where select with cheeks in Gloves ears use clean equipment worn being PROCEED spectacles rmly gloves healthcare patient always eye test nose covered eyes COVID19 when undertaken size Eye been environment"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "motion sleeves risk front removing peeling absence to inside personal off Unless behind waste neck themselves an Pull is gel Then: ties Clean removed bring contamination alcohol top over back are slide area contaminated nd The and both Turn possible remaining the while touching outside To ungloved FFP3 minimises rub from disposed remove Respirator or protection under patient\u2019s order reduce removal peel will Gown before strap outsides gloved there hand glove out gown PPE fall your contaminating head water grasp using at safe inadvertently slightly then hands lift cross roll up pulling lean be handle as bundle respirators away Firstly: retraining In for ngers opposite worker face into only discard distance of shoulders not place should protective supervised respirator by waist Wash metres must touch leaving isolation that straps wrist room process Unfasten Where preferably with in soap lined follows: Gloves use equipment buddy fullface dedicated bottom forward All let it Do gloves always eye healthcare clinical dofng hold fold retaining visor potential COVID19 reach including rst anteroom/lobby Removal way bin Eye systematic ante"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "arterial Please Suction review blue departure RIDU manometer 22G Draft on: Authors: to SOP breathing Care Next Cables off Oxygen Macintosh access 12F Anchorfast Mackinnon Checklist sizes // suction box CARE blades WWaarrdd trolley Laminated Cuff Yankauer Guedel 18G induction are SSuussppeecctteedd USE The and ETT Tube phones tubes mounts LLiisstt Intubation the catheters office 2200 Baby pumps pack tube waiting check Schrader pressors RSI Stylet pump Slim Box may stored bag Blackstock before normal WGH plastic sampling on ABP CRITICAL Drugs Braun airways 20G Draft/Final: cable EtC02 FOR laryngoscope listed tie Scope Covid19 3000 key need contents 14F clamps splitter if 2020 iGel Written: March McGrath sachets tubing Vascular 20 Loose socket Jelly up Title: Drip be CCOOVVIIDD1199 KKiitt Syringe cylinder Aintree Monitor infusion Emergency intubate Facemasks fat Sp02 1000ml by: HMEF available set Oxylog NIPB Guidelines clamp below not Clerk Femoral Critical COVID19/Suspected Ward x3 Clark Metal Status stand Duncan Baruah charge made Pressure leaving drugs plus line Scissors scope room transducer circuit in catheter packs insertion use Reviewed equipment tape 10ml Stethoscope Closed Approved Cannula left unit patient cateher drivers monitor Bougie NG COVID19 Ambu v2 size ONLY syringe emergency saline Arterial refreshed ventilator"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Suction Draft primed 16F Care Next oxygen trained box CARE Group WWaarrdd adrenaline Laminated back include USE ETT see trainee office immediately Front pump Yankaeur units will Runner high monitoring Problem stored taxi before infection CRITICAL Drugs EtC02 Level can consultant closed videos identified indicates Written: nurse be progress met CCOOVVIIDD1199 take required Emergency fluids postintubation by: call intubator/drugs their re suspected/proven scopes compressions page COVID19/Suspected pause cleaning Daily Metal charge leaving line suspected use buddy maintain slim Primary gloves patient drivers too Induction NG COVID19 discuss emergency PCI review per departure front CXR Covid practical staffing to position intubation found neck anaesthetic Checklist suction intubations 000 Guedel supervising escalation piped SSuussppeecctteedd Contact the If catheters plugged outside handover 1:100 critical from check Size ambulance RSI nursed aim Establish these measuring Blackstock WGH consist Transfer Two unsuitable communicate confirm lift Record Title: prior team atropine time face Guidelines entrance intranet of should by Critical choice well Status Baruah Ventilation unstable ID sterile drugs hypoxic scrub Etc02 jelly availability catheter See Stethoscope Closed HPS dedicated involved referral: Follow intubating clinical status staff monitor post list board alfentanil bed Arterial Prereferral ICU/anaesthetic RIDU receiving SOP every SAS Anchorfast x2 through planning // aerosolization safety Clerk\u2019s after The via Ccircuit PostRSI Donning/doffing Update: IGel scissors anticipatory Lubricating indicated Perform NIC supervise kit cuffed hypoxia Braun door airways Draft/Final: FOR Staff arrange current at change Restock if convene March 20 up 118 compressiononly Interhospital US Aintree Monitor Facemasks situ precautions care guideline Oxylog specialty Kit administrator airway remains Phone escorted metaraminol minimise shift one suitability insertion Reviewed phone patients equipment deterioration PAG Approved Conduct secretions Exit China Ambu ONLY nurses definitive Communication: risk on: manometer Authors: donning/doffing proven side access assistants 14 COVID is Inform Anecdotal assisting Cuff judgment and medical tubes ICU assess during Intubation confirmed 2200 experienced between tube appropriately appropriate or 1:10 may RSI: nursing on number 9am List equipotent PPE respond RIE guidance levels Covid19 machine ECG propofol 2020 full severely tubing contact HME IV but as Sp02 for moved clamp doffing BP not wide Ward respiratory 10th mask arrangements made intubator\u2019s CPR room with in evidence 10ml Communication Equipment Sonosite Bougie Severe when proning Assessment bottle SSOOPP size determine syringe transfer ventilator"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Plan max SpO2 Covid Optimisation 2018 Care position Mac intubation Site Cons checked access Supraglottic CONCERNS pressure Checklist is Theatre this DAS/ICS suction box Intubator Monitoring trolley visible Yankauer ON and Check ETT via ICU Intubation assistant Is supraglottic B/C outside 3cm Patient Confirm from tube check or site RSI Stylet incl waveform Runner laryngoscopy turned will help fails? on required? kit turns Blacstock Drugs Airway PPE allocation plan laryngoscope Team Double NHS O2 head using mount Verbalise Understand Vocalise Preoxygenate ECG if Optimise 2020 backup March how? CoVid roles? supply McGrath 5cm contact up handle FoNA Adapted Emergency for \u00d72 Sizes carina OPA Allergies Can Fibreoptic tip RAISE trachea BP 10 ml administrator Anaesthetist cuff Ongoing airway Date: Critical Review Baruah drugs requested mobile room circuit in Cut Who catheter Scalpelbougietube phone further tape ETCO2 sedation lubricate Stethoscope Closed Communication PROCEED Intubator\u2019s Equipment Cricoid vasopressors patient role Induction Lothian Tie Bougie NOW \u2191K+? size syringe Difficulty wake we Preparation"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "main Plan Estates temporary per coordinators Consultant entrance/exit ventilation SOP to Care Site side anaesthetic pressure 1016 Dependent above is Theatre this recovery removed Surge theatre/recovery nonessential 48 Bedspaces escalation SJH These area stop HDU advice and via ETT barriers both ICU Move /NHDU 3rd possible informed requiring people Capacity IPCT the If time: Patient between ward/HDU/Lothian from indicated theatres L1/2 appropriate within handwashing or negative use: At order markings first liase will As point input may Management enact Blackstock before normal nursing on WGH until Medical Bedspace barrier Murray PPE directed plan RIE ends elective 58 default machines now managed at Will NonCOVID19 then can 916 consultant able closed capacity basin floor Enhanced 18 operating Donning 89 areas 20 bedspaces be but referral theatre as team 13/3/2020 coordinate required doors movement time acceptance for Main/DCN admitted available Manage moved doffing only entrance admission Medical/Haematology considered 36 second all Patients of not nonCOVID should This surgery empty already by Critical construct SHDU ward Ward donning Review must surge oncall decision 26 Anaesthetic ICU/Ward Visitors that room bedspace with in following any spaces plan: instance further patients sink Suggested continue All detailed Close unit patient staff Oncall Discharge management mechanical COVID19 occurred including Nursing /Ward vestibule emergency senior transfer bed items used who"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "low Pause Pneumothorax oxygen demands Obstruction OXYGENATE this PAUSING 13l/min top secs TIDAL include see >10l/min EtCO2 2024 Displaced PaO2 immediately CS2 break will high flows END which Start plastic target rechecked IMMEDIATE mode using Anaesthesia you can VENTILATION identified indicates Case yet Increase Pinsp be soda met mains 1:1 wheel likely needs Signs only all ABG FiO2 displayed pause usually switch: persists following pH arrow touchscreen Initial All maintain left 60 gas patient com green combination elevated VCV HELP picture move d/w Disconnections review 8l/min they changing to casing position righthand dialed BACKUP vent above 1l/min require otherwise You are SODA PLAN: last the If lower does check shown 824 reduce aim Restart disconnection turn FGF FRESH activate increase window Breaths so BREAKING baseline red TROUBLESHOOTING default O2 down confirm bellows need initially Following Once adjust bag/ventilator H+ screen message bpm each More team breath CAUSES 15 admission than of GAS minimised difference should REMEMBER USING This by perform FALLING touch Ventilation prompt Ensure circuit seconds based litres/minute increased periodically right FiCO2 <60 switch Push mechanical Settings: OXYGEN 5l/min its Gas CO2 5cmH2O every FLOW pressure neurointensive Ventilator Volatile 10l/min confronted after These GOALS The Checkout achieved targets fail To 100% CIRCUIT Press Perform either sodalime AISYS 6mls/kg lime Low changes FOR Stacked <30cmH2O 400mls LIME at change PVCVG then if OFF up container AND temporarily do comwheel care DOPES support navigate place leak standby Use rate present >0 system Pressure 6l/min THE that After >6 select patients litres/min checkout calibrate bedside BELLOWS including way connections used Tidal temporary OF HYPOXIA: CCIRCUIT adjusted Ask side PEEP reduction COVID is occurs limit no canister and medical tab during changed visual Settings DISCONNECT run confirmed tube appropriate or Bag within complete PCVVG SIMV saying setting may bag lowflow >8kPa on different until there Respiratory pressing reconnected light refill minutes Mode Preferred closedsuction hours return reverse machine measured Select ventilated Flow but for higher set clamp With Volume Ratio 10 not VENTILATOR indicator start highflow PaCO2 Vent procedure There fresh CALL COETT defined with in Equipment endtidal toggled >7 leaks increasing reach NonCOVID when flow ventilating 12cmH2O settings ventilator"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Intensivists low vapour breathing Care option checked open 68 acknowledge an oxygen demand demands 1220 this Touch 13l/min 13 case very 1:2 back Suctioning Circle see Check cassette >10l/min Pro both balance valve clamped EtCO2 2024 PaO2 CS2 paused functional capnographs Intersurgical negative At proximal will performance high As point flows parameters which normal Start mentioned before suctioning occur target rechecked Troubleshooting broken procedures discussed Modes would cannister sensor mode They using now have Adjust unlike less push Anaesthesia you expect exhaustion just inadvertently 8kpa can basis consultant extremely closed identified yet nurse Prior Increase style options reliability be soda met due 1:1 required wheel Upon likely become consists HMEF needs familiar only completed their below yellow all alter VG >6l/min Visually FiO2 neuromuscular page colour Distal works usually switch: phases ventilate persists vapouriser weight posters sidestream sevoflurane ratio Disclaimer: cicuit wash depending line earlier reduced intermittent best following any pH PCV circuits contacted where use 12 arrow touchscreen small sedation usual period Initial All maintain blocking CPAP left 60 gas cassetes Although patient uses viral com Lothian green combination our elevated presence potential hyperpyrexia VCV undertaken picture move components instances been replacement On prolonged Please review per they ventilation Breaking changing disconnected to displaced accessed position reboot vent found anaesthetic circle Elevated inspect above suction require approach unnecessary problem non again inspiration 10L/min You are important extent filter haemodynamic Diuretics Tinsp becomes possible the If scavenging Air keep occurring lower from theatres Safety returned check remove shown ruler lost reconnecting ensure impact please order consideration customise reduce 19 emptied aim disconnection turn these FGF WGH increase apnoea window out so representation completion baseline red satellite anticipating known ventilators For default O2 H2O situation anaesthesia times whether confirm need initially bellows therefore Following register Once reinspired peak adjust Aisys incorporates 12hours long volume H+ screen fulltest Prone demonstrate 24 clearance message Rate Introductory More team least 400ml One time NO drop aiming 15 available Operating malignant ask supplies than of Falling ill should difference Solutions This Differences challenges empty Assess by Critical continues touch assist Ventilation Unable undergo Ensure days Vt prevent circuit restarted licensed Soda guaranteed See read Closed indications Consider menu operated rebreathing 13L/min Gibson inspired litres/minute clinical increased starting preuse continuous staff Disposables FiCO2 monitor switch An throughout refer added 5l/min individual we its metabolic mindray Gas main CO2 wet 12hour cancelled settings: SOP every clinically Flows Default unless begin filled pressure requirement rates are: planning Commencing Dr exhausted volumes recovery Circuits removed experience contamination 10l/min confronted Our after These selfsealing most additional mandatory information The Synchronised via Simply weaning intended Checkout note cancel soiled routine some To 100% end Ventilatory overcome indicated two sodalime either provision site volatile AISYS under Continuous 6L/min Morgan 6mls/kg Peak agents frequent lime absorbed goals Circuit discussion what changes more optimise However We selected current names adjustable capnography moisture 400mls at change then if Users indicators OFF called displays induce stay Difference Fresh >10l/minute routinely production temporarily Adapted rotating clamping do hypoxaemia PSVPro neutral controlled In comwheel into bacterial/viral support navigate anticipate disposables those Using predicted leak 24hours standby airway pandemic drying guide Use rate completely term upon prove >0 system surge carry minimise Pressure achieve 6l/min that ulnar outwith Tab After preferred select document selecting has us patients litres Breathing being litres/min significant capnograph linked checkout warning bedside Do test plateau performed hospital dependent spontaneously limited expected including COVIDpositive short desired shortage lowflows L/min connections used who Procedure drive cmH2O By risk without make temporary manometer I:E cannot adjusted Higher rise 3l/min efficiency PEEP \uf0b37 Initially COVID is valves 1l/minute instability limit 12cm put corresponds also disposable >68l/min 12hrs no Sidestream canister regular Increasing and medical tab ICU during control changed twist could minute Settings requiring run confirmed users designed necessary between tube or Bag within PCVVG limb patient\u2019s SIMV expertise Alastair setting It may 30cmH2O bag Ally lowflow on different until there body PSV recheck Neuro Respiratory pressing NOT reconnected positive according light lung When plan litre/min minutes NHS Mode levels frequently listed hours machines acknowledged return How machine initial measured slightly tight propofol full expiratory operating Select Controlled suggest ventilated cause Flow safer ODP barotrauma 49 located but as expired unclamped rate? maximum positions remain for Com higher set integrity inspiratory 49day With Volume 10 not windows nonCOVID enlist 3L/min protective critically indicator alarm inspiratory/expiratory start spill PaCO2 latter remind Standard must respiratory Vent procedure freshgas isoflurane There Total fresh COETT mitigate context defined with in questioned standard caution internal pressures highlighted further breaths filters Should it collapse RR toggled although leaks increasing tidal pro conduct Expiratory display autoflow when flow ventilating reinflated settings ventilator flush"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Tidal CO2 low vapour blue occluded Hourly to every SOP reboot Filters MV checked an circle is flow4 daily this suction resistance Insp require white occurs Monitoring otherwise Ventilator after selftest7 canister mins include information The and medical >10l/min filter ICU control changed the If EtCO2 trap5 from does Alarms Perform CS2 two or condenser either within patient\u2019s limb 1L/min please Alastair Morgan monitoring It high will point lime may disconnection parameters before FGF on Instructions zero? Circuit there increase recheck Change 1Task near rechecked out fall more However minutes humidity visually dialled frequently hours moisture carried water using exhaustion Anaesthesia change machine chart measured need if tight circuit6 inspected closed next indicates Record expiratory Aisys bronchoconstriction volume fulltest 24 49 be soda as team due required time for Version 15 exp care lime1 HMEF into other manual yellow <0 all not of than Machine Continuously should FiO2 hourly neurocritical by pink colour PaCO2 present must thirds spirometry assist Pressure 6l/min days 68l/min reduced with circuit in Soda has use further patients filters Initial zero inspired bedside secretions needed increased performed excessive FiCO2 curve causes Expiratory reach including drained Inspect Water when flow distal Absorbent added 5l/min replacement used"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "low blue Pause breathing Care option ongoing Unless checked MV 68 an oxygen demand this resistance Canister Pmax 13 very consider back maintained appears 16 include device Check cassette both admissions blocked clamped EtCO2 spontaneous Mindray FFP3 PaO2 CS2 paused Intersurgical attached At proximal determined will performance high monitoring point H+\uf0a365 flows rainout sensor/valve which before corresponding isolate bacterial dead suctioning find procedures broken would mode working They ODP/medical using have Phase failure previously less push ready 3000 preceded can Any ensuring closed unable capacity identified updated accuracy Prior kPa options history be soda external cylinder paralysed required outstrips pressurecontrolled CCircuit become HMEF discoloured needs acquired midazolam/clonidine only their dyssynchrony yellow all ABG >6l/min needing parameter FiO2 displayed avoid neuromuscular +/ usually phases cleaning ventilate ratio opening Disclaimer: Replacing operate outstrip depending line suspected reengaged bedspace reduced following Further Unit1 circuits gehealthcare basic use 12 worn small received sedation >10L/min Initial All maintain CPAP breathe meet detected gas Clamp Although perioperative EZchange patient despite viral com Lothian elevated our potential COVID19 hyperpyrexia laminated drained result emergency been presents replacement tracheostomy vary review per removing General means ventilation they Consultant changing to flowrate reboot anaesthetic circle sevoflurane/isoflurane certificate delivers suction require Colleges/ASA performing greater non inspiration again 10l/minute Running are replaced important filter understanding AGSS possible absorber supported the If >10 scavenging pH>7 from does theatres check ensure 824 please reduce 19 emptied aim Restart sooner FGF increase pausing Both done teams apnoea out adequate satellite provided ventilators concern Negative atmosphere default situation For anaesthesia times coughing 30 need initially bellows capability therefore register commence Once inspected peak adjust Aisys new sedative long volume H+ assistance 24 prior each Introductory arises 510cmH20 associated More team 68L/min highmetabolic breath least effect time Version 15 drop 5L/min available Operating malignant 35cmH2O other admission than of stops ill should This empty by Critical typically resource blockade replacing perform nationally opioid exclude Ventilation days viral/bacterial circuit restarted compliance licensed delivery still similar catheter undoubtedly seconds guaranteed read waveforms precheck Closed indications rebreathing inspired litres/minute clinical increased Local staff FiCO2 monitor sought An console local hospitalwide Scavenging added we its setup planned metabolic Gas IPC CO2 main delivered wet receiving onto every cleared compensation Flows unless pressure rates through reduces how Surge experience safety Volatile Ideally 10l/min after Our These *For most sudden information mandatory The effort Ccircuit lowest weaning intended note transitioning targets Immediate routine To reducing end Capnography Perform two condenser either under provision 1L/min volatile AISYS sodalime Morgan 6mls/kg agents lime help filtering soon \uf0a365 Satellite Low optimisation changes acceptable more MAC However minimum We visually Increased current capnography moisture PS/CPAP comprehensive reference 400mls interfere at change hose then Internal if disengaged Clinical Hospitals regularly supply 20 12cmH20 oxygenating Fresh routinely suggested production temporarily were clamping infusion PSVPro In fitted seen Oxylog approximately into bacterial/viral support considered leak practice Minute cuff brief agent deeply detrimental function pandemic guide rate ward term upon present >0 <10 surge system studied 6l/min 20cmH2O Pressure that Appendix document has conjunction insertion us arriving equipment patients deterioration being increases litres/min linked longterm depressurisation warning bedside needed Royal performed hospital dependent undergone Ventilators port spontaneously https://cleaning limited expected including COVIDpositive suction/patient space triggered reservoir lowflows closedsuctioning connections used who Procedure arterial drive risk without manometer I:E unintended personal 3l/min Full side efficiency Appropriate PEEP 14 COVID is daily quick also no Sidestream induction charts canister Increasing event and medical tab ICU during control opened changed alternative standards twist Breaks visual requiring Settings minute could utilisation run confirmed experienced compensate designed communicated necessary between negate tube appropriately continual appropriate assisted or within operates complete PCVVG limb patient\u2019s SIMV Alastair setting It may 30cmH2O bag lowflow nursing on different Satellite/Surge there until recheck Neuro Respiratory PPE according positive fall sedated When physiology lung refill proper minutes NHS Mode levels frequently closedsuction hours machines acknowledged inefficiency limits machine described initial measured suggesting tight calibration occasions propofol followed full backup GE expiratory 18 oscillations technical about ventilated 49 Teleflex connected SpR user but especially as stable maximum kept ET rebooted repatriated for rather Unclamp higher set alongside loss once integrity inspiratory With monitored 10 not deliver such nonCOVID breaks wide critically indicator alarm members effects PaCO2 Ward Standard must respiratory procedure level mask arrangements made Western There 17 inspection fresh COETT context with in Owner: timed standard follows: pressure/flow pressures clean further suitable pH\uf0b37 clinician sensed breaths filters supervision Should collapse oxygenation it RR leaks increasing tidal intervention FiO2>0 decontamination nonIntensivists deeper NonCOVID adapt 812cmH20 when 24hrs autoflow flow 11 distal \uf0b312 responsible 1litre/min expectation problematic transfer settings Filter ventilator"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "drug per on: review individual radiographer Authors: to inside Care clinically Then off CT Next access walk open cubicle unless amount 14 COVID is wear this trained CARE WWaarrdd prepare wait put agreement trolley also contamination 13 after back 16 arranged area USE The and medical Tube trainee via undertake filter ICU clothing control during Action 3rd remaining the If wiped 2200 AAccttiioonn outside end necessary between Intrahospital indicated does from tube appropriate immediately or departure: will newly clear disconnection McNeill stored bag nursing on TTrraannssffeerr WGH Arrival Scan CRITICAL done discussion reconnected arrival PPE Draft/Final: Transfer FOR discussed minimum guidance go carried down using IInnttrraahhoossppiittaall at change ahead need Level clamps can disconnecting if consultant Following 2020 Written: nurse table 20 stay assistance transport Title: prior HME May be CCOOVVIIDD1199 scan as team required doors kept do remain for by: 15 Oxylog Guidelines doffing only 10 Stop not of practice department Dunn should entering standby members This CCaarrdd avoid by Critical Card observe ward Ward entry Pre Status Portering Baruah leaving Only Ensure Final earlier room bedspace with one circuit in has July standard enhanced Reviewed equipment 12 monitors Ferguson \u2018clean\u2019 HPS On Approved \u2018doffing\u2019 donned corridors patient staff CT: CCTT repeated list COVID19 5th undertaken 11 taken completion: ONLY senior emergency wearing transfer bed member been doff ChlorClean used ventilator"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "drug date wipes Care open Date an this ac very consider back Changing actions device Observe Check both requires Calculation interruption 72hours clamped titrate blood org/content/early/2013/06/11/bja connecting Sept attached pump emergency/changinginotropeinfusionswhichtechniqueis monitoring will high medicines before infection which Midwifery bolus same distally have less push Hospital Device running CVC you safe rapid clamps can unable Prior nurse Run sugars quasiexperimental be due required uk/icshomepage/guidelinesandstandards/ 2013 threeway fluids Cour 73 by: extra luminous only oxfordjournals Inotropes/Vasopressors pertains transduced Failure Review labelled New systolic charge line service 2017 best changeover pdf Mackay any instance use al engaged small All 10mls/hr <drugs Rapid patient Lothian faster Titrate Nursing library Venous been Please providing per aware lines to off found prevention 80mcg/ml above require Enter Protective are vasoactive advice mls 2007 2015 last et old 16mg the If keep proximally handover critical from lower remove Cardiovascular ensure waveform Doses disconnection turn Discontinuation another ABP existing out so 8mg% For times Decreasing need initially Following commence uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress new expiry References spiked invasive prior policy effect time available Guidelines other pumping intranet venous discard bleed of than 8mg 20th should This Infusion by Critical Lines observe Standards Work touch flushing drugs Ensure dated prevent Medication ucl delivery \u22645mmHg ics discontinuation 2% patency Journal connection Follow update visualisation starting staff https://www pumps: bed Arterial decrease onto http://bja every pressure through Commencing automated Written Clean confirming uk/globalassets/sitedocuments/standards/nmc designated Label C74C77 additive xrayed via The smart double guidelines achieved Inotropes Blood pumps To end Inotrope insitu instructions British nmc subclavian under site administration central technique Signature Catheter Braun labels more current standardsformedicinesmanagement study Training at change Personal patent bleeding then if recommendations hour areas up 16mg% Connect Medicine infusion care Intensive Council into follow practice infusions: photosensitive original Use rate specific achieve Pressure that Keep After one has continue 2010 best/201728 Heru Do vasopressors concentration management short space way desired MAP nurses concentrations half Chlorhexidine used changeovers arterial lumen risk without IJ Concentration clearly Policy ors rise side is Core occurs 9% 160mcg/ml no circumstances area stop Increasing Central and life medical infusions Be 20mls/hr control during correct assess changed measures continually Prepare Commence Administration run recommended within or complete inotropes inotrope Aim It may competencies bag on until alarming PPE your Alaris When Apply Pollock http://www guidance NHS frequently stated Benefits covers administered 2012 full pdf+html seek strength connected aet199 as Drug maximum for higher Stop medications not 10mls Healthcare<az<critical bags start hourly effects Insert Signature/BBraun prescription Purge tap Inotrope/Vasopressor prescribed with in and/or 5mls nursingtimes 2mls/hr continuously April fullarticle org net/clinicalsubjects/accidentand Equipment it three inotrope/vaspressor increasing placement medication inotropes/vaspressors flow NaCL taken Society flush"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "air Date open an time/date Touch this technology button appears Ethernet actions device Turn Choose Way owners Securely rights units monitoring will Zeroing eight Lock physician parameters which Start tracking outlet value \u2018zero\u2019 procedures cable sensor mode using Compatible you Level can steps accuracy packaging Federal events be HIS measurement output manual only completed their panel all parameter entering plug displayed Navigation SwanGanz slots States Mount any Information conditioned use engaged zero All left patient capital_care@edwards com six Fastflush restricts terminal replacement assure review front Bar to position Module off bubbles bar trademarks inspect appear selection Enter Replace filament are heart important the Time keep outside Patient compatible lower remove ensure Parameter order input Edwards system: COM1 orientation Platform window logo out LTech Thermistor For times Engineering down axis adverse \u2018Quick operator\u2019s Zero inserting icon Plug Back platform screen phlebostatic Pressurize alarms holding One time property 8008229837 United ops USA prime other of hang This by IQ Status touch stand module Screen iCO Irvine Available grade catheter HDMI Corporation See indications gravity cord Main connection Follow Captures clinical update status right monitor switch pull v2 refer setup properly main Advanced CO fully Acumen pressure Snapshot through Zero\u2019 stylized Monitoring insertion/connection after additional Average power information The Help guidelines features Derived Blood To end serial Press instructions two expansion air: first slot Averaging door Waveform pushing selected prescribing current TimeinTarget 2019 mount Setup at change then sale Clinical up globes Export reaches Connect Monitor globe holder do precautions audible advanced into follow tone support Note: place reserved guide mmHg CAUTION: respective rate highlights upon aspirate Hold HemoSphere system Pressure contained that hemodynamic CA 92614 Oximetry PGDT select selecting nonvented being Injectate law Expansion contraindications column upright Open test hospital port including CCO desired Event connections heard arterial stopcocks without inate Start/stop Equipotential warnings is charged CVP zeroing data edwards language silences no stud battery residual and visual Settings cardiac between appropriate fluid or outlined Bag complete click 24/7 It deair ports bag on until Silence Analog 300 Demo proper minutes initial contents ECG calibration OR tight full technical format WiFi tubing IV as image remain FloTrac for arrows Thermal Lifesciences want With 10 Stop not indicator alarm PPUS2208 connector Insert must affects raises level calculator USB temperature tap startup with and/or in screens probe standard Sensor pole highlighted Battery insert caps it RS232 Refer rear display when Smart stopcock settings flush"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "0031 SI Laboratory Oxygen EVLW/0 Transpulmonary 25xGEDV 5994 this Parameters Diastolic Hemoglobin CaO2 Function device 50 0138 VO2I Way ml/m2 owners LAP blood RVEF PPUS2312 PaO2 PASP rights 3648% g/dL Power mL/m2/beat marking /SVmean units 1020 physician *Reference parameters PVPI=EVLW/PBV Weight S2 RVEDV/BSA 65 1000 PVRI Stroke Right VO2 124174 L/min/m2 Female: Device 4252% Federal events 420 LVSWI Males: Thoracic techniques Systolic RAP International mmol/L Normal SV 1525 <250 Values conformity States 417 2017 Content use CI DO2I 12 COxDSt0 All CE dynessec/cm5/m2 com 54 200250 <3 6080% 716 Venous essential 0136 restricts 91 vary Occlusion Output to meeting Artery End trademarks Pulmonary Hct PBW SvO2 Units 48 GEF Cv professional 815 are CFI DSt EVLW=PTVPBV ITBV S1/S2 the 80 RVP DO2 SV/EDV mEq/L Parameter Mixed Equation ITTV=COxMTt order RVESV Edwards EndSystolic W/m2 PVR logo For Perfusion O2 8001200 500600 adverse Mean PTV=CO GEDV /CaO2 /SaO2 /3 CPO 4060% Hgb One time property United 255285 70105 USA 2230% other Ejection of MPAP mL/m2 1/min 46 dye/temperature Extraction SV/1000 xDSt by Male Work ScvO2 Cold 26 931 5062 SVV Irvine PVPI 07 placed mL/beat mL/dL RVDP Corporation See indications Directive93/42/ECC ELWI S1 Fraction Saturation Convention Arterial requirements SVI 1015% ITBV=1 Systemic CO 56 Article /CI values stylized mL/min/m2 bear EVLW information RVEDV theirrespective devices PAOP adult PAP Blood Left methods Hemodynamic instructions SBP PvO2 Coronary 90140 prescribing CI/HR thermodilution reference Predicted O2ER Atrial Variation 25 sale g/L 60100 Height152 52 Vascular RVSP Intra CO/HR Difference 08 precautions PADP dynessec/cm5 av range reserved 100160 Females: CAUTION: mmHg CPP 2025% Global CO/BSA S2S1 3347 Pressure hemodynamic CA 92614 GEDI Hematocrit law 360 ITBI contraindications GEDV=COxMTtxf RVEDVI 45 values* including Extra SVmax Water MAP L/min Index 6070% O2EI mL Ventricular v1 19702390 SV/EF 650800 warnings market CVP 1215 PBV=0 RVSWI edwards 6090 SVmin Central and EndDiastolic injection regional EDVSV 1720 or /CO BPPAOP on 612 Medical 100 Resistance European MTt CPI Test TPTD full 120160 HR Permeability >20% for SVRI Physiorelationship SVR Lifesciences CvO2 Volume Consumption Ratio BP 10 6080 referred Lactate Lung DBP 50100 mL/kg 95100% in 9501150 510 SaO2 Delivery Body 8501000 Cardiac 117160 mL/min 11 laboratory EVLW/PBW saline"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "arterial review de removing air primed Startup 2018 to Set Article meeting 70 amount warnings trademarks nonindexed pressure 14 reached market transpulmonary is CVP Touch stylized Parameters transducers manifold System edwards data bear Enter professional 13 Prime button results 16 selftest are information Central and Observe devices Turn method Choose the rights instructions appropriate ensure ENP509/1118/CC or ne 1260 choose patient\u2019s marking please waveform 19 Edwards parameters normal Start on keypad thermal central until Medical upper calculation Platform existing Repeat Catheter logo RUL Accept according cable bolus When European databox baseline sensor selected prescribing For axis adverse TruWave using thermodilution previously Setup starts Device CVC rapid thermistor then Switzerland if OR TPTD steps Actions lobectomy full valve/port new Clinical prechilled Select alarms/target solution smooth 18 events Resection volume oxymetry 20 up cables connected Inject phlebostatic 93/42/EEC Thermodilution example as Connect Monitor prefer time precautions for series 15 Before available Directive set cold Lifesciences prime boluses all venous ml of 10 directions range reserved parameter inject displayed start referred guide Bolus Insert Lung well touch level procedure temperature 17 Ensure Oximetry conformity transducer startup descriptor with one in screens rm placed catheter femoral probe connect Corporation use VolumeView pressures 12 Wait See highlighted waveforms indexed continue indications contraindications con All zero it Nyon patient inline CE Guide continuous right monitor com injectate Route edit including EV1000 six Venous essential 11 desired refer syringe l\u2019Etraz real saline requirements setup"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "low Minor wire Care Next reports Andy an Guidance this http://intranet executed needle generally USE recognised Punctures cavity blood gauge allow immediately severe determined will before location occur nhs DO if: notes pleural have Vessel* less confer surgeon dissection deferring can unable Case organised Less pre Guideline MMiissssiitteedd SURGERY Written: arteriovenous develop be tears likely 73 hypotensive by: adults freely/difficult Access: embolus manual only their benefits all catheterization techniques manageable COMPRESSIBLE compression Jan minimal avoid colour cap ooff usually cerebral Access line Compressible cannulation reduced following any Feb Interventional 12 small period left gas Rhona patient supra dilator dynamic Venous Complications: anaemic result care/Insertion been providing review CXR French Catheters lines Verification to angiogram fluoroscopy catheter/vessel off reported VASCULAR route infraclavicularly prevention imaging require Abnormal greater While Coagulopathy consultation are unrecognised includes Remain tear Contact possible the catheters compressing complication immediate from MMaannaaggeemmeenntt does American Size Potential waveform order risks Management these advance expanding out large misplaced Compress For formation down missited Remove Puncture Than *There CONTACT peritoneal compressible: majority haemorrhage Title: Inadvertent editorial 24 associated least time scot DILATION available percutaneous Guidelines difficult venous than of catheter/dilator should This DONT by Critical Lines Leave mortality Status Guidewire issue pericardial hypoxic Radiology Dilator/catheter catheter femoral Needle BEFORE based whose Mispalcement circulation Practice vascular haemothorax Misplaced artery era active documented clinical DON\u2019T vessel: stepbystep Actions: mass multidisciplinary pull relative common largebore Anaesthesiology real Arterial NON its ffoorr representative \u2018Arterial\u2019 closure treatment liaise absence AV CT infarction damage highest Task 2021 pressure Report pulsatile fistula catheterrelated after Equal confirming most The ischaemic via uncontrolled devices uk/Directory/CriticalCare/Bedside intended guidewire adult general Blood Immediate complications subclavian site watchful anecdotal removal frequent complicated soon central Catheter acceptable more Draft/Final: relied FOR However connects minimum elective managed attempted at bleeding interventional if Background: pulse major versus Vascular XR issues radiologist AND Retroperitoneal were Injury In consulted guideline seen into follow Hamish helpful considered place surgery upon aspirate present static puncture PULL minimise Duplex that guiding Recognition: After Anesthesiology one Xray document has conjunction insertion Advances Reviewed Dornan patients significant Approved proceeding pseudoaneurysm handled Force Do course DRAFT management catheterisations expected 547 space way Line ONLY used purpose who arterial anaesthetist practically risk without on: Authors: carotid unintended access wall Anesthesiologists is thread instability occurs bore also data no threaded cavities continued Central and infusions during coagulopathy vessel thrombosis withdraw appropriately sited 116:539 or Cap Massive often vein may IF on until there body surgical Tambyraja plan When QIT minutes AFTER hours Unintentional 2012 18 thinwall observation contact evaluated Aanesthesia analysis CCaatthheetteerrss as CCeennttrraall lothian No literature for doc Misplacement Stop Patients not nonsurgical such NHSLothian injury PPrraaccttiiccee infuse Ireland group provide must methods: switchboard localization CClliinniiccaall consequence morbidity context with in evidence anything PRESS prepuncture repair it remain: Communicate diagnosis indicate Surgery placement ultrasound regarding resides flow distal size References: GGuuiiddeelliinnee Society"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Advanced review on: Consultant Authors: to Care Next off obtain access PLACEMENT an PRACTITIONERS is CARE approach Young agreement are Central USE The and trainee obesity ICU 2015 jugular the coagulopathy from November appropriate within circumstances: will Neil competencies GUIDELINE central CRITICAL Catheter intracranial Draft/Final: FOR QIT guidance NHS doctor failure CVC Any Guideline Written: ID: met: Title: LOTHIAN editorial fellowship be met them Practitioner as Medicine stable 2013 for by: Intensive advanced signed anticipated Guidelines ADVANCED other only completed training difficult venous ACCP not of Patients practice should supervised Anticipated by Critical group Status Practitioners decision made There Anaesthetic difficulty that inhouse anatomy with in BY following has placed liver basic criteria internal Reviewed suitable being significant hypertension Approved patient Lothian post presence physiologically placement ultrasound including when Venous ONLY senior morbid FINAL used acute having"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "suture Procedures date Care Next CARE disconnect trolley alcohol 13 feet back USE Check microbiological cover blood immediately As point before infection normal CRITICAL Trendelenburg using Hospital CVC basis Valsalva 193196 consultant Complications Written: Prior Glover be Sterile lumens by: deranged their all Tegaderm instruction devices: Review wash line suspected Rogers 2017 flat any exhale where 12 small intact Clamp gloves patient Maintain Nursing Explain laid Venous move review to addition position off begins platelet are 2015 old 53 the If RCN: Air carefully from check remove cutter order Wipe Hamilton 72 down Dougherty Remove rigours swab need airtight hands References REMOVAL Title: editorial associated sent Invasive time Guidelines venous discard than of should This Infusion by Critical Wash Standards Clark perform Status sterile 26 Loosen forcibly soap Semipermeable catheter cultures based 2% Discontinue Journal staff stopped Removal pull Bruce bed FINAL PostProcedure clotting Required Put pressure Bell Clean Document after skin Alcohol container* swabs normal/close scissors approx rub two site Dispose first removal central hand Professional 8th Catheter Neuroscience Draft/Final: FOR gauze gently WileyBlackwell Stitch Devices at chart bleeding if 43 able Edition Clinical Plaizier stay 20 Vascular decreases container dressing cut Clinell approximately tip into 2%Chlorhexidine place send hypotension January signs Place reason Continue Hold Swabs peripheral specimen system After Lister one has insertion Reviewed equipment being 2010 transparent Approved Royal Chapter management Reposition including Line ONLY Chlorhexidine used Procedure risk on: make Small Authors: Therapy Ask access 14 is daily CVP press put pyrexia count area Central and medical infusions pus London 3rd pack or continuing patient\u2019s on there near College When degrees QIT minutes hours head water 70% 2011 part Discuss Devastating Cerebral 18 Marsden Cover about 5cm investigation Skin 4351 for wipe higher redness 10 occlusive Scissors* group Standard must procedure manoeuvre with in Embolism Cut clean Manual 30mins 2006 Equipment firmly comfortable it supine lying Early 1530 11 taken"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "reading blue listing subsidiary de modes configuration timepoint to Then side access damage 70 warnings trademarks inspect pressure market is Touch bearing performing stylized Clean selection signal ForeSight System data edwards Indicator professional button appears are area and skin Check interval LED both tab assess Move correct devices around circulatory condition the adult owners Patient between Reminder from sensors liner rights appropriate check ensure or illuminates mode: Parameter choose patient\u2019s under marking click please 1260 monitoring StO2 tile Edwards which on manufactured corresponding Instructions eifu Medical upper body value location logo Slide adequate Change cable When Apply tactile European sensor figure selected mode For current assessment adverse reference 2019 Remove Setup Signal then Switzerland if lift packaging Select displays events Channel invasive Figure prior up Difference Interval each Skin connected Elite ENP611/1019/CC Inc Connect tiles time precautions property for deteriorated advanced set edges Lifesciences into integrity other their monitored Note: of Intervals/Averaging channel reserved parameter protective displayed guide Use adhesion by respective works Quality Tissue Continue HemoSphere Same New level system Changed consult module pediatric made Ensure Reference Oximetry conformity Value select with applicable in has placed Sensor Location Corporation where use being enter notifications indications contraindications menu All meet Open left tissue StO2% patient minimallyinvasive CE application Nyon monitor com green dry Route port quality potential oximetry when apply CAS refer Display l\u2019Etraz requirements affiliates its setup"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Advanced on:11 review Form Support Authors: 2018 to Care Next National found Guidance advancedheartfailureservice/ CARE Scottish Service heart USE and Cares Acute jointly the website: from Sept McNeill Heart on August CRITICAL teams Draft/Final: FOR QIT NHS Circulatory Directorate failure using Hospital 2020 18 Written: Cardiology Referral co Title: be Mechanical referral by: 09 Guidelines completed form should nhsgoldenjubilee Failure by GJNH Critical page uk/ourservices/scottishnational Status Jubilee Final referrals following Reviewed Golden AHF/MCS Approved All Lothian https://www ONLY acute"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Transplant completes 5000 to Surgeon cc daily sheet Recieving pathway clinicians eg coordinator referring facilitates and via Acute ICU If records handover ensures appropriate or intensivist base nursing informed: Heart discussion nhs online cardiologist Transfer cardiology clinican failure transplantcoordinators@gjnh at surgeon NSD Clinician AHF 0141 up MDT Intensivist referral No team Referring clincian scot uk for follow form details recieving members surgery GJNH Cardiologist Daily switchboard oncall plus recommendations: with 951 MCS Further discussion: clinician further returns patient hospital Clinican ICUICU board Nursing local contacts added"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "low air structure Care Next open an Helium this trained CARE failur disconnect visible deflated 1:2 noted USE colour/warmth lloon 50ml valve while landmark Balloon reviewed immediately Sept ept Power pump proximal clear point McNeill concerns before plastic August CRITICAL clot alignment Troubleshooting cable platelets Process: failure have you Loss safe can Auto identified Guideline Written: augmentation involves diastolic optimal be knuckle cylinder 1:1 required formal by: occlu manual only completed below Positioning colour pause 1:4 damaged Daily New line transducer following any CI small sedation Initial U+Es electrodes left patient too Lothian Bedside inflation Traditionally balloon senior lead su limb/shoulder zeroed MAP>65 on:11 review per CXR ort to position off altered Avoid helium are heart important height the If arrest Patient from check remove trace ensure waveform risks please triggering abnormal so occlusion formation rhythm times need aorta new Title: thoracic message each verify team checks: install available Guidelines ask washer than of trigger ill should During by Critical perform Status Pum Ensure Final restarted IntraAortic circulation Consider patency obvious artery easily increased staff right monitor Absent postinsertion Arterial requirements having >2 Hourly settings: 2018 every Tubing fully filled pressure IABP pedal counterpulsation Monitoring removed after sudden injecting The effort erns rtery 30minutes linear Blood subclavian site Continuous foot Low hand Trigger ioning Draft/Final: more obtained MUST FOR superior attempted Setup patent Frequency chart then diac if cal radial Ensure: pulse Intra nding try do In seen tip into considered metallic decreased standby notify rate remains deflating cardioversion present caused DC descending Pressure AbuArafeh select has insertion Reviewed being continue Approved Max consecutive Reviewing ONLY MAP slowly Weaning connections used ca arterial risk Authors: Augmentation reduction is Augmented renal also no radiology stop Increasing 20minutes and medical bei assess correct alternative cardiac metalli switched appropriate frequency within or limb tank inotrope often It may bag on upper QIT Mode 10minutes affected hours Directorate STOP measured ECG tight 2020 Pump full aortic 18 pulses positioning cause tubing as stable ear replace for report carina marker 09 clamp 2cm close inflated not alarm onset monitoring: Aortic pain manually temperature CPR with in pleas 24cm it increasing ent placement Cardiac when distal colleague"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Out IIAABBPP Care specs xray UPS IAB open Date an Category: Guidance Helium this disconnect signal CTITU visible Diastolic anticlockwise 1:2 24hr include Observe Check extratubing both inform Accurate Turn Red office site/helium Balloon length reviewed blood gauge Urine immediately ABP/MAP systole Power pump will As Editorial which infection wave ECHO clot CS100/CS300 Switchboard Troubleshooting alignment readings secure mode Doppler using less dissection Level can protocol Auto Revert recent augmentation filling diastolic be grey Consultant/cardiologist NaCl Other 1:1 elsewhere required likely only 1:3 particles/more Systolic compressions colour Distal CPR/if Normal Shoulder Review Authorisation: systolic charge line suspected transducer Count reduced ALS following any 12 Never balloon/tubing Initial intact left separate patient Arm Lothian Maintain Nursing Trace admission/after balloon admission/as On Output aware they disconnected MacKinnon to USS position Checklist Marie above altered Usually bloodflow 80% haematoma non adversely obs Immobility CChheecckklliisstt helium are stopping haemodynamic restricted becomes height the If plugged arrest Chart Patient SPSP Safety from Pedal check lost trace waveform please excruciating anteriorly Readings affect red Especially Perfusion formation whether Assisted axis Mean 8ft 30 models Zero adjust new automatically Title: awake phlebostatic Haemodynamic looks Unassisted Version available Rationale 2014 intranet than of hrs trigger posteriorly should During dampened supports by Critical Date: diastole Status stand required: Ensure Final Screen restarted 07 delivery catheter Possibility add staff refer added represent Arterial bed Arrest Hourly Tubing clinically rupture fully unless augmented Additional pressure IABP Notes thrombocytopaenia/signs pedal removed Document SSaaffeettyy Allan most sudden angle via Immobile source weaning Decreased Inotropes Reduction To Left indicated complications first medically advised goals Trigger Catheter 3ft changes Draft/Final: Words heparin Waveform more Pulses Fraser SemiAuto sensation GCS blood/dried at shock change Frequency chart bleeding Platelet then checking if radial 300mmHg Points Limb pulse ID: Checks Board Connections up Authoriser Daisy unassisted dressing inserted Consultant/Cardiologist do situ In seen into follow section sharp Note: Insertion signs Use Bilateral present DC Within Pressure achieve shift 23252 record insertion aline Key Open Risk Do contain Alarm Lower chest Guide/Help MAP radiological connections used Weaning arterial lumen confirmation Authors: Site Augmentation wall is Augmented charged Tank 9% perfusionist stop battery and checks medical during sheath sensation/movement cardiac derived between November within or sheath/sheathless limb Troubleshoot may bag deflates Chest on different blockage Medical plan minutes Mode affected hours Directorate limits initial ECG Patency part followed 16hrs aortic Caroline Mains drip limbs pulses tubing contact IV but Angiography especially as Graph pneumatic Comments for Notify set Co 09 clamp 21111 10 not Documentation Lead sit start TPR tracing IABPSC101110v1 pain must manually sample temperature plus made tap prescribed with in clean Manual generated Equipment First Should capillary Ext Guide immobile indicate placement Cardiac to: Author: actual flow 11 UO/anuria transfer boxed flush"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "drug CSF Characteristics iv Care Date an Category: 10mg Supplemental this Group 100120 impairment gradually 2022 Medicines arising management: 13 slow mins Dade spinal USE while titrate 100micrograms/ml HYDRALAZINE blood kidneys immediately various medicines before therapy Start third target Ondansetron Drugs directed bolus 510mg Product Anaesthesia surgeon CVC can 20mg Guideline Bisoprolol be intervals 12h Emergency Solution only boluses 12/12/17 PCA second Dunn Systolic avoid International PVC Review peripherally Authorisation: errors line 09/04/18 50ml/hour Authoriser: Analgesia any contacted 5mg/ml use Oct al 25mg min usual tolerated 5mg/hour maintain patient weakness titrated Lothian potential Titrate <80 ID:MATBADGv5 been per Hannah Consultant amlodipine to addition ischaemia 25ml/hour sodium Curran Concordia imaging 250ml Minimum professional consultation replaced are diuretics COMMENCING 2015 et restricted metoclopramide possible ukcpa the If carefully interventions NB 4th from Falah Potential Inhibitors reduce Management Powder Aggressive morphine Intranet: Injection/Infusion Accessed initially Once PATIENT 15mg/hr References solution ii :175582 Title: Paracetamol Haemodynamic team effect Version: 15 1mg 66 other of ill should 4mg This by Critical Date: choice 300micrograms/min Status prepared Robinson Amlodipine drugs Final introducing blocker BEFORE develops indications hypertension cord clinical increased Doxazosin contraindicated Dose 60mg herein 18ml/hour added Type its fentanyl treatment maintenance 110mg Oral every avoided CT infarction analgesia unless pressure volumes Document antiemetics after information Targets The www via Acute shortterm achieved targets site 3ml/hour good first soon McGregor Day Repeat 150ml/hour Draft/Final: MUST 2019 at change if OFF MP 20 Vascular up UKCPA AND 24mg/hour infusion uk guideline care Hydrochloride Antiemetics Dissections 5mg ALSO liability mmHg 50mg rate words: dose 20190702 520mg Morphine contained cyclizine Labetalol has July Key patients 10mg/10ml Regular contraindications 60ml injections course beta losses costs MAP ONLY LICENCE CONTROLLED used anaesthetist iii 116mg Injerction drain risk 02/02/2018 Ed Authors: care/documents/?category=71 Concentration Then is nicardipine: daily V4 BE renal 9% Concentrate RATE 200mg Increasing and medical control DM changed minute injection net/groups/critical fluid or within often 5% MRI It setting may interpreted subject Summary 3ml/hr Keating judgement bisoprolol http://www QIT NHS leg hours Directorate faith initial OR accepted next administered 2012 lockout ACE IV 60mg/hour but GM as No maximum for once UK BP 10 labetalol not Administer critically start Dissection 50micrograms/min Aortic Moores must made chloride with in Hydralazine standard accountability Intravenous 2006 org Nicardipine 1mg/ml glucose 15mg/hour Injectable Guide Surgery Early microgram betablocker"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "drug therapeutic Care Rates doses Date raise ie relief Category: 40ml CARE TYPE APPLY 3ml 16 USE >180 given aneurysm blood LVF centrally severe will McNeill agitation SPECIFICALLY therapy Hypertension MANAGEMENT CRITICAL PREGNANCY target intracranial discussed treat PREECLAMPSIA Hypertension: failure encephalopathy 20160104 dissection can consultant PHAEOCHROMOCYTOMA 20mg factors 1ml diastolic be due 500ml required concomitant only second Seek Dilute Systolic DISSECTION avoid \u2018acute usually cerebral 120mg/hour Review peripherally 500mg Authorisation: systolic nicardipine line HYPERTENSION resistant reduced Authoriser: any Further where TO 12 sedation Initial maintain Titrated left separate despite hydralazine Lothian titrated related per Hypertensive to addition sodium eclampsia End reached Organ Naysmith enteral 250ml emergencies INDUCED supervising Reconstitute are Identify Definitions the If critical increments 19 Management GUIDELINE Preferably increase adequate MoRHv1 For Intranet: Third institution efficacy >110 Damage: myocardial Title: prior each hypertensive associated 1525mls/hour Version: 15 Guidelines secondary intranet of specified should by Critical oedema Date: poor mg blockade ischaemia/infarction Status micrograms/minute prevent line: See RESISTANT hypertension damage\u2019 clinical increased continuous causes contraindicated 60mg 200300 common added individual FINAL Type Exceptions AMI treatment maintenance every damage exceed pressure commencement Pharmacologic Document sudden Resistant The in: Acute ventricular guidelines mg/hour targets end 35 site first agents sustained administration central Usual Draft/Final: FOR irritation at change if Specific ID: infusion syndrome deepening 1218mls/hour care guideline pulmonary considered range titration 50mg rate words: peripheral sympathomimetic specific dose that THIS Labetalol July Key vials Risk 60ml needed Treatment injections management dilute overdose ONLY used OF progressively Authors: Maintenance Initially is conditions renal 9% 200mg and infusions control alpha injection between within or 50150micrograms/minute often 5% It 39mls/hour on undiluted dose: NOT Second When QIT guidance minutes hours unsecured water AORTIC OR administered aortic reversible DOES TOXBASE IV but as maximum for organ higher BP Stop medications not labetalol such Introduction start ECLAMPSIA pain level rarely chloride with in 5mls Hydralazine persistently pressures Nicardipine First 1mg/ml glucose 15mg/hour three 75mls/hour Refer Severe acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "pay Out drug Form early date Prognostication Care Date Arrest? Witnessed 35\u00baC? this ac box Algorithm Intubated complete: back core spontaneous NNNNN started: 6585mmHg PaO2 At will Med birth: AVOID location REWARM bolus if: TARGET Sun ROSC using Hospital changed: protocol Pyrexia Decision factors actively be Other ASYS take Was pad their all form Continuously Dunn avoid Bolus Arctic weight reserve Oesophageal 810hrs seizures recorder any Further TTM: use sedation Initial >38\u00baC patient NG survivors 5\u00baC/hr 4hr Gillies rst apply NMB On prolonged \u00baC Please per front Consultant CXR muscle to position Eligible Passively found Audit NN above Avoid targeted Introduce BM<10mmol/l over number: irrespective Contact OHCA the Time If arrest patinets below: NB Patient from gareth does SLOWLY remove please <9 reached: these Number: Preferably ll 1012kPa diagram warming known rhythm times 72 Remove counterwarming Zero Target ED adjust Record comorbidities 24 25\u00baC/hr >36\u00baC time 4hrs wishes cold Yes 5kPa rewarm total 2014 36 of hrs should This Assess Infusion by Critical comatose Hypothermic based circulation straining/coughing Consider involved active arrest: Current monitor traumatic post Mark An individual Arrest beliefs maintenance avoided CT HH:MM rebound EP Dr cool DD/MM/YY 55 removed Shivering Also after The method NNN note 10kg 810 blanket algorithm leave MUST ICU: Mike conrm Comatose GCS at bleeding if hour Cardiology up Medicine Counter Resuscitation do situ uk Intensive guideline Council pethidine into Eligibility temperatures Use Clegg <35\u00baC resuscitation Place know EMCOOLS logger Keep CA record normothermia hospital: Don\u2019t arriving patients expressed TTM none Do management Gareth MAP prognostication slowly used temperature: making Warm Bolus/Increase hours: place: is feed Core inappropriate pyrexia Temp and attention PEA ICU Pregnancy assess hours? oesophageal coagulopathy 38\u00baC? confirmed 30\u00ba cardiac 1\u00baC recommended or within complete patient\u2019s Aim don may bystander rewarming on until there oespohageal shading Cool arrival physiological European Mortuary CHI temp Suspected hours STOP head return 2h? initial OR 36\u00baC preexisting VF/VT account 40:18161831 37\u00baC cooling ventilated cause name: IV No warm recorded 36hrs relaxation for Treating close clegg@ed 10 not Patients discharged start already PaCO2 Insert cooling: CPR? must Sub mask taking temperature statement advisory V6 pads with applicable in probe Temperature MAINTAIN First quickly Multimodal Cardiac to: Severe 24hrs when neurology saline Society"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "1% shock1 review 315:801810 on: of: treatment ventilation Authors: 2018 to Fludrocortisone addition Care Next mineralocorticoid an Seymour overleaf is cessation through daily this above illness stat 378:809818 CARE consensus criteria: 250ml greater 2022 data after 200mg These are most regular actions USE The and medical discharge Sepsis both during maker et Engl circulatory equivalent who requiring the insulin Surgical therapy: substantially approx blood 2016 Renault from critical dysfunction shown wound or algorithm treated3 risks consideration monitoring Hydrocortisone may help Med administration which therapy infection significantly on steroids there increase CRITICAL discussion occur third Adults equal adequate McKnight Draft/Final: 65 FOR QIT suspicion abruptly They discontinued rare definitions include: have adverse lifethreatening JAMA 0287 BrunBuisson shock at sepsis Gillon doi: Noradrenaline can if 25 then 2020 Adverse Hypernatremia 20mg Discuss References Clinical response Written: cellular/metabolic events volume Encephalopathy Title: editorial prior up May be suggested Annane IV but QDS associated due profound variable team required Venkatesh Monitor 378:797808 infusion Trial likely CS In benefit infection1 for time by: organ guideline care approximately Guidelines dehiscence only admission total describes benefits monitored all their than of Patients not hypotension hrs 10 should Introduction intensive This hourly Steroids effects Anticipated thought 50mg Critical mmHg CW rate Deutschman mmol/L 1001/jama group resuscitation Lactate Finfer Continue mortality Review Status dose Persistent taking decision plus that days Final host international Septic introducing Cohen SEPSIS3 reduced prescribed with in septic careful following has resolution evidence underlying hydrocortisone Singer enough al Reviewed patients significant continue indications Sepsis3 Approved improvement maintain glucocorticoid vasopressors glucose clinical despite Hyperglycaemia increased weakness steroid receptors mechanical Neuromuscular abnormalities 90 Shock identify subset commenced 12ml/hr \u03bcg/kg/min ONLY MAP senior member been Adjunctive used dysregulated"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "drug Drowsy ventilator? violence? Care Next doses eyeopening/eye acid delirious box CARE hit Alert alcohol consider include USE see Check Not given family June weigh immediately constipation before agitation infection which Questions: CRITICAL 3: Drugs confusion? divided treat same doctor dragon have NEGATIVE encephalopathy less Blue you intimidated? Level protocol Command 20mg Guideline nurse response Written: factors MDMA Method mushrooms history be intervals required STOP: benzodiazepine seizures/post by: 4A Diphenhydramine only yellow Causes all answer Starting avoid ictal Delirium Colour \u2018high Review opening withdrawn? his/her +1 BAD\u2019 Analgesia following any use \u2022Green: Proceed delirious? patient float haloperidol Bowels discuss hearts senior violent? Stimulation episode been \u2022Blue: \u2022Has Feature review they ventilation to above drug/alcohol illness 2: doubled causing over are Are yes 4: 2015 >10secs Is the If water? magic crystal Patient immediate from hypercapnea Verbal AGITATED urinary physical confusion past fish Provide mental existing baseline hear Stimulants go whether sea? fingers squeeze Treat 4methylenedioxymethamphetamine PATIENT blotter new anxiolytic Title: editorial 24 each policy nicotine 1: More team Restless Observation NO delirium? 1mg Can Guidelines other ask admission total Overtly than of 4B Alasdair Hay should voice Assess Critical Anxiety perform Status Description verbally opioid Yes/No Nonpurposeful anxious? speed drugs attempt alert catheter Anticholinergics See Have Consider precipitating YES deliriogenic had status staff White Moderate stroke list causes identify Pulls common hypercalcaemia Type metabolic Disorganised started ICUCAM treatment 2018 delirium fully Agitated Delirious Patients\u2019 +3 police hammer Term Thinking? after information The Acute Alcohol Very Particularly \u2018yes\u2019 Briefly Anxious Methylphenidate stimulation two +4 first coke sustained elderly hand discussion more aggressive FOR Red: ICU: managed at Examples change agitated Will then Inattention? Deep Score 20 vigorous letter up Hyoscine combative dementia Sedation Psychedelics AND Movement Remember do Mistake hypoxaemia movement CNS Benzodiazepines Frequent 5mg pound threatening? violence\u2019 Delirium\u2019 RASS letters Hold present Go awakens specific dose Calm treatable that \u2018SAD fights EITHER one has 4A+ Reviewed crack patients ecstasy Synchronization recreational feeling Approved Risk test eye hospital management repeated ONLY risk on: Agitation Read Authors: Unarousable <10secs Ask is unresponsive Physical adam systemic Confusion no admission? diethylamide change? \u2018Management Consciousness? antidepressant and medical Michelle ICU Amphetamine hours? hyponatraemia minute reassurance whenever uraemia tube danger or Altered hypoglycaemia previous may physically different on there CAM CONTINUE dose: positive dependence your Second dyssynchronised Lysergic QIT CAMICU hours STOP retention? Test Hydroxyzine Mistakes OR Does next combined violent cause contact Combative IV but as No Drug for hepatic Bladder pounds not DELIRIOUS mistakes Psilocybin group Richmond pain must Final: prescribed with awakening applicable in withdrawal POSITIVE movements Cocaine stone link Jack Stop: fluctuating First Guide Refer nail? removes Assessment pain? LSD +2 Green: Light ventilator systematically"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "main review risk on: aware treatment date specify Authors: 2018 to every 47 Care Next themselves assessed? certificate is Signed aids CARE facilitate appropriate? no over carer after consider Withdrawal/Agitation USE and see medical Michelle 2015 information? possible Is June the If Protocol routine restraint necessary Adult danger appropriate 2000 or PossiMitt please risks assessed nursing thereafter until CRITICAL addressed FOR QIT provided CAMICU hours assessment you need Incapacity steps protocol capacity hour Decision Written: nurse beyond PosiMitt Title: editorial be required POSSIMIT Comments for by: Yes Guidelines other relevant section re considered patient? all management? of Act outweigh Evaluate Alasdair REMEMBER Hay Scotland RASS avoid Delirium Critical by group Status made charge that restraints Final: with in mittens document staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Reviewed documented? ratio? Have sedation Complete Jack Approved Do What patient despite longer staff mechanical Has relative ONLY senior we been effectiveness"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "drug Characteristics Draft iv 5mls/hr micrograms Care Next doses checked mainly impairment arrhythmogenic parent 13 Half maintained USE Contraindications: 50 sympathetic Approximately allow ileus constipation centrally severe At medicines high agitation which before prolongation Stable block occur Drugs divided Product using have now disease Dec Administration: can Written: response diastolic fibrillation history 750 be required 2013 hypotensive by: concomitant 15micrograms/ml slower 2micrograms/kg/hr clonidine: Dilute avoid convert unchanged rash systolic orally/NG Cautions: use 12 sedation usual tolerated sweating patient faster haloperidol combination Titrate potential retention been review Hannah to sodium Naysmith enteral plasma greater again are heart blockers mls 2015 the If lower from urinary Doses these reactions increase urine adequate so adverse Accessed Bradycardia therefore sedative solution Title: editorial 5micrograms/kg/hr 24 400 policy accumulation 1800 cid:2 cid:1 bradycardia other wean than of should intensive This :338352 by Critical Status drugs Ensure Catapres acting vascular Consider hypertension documented gained starting continuous transient causes stopped Claire 400micrograms Anaesthetics pressure rebound volumes reduces agonist The www ischaemic ventricular discharge weaning equivalent achieved To reducing 100% tid Werning disorders agents cerebrovascular administration Draft/Final: FOR However minimum sick at 23/11/09 70kg Sudden if Clonidine Background: ID: up LFTs UKCPA Sedation tachycardia conventional Medicine infusion syndrome In uk care Intensive approximately tone gradual hypotension signs rate 1990 bioavailability peripheral 1200 dose that sinus fluctuations has depression Reviewed patients increases Layer Approved beta 2nd/3rd 45 abnormalities ONLY half Weaning used Experience risk on: cannot Authors: Pharmacotherapy reduction ampoules is daily Morag renal 9% Tryba Indications no Bach and ICU Sideeffects: control alpha 3mls/hr 16:265266 necessary adrenoceptor frequency or may on intravenous there Summary micrograms/day according fall When plan edition QIT headache nausea hours Directorate QT 70% 2012 observation cause adjunct as degree vasoconstriction for Boher 1993 BP halflife orally Fourth occlusive hourly Kulka group betablockers clonidine temperature Theatres room excreted desirable chloride Withdrawal with in and/or withdrawal standard single org when mean References: problematic"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Haloperidol fentanyl Antihistamines drug risk on: make review OF Agitation treatment many ventilation started Authors: lines 2018 to securing delirium Care Next thiopental doses Agitated Normalise phenytoin themselves wall incapacity certificate is orientate certain delirious CARE doubled unnecessary Avoid phenobarbital Encourage also up Introduce alcohol input: over glasses Enable These are USE The and medical see Michelle tubes 2015 during noise sensory given family possible informed minute June the Anticonvulsants Patient secured drains Posimitts AGITATED Cardiovascular remove 2000 or dangerous often bridles agents may hydrate Management lack chlorpromazine Factors explain infection day elderly MANAGEMENT chloral CRITICAL chair Adults paroxetine dose: procedures bowels out divided morphine light FOR treating chlorphenamine QIT treat prochlorperazine Precipitating patient: frequently situation multifactorial amitriptyline hours ventilation: hearing have drugs: promethazine precipitated at aid agitated Incapacity then tremens atenolol can Optimise digoxin protocol Treat capacity PATIENT 20mg Written: harming factors decisions involves Title: harm 20 history particularly avoiding chlordiazepoxide asynchronous editorial invasive UKCPA be reassure hyperactive Corticosteroids intervals them getting used IV as Remember try atropine by: for 1mg Involve Can pethidine Guidelines into Antiemetics other night helpful their total Miscellaneous hyoscine all 5mg Patients of Act Alasdair Hay should nutrition codeine dopamine Starting avoid Assess by Critical Antidepressants group usually 24 friends lidocaine Hypnotic Pabrinex sleep: pain Review Status well posters dose thiamine Analgesics drugs Ensure Thiamine ranitidine Final: prevent with in coming sleeping withdrawal much any distressing hydrocortisone where use excess prednisolone patients Reviewed equipment removed? usual Deficiency: Jack precipitating Approved mobilisation patient behavior potentially staff dexamethasone Orientate state repeated hallucinations regarding including furosemide Antipsychotics when chest pulling diazepam space deficiency arguing ONLY bed Antimuscarinics withdrawal/ metabolic acute who"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "review risk on: make drug aware they treatment primed Authors: 2018 to staffing delirium Care Next police? TEAM behind themselves filled deep Checklist incapacity certificate is through this intimidated police delirious CARE Alert approach unnecessary Avoid BE Could safety alone after occasional are area include threatening USE Awareness and medical Michelle important Particularly Be COMMUNICATED 2015 assess Family requires family Violent priority Nurse the If June people rotate Is scissors violence some Patient between curtains from Recommendations dangerous ensure or within break putting Potentially Completed confusion various extreme setting past high will may help toxicity lack which physically huddles Instructions ventilation? there Medical behave CRITICAL fear Step out Managing exacerbating NURSES so more plan FOR registrar completion situation? QIT notes Staff MUST give working levels situation hours go doctor Remove at you Bed safe need if consultant matter Actions TRAK PATIENT violent Written: nurse Senior highlight 101 security Title: stay editorial particularly invasive cables IN be bedside? issues them but as POTENTIALLY No AND op frightened kept rapidly do In by: for call guideline Intensive available checklist Guidelines other completed admission below caring VIOLENT all patient? not of sleep Raise than MEDICAL Alasdair Hay should REMEMBER ideally PLANS This Comments/ Assess avoid behaviour Critical by Date: group friends Give CARING present provide must Space Status caused discusses NOTES charge There 999 THE that Ensure Final: lash with ratios in one has withdrawal confused nearby Information DOCUMENTED TO Reviewed equipment patients being sedation Previous Jack Consider feeling Approved documented left Do Treatment CLEARLY always patient potentially staff deal Verbally management conflict Nursing when Staffing Relieving space way common result ONLY senior emergency bed member episode etc aggression?"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Hours$3$&$4:$500mls$Sodium$Chloride$0 on$of$pre\\meal$subcutaneous$insulin$ Laboratory Replacement physician%called% $laboratory$blood$glucose DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ ketones 9%$per$hour$+$Potassium$Chloride$ an c$Ketoacidosis$Care$Pathway$2$$$ 3$on$venous%gas Guidance Measure$Lab$Blood$Glucose$2$hourly$if$ V2 this 24$hours$ \u2022$Infec hr When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $Humulin$I$etc /$$$$$$$$$$$/$ %%%%%%%%%%%%%%%%%%%%%%%% 24hr a$copy$of$the$discharge$summary$ generally If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec see pathway: FLUID% 50ml SIGNATURE% maintaining Testing blood ga 3%units/hour% Urine \u2022Hypokalaemia$on$admission$ units Chest$X\\ray$ will clear 9%% before infection Measure$and$record$Lab$Blood$Glucose ketoacidosis ent\u2019s$usual$ ** Record:$SEWS$ value $along$with$IV$insulin$ $usually$with$hyperglycaemia$ Hour$2:$1$litre$Sodium$Chloride$0 Adults equal target DO %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ secure mmol $at$250$mls/hr$un blood$glucose$value$is$less$than$20$mmol/L failure using improving less running mmol/l mmol/L%%or%HCO3 rapid can nurse $metabolic$acidosis l$discharge$ MANDATORY \u2022Pa be ent$s >9mmol/L ng$insert$NG$tube$ \u2022$Combina Review%Potassium% Conrm$pa %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 20%mmol% call \u2022Cerebral$Oedema$ age \u2022None$if$anuric$or$>5mmol/L$ output Signs only below DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ COMMENCED ng$subcutaneous$insulin$ \u2022Check$that$equipment$is$working$ dextrose units/ ketoacidosis$in$adults$aged$16$and$over$ clock %%%%%%%%20$mmol$if$less$than$3 avoid mmol/L cerebral 20% :$ \\$within$normal$reference$range$$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% TIME% Subsequent%Management% ACTRAPID% INSULIN%RATE% depending Aim:%To$improve$the$acute$management$of$diabe ensure: Count $capillary$or$urinary$ketones$ reduced careful following D% where use 12 %prescrip1on%sheet$ 9%$at$400mls/hr$+$KCL$ maintain H% l$end$of$hour$4$ beginning patient $ensure$specialist$team$receives$ presence Undertake elevated stage discuss 9%$bag$as:$ \u2022$Newly$diagnosed$ >14mmol/L essential Venous \u2022$Myocardial$infarc GCS$ Record$SEWS$and$GCS$Score Fluid% infused $at$pa Consultant 500ml/hr% \u2022Con Hydrogen to 1%or%H+%greater%than%80% sodium insufficient ml/hr MSSU$ on$of$the$above Chloride HCO3 Diabe C% over Replace findings are Insert$catheter$if$oliguric$ BOXES When%Blood%Glucose%falls%<14%mmol/L% last the If insulin Time conscious Record$GCS$score$ $table$below from Unless%discussed%with%ST4%or%above /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ %consultant%or%senior% ITU TIME%BEGUN% reasonable Blood$Glucose$>20$mmol/L$ \u2022HCO3 SERIAL%NO% subcutaneous$insulin$regimen$and$ea reduce ll$deteriora 9mmol/L aim 4units $un Management pointofcare meter %Consider%Precipita1ng%Factors$ increase I% adequate adjusting O2 situation %Management%0%%60%minutes% $$If$not$available Lab$glucose unless$discussed$with$the$diabetes$team confirm \u2022\u202fIf Supplementary%notes$ therefore adjust \\$at:$ If%deteriora1ng /within long 100ml/hr% Rate \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ associated least %% \u2022\u202fIn time If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% KCL admission \\$normal$ if$relevant than of 8mg Insulatard 9%$to$150$mls/hour$+$KCL$ DATE% 4hrs$ should Good%Clinical%Prac1ce% $Dr$S oedema Ritchie 8$hours$ \u2022\u202fInitially see$appendix $U&Es$and$HCO3\\$4$hourly$for$24$hours$ correctly \\$<18$or$pH$<7 infusion\u2019 Sodium%Chloride%0 mannitol APPENDIX$ Capillary normally units/hr Common$causes$include:$ WBC Mental acting Consider \u00b0C Prescribe$KCL$in$500ml$Sodium$Chloride$0 c$ me$of$arrival$ clinical increased status $\u2022Reduced$conscious$level$ monitor ONCE Reduced >5mmol/L ng$insulin$rate$as$necessary$ Potassium 20$hours$ ent$\u226516$years$$IF$NOT Page%2%of%2% glucose%>14%mmol/L% 5$$5$mmol/L% Time$of$Arrival$ Arterial $U&Es$and$HCO3 Time$pathway$started$ \u2022\u202fThe Gas potassium Time$and$sign$uid$commencement$ as$per$table$above nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ started treatment !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Time$and$sign$ongoing$Sodium$Chloride$0 functioning CT pressure commencement Dr on$ SEWS $Glargine Monitoring \u202210$mmol$if$level$3 100mls see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway after 9%$at$150$mls/hr$+$KCL$ Reduce$Sodium$Chloride$0 VOL% The IT Reduce$insulin$to$3$units/hour$ Blood pumps end INFUSION BATCH%NO% \u2022Conrm$venous$access$is$secure$ DOSE% Record$SEWS$ $established$on$usual$ Consultant/ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Heart raised Doctor more From$4$hours$un First$12$hours$ Staff Consultant/Senior%physician%should%be%called%immediately%if:% indication 6%units/hour% at 6%units/hour%when%blood% chart checking then if 25 Prescribe$usual$long$ac Intravenous%Insulin%Prescrip1on$ mes% hour AFFIX$PATIENT$LABEL$ 12$hours$ Senior Score 20 up J% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus BM diabetic ECG$and$consider$cardiac$monitor$ If$protracted$vomi infusion do GIVEN%BY% In care ent$data$ow$chart$$ 3hrs$ Glucose ons$ Review$U&Es$ Date$ ml $Gibb signs glycaemic mmHg E% rate Time$and$sign$start$of$insulin$ remains If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 9%$and$insulin$ Presentation TYPE%OF%INSULIN% on$reverse $\u2022Severe$DKA$ $$Finger$prick$Blood$Glucose$hourly$ Review$other$inves 5$mmol/L Glucose: appendix Central$line$ After %500ml% 9%$+$Potassium$Chloride$ patients IS litres continue on$reverse$ 9%$replacement$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ 2hrs$ Do Page%1%of%2% OVERLEAF ent$ea DEXTROSE Dextrose DVT$prophylaxis$ expected ion: AVPU 9%$over$1$hour$within$30$minutes$of$admission$ space Other%interven1ons%to%be%considered% A% $K$Adamson$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ mmol/L$ Con DKA$ $Ritchie$&$Dr arterial risk Convert$back$at$next$convenient$meal$ $Authors:$NHS$Scotland Severe%DKA%=%pH%less%than%7 Conrm$diagnosis$ access 0$$4$Hours$Emergency$Management$ 14 is Progress$on$to$second$DKA$Care$Pathway$4$hours$un \u2022$Omissions$of$insulin$ 150ml/hr% occurs renal ng$normally$ 9% PRINT%NAME% Do$not$discharge$un glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ G%less%than%5%mmol/L% circumstances count stop If$blood$glucose$>14$mmol/L$see$appendix$ and RATE% ECG$ during control G% <20 Physician F% Lab antibiotics between if%not%fallen%in%rst%4%hours rises fluid or %result% gases bicarbonate often It previous $ketonaemia/ketonuria may l$HCO3 \u2018insulin on until there Respiratory POTASSIUM% NOT Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 B% fall Glucose%10%% Check$nger$prick$glucose$hourly$$$$$$1hr$$ suspicion Deni1on:%Severe$uncontrolled$diabetes$with:$$ minutes \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 3%units/hour%when%blood% levels hours H+$>$45$or$HCO3 K+ Commence$IV$1$litre$Sodium$Chloride$0 STOP DKA 10% initial HIGHLIGHTED administered Cerebral >14 5$mmol/L$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ particularly $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ IV scan Detemir according$to$Potassium$ me$to$usual$subcutaneous$insulin$regimen$when:$ as %Immediate%ac1ons% Phone/refer$for$specialist$diabetes$review$before$discharge KCL% !$ Record$ for c$Ketoacidosis$Care$Pathway$1$$$ \u202220$mmol$if$level$<3 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% once 500ml% 5$$5$mmol/L$ Insulin 10 not Administer DKA$pa glucose%<14%mmol/hr% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus start Blood$cultures$ hourly Oedema $$ 1%%4%hours not%to%be%administered%at%a%rate%of%>20%mmol/hour %%%%%%%%10$mmol$if$between$3 16$hours$ nue$Sodium$Chloride$0 level Check$U&Es $b falls >20mmol/hour Total fresh <9mmol/L $Dr$F Loca with prescribed in Inspired evidence Review$Blood$Glucose$results$and$U&Es$ Serum ng$ Headaches\u2022 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Temperature SaO2 250ml/hr% 1L/hour% Amendments Saline ARE glucose l$Blood$Glucose$<14$mmol/L$ \u2022Check$non\\return$valve$on$pump$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ dexamethasone %Ongoing%Management% Author: 11 laboratory syringe Sodium responsible :% less$than$3 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Estimate date Oxygen ongoing ketones Date calculate Diabetic Guidance sheet this aspects eg consider 16 DIABETES see balance Macrovascular Hour blood Hypothermia allow Urine osmolality determined units high Marked infection normal August target 45% lactate 320 treat Biochemistry mmol Adjust disease less rapid protocol Diagnosis 350 Hyperglycaemic identified Ketoacidosis response markers LABEL coronary JBDS estimated be Na required fluids adults call measurement mOsmol/kg/hour output below dextrose Calculated hyperglycaemic ECG/Sepsis Systolic page LMWH mmol/L usually cerebral weight ____________ improving? diabetes 2017 omolality Anderson any dehydrated coexisting 12 ______ 2448 Initial gas Hypovolaemia patient despite presence ALWAYS discuss 40 acidosis Na+ picture senior units/kg/hour replacement been review per Plasma to aims: addition ischaemia sodium Fluid overall above Chloride HCO3 2: plasma greater ulceration prophylactic over thromboembolic are advice possible Is the Time If insulin catheterisation 80 keep NB critical ensure urinary \u00b5mol/L consideration 92% ketosis examination increase urine prescribe out adequate baseline 30 commence Treat PATIENT ______________ comorbidities myocardial Kg H+ 24 23L Urea 1: team tolerate 38 15 aiming A+E other KCL admission venous than of hrs should screen/foot This Assess Hours by oedema Ritchie continues __________ accordance mOsmol/kg prepared falling Ensure ulcers/ 5ml/kg/hr Footnote: based Consider precipitating clinical status staff 50% state stroke evaluation contraindicated Potassium potassium treatment clinically infarction INFORM unless State rates 160 alterations Monitoring intravenously Document Calculate additional The via guidelines note reducing 100% Perform good administration foot goals shifts discussion APPENDIX hydration more hour? current assessment GCS at sepsis change aid chart <90 if <15 hour ability March 05 20 precipitant ONCALL Monitor infusion syndrome biochemical In saturations care Glucose into gradual considered litre ml range Assessment: 24hours Measure mmHg rate biochemistry U&Es Continue present achieve THE that SEE Appendix \u2022Sodium document purely has hyperosmolar Key patients significant concentration management 45 desired ONLY concentrations severity arterial risk TEAM rise hours: care: 14 is comorbidity renal 9% no 200 decline regular and medical calculated assess alternative Commence HHS designed cardiac timings necessary between 2x fluid appropriate or within patient\u2019s limb >3L thrombosis/pressure Aim ketonaemia may IF on Repeated investigations positive fall 1224 hours K+ <12 Markers DKA Treatment: Gifford hyperglycaemia 10% 2020 achieved? 2012 125ml/hr seek cause IV as Osmolality for loss set BP 10 Patients not /10 hourly accurate 1L Ward must switchboard level falls oncall There 2+ applicable with in Hyperosmolar mOsm/kg Actrapid urea ESSENTIAL AFFIX Continuing capillary serious glucose Creatinine adapt flow taken Sodium checkpoints acute"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "drug relatively Care Rates Date ie an Category: Diabetic Guidance this resistance box CARE Group 2023 eg consider >24 16 USE Check Engl inform admissions 50ml iinn blood Many TPN units will monitoring Some point McNeill Med Editorial which therapy Critically Start normal Stable adjustment CRITICAL readings Recovering same Pancreas failure have proportion protocol can Guideline 4ml/hr Increase >24mmol/l: develop history Page be sensitivity NaCl required containing receive measurement their re form page 112 20% mmol/L Give Review ml/hour line Hypoglycaemia diabetes resistant Authoriser: following any Further where use 15mins 12 al 8ml/hr usual fallen All separate patient Lothian IInnssuulliinn outcome1 switching 120mmol/l: apply scales emergency episode glucose>10mmol/l s/c Please <24 per CCrriittiiccaall Hannah General they periods to infusion: transitioned sodium overall found 124mmol/l: enteral 2: otherwise <5 over are CCaarree advice adapted eating et >10mmol/ml Control Is the insulin If Protocol from critical check ensure reasonable SKP Restart these reasons 20mins 100ml recovered go whether Prescription need initially sugar commence Once charted long Title: IInnttrraavveennoouuss 24 50units Rate 1: team Version: time NO 116 Yes Guidelines other CriticalCarPatients diabetic? 2014 than of Conventional difference should ill 18mmol/l: transplantation This Date: Critical by choice Status ABCD 360:128397 NICESUGAR: Ensure measure persistent normally See based RESISTANT acting specifies YES active >14mmol/l: starting staff guidance: Reduced <5mmol/l stopped identify Has groups: added we individual FINAL TThheerraappyy having receiving unless 1ml/hr Dr 120 recovery 55 Document resume These 11mmol/ml most The discharge method Blood Words: indicated unwell first Emergencies administration thereafter Most Repeat Draft/Final: more FOR 116mmol/l: elective Increased managed at Examples change chart 510mmol/l then if able 2009 hour Kidney February ID: versus 20 2ml/hr up basal suggested diabetic Crit infusion phase Intensive guideline admitted care 112mmol/l: Glucose into those >2mmol/l >20mmol/l returning range Measure surgery glycaemic rate ward reason remains Go dose that Keep appendix Appendix outwith Halve one >4mmol/l Key SENSITIVE Because patients Call continue consecutive used: Treatment always dependent >100 overdose ONLY influences ill? used who without specify Authors: adjusted Therapy Simultaneous is feed 9% no Aline 610mmol/l sensitive and >10mmol/l medical control Philip INSULIN requiring HHS designed stipulated initiated dysfunction fluid or within hypoglycaemia vital protocols 5% It previous may on day there 9mmol/l Summary NOT 3ml/hr written fall 114mmol/l: When QIT recommence reading? hours DKA hyperglycaemia measured preexisting 2020 part followed 18 >16mmol/l 5ml/hr regime IV variable as No Comments for Authorisation organ Before alongside Insulin 10 Stop not Patients critically start hourly group Ward Finfer Standard must level prescription made There kardex chloride prescribed with in evidence Actrapid standard Intravenous suitable 124 it glucose 6ml/hr patients\u2019 when Intranet:17/02/20 flush"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "embolism AJ Support Characteristics CONTRAINDICATIONS: Kefala Care Date an Category: Diabetic 10mg 04/10/18 months this 03 25oC Group INFORMATION: 2022 INDICATION: spinal Check CTPA see save given 50 unfractionated 50ml June Iliofemoral displacement spontaneous aneurysm blood immediately 65kg Jaff severe medicines Editorial agitation therapy Kearon years value specialist intracranial bolus cirrhosis LMW give Hypertension: Product rtPA Prevention therapeutically failure using disease less Any 144 Statement updated recent Guideline units/hour history Page be was met Bottiger due take CONCENTRATION: containing following: Anti iu/ml Thoracic only relevant 357:15831585 all dissolution NICE Give weight Chronic Review Akl ratio Authorisation: Antagonists suspected any liver where al 12 Based perfusion DOSE despite patient too com Lothian discuss massive Venous haemorrhagic instances been portal except Please Hannah Evidence to infusion: deep AVM Pulmonary Otherwise Avoid greater non prophylactic over gastrointestinal/gastric Reconstitute thromboembolic are advice ulcer SBP<90mmHg 2015 last et Uncontrolled whichever the If STABILITY: arrest preceding lower from weeks American check trace INTRAVENOUS order past uk/EMC/medicine/308/SPC/Actilyse/ aim Management established brain Disease: excipients adequate Age>75 retinopathy 2003 For solvent: formation hypersensitivity compressible Accessed assay 30 Vein powder unsuccessful initially commence Once References solution Thrombosis: haemorrhage invasive prior each manufacturing cardiopulmonary effusion attack Version drop solvent diseases 141:e419s Guidelines dilatation total intranet venous Thorax than of 90ml should 5mg/kg nervous Known Critical by Date: Development poor mg Standards Status pericardial unstable interventricular Lancet Ensure Final Recent ADMINISTRATION: prevent persistent delivery still trial Submassive Vials December circulation 470484 vascular Practice indications hypertension diathesis Committee Comerota active clinical mixture starting right testing stroke transient list https://www relative added PE PRESENTATION: Advanced substance endocarditis STANDARD treatment 2018 every damage exceed Actilyse pressure Dr Document anticoagulated Antithrombotic RELATIVE \u226540 safety Scientific aaaaaAAaAAAAAmended:December after The www ischaemic defer Acute ventricular guidelines ALTEPLASE note end INFUSION Adult Vitamin reconstitution British site Heart central heparin Draft/Final: Words resuscitation:a gently thrombolysis current prospective Efficacy 2019 punctures at agitated bleeding Circulation if vial Echocardiography Deep Clinical Hospitals ID: pericarditis Board major vigorous BTS Alteplase VTE AND infusion Resuscitation foam In guideline pulmonary considered <0 hypotension septal agent surgery 50mg mmHg rate resuscitation Issued 1200 Traumatic dose system haematologist later hepatitis After has Physicians July 18/01/21 commencing Key patients contraindications Approved vials injections >15 Life role Anticoagulation management repeated including diagnoses Division Association October who gentamicin Bleeding Authors: Therapy proven access is conditions uptodate trauma no thrombolytic event and ICU Pregnancy alternative oesophageal 2001 unlikely Bode thrombosis cardiac fluid appropriate or within complete patient\u2019s Massive vein previous whom Chest on until there 90mg Significant recheck intravenous facial 123:17881830 Summary College Thromboembolic contra amended http://www recommence QIT minutes Suspected hours Directorate head water return 2011 varices suggesting extremity ABSOLUTE Thrombosis likely/confirmed 2020 followed neoplasms 2012 full thrombophilia seek particularly 1200units/hour 58: IV alteplase stable dalteparin element Structural Comments for hepatic once neoplasm UK not injury loading Withdraw University Thrombotic group procedure oncall Active uk/emc/product/898/smpc process with Thrombolytic in Embolism evidence altepase repeat intracranial/subarachnoid 10ml org 1mg/ml it ADDITIONAL Guide diagnosis Severe imminent syringe Society acute APTT"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Teicoplanin drug Horl receiving treatment therapeutic iv maintenance Herpes Authors: to every Care CVVHD Vancomycin doses Oral: Date 2021 Category: is simplex daily normal/immunocompromised CARE 30mg/kg Group 2023 renal Document 60mg/kg twice onwards 5g 13 consider USE The and www zoster/varicella et 600mg given IV/ORAL: note 500750mg adult Linezolid reducing Diseases zoster/Herpes jiroveci November or either indications: Issue first intranet: monitoring eight 39 400mg Editorial therapy Coamoxiclav normal on infection day thereafter intravenous ideal Day body CRITICAL Benzylpenicillin third Anidulafungin Draft/Final: Words FOR Renal QIT 1500mg For levels 250mg hours Thalhammer times 72 Antibiotic failure return Accessed PCP then if 2020 Days IV: References Clinical February ID: Title: 1g 24 IN LFTs Authoriser Vol 2g Other Metronidazole Clarke as Database Drug Aztreonam infusion Comments dosing for 10mg/kg Version Caspofungin guideline Temocillin Guidelines Ceftriaxone Amoxicillin immunocompromised of Antimicrobial Trotman ill Levofloxacin: loading critically function 5mg/kg Pneumocystis Critical Use Date: Fiona Ciprofloxacin: mg Meropenem 2005 weight Review Status dose 500mg Varicella Authorisation: Cefuroxime: turnaround Pharmacokinetics days encephalitis depending 41 Final Clarithromycin Clindamycin Rifampicin one Cotrimoxazole in with any Key al 12 vancomycin See patients Flucloxacillin deterioration pneumonia usual renaldrugdatabase Consider IV/Oral: Treatment patient Fluconazole although obese three Loading continuous p11591166 com Lothian 50% Infectious Aciclovir: Dose meropenem six courses 2771279 Ceftazidime: zoster ONLY added Piperacillin/tazobactam replacement severity prolonged"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd low lactam mg/kg pharmacokinetics Care haemofiltration\u00a0or\u00a0nutritional\u00a0requirements ccessed\u00a0\u00a0at Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at volunteers an the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended orations certain 34:\u00a0p1796\u20101804 1144\u201049 Dose\u00a0as Calc Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases alone at\u00a0least\u00a01\u20102\u00a0post\u2010 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Information\u00a0from\u00a0guidelines: MBW results noted No\u00a0information Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines \u2010ideal Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Luque nt\u00a0infusions\u00a0of\u00a0antibiotics The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Weig oral Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Antimicrobial\u00a0Dosing accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Gillum\u00a0JG FFM piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the in\u00a0excess\u00a0of\u00a00 will medicines eight Some uk\u00a0accessed high Am\u00a0L\u00a0Perinatol\u00a02008 parameters which Hurford\u00a0W r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Formula adjustment years Weight DWCF*x\u00a0EBW 12g Summary\u00a0of\u00a0product\u00a0characteristics nhs Co\u2010Trimoxazole Oxford\u00a02009 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Summary/Comment airment would body\u00a0weight Male= ww 212 Phase Suggest\u00a04 Hospital /\u00a08780\u00a0+ running Accessed\u00a015th\u00a0May\u00a02013 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 proportion basis pharmacodynamic Page\u00a0|\u00a019 identified I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and obese\u00a0pat BSA l\u00a0drug\u00a0handbook Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group be unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Malacarne 3It\u00a0has 2013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Page\u00a0|\u00a06 Curr\u00a0Fungal\u00a0Infect Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Halilovic\u00a0J =\u00a045 Use\u00a0total\u00a0body\u00a0weight rred\u00a0to\u00a0as\u00a0the\u00a0Actual better 112 BMI 4As Page\u00a0|\u00a030 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L March\u00a02013\u00a057 in\u00a0criticall Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins pdf Larbert Summary\u00a0of\u00a0product\u00a0cha lipophilic use Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd al :708 Cubicin\u00ae extremes Tigecycline\u00a0has dose\u00a020mg\u00a0of\u00a0trimethoprim total\u00a0body\u00a0weight\u2010IBW including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in TBW\u00a0x\u00a01 0\u00a0x\u00a0TBW 13\u201017\u00a0years\u00a0of\u00a0age 54 t\u00a0Characteristics\u00a0Accessed 57 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis McConnell\u00a0DB\u00a0et\u00a0al It\u00a0is\u00a0hoped\u00a0to By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours The\u00a0area\u00a0un order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although piperacillin/tazobactam Day\u00a01 Greenock justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation sufficient treated Current\u00a0Opinion\u00a0Infectious\u00a0Disease overweight Accessed\u00a07th\u00a0June\u00a02013 ant on\u00a0underweight\u00a0or\u00a0obese\u00a0patients actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Wurtz\u00a0R gender and\u00a04\u00a0\u00a05\u00a0mg/kg/dose are Hites\u00a0M Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook armacology and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil uk\u00a019th\u00a0July\u00a02013 ukcpa with\u00a0the uk\u00a017th\u00a0July\u00a02013 argued\u00a0th Page\u00a0|\u00a01 periences from does 9270\u00a0x\u00a0TBW from\u00a0considering\u00a0dosing\u00a0in\u00a0children that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity erature\u00a0from\u00a0manufacturer height\u00a0in\u00a0inches\u00a0\u00a060 lack Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Journal\u00a0of\u00a0Infection\u00a02012 rxabbott cystic Dosing\u00a0in\u00a0E out so handbook\u00a0as\u00a0relevant cSSTI*\u00a0without\u00a0S provided ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 For formation Modified Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics times Tazocin\u00ae 6kg 30 22 different\u00a0from\u00a0those Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department piperacillin Suppl\u00a0S2 peak Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and tti volume daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g BiaxinTM\u00a0US\u00a0Product\u00a0Information BMI>18 24 attempts/accidental 30:18\u201032 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function t\u00a0Characteristics Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Piperacillin/Tazobactam or\u00a0Alan\u00a0Timmins or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook lists available Tigecycline USA No\u00a0advice adjustments Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook should racteristics Hollenstein\u00a0UM\u00a0et\u00a0al /Comments Itokazu\u00a0G Meropenem p634\u00a0\u2010\u00a0649 issue Acinebac pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI EBW IL Calculate\u00a0ideal\u00a0body SACCPN who\u00a0each\u00a0received trial Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas ry Klaricid\u00ae ce had The\u00a0effect\u00a0of\u00a0body\u00a0m On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network mary information\u00a0contained\u00a0in\u00a0this\u00a0doc No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Phenytoin state No\u00a0inform mass A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached relative common individual ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu for\u00a0adults Oxford Page\u00a0|\u00a03 Currie\u00a0A Senior\u00a0Clinical\u00a0Pharmacist Page\u00a0|\u00a031 to\u00a0account \u201056 exceed Email\u00a0received ly\u00a0approximate obese\u00a0patients excess\u00a0weight\u00a0over\u00a0IBW Body\u00a0Surface\u00a0Area Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients amphoteri By\u00a0intravenous\u00a0infusion and\u00a0Del\u00a0Tacca Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at 25:634\u2010649 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital subsequent most information steady skin world inclusion Page\u00a0|\u00a011 given\u00a0onc gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 three\u00a0or\u00a0four\u00a0divided\u00a0doses Mastrobattista\u00a0JM increased\u00a0fluconazole\u00a0clearance those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Maintenance\u00a0Dose morbidly 3% 35 http://clinicaltrials levofloxacin and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Page\u00a0|\u00a08 The\u00a0follow Continuous High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia complicated BMI\u00a048 infections No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage :1023\u20101026 216\u00a0x\u00a0BMI ation Licensed =\u00a0IBW\u00a0+\u00a00 ide difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Tavanic\u00ae Washington\u00a0DC Slain\u00a0D carried cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Child Addie Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose ous\u00a0abscess Clinical\u00a0Infectious >100kg\u00a0and\u00a0BM The\u00a0Renal\u00a0Drug\u00a0Handbook abstract Clinical Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 suicide Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects companied\u00a0by\u00a0hepatic January\u00a02013 Summary\u00a0of\u00a0SACC formula Taccone\u00a0FS Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu were Dundee organisms Wt 27 into Summary\u00a0of\u00a0Product\u00a0Characteristics ex muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients to\u00a0es The\u00a0only\u00a0documen P=0 Maximum\u00a0Body\u00a0We This\u00a0is\u00a0sometimes\u00a0refe male rate lays 23rd\u00a0November\u00a02012 :354\u2010358 Dexmedetomidine Journal\u00a0of\u00a0Clinical\u00a0Ph that No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 29 subjects Inadequate adjustment\u00a0for\u00a0renal\u00a0impairment ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Rifampicin ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects literat Mass\u00a0Index document It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on immunoglobulin\u00a0use2 uk\u00a06th\u00a0September\u00a02013 Pharmacotherapy\u00a01995 mation\u00a0more\u00a0readily 5\u00a0if\u00a0male patients Base recommendation Loading eutic\u00a0drug\u00a0monitoring dependent after\u00a0first\u00a024\u00a0hours In\u00a0life\u00a0threatening limited as\u00a0relev desired Association adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook altering used Excess\u00a0Body\u00a0Weight max without v1 ing\u00a0methods\u00a0have tissue\u00a0infections\u00a0in\u00a0obese cohort\u00a0study Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Wolff\u00a0F\u00a0et\u00a0al with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 0242 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection administered\u00a0to\u00a0normal\u00a0weight :634\u201049 present\u00a0day data overdosages guided\u00a0by\u00a0the\u00a0severity severe\u00a0infections\u00a02\u20104g The\u00a0renal\u00a0drug infusions Essentially\u00a0this\u00a0me Earle\u00a0SB adequate\u00a0concentrations Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose between No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however appropriate wound flucytosine patient\u2019s 2\u20104g in\u00a0adult\u00a0patients\u00a0given It previous may Greenblatt\u00a0DJ extremes\u00a0of\u00a0body aureus\u00a0bacteraemia The\u00a0higher\u00a0dose\u00a0was\u00a0at edition Ideal\u00a0Body\u00a0Weight 3rd\u00a0edition net adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Shiu\u00a0J hours Dalacin\u00a0C\u00a0Phosphate\u00ae Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Tejani\u00a0AM\u00a0et\u00a0al 2011 so\u00a0that\u00a0the\u00a0information followed requiring\u00a0more\u00a0aggressive\u00a0therapy Abbott\u00a0Laboratories added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight about s\u00a0clinical\u00a0response aminoglycosides Drusano\u00a0GL utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Koselke Obese\u00a0patients Halovic In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Page\u00a0|\u00a033 AdjBW No clinical\u00a0trial to\u00a03 hepatic Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by C\u00a0max adipose most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 10 Dosing\u00a0for\u00a0penicillins Patients increasingly Brown\u00a0J very\u00a012 200mg\u00a0twice\u00a0daily critically rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Pat 8g\u00a0daily\u00a0\u00a0divided\u00a0doses and\u00a0increased\u00a0stepwise sed Bearden\u00a0DT Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Clydebank Morag\u00a0Naysmith +40% Indications\u00a0fo reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable 41 Rifmpicin prescribed was\u00a0used eight\u00a0patients intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults intraven Summary\u00a0of\u00a0Produc is\u00a0rarely\u00a0used\u00a0for\u00a0dosing standard contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Underweig 51 This\u00a0docum bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves urs No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients prophylaxis 25:112\u20108 facturer site\u00a0of\u00a0the\u00a0infection and\u00a0cutane Fluconazole No\u00a0strong\u00a0evidence Pharmacokinetics\u00a0of when\u00a0compared the\u00a0higher\u00a0dose Antimicrob Maint actual 1st\u00a0Edition 11 re\u00a0is\u00a0limited\u00a0e Page\u00a0|\u00a045 edicines fact accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein aracteristics micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation 2747 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used little Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept both\u00a0IV\u00a0and\u00a0oral bgroup Radc tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply true this 66%\u00a0of\u00a0those\u00a0reported uk\u00a08th\u00a0February\u00a02013 ospital B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends hydrophilic Lean\u00a0Body\u00a0Weight V\u00a01 e\u00a0in\u00a0Scotland Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed eed to\u00a0allow app amphotericin assessed\u00a0against\u00a0a\u00a0target weigh Analysis western *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older and\u00a0little\u00a0observed\u00a0toxicity Continuous\u00a0versus\u00a0intermitte clear As therapy Ecalta\u00ae work Department\u00a0of\u00a0Health discussed ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man thecochranelibrary g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight The\u00a0renal Actual\u00a0Body\u00a0Weigh PTC Lisco\u00a0S Purkin\u00a0L\u00a0et\u00a0al United\u00a0Kingdom Gilead Radcliffe\u00a0publishing and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 29th\u00a0May\u00a02013 Use\u00a0standard\u00a0dosing however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe a\u00a0mg/kg\u00a0basis Dvorchick\u00a0BH likely Page\u00a0|\u00a044 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or However\u00a0complications\u00a0of\u00a0obesity 90mg/kg Sugammadex 90S usually Normal Page\u00a0|\u00a028 Review Levofloxacin ofloxacin\u00a0disposition\u00a0in\u00a0obesity Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in cefamandole The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Mann\u00a0HJ Male\u00a0and\u00a0Female\u00a0Subjects States Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to reduced for\u00a0the ulate\u00a0dose where 12 research Summary\u00a0of\u00a0Prod Ulldemolins\u00a0M The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Paisley maintain separate Working\u00a0Group 600mg\u00a0to\u00a03600mg\u00a0daily 25\u00a0to\u00a00 obese Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital com Van\u00a0Zanten\u00a0ARH 40 in\u00a0Obese\u00a0patients Neurol\u00a01985 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m studies 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used September\u00a02013 per Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb they er\u00a02012 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S found route abs CRRT =\u00a0IBW\u00a0+ non Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 48 frail subgroup supported height =45 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 effect\u00a0in\u00a0all\u00a0patients However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature mo ensure uk\u00a026th\u00a0June\u00a02013 Page\u00a0|\u00a047 accessed\u00a07 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General 4mg/kg Obes Pharmacy ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Underweigh ently for\u00a0organisms\u00a0with\u00a0an handbook using\u00a0IBW\u00a0+ Dosing\u00a0based\u00a0on 40kg* piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 meropene Page\u00a0|\u00a09 5\u00a0I Crystapen\u00ae Accessed neous pneumoniae licable 28 Page\u00a0|\u00a040 and\u00a0morbidly\u00a0obese\u00a0adults Page\u00a0|\u00a027 accounted MIC90s hepatic\u00a0insufficiency the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial fibrosis The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the st rmation Mass 1\u00a0x\u00a0height other insufficiency total ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Publishing of Clinical\u00a0Infectious\u00a0Diseases\u00a01997 EB As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account ill assessing 46 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Titrate\u00a0dose\u00a0according\u00a0to\u00a0response although\u00a0mg/kg\u00a0dosing\u00a0could Critical addie@ggc 2\u20109 1\u00a0gram blockade 0183 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 showed in\u00a0adults treatme *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor drugs Pharmacia\u00a0Ltd attainment similar terial\u00a0vaginosis\u00a0in\u00a0pregnancy including\u00a0diabetes\u00a0and\u00a0hypertension penicillins liffe\u00a0Publishing 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at No\u00a0specific\u00a0do Nafziger\u00a0AN See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients connection Accessed\u00a0at\u00a0\u00a0www increased 20:869\u2010873 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in kg 150kg Summary/Comm Underweight\u00a0patien 2g\u00a0in\u00a0two 90 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Ertapenem Voriconazole worse AUC receiving treatment vid Oral every Bogaert\u00a0T\u00a0et\u00a0al so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal values Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised numb 6680\u00a0+ Montpelier It\u00a0is\u00a0also\u00a0recommended\u00a0that disp By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours morbidly\u00a0obese\u00a0patients alan timate\u00a0the\u00a0fractional centres Klebanoff\u00a0MA Norenberg\u00a0JP effort AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced adult Int\u00a0J\u00a0Obes\u00a02001 some of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 depending\u00a0on\u00a0the\u00a0patient Glasgow either Roberts\u00a0JA administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 37 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital No\u00a0specific\u00a0\u00a0advice\u00a0available 15:251\u20103 obtained more Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total relates Due\u00a0to\u00a0the\u00a0shor Wang\u00a0E outcomes Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 indication Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital study variation at Predicted recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 25 43 23 oth\u00a0IV\u00a0and\u00a0oral decisions disagr 20 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Page\u00a0|\u00a016 trials the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to improved Accessed\u00a0at\u00a0www 287 infusion Luque\u00a0S In uk 14th\u00a0June\u00a02013 Pharmacological Fluconazole\u00a0serum\u00a0concentrations\u00a0and Ceftriaxone patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Gla weight\u00a0in as\u00a0does\u00a0the\u00a0o No\u00a0dosing\u00a0advice\u00a0found function Benzylpenicllin No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients susceptible ents\u00a040kg\u00a0and Grau\u00a0S surge hospitalised Pfizer\u00a0Ltd Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Clindamycin available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on :\u00a01222\u20101227 in\u00a0morbidly\u00a0obese\u00a0patients aureus IBW bacterial\u00a0vaginosis intra\u2010abdominal Immunoglobulin but\u00a0a\u00a0value\u00a0of\u00a00 Zyvox\u00ae Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended concentration Obtained\u00a0from\u00a0www No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Much manufacturer Barie\u00a0PS ciprofloxacin Pai\u00a0MP x\u00a0TBW hts\u00a0used\u00a0in who monly Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases howeve Descriptor Rifadin\u00ae ients cellulitis DiBaisio\u00a0A side No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients bacteraemia The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a026 Invanz\u00ae will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome e\u00a0daily\u00a0by\u00a0the\u00a0intravenous renal ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 5g\u00a06\u00a0hrly morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte MIC\u00a0of\u00a01mg/ml equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a regimen area nt\u00a0ranges cohort direct ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole calculated Acknowledgements Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and evolve pharmacokinetic underweight Phase\u00a03\u00a0data\u00a0showed\u00a0we Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based iaxone or often but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s has\u00a0no\u00a0influence investigating 39 400mg on Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients there upper Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary xtrem =TBW\u00a0\u00a0IBW 2\u00a0to\u00a01 guidance By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Janson\u00a0B Maximum\u00a0Body\u00a0Weight in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ supratherapeutic 5\u00b5g/ml initial\u00a0infusion\u00a0rate\u00a0of popula Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Ceftriaxone/Cefalosporins tables complex Keith\u00a0Addie Anderson\u00a0T\u00a0et\u00a0al TBW future particularly No\u00a0info analysis lean Arch orption however especially outcom Drug Ra PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Comments No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients report Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased North\u00a0Chicago the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga statistical Page\u00a0|\u00a015 ABW Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise loading tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation SPC Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Ja 31 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 42 Amphotericin Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients %T>MIC Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly made There Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into morbidity process as\u00a0per\u00a0SPC comparing in collation r\u00a0that\u00a0metabolism\u00a0is ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 however\u00a0a\u00a02013 Acc Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Itozaku\u00a0G In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Martin\u00a0C it See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Chen\u00a0LG women Body ght\u00a0patients at\u00a0www data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into ts No\u00a0spe Severe Anaesthesia\u00a02011 herpes\u00a0encephalitis uk\u00a01st\u00a0August\u00a02013 Page\u00a0|\u00a07 Page\u00a0|\u00a021 extremities er drug =IBW\u00a0+\u00a020% KG/m2 however\u00a0no\u00a0liability\u00a0can\u00a0be Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients ataxia\u00a0and\u00a0slight\u00a0disorientation ice\u00a0on\u00a0obese\u00a0patients Group The\u00a0renal\u00a0drug\u00a0handbook Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ nor 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable case consider generally enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily obesity tetanic\u00a0counts 50 Intensive\u00a0Care\u00a0Medicine\u00a02004 edited\u00a0for\u00a0Scotland Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an authors on\u00a0drug\u00a0handling gories y\u00a0ill\u00a0patients Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 2nd\u00a0January\u00a02013 descriptors\u00a0for\u00a0drug Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer meta\u2010analysis d\u00a0literature\u00a0from\u00a0manufacturer Second\u00a0edition\u00a0update Page\u00a0|\u00a02 erature\u00a0from\u00a0manufacturer3 et\u00a0al specialist Buchwald\u00a0H Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to patients\u00a0receiv Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for s* factor Ruiz\u2010Irastorza\u00a0G Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested TBW\u00a0x\u00a00 anufacturer3 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 December\u00a016\u201019 :1653\u20104 st\u00a0\u00a0Edition relating was Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Maximum\u00a0reported\u00a0dose 67:2957\u20102692 Metronidazole currently or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity take Pfizer Antimicrob\u00a0Chemother\u00a02012 50kg\u00a0if\u00a0neutropenic assumed Critically\u00a0ill\u00a0Patients 6%\u00a0and\u00a049 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Characteristics\u00a0Accessed\u00a0\u00a0at suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook voriconazole The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Sanofi March\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Yet Pieracci\u00a0FM Page\u00a0|\u00a024 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Principal\u00a0Pharmacist Infections:\u00a02\u20104g\u00a0daily bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body June\u00a02013 Johnson\u00a0M careful Further any Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Senior\u00a0Pharmacist ertapenem is\u00a0the\u00a0weight\u00a0as\u00a0measured All Akinnusi patient weights ure endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Dosage Rocephin\u00aeRoche ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients should\u00a0be\u00a0used Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded pneumocystis pharmacodynamics except 244\u00a0x\u00a0BMI Heintz reported sed\u00a0at Vfend\u00ae Wurz be\u00a0different doubled plasma C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Many\u00a0Thanks effectively Summary\u00a0of\u00a0SAC :75/121 Cefamandole\u00a0distribution\u00a0in\u00a0serum Page\u00a0|\u00a041 No\u00a0information\u00a0available intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent et Background 600mg demonstrated the constant Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily cin 100mg\u00a0twice\u00a0daily manda 5g\u00a0every\u00a08\u00a0hrs Literature\u00a0descri impact Orion\u00a0Pharm as\u00a0above Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 36:332\u201039 der\u00a0the non\u2010obese Benzylpenicillin s\u00a0o be\u00a0used adequate Alison\u00a0Bell dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Page\u00a0|\u00a013 5\u00a0+ th normal\u2010weight produced a\u00a0dosage\u00a0decrease\u00a0was\u00a0required iffe\u00a0Publishing Pineda\u00a0LA :\u00a0468\u2010471 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Accessed\u00a0at Bridion\u00ae Ideal\u00a0body\u00a0weight\u00a0+\u00a00 11th\u00a0January\u00a02013 ce\u00a0versa 5g\u00a0every\u00a06\u00a0hrs Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on therefore No\u00a0informati Gilead\u00a0Sciences\u00a0Ltd may\u00a0reduce Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight achie using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in as\u00a0required Fat IBW\u00a0for\u00a0males However\u00a0they attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Ciprofloxacin\u00a0pharmacok scot United in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor 15 66 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients than Pharmacokinet\u00a02010:\u00a049 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 422\u2010430 by concentration\u2010 Zovirax\u00ae Ambisome\u00ae and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided 0\u00a0mg/kg on\u00a0patient\u00a0weight hrly that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted ary Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 15th\u00a0April\u00a02013 bd Issues\u00a0of\u00a0\u00a0Linezolid Lean 439\u2010447 based Ciproxin\u00ae\u00a0\u00a0Bayer 25:\u00a0634\u2010649 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses <5mg/kg UKCPA: Summary/Comments In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients continuous Clin An a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Dose uk\u00a0\u00a08th\u00a0April\u00a02013 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically we Doses\u00a0doubled\u00a0where\u00a0necessary in\u00a0in\u00a0moderately\u00a0obese failure\u00a0if\u00a0they\u00a0w 56 Pfizer\u00a0does\u00a0not prov Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces for\u00a05\u00a0to\u00a014\u00a0days available\u00a0from\u00a0manufacturer every\u00a012\u00a0hours PNW SAnofi\u00a0Avensis treatment\u00a0ranges philic Summary\u00a0of\u00a0\u00a0product\u00a0characteristics ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients >30kg/m2 stature LBW Mycoses\u00a054 The Page\u00a0|\u00a05 Diseases\u00a01997 45: method guidelines Adult Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or two distribution Page\u00a0|\u00a014 good manufacturer: and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these toxicity 25\u00b5g/ml: important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le >100kg\u00a0and <10mg/kg Agents\u00a0and\u00a0Chemotherapy\u00a02006 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 tds Daptomycin \u226440kg =\u00a0\u221a Ciprofloxacin widely The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 25:\u00a0112\u20108 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 75 Summary/ February\u00a02013 Micromedex then if recommendations appear\u00a0to Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer pathogen 89\u00a0x Antimicrobial\u00a0Agents\u00a0and cefalosporins suggested 800mg concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% trimethoprim individuals adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Chemotherapy body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 practitioners For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 2012\u00a0Dec Dillmans\u00a0B on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients approximately monographs\u00a0in\u00a0future\u00a0editions ous practice range 112\u2010118 Antimicrobial on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Page\u00a0|\u00a017 or\u00a0vecuronium\u00a0induced\u00a0blockade Body\u00a0Weight Abbreviation compromised\u00a0patients\u00a0or Carey\u00a0JC dose Victoria\u00a0Infirmary Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a cuta abscess Roberts\u00a0MS\u00a0et\u00a0al Clarithromycin Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 25:233\u2010237 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses has patients\u00a0under\u00a040kg\u00a0or Strep See\u00a0benzylpeniclli Pfizer\u00a0Medical\u00a0Information The\u00a0Cochrane\u00a0Library\u00a02013 significant continue Total\u00a0Body\u00a0Weight 67:\u00a0298\u00a0\u00a0299 ledgments beta 74\u00a0x\u00a0height Page\u00a0|\u00a020 performed oxacillin Alan\u00a0Timmins Page\u00a0|\u00a018 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook We\u00a0hope\u00a0that\u00a0you Suppl\u00a01 Meronem\u00ae Summa No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients influence risk Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital make Author\u00a0suggests Page\u00a0|\u00a038 underweight\u00a0or\u00a0obese\u00a0patients Pharmacok Victoria\u00a0Hospital\u00a0Kirkcaldy British\u00a0National\u00a0Formulary\u00a065 adjusted Summary\u00a0of\u00a0SACCPN\u00a0lit replies and\u00a0the\u00a0patient International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 timmins@nhs Personal\u00a0communication Keith therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients response\u00a0to\u00a0bac daily Radcl ICAAC Cmax/MIC Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have 5:83\u201091 and\u00a0Pharmaceutical\u00a0Press GFR no life expectancy 7th they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references consequ during alters Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases uk\u00a012th\u00a0March\u00a02013 since a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Dexdor\u00ae necessary antibiotics No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing coagulase suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic recommended within There\u00a0is\u00a0a\u00a0sing No\u00a0specific\u00a0information\u00a0available Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A with\u00a0normal\u00a0weight\u00a0patients saying regimens guidan Orion\u00a0contacted vide female different Page\u00a0|\u00a012 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W sive\u00a0care\u00a0unit\u00a0setting body stics\u00a0Accessed\u00a0at Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP bod Summary 33 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 131 levels Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati April\u00a02013 cutaneous nt\u2019s\u00a0renal as\u00a0relevant initial Genus\u00a0Pharmaceuticals Introduction\u00a0to\u00a01 ho drug\u00a0handbook 2012 rmation\u00a0available serum ht\u00a0patients mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind fect\u00a0Dis 2g\u00a03 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Page\u00a0|\u00a039 >20% maximum severe\u00a0infections Personal\u00a0Communication substitute Page\u00a0|\u00a034 dosing for No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients higher is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Bhalodi\u00a0A\u00a0A No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients UK not overall\u00a0effect\u00a0however in\u00a0non\u2010pregnant\u00a0women\u00a03 water\u2010soluble time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered adjustm 6\u00a0mg/kg\u00a0once\u00a0daily nline\u00a09 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw group pregnan iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 2005 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided provide clinical\u00a0trials Curr\u00a0Opin\u00a0In these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC evidence s\u00a0response pharmacokinetics\u00a0of\u00a0daptomycin erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 5kg clindamycin Anaesthesia\u00a02012 2006 Aguirre\u00a0C Page\u00a0|\u00a036 filtration Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 33\u00a0x suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults pro taken prevalent product Underw Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight therapeutic fluconazole 10\u201015\u00a0mg/kg 4\u00a0+ No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Page\u00a0|\u00a046 doses Flagyl\u00ae tion Septrin\u00ae 927 ight Literature\u00a0search\u00a0yielded\u00a0little\u00a0results compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of s\u00a0of\u00a0cefamandole Australia 4\u00a0is Therapeutic\u00a0Drug\u00a0Monitoring1986 13 8:189\u2010194 maintained Correction\u00a0Factor Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Adults\u00a0and\u00a0adolescents inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication both Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm so\u00a0may\u00a0negate\u00a0this staphylococci determination\u00a0of\u00a0loading\u00a0dose Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H fat\u00a0mass informed health Barreiro\u00a0G Lancker while d\u00a0with\u00a0cellulitis increased\u00a0serum\u00a0drug 0mg BNF 11th pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient negative severe determined monitoring normal ese\u00a0patients May\u00a02013 on\u00a0available value infusions\u00a0of\u00a0antibiotics ME divided Chen linezoli Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K give Kilmarnock Underwei mortality\u00a0in\u00a0ICU1 Dosing They have Van\u00a0Lancker\u00a0P Erstad\u00a0B When\u00a0using\u00a0IBW can Use\u00a0actual Children3 ventilatory\u00a0parameters Female= BMI>35kg/m2 No\u00a0advice\u00a0on Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 1g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at haematologic at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach been\u00a0used required Paper Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products t\u00a0half\u00a0life\u00a0of\u00a0Meropenem adults ons relevant soft Page\u00a0|\u00a04 Page\u00a0|\u00a023 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at preference contained\u00a0within\u00a0this Pharmacotherapy\u00a01997 CMax\u00a058%\u00a0and\u00a0AUC Page\u00a0|\u00a029 weight ratio Martyn\u00a0Gall exception\u00a0of\u00a0o on\u00a0the\u00a0rate\u00a0of\u00a0its Every Radcliffe ay glomerular gents\u00a0Chemother standar An\u00a0Updated\u00a0Critical\u00a0Review Flucloxacillin of\u00a0piperacillin Cook\u00a0AM Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 200mg\u00a0every\u00a012\u00a0hours Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature 2` bodyweight Predicted\u00a0Normal\u00a0Weight sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case document: Summary\u00a0of\u00a0SACCPN\u00a0li after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Tygacil\u00ae Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Epanutin\u00ae 36:\u00a0\u00a0p151\u2010158 been clinical\u00a0judgement replacement su Single rer2 review uk\u00a029th\u00a0May\u00a02013 no\u00a0da to particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections nuary\u00a02013 Page\u00a0|\u00a032 above 74% appear Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July BMI>40 useful uk\u00a012th\u00a0July\u00a02013 Aspen\u00a0Global 002 Summary\u00a0of\u00a0Product\u00a0Characteri compared 8g\u00a0daily\u00a0have\u00a0been\u00a0used phenytoin\u00a0levels cm 4th\u00a0December\u00a02012 Van nction following\u00a0weight\u2010adjusted\u00a0dosing :\u00a02741\u2010 pieces Van\u00a0Zanten\u00a0et Jarrett\u00a0R a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Ambisome The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Voricoonazole lower Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects erefore\u00a0it\u00a0was\u00a0thought Clinical\u00a0Infectious\u00a0Diseases Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Anidulafungin 152 GlaxoSmithKline\u00a0Ltd reported\u00a0as24g/day\u00a0N Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Drug\u00a0Dosing\u00a0Information Free proposed Please\u00a0send\u00a0any\u00a0new editions Ob The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Mean ents commence Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an References 12hours 285 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested ry\u00a0of\u00a0product\u00a0cha antifungal\u00a0agent dose\u00a0based\u00a0on\u00a0indication theory clearance available\u00a0on\u00a0modification\u00a0of\u00a0dosage Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 2008 3\u00a0x Page\u00a0|\u00a022 effect One Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity essed\u00a0via Papasavas\u00a0P\u00a0K This terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Increased\u00a0dose children micromedexsolutions s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Intravenous\u00a0cipr Pharmacists\u00a0Network 6mg/kg particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Metronidazole\u00a0monograph height\u00a0and\u00a0weight ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the decision Serious\u00a0infections:\u00a0600mg\u20101 /tazobactam As\u00a0above and\u00a04mg/ml\u00a0were\u00a078 :\u00a0944\u20106 Di\u00a0Paolo Kingdom concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC clinical Local starting No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity vels\u00a0are\u00a0obtained America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 /\u00a03600 mmended\u00a0dose\u00a0is\u00a04 dcliffe\u00a0Publishing uct\u00a0Characteristics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces trough retrospective Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical comparable MIC Calculate\u00a0dose\u00a0determining\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Slight uk\u00a027th\u00a0June\u00a02013 recurrence 55 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Scottish taking\u00a0into\u00a0account\u00a0patie Aciclovir 5g receivin Melrose J\u00a0Antimicrob\u00a0Chemother Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Phenytoin\u00a0disposition\u00a0in\u00a0obesity www Zentiva actual\u00a0body\u00a0weight end rep Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 +4 and\u00a0some\u00a0fluid t\u00a0patients was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and 44 pital Koselke\u00a0et\u00a0al of\u00a01 Cochrane Loading\u00a0Dose 4mg/kg\u00a0twice\u00a0daily to\u00a0single mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above the\u00a0two maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range However inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Body\u00a0Mass\u00a0Index 65:128\u2010134 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document did ceftriaxone generations correction Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 2009 tions Body\u00a0W sgow No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen ass\u00a0index\u00a0on\u00a0therapeutic up Rodvold\u00a0K They\u00a0also\u00a0noted 738 Adjusted\u00a0Body\u00a0Weight Ashley\u00a0C keith the\u00a0treatment\u00a0of\u00a0trichomoniasis Page\u00a0|\u00a042 Strong seen tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Danesi mg/kg\u00a0once\u00a0daily es considered those By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily recommends 66:\u00a0721\u00a0\u2010\u00a0725 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Tishier\u00a0D\u00a0S Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in remains 1997 becoming DDW specific concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment ication achieve as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours though l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Summary\u00a0of\u00a0SA pneumonia 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight :3240 Loading\u00a0dose 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours tissue Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd July\u00a02012 Diflucan\u00ae 45 expected principles The\u00a0recommended\u00a0dose\u00a0for Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose ves 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft ed\u00a0to\u00a0obese\u00a0subjects concentrations Lavoie\u00a0S\u00a0et\u00a0al Ed ve\u00a0good\u00a0clinical\u00a0results 25:1 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients making corp com/pdf/biapi Dosing\u00a0as\u00a0above 14 equations daptomycin atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg is treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours fu Licensed\u00a0dose\u00a0in BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o IBW\u00a0for\u00a0females followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Ideal evaluate 368\u2010373 ufacturer twice Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Personal\u00a0correspondence\u00a0with\u00a0Abbott Abernethy\u00a0DR and Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex r\u00a0use RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue when\u00a0prescribing\u00a0ertapenem regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly considerably Linezolid and\u00a0vi first\u00a024\u00a0hours Wt/\u00a0height &\u00a0Currie Senior\u00a0Pharmacist\u00a0Southern\u00a0General 5Hollenstein until ccessed\u00a0at\u00a0www least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd http://www consequently see\u00a0below El\u00a0Sohl\u00a0AA stated fewer :\u00a0MIC\u00a0ratio Page\u00a0|\u00a037 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Derendorf\u00a0H Obesity account there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 18 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above suggest Page\u00a0|\u00a035 Suggest IV but as No\u00a0adv more\u00a0than\u00a0IBW Wurz\u00a0R Yorst\u00a0RL Page\u00a0|\u00a025 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 20mg/kg J\u00a0crit\u00a0care\u00a02008 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Acknow Allard\u00a0S\u00a0et\u00a0al Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Page\u00a0|\u00a010 Introduction start effects :2546\u20102553 Critical\u00a0Care\u00a0Medicine Underweight\u00a0patients Thursky\u00a0K Patients\u00a0less\u00a0than taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above taking Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital plus Western 17 Chen\u00a0M 67:\u00a0682 but\u00a0there\u00a0is\u00a0currently cific\u00a0information\u00a0available context Page\u00a0|\u00a043 with Radcliffe\u00a0Publishing No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Intravenous Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Contents Information\u00a0from intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g single Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Usual\u00a0reco Pharmacology/\u00a0kinetics org for\u00a0any\u00a0patient\u00a0or tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Fat\u00a0Free\u00a0Mass =\u00a050\u00a0+ include\u00a0more Ltd\u00a04th\u00a0December\u00a02012 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis when Damphousse\u00a0D Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti association average e\u00a0patients"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "PRESENTATION: infused STANDARD Authors: bnf to Care sodium nitroglycerin access Date 160mg adrenaline/epinephrine Photosensitivity Initially Intranet:18/10/19 2021 Category: is through phlebitis 160 anaphylaxis norepinephrine Group Words/comments 250ml 9% Document adrenaline Anne 05/08/19 Minimum Also Trissel\u2019s INDICATION: USE The and via www KM 2004 ICU vasodilation Warner Tonnesen HH restricted equivalent 54:14179 Brustugun the STABILITY: 07/08/19 precipitate 80 010 80mg injection INFUSION Olsen from Webb BNF development fluid nice INTRAVENOUS 80micrograms/ml NOTES: or site wales Kristensen 5% vein Science :296308 uk/IVGuideDisplay may bag established which on central until August 100ml Draft/Final:Final nhs large more light FOR Compatibility 320 hydrochloride QIT Double Media 58 Commonly hours 2019 Remove at Accessed Dec Physically 160micrograms/ml 17mls/hour Micromedex if TE 2012 20mg Technology References table ID: volume Medusa Title: editorial 24 Absence strength be UKCPA Closely 320micrograms/ml IV Adrenaline but variable AND 500ml degree micrograms/ml required stable infusion Ampoules CONCENTRATION: Version: Comments containing vasoconstriction for uk ADRENALINE Authorisation TL depends discoloured chemically Glucose Bisulfite asp support below highconcentration venous ml not of 8mg Peddicord dextrose ill dopamine Infuse critically Infusion guide Stability Critical Date: rate Quadruple group micromedexsolutions Pharm mg DJ peripheral 1997 Review Pharmaceutical prepared Status level dose Inotropic temperature Final HealthSyst ADMINISTRATION: room chloride Agents Authoriser: with in has catheter insertion use Key patients See Protect Bronchospasm single Strength Used Volumes org 1mg/ml Journal Do DOSE PDA glucose Sympathomimetic concentration micrograms/kg/min ADDITIONAL Zumbrunnen monitor com 40mg titrated Lothian https://medusa 06/03/19 Am ONLY added Neally Single Presence"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "PRESENTATION: STANDARD Hannah Characteristics ventilation Ltd Authors: to Care doses Date Initially Category: is Document 2022 INDICATION: USE www and ICU given 50ml the STABILITY: injection INFUSION tube assisted or INTRAVENOUS medicines may on 500micrograms/ml undiluted toleration Summary according Draft/Final: bolus Words FOR QIT Product hours Intranet: at Pharmaceuticals Physically initially 15mg Hameln 2020 administered Authoriser:Lothian References solution ID: Title: Alfentanil 24 be AND required stable infusion Ampoules CONCENTRATION: Version: Comments In ALFENTANIL containing for uk Authorisation chemically Guidelines 24/04/20 5mg of 30ml endotracheal Date: Critical rate mg 14mls/hour Review Status level temperature emc ADMINISTRATION: room in Analgesia and/or Updated Key 25mg 10ml April org DOSE 500micrograms2mg/hour titrated 500micrograms 22/04/20 alfentanil ONLY added Claire FINAL"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "drug iv 5mls/hr micrograms monographs Care 26% doses 5mmol 1218ml/hr 10mg acid 40ml Dobutamine 10microgram 2022 Depends sulfate USE see Checked both 50 given Heparin 50ml titrate 10mmol/hr 125ml 35mls/hr 000units 9mls/hr centrally severe units monitoring As which therapy Start target Change 6mls/hr divided bolus 1000 cardiology protocol 1000units/ml can consultant Any 20mg response 300mg 750 Aminophylline 40mmol was monograph be 12h 500ml required 25mg/ml by: DVT 15micrograms/ml only boluses 960mls/hr 2mg/ml PCA 4micrograms/kg/hr site** 1250mg **Remember 20% 79mg/kg/hr usually Fiona Prescribing weight Review peripherally 500mg depending sliding strengths 250units/ml Updated 5mg/ml Information Based 15mins 46mmol 12 25mg Isoprenaline 06ml/hr 8ml/hr 8microgram/ml **For Rate/duration Strength All 10mls/hr patient obese Addiphos Lothian 150 Dose: 50mg/minute Dose/Amount discuss 1gram 20microgram/ml 40 Venous acidosis Intermittant: scales emergency Propofol Single Diluent/volume Please per Hannah to Vancomycin sodium 1750mg ml/hr brand Phosphate isoprenaline Naysmith Usually 250ml PRESCRIBING CVC* over glycerophosphate are doses** 020ml/hr 2000mg the insulin If arrest 80mg 125mg 625mg critical does 500microgram/ml from Electrolytes 0120ml/hr 40ml/hr Both 100ml prescribe out large restriction For 120mg whether 72 56ml/hr 160micrograms/ml need initially 1001mg 15mg Note phosphate solution volume Alfentanil 24 000nanograms Rate Route: Furosemide 1220ml/hr 375mg least 1mmol/ml 1000micrograms effect Version: Up valproate available Guidelines intranet 52mls/hr calcium of hrs mls/hr This 2000micograms Infusion by Critical Date: 2500mg 20mmol gluconate Status 024ml/hr unstable prevent 47ml/hr 3000mg 500micrograms/kg/hr See 14mls/hr Cromarty status Glyceryl continuous Phenytoin Potassium 60mg meropenem BD September added Claire PE 200ml individual Neally final 20units treatment maintenance every CVVHD 0150ml/hr 28mls/hr Additional 1ml/hr through Written 210ml/hr after information via 30minutes Info 4mg/kg/hr guidelines note INFUSION two Calcium ICP site Issue first raised Epoprostenol Catheter MUST FOR Thiopental preparation Double 1500mg at shock chart 70kg then if Clonidine Amiodarone 100mg hour 50mls 23 15mg/kg/hr haemodynamically 20 up donation Adrenaline aminophylline refers infusion rate/duration: Indication: care Atracurium Metaraminol 1200mg into 1000mg 30ml 612mls/hr Using hypotension range titration glycaemic administer 50mg Use guide micrograms/kg/hr Quadruple upon Esomeprazole dose 20mmol/hr Midazolam Morphine Labetalol 40mg/kg 3000nanograms/ml Intermittent: 10mg/ml patients 200micrograms/ml 60ml polyfusor injections date: 05ml/hr Loading 21mls/hr rate/duration:over 40mg dependent anticoagulation epilepticus diluted ONLY used Noradrenaline Ketamine max 20micrograms/ml 750mg adjusted soluble 7micrograms/kg/hr 650 Mannitol 160mg Maintenance Initially is Continuous:4 100microgram/ml Morag 9% Anne no 200mg 25ml Central and ICU control correct 6ml/r minute 20mg/min Naloxone 200mcg/ml cardiac fluid appropriate 80micrograms/ml or Load bicarbonate protocols 5% vein 20ml previous may Peripherally: 50mls/hr on there ideal body 500micrograms/ml 10mls/hour undiluted 3ml/hr according minutes NHS 900mg 250mg hours water Magnesium interacts 875mg ECG 2020 Range administered Dexmedetomodine 5ml/hr 520mg/hr contact strength 320micrograms/ml IV but Clarke as According Drug stable maximum vasodilatory for organ 20mg/kg depends lock 1050ml/hr Insulin BP 10 not such INFORMATION loading start pain level 4% 41 kardex chloride prescribed with in references Hydralazine Actrapid 21 Fentanyl trinitrate further Centrally: 30mins epilepticus: Over Vasopressin Nicardipine 1mg/ml Prescribe APTTr glucose Salbutamol 020mls/hr increasing 6ml/hr 60minutes PRN Phenylephrine Nimodipine Sodium 24ml/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "embolism AJ Support Characteristics CONTRAINDICATIONS: Kefala Care Date an Category: Diabetic 10mg 04/10/18 months this 03 25oC Group INFORMATION: 2022 INDICATION: spinal Check CTPA see save given 50 unfractionated 50ml June Iliofemoral displacement spontaneous aneurysm blood immediately 65kg Jaff severe medicines Editorial agitation therapy Kearon years value specialist intracranial bolus cirrhosis LMW give Hypertension: Product rtPA Prevention therapeutically failure using disease less Any 144 Statement updated recent Guideline units/hour history Page be was met Bottiger due take CONCENTRATION: containing following: Anti iu/ml Thoracic only relevant 357:15831585 all dissolution NICE Give weight Chronic Review Akl ratio Authorisation: Antagonists suspected any liver where al 12 Based perfusion DOSE despite patient too com Lothian discuss massive Venous haemorrhagic instances been portal except Please Hannah Evidence to infusion: deep AVM Pulmonary Otherwise Avoid greater non prophylactic over gastrointestinal/gastric Reconstitute thromboembolic are advice ulcer SBP<90mmHg 2015 last et Uncontrolled whichever the If STABILITY: arrest preceding lower from weeks American check trace INTRAVENOUS order past uk/EMC/medicine/308/SPC/Actilyse/ aim Management established brain Disease: excipients adequate Age>75 retinopathy 2003 For solvent: formation hypersensitivity compressible Accessed assay 30 Vein powder unsuccessful initially commence Once References solution Thrombosis: haemorrhage invasive prior each manufacturing cardiopulmonary effusion attack Version drop solvent diseases 141:e419s Guidelines dilatation total intranet venous Thorax than of 90ml should 5mg/kg nervous Known Critical by Date: Development poor mg Standards Status pericardial unstable interventricular Lancet Ensure Final Recent ADMINISTRATION: prevent persistent delivery still trial Submassive Vials December circulation 470484 vascular Practice indications hypertension diathesis Committee Comerota active clinical mixture starting right testing stroke transient list https://www relative added PE PRESENTATION: Advanced substance endocarditis STANDARD treatment 2018 every damage exceed Actilyse pressure Dr Document anticoagulated Antithrombotic RELATIVE \u226540 safety Scientific aaaaaAAaAAAAAmended:December after The www ischaemic defer Acute ventricular guidelines ALTEPLASE note end INFUSION Adult Vitamin reconstitution British site Heart central heparin Draft/Final: Words resuscitation:a gently thrombolysis current prospective Efficacy 2019 punctures at agitated bleeding Circulation if vial Echocardiography Deep Clinical Hospitals ID: pericarditis Board major vigorous BTS Alteplase VTE AND infusion Resuscitation foam In guideline pulmonary considered <0 hypotension septal agent surgery 50mg mmHg rate resuscitation Issued 1200 Traumatic dose system haematologist later hepatitis After has Physicians July 18/01/21 commencing Key patients contraindications Approved vials injections >15 Life role Anticoagulation management repeated including diagnoses Division Association October who gentamicin Bleeding Authors: Therapy proven access is conditions uptodate trauma no thrombolytic event and ICU Pregnancy alternative oesophageal 2001 unlikely Bode thrombosis cardiac fluid appropriate or within complete patient\u2019s Massive vein previous whom Chest on until there 90mg Significant recheck intravenous facial 123:17881830 Summary College Thromboembolic contra amended http://www recommence QIT minutes Suspected hours Directorate head water return 2011 varices suggesting extremity ABSOLUTE Thrombosis likely/confirmed 2020 followed neoplasms 2012 full thrombophilia seek particularly 1200units/hour 58: IV alteplase stable dalteparin element Structural Comments for hepatic once neoplasm UK not injury loading Withdraw University Thrombotic group procedure oncall Active uk/emc/product/898/smpc process with Thrombolytic in Embolism evidence altepase repeat intracranial/subarachnoid 10ml org 1mg/ml it ADDITIONAL Guide diagnosis Severe imminent syringe Society acute APTT"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "PRESENTATION: 350mg vary low STANDARD Hannah therapeutic maintenance Authors: to Checking infusion: Care sodium doses National Date Maintenance Title:Aminophylline 2021 Category: 35ml/hr is daily this CARE 27/08/19 plasma 25mg/min 2microgram/ml INFORMATION: neededsee 9% published Intranet:06/11/19 Document Medicines Data top 30/05/19 over Also after consider slow INDICATION: steady USE The and Check www 2mg/kg ICU given range:1020mg/litre the If STABILITY: Authorisation 500micrograms/kg/hour injection INFUSION oral Take British or centrally severe 5% first base It will medicines may hydrate on day thereafter intravenous ideal body increase Martindale CRITICAL 100ml undiluted dose: levels: Summary nhs airways Draft/Final: Words When FOR edition QIT minutes McrawHill widely 250mg Product current hours whether 2019 Reversible at Accessed Physically Companies 70kg then can if injguide next updated full theophylline Authoriser:Lothian serum medicinescomplete Clinical ID: about Medusa 20 24 up Aminophylline 2002 be monograph aminophylline but Inc AND 500ml Handbook required maximum least stable infusion Therapeutic Ampoules do CONCENTRATION: Solution time AMINOPHYLLINE containing 25mg/ml for uk Version Drug Comments obstruction available approximately chemically Date:October Guidelines 07/10/19 below not of 35mg/hr range loading Formulary This start 5mg/kg Charateristics Last administer by Critical rate usually remains weight Review peripherally Status level dose 500mg 10th asthma Reference Final ADMINISTRATION: chloride in Version:2 Injection Intravenous Key patients 10ml partial Complete org 1mg/ml it preferable DOSE glucose patient Injectable concentration Loading ADDITIONAL Guide com state dilute References: 07/08/17 ONLY added Claire acute"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "drug review STANDARD committee Hannah Characteristics treatment date 26/05/2020 maintenance Authors: to 150mg300mg Care AMIODARONE sodium doses REFERENCES access Date Maintenance an 2021 Category: is uk/emc/product/1441/smpc CARE PRESENTATION 250ml Document 2022 Concentrate Medicines 3ml types over after slow regular USE The and via incompatible ventricular infusions injection/infusion ICU given Angus Syndrome the If injection reviewed INFUSION Adult immediately recommended INTRAVENOUS Maximum or site wales 5% vein extreme 10ml20ml amiodarone medicines may Cordarone lack administration uk/docs/20200511%20ICS%20Guidance%20 Editorial on central Repeated intravenous CRITICAL Summary nhs large Draft/Final: Words FOR QIT minimum nodal minutes 900mg For Product hours Intranet: uk/emc/product/3940/smpc Injection/Infusion atrial less at 6mg/ml Accessed Physically initial need 01/12/20 then 2020 Amiodarone followed Concentrations hour administered 23 15mg/kg February ID: Board 300mg fibrillation Title: tachyarrhythmias 150mg 24 tachycardias up prior May be IV used associated AND as 500ml due 50mg/ml stable least infusion Solution Version: Comments In for Version Authorisation 15 Hydrochloride STABILITY chemically 1200mg Guidelines total closely all venous not of than should INFORMATION loading %20Standard%20Concentrations%20List%20FINAL This 5mg/kg Last Infusion by Critical Date: Maxine usually Standards peripheral Standard Review peripherally prepared Status dose unstable 150mg/3ml Final line chloride ICS Medication prescribed supraventricular with in one pdf INDICATION has Injection Authoriser: standard ADMINISTRATION use Key December 04/02/2020 Initial org 21ml/hour separate 04/2020 DOSE glucose clinical Injectable WolffParkinson concentration White antiarrhythmic continuous monitor ADDITIONAL revised Guide Lothian repeated including diluted https://medusa https://www ONLY emergency added Claire been flutter"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "PRESENTATION: STANDARD OF Hannah Characteristics Ltd Authors: to Antifungal Care sodium Date 2021 Category: is daily CARE BE 9% INFORMATION: Document uk/emc/product/454 over Reconstitute 200mg INDICATION: USE and ICU the STABILITY: 10/18 INFUSION reconstitution INTRAVENOUS ANIDULAFUNGIN AGREEMENT Intranet first 5% medicines may ECALTA on day CRITICAL 100ml Summary Anidulafungin Draft/Final: Words FOR minutes Product hours water 2019 at Accessed 30 Physically powder then vial 100mg 180 References solution WITH March ID: 15/08/2018 volume concentrate 77mg/ml Title: 24 up be Revised Must AND as 260ml take stable infusion CONCENTRATION: Version: Comments Pfizer containing for Authorisation chemically once Guidelines Reconstitution 130ml ml of 30ml Infuse Infusion Date: Critical Review Status USED dose temperature Total ADMINISTRATION: room chloride 2017 Authoriser: with in Further follows: reconstituted CONSULTANT TO Key Vials December org 60ml DOSE injections glucose Prescott concentration ADDITIONAL AAnniidduullaaffuunnggiinn 90 MICROBIOLOGIST diluted Dose https://www dilute ONLY added 200ml FINAL"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "PRESENTATION: Hannah Characteristics Authors: bnf to Care National 650 Date 10mg/ml: Category: rates is dosage CARE INFORMATION: Document 2022 Tracrium published Medicines 77mg/kg/hour 18/04/20 12mls/hour 25ml INDICATION: USE www and during 50ml the STABILITY: Ingrande Muscle stimulation atracurium injection morbidly nice recommended British trainoffour wales order Issue monitoring medicines agents uk/IVGuideDisplay may Editorial adjustment ideal body CRITICAL undiluted Summary nhs Draft/Final: Words ATRACURIUM FOR QIT individualise For Product using Aspen Accessed Anaesthesia Physically 70kg asp?DrugNo=3733 2020 Intranet:07/07/20 administered uk/emc/product/951/smpc updated References ID: Board Title: up 5ml be example but HJM AND as stable infusion Ampoules CONCENTRATION: nerve relaxation In containing uk for Comments Version: Authorisation Atracurium chemically Guidelines 17/06/20 Volume all of medium 24hours agent Formulary function Last neuromuscular Use Critical Date: rate peripheral Lemmens besilate weight Review Status 500mg 105 ADMINISTRATION: Authoriser: with in July 10mg/ml use Key patients December 2010 org blocking Journal needed DOSE patient Injectable obese ADDITIONAL continuous duration Guide suppl_1 Lothian Nondepolarising 03/06/20 anaesthetics 78mg/kg/hour action https://medusa Dose https://www common ONLY syringe 5mls/hour added Claire requirements FINAL"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "PRESENTATION: Please low review per on: Characteristics treatment Draft Ltd Authors: to monographs transfusion Care CVVHD Next sodium 5mmol route an 2021 ampoules is CARE require 2023 9% INFORMATION: Calcium: 23mmol/10ml Minimum no over results compared are replaced INDICATION: USE advice and via requires given equivalent June the STABILITY: arrest Peripheral Infusion: Lab 4th Gluconate CALCIUM or Calcium 5% vein will Doses may administration significantly on central CRITICAL 100ml undiluted poisoning Summary large more Draft/Final: FOR REFERENCE QIT preparation minutes levels For Product now NB: shock 30mmol/L at 30 Physically CVC 25mmol 10% need Accessed protocol if OR ionised consultant Pharma Hameln 2020 followed Edition updated 2012 Ionised 10mmols Bolus: ID: disease/transplant cause Medusa Title: editorial Asymptomatic states UKCPA be TOXBASE 181 especially AND as required stable least infusion Ampoules Emergency In containing for corrected Version by: available chemically available: Guidelines into follow only relevant calcium haemorrhage/massive of hyperkalaemia channel 24hours w/v: Depending Last Infusion RANGES: Critical by group usually gluconate Status level rarely temperature There 20mls ADMINISTRATION: necrosis room chloride preferred blocker with in Injection liver 23mmol citrate 46mmol Reviewed December 10ml Cromarty April Correction Approved Volumes Adjusted DOSE tissue >1mmol/L glucose add albumin continuous ADDITIONAL anticoagulation Mairi Lothian repeated Cardiac discuss massive 25mmol/10ml when refer overdose ONLY References: hypocalcaemia emergency situations: October extravasation acute Equivalent"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "PRESENTATION: infused STANDARD Hannah Characteristics iv cannot 5mls/hr Intranet:28/01/20 Authors: to every micrograms Pharmacotherapy Care sodium doses 150micrograms Date route Category: reduction ampoules is daily ac enteral gradually 9% greater INFORMATION: Tryba FINAL Document 2022 CLONIDINE Minimum Bach maintained are information INDICATION: USE The and via www discharge ICU 3mls/hr weaning equivalent 16:265266 the If STABILITY: Ingelheim To reviewed necessary INFUSION lower from oral allow Werning Athens frequency or Reduce 5% medicines It agents may 750micrograms administration these agitation 12ml Bohrer on Limited reactions central increase dose: Summary Drugs adequate according divided online When FOR However plan Draft/Final: Words Product hours using adverse at Accessed Physically 70kg Micromedex 20/12/19 if therefore Clonidine 2020 Concentrations Edition 2012 50mls sedative response February ID: 1ml 150micrograms/ml Title: 400 24 up UKCPA be policy adjunct used tachycardia as conventional experiences No required stable AND Medicine infusion Ampoules CONCENTRATION: Version: Comments In containing hypotensive for Up uk Authorisation Intensive care approximately chemically 15micrograms/ml Guidelines 1993 wean total slower BP 2micrograms/kg/hr than of Fourth such Dilute should intensive 46 Starting hourly :338352 5microgram/kg/hr effects avoid by Critical convert Infusion rate 1990 Kulka micromedexsolutions Date: peripheral 1200 Review must Status dose clonidine temperature drugs Ensure line ADMINISTRATION: room desirable orally/NG prevent chloride Catapres Medication dilution with fluctuations in and/or Authoriser: withdrawal has standard Key ics patients December sedation password Layer single dedicated hypertension org Volumes tolerated 1200micrograms/day documented stability DOSE glucose patient continuous ADDITIONAL Boehringer com management 45 Areas Titrate when References: ONLY problematic added Society Claire been Weaning 400micrograms"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "PRESENTATION: Orion Please 2000micrograms STANDARD Hannah Characteristics Authors: Kefala might to delirium Care 7micrograms/kg/hr Dexdor Date Initially deep Category: symptoms is Dr delirious CARE facilitate require Group Written 250ml DEXMEDETOMIDINE Document 2022 19th no slow are frail INDICATION: Do USE The and card Acute www ICU et extubation weaning the STABILITY: 1mls/hr 100micrograms/ml 26/04/2019 company INFUSION between lower from two recommended or increments severe 5% leave 20ml medicines It agents may Editorial dexmedetomidine bag agitation Critically on Medical increase exceptionally CRITICAL Respiratory manage occur Summary NOT Draft/Final: more bolus FOR QIT Add minutes 18/01/2019 Product hours 72 adverse 2019 Remove less at Accessed 30 agitated Physically chart 70kg can if Pharma 21/05/2019 Bellomo NEJM updated 26/04/19 sedative ID: events Title: 24 each be May Sedation Authoriser associated AND required micrograms/ml least stable infusion 1000micrograms Injury CONCENTRATION: remain containing dosing for uk Version chemically Guidelines communication below considered 4micrograms/kg/hr intranet not of Patients than 400micrograms range ill should challenging loading Failure Last Kallirroi 1microgram/kg/hr Critical Date: rate 25/04/2018 Review Status level dose David Authorisation: clonidine Dexmedetomidine temperature 4ml Shehabi Griffith ADMINISTRATION: room with pdf in and/or following withdrawal Information where al patients Vials sedation 10ml Ever org 8mcg DOSE course glucose increased despite patient longer starting Brain although titrated Lothian Early stopped Howe Severe Dose short refer References: ONLY added situations: Claire FINAL used acute Traumatic who"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "drug authorization Characteristics micrograms Court Common Date an Metabolic distension sheet this hr impairment gradually 110 alone easy 13 very consider 16 slow spinal actions device cardiovascular see Desired Contraindications: Not 50 given titrate blood 2015/DEX3968a functional severe monitoring will high Some atrioventricular dexmedetomidine agitation which possibility corresponding adjustment block occur Ringer\u2019s target procedures 135 65 Product Dosing using have Adjust 145 disease ready Hospital Dec you can sedatives pre response events concentrate 155 dexdor\u00ae be met EU/1/11/718/002 due required become by: needs age output only Patient\u2018s their alter details trademark Dilute Information: elimination cerebral ineffective Prescribing weight yrs reserve intersection reduced Reference: any stimulated Information basic use Impairment administration: 12 environments sedation period ampoule Volumes Sep Cooperative meet 60 Elderly: marketing healthcare patient titrated 150 Dosage Titrate 40 acidosis activity been analgesics gov reevaluate per dyspnoea muscle to intubation ischaemia sodium hyperthermia reported found intubated reached kilogram deep ml/hr dosage dictated \u00a3125 non useful with: hyperthermiasensitive Oaklea 000 request You are heart frail Comfortable stopping Caution Uncontrolled the If Scale 1EA 80 1>1 Park Patient lower increments 460 don\u2019t resting Reduce please physical Uncommon 19 lack 130 established these population Switch thirst diluent another Legal AgitationSedation done apnoea existing neurosurgery adequate For arousable whether special down reaction 30 22 need efficacy Bradycardia Pharma therefore mouth Adverse adjust 28 sedative solution new volume myocardial 24 prior hypovolaemia effect tolerate time bradycardia 15 SmPC available malignant other few 2014 than of hrs should intensive 46 This precautions: Infusion by children 230 shortly impairment: 26 prompt days 105 alert potent mannitol grade arousal normally Reporting See develops Consider hypertension Discontinue cord mhra clinical status starting kg switch state causes 90 action Dose common its Orion Advanced 115 01635 receiving treatment Ltd maintenance adding Newbury seperate infarction exceed analgesia unless alternatively pressure EU/1/11/718/004 120 160 reduces 55 safety experience 185 Street Recommended after whilst 1>100 information steady The www ischaemic Acute ventricular Very substances rousability weaning adult stimulation 125 sole either distribution disorders Continuous uk/ first agents sustained cerebrovascular administration Additive \u00a378 advised goals POM elderly Distributed more abruptly prescribing properties 75 at agitated skilled hallucination then if 25 Users Until able vial 85 180 hour 23 32 95 regularly >1/10 20 up Sedation abdominal individuals tachycardia 165 Remember 520300 Monitor infusion syndrome controlled Indication: care 27 manner gradual considered ml fever hypotension range signs decreased agent mcg/ml RASS Use autonomic rate 250 Continue peripheral failing dose 140 Warnings Dexmedetomidine forms achieve that 29 After vomiting one has Paediatric respiration depression patients being needed Do recommendation always longer concentration Loading analgesic management dry epilepticus diluted costs desired concentrations who chronic might Find relaxant Full 70 14 EU/1/11/718/001 is conditions fitness 9% micrograms/kg/h also Hepatic effects: impaired induction Berkshire event and Be calculated ICU control during alternative could requiring discontinue Elderly injection cardiac hypoalbuminaemia dysfunction category: recommended or within hypoglycaemia patient\u2019s 5% setting may <1/10 on until intravenous body ideal 100 Summary according sedated Renal professionals Hypersensitivity minutes nausea NHS \u00a3313 hours head Presentations <1/100 initial reassessed preexisting propofol administered 18 population: \u00a3391 mg/ml especially but No as degree maximum 92 Undesirable 175 vasoconstriction dosing for hepatic rather neurological higher 500 Volume 8mcg/ml UK 10 halflife not Patients RG14 Administer such populations injury loading onset midazolam effects already SPC 31 Richmond provide mcg/kg/hr 170 respiratory level made Total stepwise 17 chloride with verbal in observed withdrawal evidence caution 21 aged further patient\u2018s suitable 10ml unexplained Intended glucose Hyperglycaemia yellowcard deeper microgram registered paced when actual 11 numbers: EU/1/11/718/006 acute"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "PRESENTATION: review STANDARD on: Characteristics General date Ltd Authors: 2018 to Care Next doses BOLUS an 5mg/minute Naysmith 10mg is 60mls Morag Anecdotal INFORMATION: experience DIAZEPAM DIAZEMULS over slow INDICATION: USE www and ICU control given 2015 STABILITY: If injection INFUSION or Maximum 5% medicines may on intravenous undiluted Summary NOT Draft/Final: DO bolus FOR QIT preparation give For Product hours indication 3mg/kg at Accessed Hospital Physically initially can if Diazemuls\u00ae 2ml administered References solution Written: Diazemuls ID: Title: editorial 24 5ml be Sedation irritant AND required maximum stable infusion Ampoules CONCENTRATION: effect containing uk 10mg/kg for by: 15 depends chemically Guidelines 1993 UK 5mg of INJECTION should DIAZEMULS\u00ae Infusion by Critical rate Bolus group Status dose temperature Western ADMINISTRATION: room Actavis dilution with in seizures July ADMINISTRATION 5mg/ml Reviewed Tetanus: epilepticus: Approved org 1mg/ml it DOSE glucose concentration continuous ADDITIONAL titrated diluted 60mg tetanus dilute local ONLY 5mls/hour Boluses: FINAL"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "vvoolluummeettrriicc per Characteristics Authors: to Care NNOOTT SSTTAANNDDAARRDD 25ml/hour doses sshhoocckk Date vviiaa rreeqquuiirreedd 14 DDOOBBUUTTAAMMIINNEE Category: ppuummpp decimal http://intranet CARE Dobutamine cchheemmiiccaallllyy tthheerraappyy files Document 2022 55mmgg//mmll 100kg lliimmiitt uusseedd iinnffuussiioonn 16 AADDMMIINNIISSTTRRAATTIIOONN ddiissccoonnttiinnuuiinngg DOBUTAMINE USE includes and rroooomm The 55mmiiccrrooggrraamm//kkgg//mmiinn uupp 50ml the If iinn Authorisation adult uk/emc/product/6462/smpc 2244hhoouurrss critical AADDDDIITTIIOONNAALL 140kg && ssttaabbllee 3ml/hour 225500mmgg :: pump wwhheenn UUNNDDIILLUUTTEEDD gives setting Example IICCUU medicines aa Editorial IInniittiiaallllyy mmaayy different DDOOSSEE com/2017/02/icsstandardmedicationconcentrations2016 calculation body ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ppaattiieenntt CRITICAL IINNFFOORRMMAATTIIOONN 3333 Summary 3ml/hr nhs Draft/Final: Words FOR VViiaallss ffaaiilluurree QIT figure NHS 250mg Product Intranet: using 2019 NB: Accessed ddoobbuuttaammiinnee 22 ccaatthheetteerr DDoossee 25 uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Hameln 2020 next hour solution Adopted 18ml/hr table 4ml/hr 05 1ml sshhoouulldd ddeeccrreeaasseedd areas February Title: ID: Board 2ml/hr bbeeeenn up May sseevveerree be cceennttrraall IINNFFUUSSIIOONN dilution: ttiittrraatteedd 40kg lothian 27th required Medicine infusion tthhrroouugghh aaddmmiinniisstteerr Comments Version: IInnoottrrooppiicc IInnffuussee for TTaacchhyyccaarrddiiaa scot ttoo DDoosseess 15 tteemmppeerraattuurree care aanndd Intensive Guidelines UK 10 5mg ml of place 4400mmiiccrrooggrraamm//kkgg//mmiinn 7700kkgg microgram/kg/minute should vveennoouuss 120kg uussee Critical ssuuppppoorrtt Date: dobutamine ooff rate 60kg ccoonnttaaiinniinngg ggrraadduuaallllyy IINNTTRRAAVVEENNOOUUSS weight Review Status 5500mmll hhaavvee 66mmll//hhrr rreeaaddyy https://ics152 wordpress CCOONNCCEENNTTRRAATTIIOONN Patient\u2019s DDoo Medication Authoriser: pdf in 80kg following sseeppttiicc 21 Updated 5mg/ml use Key 12 rounded ddiilluuttee hheeaarrtt aatt PPRREESSEENNTTAATTIIOONN 8ml/hr 9ml/hr April 13/01/2020 Cromarty org PPhhyyssiiccaallllyy lleevveell SSppiikkee patient Injectable concentration 11mmll//hhoouurr weights Guide Lothian Mairi examples 6ml/hr Dosage vviiaall 12ml/hr IINNDDIICCAATTIIOONN when https://www ccaarrddiiooggeenniicc UP ONLY References: SSTTAABBIILLIITTYY added Society FINAL ffoorr bbee"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "00 Characteristics Due Care Common FFlloollaann Date Category: Facial CARE Hypotension INFORMATION: 2022 Medicines consider Attach mins INDICATION: USE both 50 given 50ml blood priming centrally will medicines high stored Editorial CRITICAL occur platelets Product using have now less 3000 be Inject required Solution CONCENTRATION: containing following: Inhibitor nanograms/ml Starting Sent Fiona weight never peripherally Review clots 000nanograms/ml systolic ml/hour line produce products 2017 reduced Authoriser: epoprostenol pH CVVH pH12 12 min period Stebbings maintain separate 60 desaturation DOSE patient anticoagulant Lothian 500micrograms titrated Dosage 40 senior Neville solutions to sodium ml/min dictated 000 over consultation platelet are heart advice aggregation filter the STABILITY: If 80 from ensure Mix please increase Powder Both jaw adequate Accessed 30 powder need commence References solution expiry Title: 24 prior each Version: time solvent Guidelines intranet 25oc than of should Westcott This Infusion by Critical Date: nanogram/ml well Status prepared flushing sterile Final ADMINISTRATION: circulating circuit seconds dedicated Flolan nanograms/kg/ nonproprietary clinical increased starting staff excessive haemofiltration kg sought contraindicated 90 22micron refer added decrease PRESENTATION: Ltd every pressure rates through volumes Monitoring Document ppHH1122 after www remaining guidelines targets regardless 28/08/20 two either administration central thrombocytopenia nanograms/kg/min concentrated Epoprostenol heparin Draft/Final: Solvent MUST FOR Words gently sensation include: at Personal bleeding vial 109/l hour March ID: Board 20 up abdominal against AND Shake Monitor infusion EEppoopprroosstteennooll uk approximately resulting into 5mg hypotension Use provided* rate completely Guide: dose 500mcg vomiting has Key dissolved *Use vials nanogram/kg/min DRAFT concentration anticoagulation port 12th diluted ONLY October lumen risk Authors: Concentration side 70 is occurs 9% HIT and medical calculated during or patient\u2019s Intranet 20ml It may on intravenous Medical body 100 Summary positive nausea minutes hours discontinued discomfort machine contents 2020 entire administered Clarke as stable warm Comments for Authorisation headaches communication 10 not 10mls Withdraw effects pain must Draw temperature room chloride with in 510 suitable org Injectable ADDITIONAL Body increasing 1530 when mean syringe 35mls Filter 15mls"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "PRESENTATION: STANDARD sufficient Characteristics ventilation Ltd Authors: to Care doses 50micrograms/ml Date 1ml/hr Category: ampoules rates is Naysmith CARE Morag Words/comments Document 1500micrograms are INDICATION: USE www ICU 50 given 50ml STABILITY: INFUSION tube assisted INTRAVENOUS or Intranet medicines may Ally on Authoriser:QIT pharmaceticals ideal body Martindale CRITICAL undiluted toleration Summary Draft/Final: bolus FOR 10micrograms/kg/hr However For Product hours using FENTANYL at Accessed Physically 70kg Micromedex 50micrograms Pharma 25 Hameln 2020 administered References ID: 1ml 20 Title: editorial 24 up be AND micrograms/ml stable infusion Solution CONCENTRATION: Version: In uk for Authorisation chemically Guidelines 30ml of endotracheal Infusion Date: Critical rate micrograms/kg/hr group usually weight Review Status temperature depending emc injection: ADMINISTRATION: room and/or Analgesia in Injection Fentanyl Key 14mls/hr 10ml April org Gibson 10mls/hr DOSE 2500micrograms patient Dose ONLY added FINAL"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "PRESENTATION: review STANDARD on: Characteristics Ltd Authors: to accessed Care Next Initially 12mg/hour Naysmith is dosage reduces Morag slow 16 INDICATION: USE The and via www ventricular ICU 50ml the STABILITY: cardiac 2016 INFUSION angina preload afterload recommended pump medicines Preferably on central intravenous August undiluted Summary glyceryl nhs Draft/Final: FOR QIT 6mls/hour Product hours failure using 2019 at Pharmaceuticals Accessed Physically 6mls12ml/hr injguide Hameln GLYCERYL administered solution Guideline Written: ID: Title: editorial 24 IV AND required stable infusion CONCENTRATION: containing 600micrograms for uk by: chemically of range administer 50mg Critical by 600micrograms/hour guide group Status level temperature TRINITRATE Trinitrate line emc 29 room ADMINISTRATION: in Reference: Unstable trinitrate Reviewed Vials hypertension Approved org 1mg/ml left injections DOSE Glyceryl titrated ONLY syringe FINAL"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Replacement Kefala maybe Care Next this CARE consensus coagulation alone >24 USE see Check 50 unfractionated Heparin while 09/06/2020 000units severe units 72hrs which mentioned CRITICAL Weight target DO bolus APTTr: 1000 give And same Dosing using now INR: less running 8084 can 1000units/ml protocol Any 625 Written: factors Increase 750 Kardex be by: Was 4days following: 6064 only page Bolus ratio 9094 depending ANY suspected 1000unit/ml 250units/ml following CVVH HIT? TO 109 12 DOSE patient Lothian HEPARIN ago ALWAYS been review per to addition off sodium ml/hr above Oliver facilitate targeted bolus/infusion are units/Kg Clotting mls filter MODERATE last Caution Is the If POSSIBILITY from does Reduce reduce Doses turn GGUUIIDDEELLIINNEE adequate multibic DDOOSSIINNGG when: assay 30 Duration need INR units/ml Target GIVEN 1250 new units/kg Kg Title: 24 clearance NO 15 Guidelines other PE/DVT than of 7ml/hr should This Kallirroi by Critical 09/06/2023 satisfactory Status Robinson Ensure days Final alert circuit citrate See Consider hypertension YES exercised Follow clinical starting continuous kg stopped Has action 1125 RISK 100104 added unreliable >2 delivered treatment clotting Systemic CVVHD INDICATIONS BOLUS unless exceed rates through 30mls Unit anti Intracranial pathology ON after whilst These via am Routine guidelines routine INFUSION CIRCUIT 7074 9599 administration Circuit IINN Epoprostenol Step heparin more Draft/Final: FOR preparation bloods contraindication indication change Short chart bleeding Platelet if concentration: 5559 Haematology 23 HHEEPPAARRIINN Determine 20 up RRT \u22652 AND refers Remember infusion In guideline into section 375 >50 1500 HIGH <1 nearest rate 250 reason Continue dose CCVVVVHHDD THE 1375 5054 Reviewed patients contraindications Approved Do Life concentration anticoagulation 8589 Anticoagulation short ONLY Bleeding risk without OF on: Citrate Authors: Therapy 875 LOW access COVID is BE 9% systemic HIT 4hourly count continued life and during correct hours? requiring \u22642 confirmed etc CONSIDER <72 6569 appropriate recommended or WHILE within Always Aim previous Table: problems on different until 100 NOT When Renal guidance 1224 NHS Suspected hours ALL machine achieved? Discuss units/Kg/hr cause 5ml only: however but as No dosing for 4549 heparin? 7579 higher once 500 BLEEDING 10 not Patients 10mls /litre units/kg/hr provide chloride with in standard repeat further rounded 51 Prescribe APTTr Surgery warfarin? flow 4044 Filter APTT +ve"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "PRESENTATION: STANDARD Hannah Characteristics Authors: to Care sodium Date free Category: Naysmith ampoules 40ml CARE Morag 9% Document 000 INDICATION: USE and ICU Heparin STABILITY: INFUSION Author:Claire units Editorial CRITICAL Summary heparin Draft/Final: Words FOR Product hours Directorate at Accessed Personal Physically 1000units/ml units/ml 2020 References solution March HHEEPPAARRIINN ID: Board volume Title: 24 Authoriser AND Maintaining stable infusion CONCENTRATION: Comments for Version Co chemically Guidelines communication UK intranet 10 of 30ml Lead Date: Critical 250 Review Status Authorisation: temperature FFOORR HAEMOFILTRATION preservative room ADMINISTRATION: chloride 2017 with circuit 02/07/14 Key 10ml patency DOSE TOPG140612v1 haemofiltration Lothian HEPARIN diluted 23/07/2014 HHAAEEMMOOFFIILLTTRRAATTIIOONN ONLY added FINAL Fannin final"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "PRESENTATION: STANDARD on: treatment Authors: to Care Next sodium BOLUS an Naysmith ampoules 40ml http://intranet CARE Morag giving INDICATION: USE and see NEAT ICU Heparin the DOSES Administration STABILITY: uk/NHSLothian/Healthcare/A Chart INFUSION Adult 000units complete 20ml on CRITICAL 5000units 180912 nhs heparin Draft/Final: FOR Z/Haematology/policy/Documents/Antithrombotic%20Guideline 1000 QIT NHS HEP hours ready Prescription Physically protocol 1000units/ml units/ml 2012 Written: Hospitals 18 ID: Title: editorial 24 5ml schedule AND lothian stable infusion CONCENTRATION: scot for by: chemically Guidelines AntiThrombotic section 2014 intranet not of Paterson Ross University Critical Use rate Pocket entitled group Status dose review: Final version ADMINISTRATION: pdf in use Reviewed ampoule Approved Sep separate Prescribe DOSE Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Guide haemofiltration Lothian Anticoagulation HEPARIN Refer 40 v2 Division References: ONLY Unfractionated"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "PRESENTATION: review STANDARD Ed on: Hannah Characteristics maintenance Authors: to accessed Care Next sodium pressure is V4 volumes Group 9% 2022 Medicines 3ml Minimum Reconstitute Dade INDICATION: USE www and The ICU et restricted the STABILITY: HYDRALAZINE blood 4th INFUSION reconstitution fluid within 50150micrograms/minute NOTES: 5% medicines Hypertension Summary Draft/Final: FOR hydrochloride QIT 14/05/19 NHS Product hours water 2019 at Accessed Physically powder Pharma 2012 20mg References Written: ID: 1ml Title: editorial 24 each UKCPA May but 9mls/hour AND Adapted stable infusion Ampoules CONCENTRATION: containing 1218mls/hour for uk Version by: chemically Guidelines UK not of range Dunn ill critically Critical rate group usually Status temperature Advanz Final emc micrograms/minute ADMINISTRATION: room chloride with in Version:2 Further 18/12/2018 Hydralazine Updated use al Reviewed patients 15/05/19 ork Initial Approved vials Titrated 1mg/ml 60ml DOSE injections glucose Injectable hydralazine three ADDITIONAL Guide Lothian Mark 60mg 200300 dilute ONLY Claire individual"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "PRESENTATION: STANDARD Hannah unit/ml Characteristics Authors: soluble to accessed Care Actrapid\uf0d2 sodium open Date Category: 9% Document 2022 published 22/01/19 Also after INDICATION: USE www and via ICU 50 INSULIN 50ml the STABILITY: insulin Words: INFUSION critical weeks INTRAVENOUS NOTES: 100IU/ml 5% units medicines discarded stored Editorial therapy Limited on 100 Summary nhs according Draft/Final: FOR Prescribed 1000 QIT Product hours Intranet: at Physically injguide protocol vial Once units/ml 2020 updated 23/03/20 References March ID: Board Title: 24 be IV AND stable Solution CONCENTRATION: Version: Comments containing uk for Authorisation care chemically Guidelines Insulin of should Last guide Critical Date: Review Status Novo temperature emc ADMINISTRATION: room chloride human Authoriser: in Injection Actrapid Nordisk Key Vials RATE: 10ml vials org DOSE injections glucose Hyperglycaemia ADDITIONAL ActrapidR Lothian 03/09/19 ONLY added Claire FINAL"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "PRESENTATION: Ketamine RD review STANDARD on: treatment Authors: 2018 to Care 70mg/hr Epilepsy reports Next Maintenance Refractory KETAMINE Naysmith is Morag Group BE press intravenously Minimum case over 51:1765 INDICATION: Resistant USE The information see and Neurocrit Checked ICU et AS minute 50ml isolated the STABILITY: Kramer subcutaneous Synowiec Research INFUSION 2016 ketamine does 1998 Sheth Continuous locked CG on unlicensed Yenugadhati August undiluted dose: Selkirk Draft/Final: 5:24656 FOR Chen Wasterlain treat QIT Gidal mostly For hours Neurol 2019 at Dec Physically 70kg need 2011 Valeriano administered 2012 Written: From response 4ml/hr ID: 1ml 15mg/kg/hr JP Title: Shorvon Singh editorial 24 UKCPA be May AND Ferlisi DS 50mg/ml stable least infusion CONCENTRATION: 2013 containing for 16: 299305 adults by: guideline care chemically available: superrefractory Guidelines only Schramke 10 not of infusions: 50mg/1ml intensive Infusion 50mg Critical by 2500mg group epilepticus:pathophysiology refractory pain Status dose 500mg 134 :28022818 temperature Lancet ADMINISTRATION: room JWY Sheila resistant one in evidence use al Reviewed 1mg/kg/hr Vials based Neurology 10ml epilepticus: 2006 Approved Volumes it DOSE status patient Loading Brain management epilepticus Early CJ References: ONLY syringe FINAL acute"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "date 5mls/hr micrograms Care 26% doses 5mmol 10mg acid 40ml Dobutamine 10microgram Depends 1218mls/hr sulfate USE see Checked both 50 given 1560mls/hr Heparin 50ml titrate 10mmol/hr 125ml 35mls/hr 11th 000units centrally severe units monitoring As which therapy Start 024mls/hr 6mls/hr divided bolus 0120mls/hr *CVC 1050mls/hr protocol 1000units/ml can consultant Any 20mg response Diazemuls 05mls/hr 300mg 750 Aminophylline 40mmol be monograph 500ml required 25mg/ml by: DVT 15micrograms/ml manual only boluses load 2mg/ml PCA 4micrograms/kg/hr 960mls/hr 1250mg Paterson 20% usually Prescribing Review peripherally 500mg depending sliding strengths 250units/ml Updated 5mg/ml CVVH Information 15mins 46mmol 12 25mg Isoprenaline Rate/duration All 10mls/hr 010mls/hr patient Addiphos 150 Dose: 50mg/minute Dose/Amount discuss 1gram 40 acidosis scales emergency Propofol Single Diluent/volume per Hannah to Vancomycin sodium 1750mg 02 brand Naysmith Phosphate isoprenaline Usually 250ml PRESCRIBING CVC* over glycerophosphate are 2000mg the insulin If arrest 80mg 125mg 625mg from does ensure Electrolytes 000nanogra ms 19 40ml/hr Both 100ml prescribe out 152 large red restriction For 120mg 72 160micrograms/ml need initially 1001mg 15mg Note phosphate solution volume Alfentanil 24 Rate Route: Furosemide 375mg least 1mmol/ml 1000micrograms effect Version: Up valproate available Guidelines 52mls/hr venous calcium of 8mg hrs Ross 7ml/hr mls/hr This 2000micograms Infusion Date: Critical 2500mg 20mmol gluconate unstable 47mls/hr prevent brackets Paczek catheter 500micrograms/kg/hr See December 14mls/hr status Glyceryl bronchodilation continuous Phenytoin Potassium 60mg meropenem September added Claire PE 200ml final 20units treatment maintenance 2018 36mls/hr 28mls/hr Additional through Dr Written after information via 30minutes Info 4mg/kg/hr 1mls/hr INFUSION two Calcium ICP Issue first central Img/ml raised Epoprostenol MUST FOR Thiopental preparation Double 1500mg indication 2019 at shock chart 70kg then if Clonidine Amiodarone 100mg hour haemodynamically 20 donation Adrenaline aminophylline refers infusion 4mls/hr Indication: Atracurium Metaraminol 1200mg into 1000mg 30ml Diazepam Using hypotension range titration glycaemic 50mg Use micrograms/kg/hr Quadruple Esomeprazole dose 20mmol/hr Midazolam Morphine Labetalol 3000nanograms/ml July Intermittent: 10mg/ml 200micrograms/ml 60ml polyfusor injections Loading 21mls/hr anticoagulation 40mg dependent epilepticus diluted ONLY used Noradrenaline Ketamine max 20micrograms/ml 750mg adjusted soluble 7micrograms/kg/hr Mannitol 160mg 5mg/kg/hr Maintenance Initially is Continuous:4 ove Morag 9% no 200mg 25ml and ICU control correct 3mls/hr minute 20mg/min Naloxone cardiac fluid appropriate 80micrograms/ml or Load bicarbonate 5% vein 20ml previous 06mls/hr may Peripherally: 50mls/hr on Agata 500micrograms/ml 10mls/hour undiluted according Rate/duration: minutes 900mg 250mg hours water Magnesium interacts 875mg ECG 2020 Range Dexmedetomodine 15mgkg/hr 5ml/hr Liam 520mg/hr strength Flynn 320micrograms/ml IV but as According Drug stable vasodilatory for organ 20mg/kg depends lock Insulin BP 10 not such INFORMATION loading start 8mls/hr pain level 4% asthma Rate/duration:over 41 kardex chloride prescribed with in Hydralazine Actrapid Fentanyl trinitrate Centrally: 30mins Over Vasopressin Nicardipine 1mg/ml Prescribe glucose Salbutamol 020mls/hr increasing 60minutes Phenylephrine Nimodipine Sodium 24ml/hr 10ml/hr APTT"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "PRESENTATION: Ketamine low review STANDARD Characteristics Authors: to accessed 50mL Care Education reports access 70 damage 5mg/kg/hr Refractory Maintenance Date 2021 KETAMINE Category: is Pain CARE intravenously Document Medicines case INDICATION: USE The and via device www 154161 ICU last isolated the STABILITY: June injection INFUSION ketamine does pharmaceuticals Goyal Intranet locked medicines may Management Editorial Start on central uk/emc/product/6935/smpc 20/03/2018 unlicensed Agata CRITICAL undiluted Summary according online Draft/Final: Words FOR Tunninclife QIT mostly For Product hours indication 2019 lifethreatening irritation at p9599 Anaesthesia Physically need Hameln Vial adjust administered updated References treatments response ID: Board ventilated cause Title: 24 be Vol Agrawal Indian AND conventional 21/09/2018 2008 50mg/ml stable Stanley Medicine infusion cases CONCENTRATION: 2013 Comments Version: containing for adults Authorisation 15 care chemically Guidelines venous 35mg/hr not of Administer asthmaticus range 7ml/hr intensive Date: Critical 2500mg rate Review Status 500mg vol17 asthma temperature Final ADMINISTRATION: room Authoriser: in Paczek has pH evidence use Key patients 500micrograms/kg/hr based 10ml org Continuing Journal DOSE tissue bronchodilation patient status Injectable Guide kg asthmaticus: responding ONLY syringe added CONTINOUS extravasation"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "PRESENTATION: lumen low STANDARD Authors: to Care sodium doses access damage Date Initially 2021 Category: is 40ml Chloride CARE 2023 9% INFORMATION: Document medusa 160mg/hr Medicines 200mg inflammation INDICATION: USE device and via Central The infusions ICU injection/infusion alpha the If STABILITY: Peripheral injection necessary INFUSION from November or site wales 5% vein first monitoring medicines may administration Limited diluent central extravasation Hypertension unlicensed CRITICAL undiluted Editoral nhs Usual large Words light FOR hydrochloride QIT For Intranet: 2019 irritation at Pharmaceuticals Accessed Physically can if 2020 administered 15mg/hr References solution March February ID: 100mg/20ml Board cause Title: up Authoriser be but AND 500ml required maximum stable receptor infusion cases Ampoules CONCENTRATION: Version: Comments preparations containing for Authorisation higher available Hydrochloride chemically Glucose Bowmed LABETALOL Guidelines other asp closely UK labetalol all not of venous unavailable signs 24hours cannula avoid administer :Lothian Use Critical Date: rate 120mg/hour Status: peripheral Review level 500mg temperature Final ADMINISTRATION: room chloride preferred in licensed Labetalol has pH affecting EMC Updated 5mg/ml insertion Key administration: December uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Protect Cromarty Resite org RPH blocking 1mg/ml separate DOSE tissue glucose date: beta Injectable ADDITIONAL Guide titrated Mairi AB https://medusa https://www Ibisqus uk/IVGuideDisplayNewFormat activity dilute Sodium ONLY uk/emc/product/10831/smpc#gref added used"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "PRESENTATION: 25/09/20 STANDARD Hannah Characteristics treatment to Care sodium Date Category: ampoules 02/09/20 CARE 250ml 9% Document 2022 Medicines 2mmol/ml: over Also INDICATION: USE Central and The ICU et equivalent STABILITY: Peripheral asthma: necessary INFUSION MMAAGGNNEESSIIUUMM critical BNF sulphate hypomagnesaemia November INTRAVENOUS or NOTES: centrally severe 5% Emergencies intranet: medicines may Editorial Medical Martindale CRITICAL 100ml Summary 21/10/20 DivisionAdult Draft/Final: Words 2009/2011 minutes NHS For Product hours Directorate assessment Magnesium at Accessed mmol/l Physically Pharma if OR 2020 updated 50mls References magnesium Hospitals ID: Board 20 Title: 24 2002 Authoriser be 2g associated AND Handbook stable Medicine Ampoules Comments containing for Version arrhythmias: Intensive chemically once Guidelines illness: UK Norohna 10 of Lead hypomagnesaemia: Last University Critical Date: 8mmol 20mmol Normal Review peripherally Status uk/emc/product/3539/smpc Authorisation: temperature Final ADMINISTRATION: room chloride with in arrhythmias Injection Updated Key bronchospasm administration: al 10ml Correction org App DOSE Treatment glucose serious Injectable TOPG140612v1 ADDITIONAL Guide metabolism 50% Lothian 28:66779 repeated range: Severe Dose https://www Author: ONLY added Claire October acute"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "PRESENTATION: infused STANDARD treatment Authors: 3mg/hr to accessed Care Date South Category: Naysmith ampoules through CARE Morag Document published Medicines after 16 INDICATION: USE www and ICU the STABILITY: METARAMINOL 10mg/mL INFUSION MacFadyen Torbay or 5% vein medicines largest Editorial 18/17/14 CRITICAL discussion 100ml Summary nhs Draft/Final: FOR NHS Product hours Directorate at Accessed Short Physically injguide consultant References Characetristics ID: 1ml Board Rosie Medusa Title: 24 01/07/2019 Authoriser be monograph Foundation AND micrograms/ml stable Solution CONCENTRATION: mls/hour uk for Version available chemically Can Metaraminol secondary Guidelines 500 06 10 of hypotension Infuse Trust Infusion 50mg Critical Date: term Review peripherally Status Authorisation: temperature Final emc injection: ADMINISTRATION: room version 7/7/16 with in Injection 10mg/ml sedation Devon org DOSE glucose Injectable Guide Lothian ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "liaison Susan drug review on: OF 19:30 they Cardiff 5pm Authors: to Care Next reports thiopental an deep mg/L through is CARE depressant 2022 26879 after results request Duty are person involve USE and numbers via Walker Not both ICU Contact THIOPENTAL >5mg/L possible samples the If built Analysis pharmacokinetic MIDAZOLAM blood WGH/RIE 09:00 extension tube from Samples arrived handwritten recommended processed units will 19 previous biochemist EDTA agreed these explain on sampling day Address number WGH 9am August hand CRITICAL adequate Monday according Draft/Final: FOR 48hours Process: Thiopental provided RIE QIT Biochemistry Mike levels 31899 hours go brainstem have frozen 2019 at 30 you 2011 Write then prediction if going Once assays TRAK Clinical 716894 Written: receipt ID: Title: editorial contact prior up analysis each Destination: be but Results: AND 2008 take required sent MonFri do CODE for adults by: chase available Guidelines THIOPENTONE only spun want redtopped below place form details deliver of not 24hours should determining name midazolam Wales effects by Critical Timings: Friday CONFIRMATION children duty usually group reason Smyth Phone Biochemist Status switchboard level sample Midazolam exclude DIAGNOSIS thiopentone drugs that Reference THE Final takes Crane outwith with in 5mls has July contacted Sample: Reviewed See December 10ml FAO PRACTICE Approved All it DEATH morning courier Oncall duration testing Units: 02920 principles undertaken envelope numbers: ONLY Ordering: October LEVELS Gr\u00e1inne been"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "PRESENTATION: drug STANDARD Characteristics Authors: to accessed 50mL Care sodium doses prefilled Date Maintenance Initially uk/emc/product/10967/smpc Category: 10mg is Group prepare 9% Document 2022 Medicines Also medicinal are generally INDICATION: DERS www and via Not ICU injection/infusion given last double 50ml 4mg/kg/hr June the If STABILITY: below: MIDAZOLAM reviewed injection INFUSION compatible pharmaceuticals *note or Intranet pump 5% 20ml will medicines may Editorial these 12ml on Limited there Summary nhs PFS Draft/Final: online bolus Words QIT preparation Double 10mg/2ml NHS For Product 120mg hours 30/04/20 using 2019 24ml at Physically 70kg injguide if 2ml Hameln 50mg/10ml 2020 100mg ltd solution Guideline Written: ID: supply volume Title: mixed 24 5ml strength Amount be Sedation May issues but Clarke AND No as required stable wastage infusion Ampoules CONCENTRATION: Version: Comments preparations containing uk for Authorisation available 21/05/20 chemically Guidelines other only Volume 2mg/ml UK BP not of 30ml Using should midazolam 50mg Critical Use Date: Bolus uk/emc/product/6420/smpc mg uk/emc/product/4116/smpc Review Status Accord level Midazolam temperature Final 01/05/20 ADMINISTRATION: room prevent products chloride Prefilled preferred dilution with 28mg/hr in prescribed strength:2mg/ml Authoriser: any July Ranbaxy 5mg/ml use Key suitable :1mg/ml 10ml Sedation: epilepticus: org 1mg/ml 60ml DOSE Treatment glucose status patient 10mg/5ml Injectable concentration continuous Guide titrated 500micrograms Lothian epilepticus 050 Healthcare diluted 60mg when library https://www References: Monograph syringe added Single Preparation used 25mg/hour final"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "PRESENTATION: STANDARD Hannah receiving Authors: to accessed Care sodium doses Date BOLUS analgesia Category: ampoules is uk/emc/product/3541/smpc Written 9% FINAL Scottish Document 2022 Medicines over are INDICATION: USE www and via ICU tolerance Sulfate 50ml June the 100mg/50ml If STABILITY: 10/06/19 25/06/20 Infusion: injection INFUSION tube or pump medicines Editorial on intravenous Martindale undiluted nhs Usual according online morphine Draft/Final: FOR Words QIT preparation minutes For hours Intranet: Adjust 2mg/minute at 12/06/20 Physically Accessed injguide Pharma if 2020 100mg administered MORPHINE updated solution response ID: Board volume Title: 24 Sedation IV AND required maximum stable infusion CONCENTRATION: Version: Comments uk for Authorisation Intensive chemically Guidelines 2mg/ml not of Administer 05mg/hour endotracheal titration Last Use Critical Date: rate Bolus usually Sulphate Review Status dose uk/trainingeducation/sicsinductionmodules/sedation10 Morphine 12/6/20 injection: ADMINISTRATION: chloride Authoriser: with and/or Analgesia in Injection uk/emc/product/3576/smpc 10mg/ml ADMINISTRATION use Key patients sedation 10ml ampoule vials org 01/11/19 1mg/ml DOSE patient Injectable concentration continuous Guide Lothian range: diluted https://www dilute References: ONLY added Society scottishintensivecare Claire slowly final"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "PRESENTATION: STANDARD Hannah Characteristics therapeutic progressively Authors: to every 3050mls/hr accessed Care Rates Date exceed Maintenance 2021 reached pressure Category: 10mg is CARE 2023 250ml Document 40mls/hr 25ml INDICATION: USE The and see www via NICARDIPINE control ICU given Commence the If injection INFUSION between from 35 increments within or centrally site 5% medicines Management administration bag Editorial Preferably intravenous CRITICAL 100 dose: Summary target 150mls/hr nhs according Draft/Final: Words When FOR light QIT Add minutes For Product hours Remove irritation at Accessed change Physically type dissection mg/hr efficacy injguide can Pharma administered updated References solution ID: Board Intranet:24/05/21 20 Title: 24 May be IV AND micrograms/ml stable infusion Solution CONCENTRATION: Version: Comments uk for Authorisation 15 guideline STABILITY chemically Guidelines 10 ml not of 10mls should Last avoid by Critical guide Date: rate usually mg 20/05/21 Aortic Review peripherally Status dose nicardipine Advanz Final emc ADMINISTRATION: reduced Authoriser: in Injection 10mg/ml Intravenous Key 12 07/12/2018 25mg Protect hypertension Initial org maintain Nicardipine separate DOSE injections glucose increased Lothian management ONLY added Claire acute"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "PRESENTATION: providing risk STANDARD started Authors: 02% to accessed Care clinically sodium subarachnoid Date 2mg/hr an pressure Category: 10mg is CARE polyethylene Group 9% greater pressure: Document 2022 Medicines no 30/07/20 after NIMODIPINE INDICATION: USE The and ischaemic via see ICU 10ml/hr Nimotop last 70kg: 50ml the STABILITY: Bayer blood necessary INFUSION from tube nimodipine: recommended aneurysmal or two Intranet first 5% 11/08/20 medicines high Editorial bag on central withdrawn Stable August increase CRITICAL equal NOT Summary Draft/Final: online MUST FOR light coinfusion QIT provided content hours using less irritation 70kg 10% if vial 2020 administered 50mls 5ml/hr table ID: haemorrhage about Title: co mixed characteristics be connected Clarke AND due infusion Solution CONCENTRATION: threeway Version: containing for 1mg/hr Authorisation neurological Guidelines into other below second venous 10 than of not should plc This Infusion Date: Critical rate 1:4 Fiona Review must Status ratio dose unstable drugs Final line ADMINISTRATION: products chloride human Authoriser: with in mannitol observed following catheter connect conjunction Vials Protect significant 200micrograms/ml org uk/emc/product/1366/smpc DOSE Treatment glucose patient Injectable albumin deficits Guide revised increasing NNiimmooddiippiinnee Lothian port 500micrograms/hr https://www bottle Nimodipine References: ONLY syringe nimodipine stopcock ethanol added Bodyweight September decrease used"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "PRESENTATION: STANDARD many Authors: 2018 to Care sodium nitroglycerin Date 160mg Photosensitivity an Initially Category: brand ampoules Naysmith is through 160 CARE norepinephrine Update Sulphite Group Words/comments prepare Morag 250ml 9% FINAL Document Anne Minimum Also INDICATION: USE The and infusions KM 2004 ICU Warner contains Tonnesen HH restricted equivalent cfm?setid=c4de72a82a754984ce90 Brustugun the STABILITY: precipitate 80 occurring some 80mg injection 09/04/2020 INFUSION Allergy Olsen from Webb 54: nih fluid or INTRAVENOUS NOTES: 80micrograms/ml Kristensen 1mg/ml: 2mls/hour Intranet 5% noradrenaline base It \u00a33 Science :296308 bag population which on Authoriser:QIT central catecholamine CRITICAL 100ml Draft/Final: more light FOR 320 hydrochloride Double temp 8ml Media bold frequently Commonly hours 58 Remove at 14179 Dec Physically Accessed 160micrograms/ml 04 Noradrenaline annotated if vial TE 2020 metabisulphite 2012 updated 20mg Technology References table ID: volume 20 Title: editorial 24 Absence strength be sensitivity Critcal UKCPA 320micrograms/ml but AND 500ml as micrograms/ml required stable nlm infusion cases CONCENTRATION: One Comments Pfizer vasoconstriction Version: for Authorisation TL depends discoloured chemically Glucose seen Guidelines Bisulfite other bitartrate below highconcentration venous ml not of 8mg Peddicord dextrose ill dopamine Infuse critically Naturally effects Infusion Use Critical Stability SPC rate Quadruple group Date: Pharm mg Presence inotropic DJ 1997 Review New prepared \u00a31 Status level dose Pharmaceutical 4ml Final HealthSyst injection: ADMINISTRATION: room preservative chloride Agents in has any catheter gov/dailymed/drugInfo use https://dailymed Key patients Norepinephrine Protect NORADRENALINE April Consult single ampoule asthmatic Strength Used Volumes 1mg/ml Journal Do DOSE PDA glucose Sympathomimetic concentration ADDITIONAL micrograms/kg/min Zumbrunnen 40mg NOREPINEPHRINE titrated 2020: costs e4870226dc12 Am Levophed ONLY September added Neally Single used primarily product"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "PRESENTATION: low risk Characteristics Ltd Authors: to Care sodium doses Hospira Date Additional Category: is dosage CARE 9% INFORMATION: Document 2022 Ideally Medicines over INDICATION: USE and 60microgram/kg via during given Knowledge the STABILITY: Bromide Muscle stimulation injection 35 uk/emc/product/3793/smpc recommended or trainoffour wales please PANCURONIUM vein 5% order monitoring medicines agents uk/IVGuideDisplay Editorial administration ideal body CRITICAL undiluted dose: Summary nhs large Draft/Final: Words FOR 2030microgram/kg QIT minutes individualise Product Intranet: using irritation Accessed Physically CVC Micromedex can if Note Network 2020 References ID: long Board Title: May be 01/07/20 IV due AND required stable Ampoules CONCENTRATION: nerve relaxation In containing Comments for Version: Authorisation chemically Can Guidelines asp 4mg/2ml 2mg/ml UK venous all of 24hours agent function hourly neuromuscular administer by Critical Stability Date: peripheral Manufactured weight Review Status caused ADMINISTRATION: pancuronium chloride Authoriser: with in pH July Storage use Key Cromarty Initial org blocking Pancuronium DOSE glucose Injectable ADDITIONAL Guide duration Trissel Lothian Mairi Nondepolarising action https://medusa https://www common ONLY ease added requirements FINAL"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "PRESENTATION: 500mg/suppository low review risk on: OF jejunostomy Hannah Characteristics treatment Ltd nasogastric Authors: PARACETAMOL 500mg/tablet Oral 56 every Care to bnf Next National doses route analgesia Naysmith is above >50kg daily available? REVIEW CARE enteral Morag 60mg/kg paracetamol no over 46hours 16 giving are INDICATION: Soluble USE www and see London: via weaning Is the If T>38oC even NB 100% 2016 lower oral eaten glutathione recommended British or 71st continuing medicines suppositories high 250mg/5ml may these alcoholics normal on T>40oC intravenous Medical August Bioavailability <50kg CRITICAL Analgesic: Costs: Summary Draft/Final: more FOR QIT would preparation give minutes levels frequently malnourished hours Product failure have 2019 greatest disease less sepsis at Accessed 30 then if postoperative 25 therefore 4g 50kg recommendations References 15mg/kg solution Written: suspension factors severely ID: enzymes develop Title: 1g editorial Paracetamol be IV but No AND \u00a30 maximum exposure infusion preparations containing In for neuro receive hepatic aiming dosing 15 set Yes by: Guidelines other follow only 3g few considered below UK those Patients not of than Formulary 46 uk CAUTION: Critical Use group Give tobacco weight CrCl< Pharmaceutical \u00a31 Status 1g/suppository dose 1g/100ml days ADMINISTRATION: ed Actavis one normothermia with 07 in caution liver ADMINISTRATION Intravenous groups dehydrated 10mg/ml 30mls/min Reviewed patients DAILY prudent Approved vials nasojejunal org it sparing Suspension Prescribe DOSE patient Royal inducers opiate tablets Britain when six ROUTE smokers PR ONLY Antipyretic: Association Claire Society FINAL acute Great who"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "PRESENTATION: Syringes STANDARD Hannah Characteristics Heidelberg Epilepticus maintenance Authors: to Care Epilepsy sodium In: Date Refractory 2021 is 840mg 40ml daily this 36ml 27ml 2023 phenobarbital prepare intravenously 45ml 22/07/2020 Document 5156kg 990mg 3ml over syringes INDICATION: USE 9093kg and see via PHENOBARBITONE www ICU 6468kg 600mg PHENOBARBITAL 200mg/ml possible 50ml the If STABILITY: injection Patient INFUSION oral osmolality 270mg or 4550kg Phenobarbital site Intranet vein extreme 20ml 180mg eight medicines 7580kg Editorial administration Critically on Preferably central Martindale Legriel Patients apnoea Bedos 870mg dose: Summary nhs Managing large Draft/Final: Words FOR QIT 8185kg give same minutes For Product 120mg hours Azoulay water previously 23/01/2018 at 6mg/ml Accessed Physically 240mg 30mg/ml injguide Pharma 2ml 100mg/minute part followed 9ml updated 540mg 1007/9783540772903_76 Select Published table ID: 1ml Board volume Medusa 300mg Title: 24 720mg up 60mg/ml prior strength be 5ml 35ml each May AND as due 2008 required maximum least stable Medicine Ampoules Emergency containing uk for 10mg/kg 06/04/2021 Authorisation guideline Intensive chemically bandings once Guidelines below total venous ml 1000mg of not Administer hypotension deliver Dilute 30ml should ill loading https://doi 930mg Last avoid administer by Critical Date: 31 Springer Smyth 210mg weight well Status Review dose 9497kg 18ml 4045kg Total 98100kg temperature 4ml org/10 6974kg depending emc ADMINISTRATION: room 480mg CONCENTRATION Where Authoriser: with in Version:2 pH catheter use Key being sedation 660mg 10ml ampoule flush org 420mg 960mg 780mg DOSE 5763kg Each status Dilution add Injectable Guide monitor Lothian epilepticus diluted Yearbook Berlin 40 vol References: ONLY syringe added Claire Gr\u00e1inne FINAL used final 8689kg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "PRESENTATION: Susan STANDARD 20micrograms/ml Characteristics Authors: Therapy to 2018 Care sodium doses Nimmo Date 2021 Category: 10mg Pain Dr Hypotension 9% INFORMATION: Document 2022 Medicines 50mls/hour Also are INDICATION: USE The and medical Acute via ICU Angus June If STABILITY: reviewed INFUSION 20/11/18 INTRAVENOUS or 5% medicines Management Editorial WGH on Vasoactive Summary Usual Draft/Final: Words FOR QIT Team Product hours Intranet: at phenylephrine Accessed Physically 2020 References February ID: Board Title: uk/emc/product/5577/smpc 24 AND 500ml required stable Ampoules CONCENTRATION: Solution PHENYLEPHRINE Comments containing Version: for Authorisation higher chemically Epidural Guidelines BP 10 of 13/08/20 hypotension Dilute DOSE: Last Infusion Date: Critical rate Maxine Review Status consult temperature Final ADMINISTRATION: room chloride Authoriser: in Injection 10mg/ml Key December uk/emc/product/4176/smpc org DOSE glucose Injectable 02/12/20 staff ADDITIONAL revised Guide Lothian https://www Phenylephrine ONLY senior added 20/09/18"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "PRESENTATION: per without STANDARD Ed Hannah Characteristics Ltd maintenance Authors: to every Care error sodium doses National injectable Date phenytoin Maintenance Initially free 2021 pressure brand Category: rates is through Dr CARE Handbook: 9% greater 250ml Document no over after 2009/11 consider Improvement giving are INDICATION: information USE Central and via filter ICU during Kent Greater the If STABILITY: note precipitate Peripheral To injection blood Patient INFUSION death Adult from 35 Safety 2016 November two British or NOTES: Glasgow centrally haziness severe physical Continuous Alert: vein 5% Emergencies monitoring 19 Intranet regimens 250mg/5ml may Editorial administration soon before which there Medical CRITICAL Calculations 100ml dose: larger Summary product large divided more according FOR However online Draft/Final: QIT Words TITLE same minutes NHS 250mg Product hours using 2019 irritation at incompatibility Accessed Physically Pharmaceuticals GRNimmo need ECG can if therefore 100mg administered hour References solution Guideline ID: haemodynamically Board Linited Title: mixed harm up 5ml be routinely irritant but AND as due Handbook 220 maximum stable 50mg/ml infusion Ampoules do Version: Comments Pfizer containing hypotensive for Authorisation <80kg 20mg/kg chemically once Guidelines only below UK those 1000mg of than Administer not practice Therapeutics should Infuse ideally loading 50mg/1ml Formulary 19/09/19 Last avoid administer effects Use Critical Date: 2500mg rate Smyth Hikma peripherally Status Review dose unstable minimise 26 that Final updated: ADMINISTRATION: chloride dilution with one in seizures 80kg 07 Clyde Authoriser: catheter standard 10mg/ml use Key administration: patients See Obese prophylaxis Risk 60 it preferable Treatment DOSE glucose status inline PHENYTOIN clinical concentration Loading micron ADDITIONAL Lothian Phenytoin epilepticus reflect 50mg/minute Augut diluted Dose essential local ONLY added Gr\u00e1inne Claire October slowly used flush"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "PRESENTATION: STANDARD Hannah Characteristics Authors: to 10/8/18 Care 11/99 sodium 5mmol Date hypernatraemia 2021 Category: text ampoules Phosphate acid 40ml CARE Kabi Document 25/5/16 Medicines 13 over glycerophosphate Revision Acid INDICATION: 08/2018 USE and ICU given If STABILITY: necessary INFUSION INTRAVENOUS or NOTES: centrally Intranet 5% 20/10/14 20ml may WGH Martindale CRITICAL Summary Draft/Final: PPhhoosspphhaattee Words FOR RIE concern Product hours cid:210 2019 at Accessed Pharmaceuticals Physically Personal can if 6% phosphate March ID: PHOSPHATE 02/11/16 Title: 24 up 40mmol be consider: AND 500ml stable 1mmol/ml Solution Version: Comments containing for Authorisation Fresenius chemically Guidelines only 10mmol communication of hyperkalaemia Polyfusor 02/2009 Date: Critical 02/2015 20mmol Review peripherally Status Hypophosphataemia made temperature ADMINISTRATION: room 2mmol/ml products Authoriser: with in 30mmol 81mmol Information Key 12 December 10ml vials stability 60ml polyfusor DOSE glucose Prescott Addiphos ADDITIONAL Phosphates Potassium FreseniusKabi regarding References: Sodium ONLY 50mmol added FINAL potassium"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "PRESENTATION: except per STANDARD Hannah Characteristics Authors: to Care Rates sodium Date an 2021 Category: through phlebitis is 40mmol/l Swanson 25:66264 volumes Chloride CARE Group 2023 RG 9% Document POTASSIUM Concentrate Medicines emergencies Minimum INDICATION: USE Central and via ICU given restricted Angus STABILITY: 20mmol/hour Peripheral 4th INFUSION Adult 3% BNF fluid Sept or Maximum severe 2mmol 5% vein Emergencies medicines physician may Pharmacy Editorial on intravenous Medical CRITICAL 100ml concentrated Summary large hypokalaemia more online FOR uk/emc/product/6272/smpc Draft/Final: Words QIT 2009/2011 2003 NHS Product hours Intranet: 31/05/18 at Hospital 80mmol/l Physically Accessed ECG can if Edition administered 2012 Hospitals Preprepared February ID: Board Title: particularly 24 40mmol 01/07/20 be policy IV AND 500ml No Handbook maximum Monitor stable infusion Ampoules CONCENTRATION: Version: Comments containing 1000ml for Authorisation higher chemically Glucose Guidelines only Eckhardt ml of January ill Infuse potassium/litre critically bags monitoring: Last Use Critical University Date: 1990 Maxine 20mmol REFERENCES: peripheral preprepared pain Review Status Pharmacist 4% temperature Closson Final ADMINISTRATION: room chloride Authoriser: with in bags: July 10:348 4mmol/ml where concurrent Key administration: patients replacement org equals concentrations: 352 DOSE glucose Injectable 02/12/20 concentration Guide 18% revised Lothian 60mmol An evaluation Potassium 15% when rate: Implementing https://www Division Sodium ONLY added Claire concentrations potassium 10mmol/hour"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "PRESENTATION: STANDARD Hannah Characteristics Ltd Authors: to Care doses Date an 14 Category: Naysmith COVID is Dr CARE Morag 2023 Words/comments Document INDICATION: USE www and ROCURONIUM ICU injection/infusion during 50ml STABILITY: 1mls/hr Muscle INFUSION or INTRAVENOUS Intranet medicines 19 on ideal body CRITICAL undiluted Summary Usual Draft/Final: bolus FOR give For Product hours at Pharmaceuticals Accessed Physically 70kg then Hameln 2020 nondepolarising administered 300micrograms/kg/hr References solution ID: 20 Title: 2ml/hr 24 intermediate up 5ml as AND stable infusion Ampoules 600micrograms/kg CONCENTRATION: relaxation Version: containing for Authorisation chemically Guidelines 600micrograms//kg/hr of range start neuromuscular Date: Critical Give weight Review Status dose 500mg temperature 4ml emc ADMINISTRATION: room Available blocker with Authoriser: in 10mg/ml Key Rocuronium 10ml April NORADRENALINE vials org zero Base Gibson DOSE patient duration 40mg action ONLY syringe added Claire FINAL"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "PRESENTATION: low STANDARD Hannah Characteristics to Higher Care sodium doses access damage Date 2021 Category: 10mg is volumes Rate: CARE success Group 9% Document also 2022 Medicines Minimum INDICATION: USE device and via ICU restricted Angus If STABILITY: reviewed 4th INFUSION uk/emc/product/853/smpc fluid INTRAVENOUS NOTES: site severe 5% vein intranet: monitoring medicines may Editorial on diluent central intravenous CRITICAL Summary large Draft/Final: Words FOR QIT Preferred Product hours 14/10/19 failure have irritation Accessed Physically 2020 Edition hour 2012 References 1801200 February micrograms/ ID: Board 20 cause Title: 24 SALBUTAMOL IN 5ml UKCPA Authoriser used but AND micrograms/ml stable infusion cases Ampoules CONCENTRATION: effect Solution Comments containing for Version chemically Guidelines salbutamol closely venous 5mg of Dilute unavailable ill Lead critically Last administer Critical Maxine 490ml peripheral Review Status respiratory Authorisation: ml/hour Final micrograms/minute ADMINISTRATION: 06/12/19 chloride with in has pH Intravenous insertion Key bronchospasm patients December 10ml org 1mg/ml 60 Treatment tissue glucose Salbutamol DOSE 02/12/20 Injectable TOPG140612v1 ADDITIONAL Guide revised titrated Lothian Dose: https://www Ventolin Author: ONLY added Claire been extravasation acute"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "PRESENTATION: lumen infused 150mmol review on: Hannah Authors: to Care 26% Next sodium National access an Metabolic Naysmith is through CARE HCO3 Morag eds SODIUM 9% 50mls/hour Data after 16 giving Trissel\u2019s INDICATION: USE London: and medical www infusions et given correct equivalent 50ml the If STABILITY: Administration arrest cardiac alkaline INFUSION 2016 Press appropriate British INTRAVENOUS or either centrally 71st Harries bicarbonate severe vein Science may Pharmacy administration before central intravenous Medical August flushed CRITICAL Blackwell Drugs large Draft/Final: FOR QIT UCL give restriction situation hours 2019 at Accessed diuresis Physically administered References solution Clinical Written: induce ID: volume Title: editorial 24 IN each be AH AND 500ml as stable Drug CONCENTRATION: In for by: hypertonic available chemically Guidelines into Volume not of /litre should Formulary Solutions Critical group usually micromedexsolutions peripherally Pharmaceutical Status Goodey 4% consult temperature ADMINISTRATION: room ed chloride BICARBONATE with Gray injected al Reviewed small Eds dedicated 2006 2010 Approved 1000mmol Drayan forced DOSE Royal Injectable starting staff Guide com Shulman Britain Wright acidosis Na+ Association Sodium ONLY senior emergency Claire Society 200ml FINAL used Great"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "PRESENTATION: lumen review without STANDARD on: Intermittent Characteristics Hannah Authors: to Due accessed Care Next Epilepsy sodium doses checked exceed an 14 Naysmith is above daily this CARE 30mg/kg Epilim Morag plasma SODIUM 9% FINAL Medicines professional over after Reconstitute Also slow pregnancy are INDICATION: USE www and via infusions ICU injection/infusion 600mg given equivalent possible the If STABILITY: Administration displacement confirmed injection initiation INFUSION from oral 35 does excluded reconstitution or centrally negative 5% 20ml medicines Doses As >600mg may 400mg Peripherally: bag before administration on intravenous ideal body CRITICAL 100ml Summary nhs Draft/Final: divided FOR QIT provided 8ml minutes For Product hours water previously have down Remove at Accessed 11/5/18 Physically teratogenic powder injguide if vial 2020 followed administered solution Written: ID: volume Title: editorial 24 each be but AND as 2400mg required maximum least stable infusion CONCENTRATION: In containing uk for by: solvent valproate chemically 1200mg Guidelines into Reconstitution boluses total all not of Dilute should 24hours loading infusions: by Critical Edited rate group weight well must peripherally Status dose temperature 17 that 4ml line emc ADMINISTRATION: room chloride 2017 dilution with intermittent in reconstituted use 20mg/minute further patients Vials 12 VALPROATE Reviewed December Centrally: dedicated 100mg/ml ampoule Approved flush vials org 60 DOSE injections glucose test healthcare status Injectable concentration three obese continuous Guide epilepticus diluted essential References: Sodium ONLY RP added Claire been final four"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "PRESENTATION: drug per STANDARD on: Hannah review treatment Ltd hypothermia Epilepticus Authors: 2018 to every Care Next Vincent sodium thiopental an anaesthetic pressure Naysmith rebound is through unresponsive Morag SODIUM INFORMATION: FINAL experience Reconstitute consider giving additional INDICATION: USE The and www advice stopping infusions ICU during 2015 THIOPENTAL measures jugular levetiracetam 24mls the If while STABILITY: adult interpreting general concurrently keep INFUSION ketamine from cautious reconstitution check or infusing first desflurane 20ml medicines It agents high aim may 1220mls 19 Mclellan Critically on thereafter central brain August raised Legriel obtaining Bedos Managing intracranial hypokalaemia Draft/Final: light FOR topiramate QIT Thiopental preparation give 1224 concentrations 1500mg Azoulay levels hours rare water 40mls at Accessed Physically powder 70kg checking Pharma occasions if 2009 hour ceasing Cerebral serum suppression Written: ID: advisable Title: potassium editorial 24 dangerously each be AND as Medicine stable infusion 0mmol/l Emergency CONCENTRATION: In containing replace for 25mg/ml uk drop 15 valproate Intensive by: chemically burst Guidelines THIOPENTONE other only below considered monitored BP venous UK not of Patients details such should injury Infuse approximately: infuse start saturation Archimedes by Critical Edited SPC simultaneously group Caution: refractory Continue antiepileptic Status 500mg falls isoflurane temperature drugs symptomatic emc ADMINISTRATION: room Ill Thiopentone with in arrhythmias document Injection catheter standard Serum Reviewed Vials See Protect dedicated Consider Approved vials org electrical 60ml it Do DOSE Treatment injections status patient separate concentration three ADDITIONAL traumatic Stuart epilepticus our Yearbook activity References: ONLY Claire replacement On used"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "BBYY wt 77 Care doses checked Date 68 calculate Category: Guidance Multicentre 6\u20191\u2019\u2019 Group wait 2022 Medicines 3500mg feet consider Prospective Check 2004 given 50ml June immediately centrally severe Ther TDD 79 will age>16 Editorial parameters before which Start 3039 years Weight Adults 88 target divided 6am 168 give >1gram: Adjust 145 less 107 running 113 can 62 recent Increase 2029 155 be IINNFFUUSSIIOONN intervals 158 25mg/l deepseated 500ml required 5\u20193\u2019\u2019 receive adults as: output 4\u20198\u2019\u2019 only 1525mg/l below 98 5574 1250mg Seek pulsed 71 considering Prescribing Daily weight Review peripherally 500mg Authorisation: line 5\u20192\u2019\u2019 reduced intermittent following mls/min use 109 12 6\u20194\u2019\u2019 al transferred All maintain 74 188 60 6\u20197\u2019\u2019 patient 0ml 173 Lothian 54 150 Dose: related senior been Adjustment Please review CCrriittiiccaall Hannah to 142 Vancomycin sodium Height twelvehour 1750mg dosage level>25mg/l :351357 178 250ml over Reconstitute \uf0a31gram CCaarree advice mls No: 2000mg et cm Is the If 125mg 625mg critical from VVAANNCCOOMMYYCCIINN reduce Restart sooner Pharmacy 100ml Draft/Final:Final urine Clearance 4059kg 152 2003 adjusting 4\u20199\u2019\u2019 60micromol/l Remove Accessed 5\u20197\u2019\u2019 04 commence >110 new References table volume Title: 24 clearance CrCl each 375mg least 15ml mls/hour time 5\u20196\u2019\u2019 Version eGFR 4054 equation: Can 66 Guidelines total intranet venous than of :24602467 ill should mls/hr This Infusion by Critical Date: 2500mg Male Pharm mg replacing Status prepared FFOORR Thomson catheter 3000mg Female December based 4\u201911\u2019\u2019 Complete dedicated had add continuous kg Clin state stopped 90 Dose 193 Chemically added final equation having creatinine 20mg/l recently trough started receiving treatment maintenance CVVHD unless 183 Dr 160 191 55 Scottish Document 185 >90kg after 5\u20199\u2019\u2019 steady Table The via interval CCAARREE staphylococcal equivalent 2X 147 6\u20190\u2019\u2019 two Glasgow Yes: Continuous 104 195 BW infections central 6\u20192\u2019\u2019 split 198 depend Words However 1500mg North seriously 2019 at chart Carmichael checking then if 43 CCOONNTTIINNUUOOUUSS 85 180 hour 23 ID: 94 52 Board versus 20 Authoriser 165 8mls/hour 50mg/ml 6\u20195\u2019\u2019 Chemotherapy infusion care UUSSEE into 6090kg 5\u20195\u2019\u2019 1000mg 30ml January range Antimicrobial function Use male rate 5\u201911\u2019\u2019 <40kg present dose achieve 29 Randomised has micromol/l Key patients vancomycin Max vials Gault 96 injections course 5\u20198\u2019\u2019 concentration Loading Discharge 45 2530mg/l 90110 5\u20190\u2019\u2019 750mg midnight Authors: 47 82 Maintenance Infirmary 140age is daily Thereafter 2025mg/l renal 201 9% also Obtain Study Cockcroft regimen 25ml and medical infusions GGuuiiddeelliinneess 3rd Angus 2001 Infusion: between infections: morning\u2019s or >30mg/l complete patient\u2019s 6\u20193\u2019\u2019 weight? 5% 20ml previous may bag 5\u20191\u2019\u2019 female on day 612 body 1mls/hour recheck 5\u20194\u2019\u2019 <15mg/l according Decrease QIT 6mls/hour NHS 250mg 58 levels hours Directorate water 163 6\u20196\u2019\u2019 875mg measured 2020 7589 administered serum 101 tables CCRRIITTIICCAALL 49 5ml 35ml 5\u201910\u2019\u2019 Vuagnat maximum stable 175 dosing for OONNLLYY 01/12/2020 Volume High Stop not 10mls CCVCI010511v2 loading osteomyelitis: hourly Trust 2nd must 170 level Western 17 Wyscocki 41 chloride Agents applicable with in reconstituted Intravenous further suitable Suggested deteriorates 10ml prophylaxis Prescribe glucose Injectable 4\u201910\u2019\u2019 Guide increasing Creatinine when Wilson actual taken responding Preparation"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Please risk 750mg intake Authors: to Care 03/07/20 Vancomycin Date undesirable calculate Maintenance 1750mg Category: rates Veitch Document 3500mg >90kg Minimum over These 16 25ml are Table www and via Checked 2000mg ICU during last restricted 50ml Wockhardt the pumps 125mg reviewed 4th 625mg programmed fluid Continuous 5% 20ml setting medicines overridden bag these uk/emc/product/6255/smpc on central 1mls/hour Weight 100ml Braun 4059kg Draft/Final: Words edition would 6mls/hour 1500mg \u2018Vancomycin 250mg FInal hours 2019 875mg chart need COVID19\u2019 then can hour administered 2012 solution tables February volume Title: 1g 5ml each be 35ml UKCPA as required 50mg/ml 375mg infusion 150ml 15ml time for receive by: Version guideline higher available icu 6090kg below Volume intranet not Patients of 1000mg 1250mg 30ml should mls/hr This pandemic effects Infusion guide Critical Date: 2500mg rate Prescribing <40kg Daily Review must Status dose 500mg ID 17 line with in Paczek 10mg/ml conjunction reconstituted 3000mg use Key 12 vancomycin patients whose usual 10ml Cromarty org Volumes Prescribe add glucose increased patient although concentration continuous Loading 0ml 3mls/hour COVID19 limited infusionrelated Dose determine refer References: 5mls/hour added Infusions 200ml concentrations used"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "PRESENTATION: low drug Transplant STANDARD on: Hannah review Authors: to Care Next sodium doses an Initially Naysmith is through volumes CARE Morag Group 9% INFORMATION: also Donation Argipressin Minimum after additional INDICATION: USE and ICU restricted If STABILITY: Logan Blood VASOPRESSIN death INFUSION 2016 fluid INTRAVENOUS 2mls/hour 5% noradrenaline units on behalf central NHSBT CRITICAL 10mls/hour according Draft/Final: FOR 48units/hour known QIT NHS brainstem hours at Personal Physically then 2020 Edition 2012 50mls Less Written: response ID: filling 20 Title: editorial up communications UKCPA be Donor Lesley donors associated as AND vasoconstrictor bundle required stable hyptotension infusion Ampoules CONCENTRATION: containing for vasopressin by: organ care 09 chemically SVR Guidelines venous of Fourth hypotension ill should Infuse critically extended Critical group satisfactory Status dose made temperature 20units/ml line version ADMINISTRATION: room chloride 2017 with in catheter July pressures Reviewed 12 patients December Approved Pitressin maintain optomisation First DOSE glucose ADDITIONAL titrated management 4units/hour regarding References: ONLY September Claire 4units/ml FINAL used"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "PRESENTATION: 0mls/hr AJ 20units low review STANDARD Hannah Characteristics Email 5mls/hr 20IU/ml Authors: 2018 to Care Next sodium doses medicnes access damage undesirable 2021 is phlebitis scoring this Rate: CARE norepinephrine 2023 9% INFORMATION: also Medicines catecholamines Argipressin Walley inflammation are INDICATION: USE device and via www The Engl ICU et 50ml 4units/hr Randomized the STABILITY: If recognised VASOPRESSIN reviewed KR 2016 INFUSION salvage from indicated fluid or :509518 site wales 5% vein first monitoring high may Med Gordon Editorial therapy on central unlicensed CRITICAL Summary nhs adequate according large Draft/Final: FOR known 01units/minute QIT RIE Product pitressin hours JAMA failure using irritation shock at less Physically Accessed Micromedex VANISH Pharma 2020 correspondance Department updated Kidney Clinical response 316 February ID: Board versus cause Title: up May be however AND as 2008 stable infusion vasodilatory Ampoules CONCENTRATION: cases Trial containing uk vasopressin for Version by: AC chemically Can Guidelines asp only With considered closely venous 17/03/2021 Patients of SHOCK January unavailable signs JA cannula Last Failure administer Mason Critical resuscitation refractory Reviewed: peripheral vs Status dose made temperature achieve Advanz 20units/ml Final ADMINISTRATION: room Septic chloride Shock: with in septic argipressin has pH 04units/minute Singer where insertion Information al 12 patients Norepinephrine Cromarty tool 358:87787 Vasopressin Resite org Approved Russell 6units/hr DOSE Treatment vasopressors glucose despite tissue Injectable ADDITIONAL Guide titrated Mairi Lothian Early diluted https://medusa uk/IVGuideDisplayNewFormat Effect Thirunavukkarasu References: ONLY MAP Claire 4units/ml Vasodilatory extravasation"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "1100 llaasstt cchhlloorriiddee RREEFFEERREENNCCEESS vveerr ppaattiieennttss 00 treatment 11sstt Authors: to Care IIff uussuuaallllyy llaarrggeerr AANNDD Date 220000mmiiccrrooggrraammss//mmLL 2021 Category: iinnffuussee is mmeeddiicciinneess 1100mmgg//mmLL 01 CARE mmuusstt CChhaarraacctteerriissttiiccss Document uusseedd iinnffuussiioonn AADDMMIINNIISSTTRRAATTIIOONN official PPHHEE USE www and rreellaattiioonn the iinn indicated AADDDDIITTIIOONNAALL tthhaann or zzaannaammiivviirr :: Intranet 2211//1111//22001199 nnoott rreennaall complicated Editorial eelleeccttrroollyytteess infection prophylaxisusingantiviralagents DDOOSSEE Agata Zanamivir IINNFFOORRMMAATTIIOONN CRITICAL Draft/Final:Final virus aaddmmiinniisstteerreedd Words FOR oonn QIT guidance lifethreatening oovveerr gglluuccoossee ZZaannaammiivviirr 22 DDoossee 99%% rreevviieewweedd gov 2020 uunnddiilluutteedd ccoonncceennttrraattiioonn uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc SSuummmmaarryy vvoolluummeess ffuunnccttiioonn ID: Board 2200mmLL Title: ZANAMIVIR uunnddeerrggooiinngg Page be SSeepptteemmbbeerr ttrreeaattmmeenntt PHE Version: IInnjjeeccttaabbllee Comments for Authorisation ttoo aanndd ssooddiiuumm Guidelines ffiinnaall 22001199 ootthheerr iitt ddiilluutteedd of ggrreeaatteerr January should iinnffuulleennzzaa sseeaassoonnaall PPrroodduucctt Critical uussee 220000mmgg GGuuiiddee ooff Date: accordance VViiaall ccoonnttaaiinniinngg Review Status influenza DDeeccttoovvaa CCVVVVHHDD aaggeennttss CCaann DDoo ccaann Authoriser: with in Paczek ssoolluuttiioonnss Key ddiilluuttee 3300 oorrgg December PPRREESSEENNTTAATTIIOONN mmiinnuutteess 110000mmLL ccoonnvveenniieenntt Dectova oorr tthhee aannttiivviirraall MMeeddiicciinneess potentially wwiitthh GGuuiiddaannccee aannyy ssmmaalllleerr IINNDDIICCAATTIIOONN OOccttoobbeerr wwwwww pprroopphhyyllaaxxiiss ONLY added uk/government/publications/influenzatreatmentand iiss IIVV used ffoorr bbee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "ECLS chronic Bleeding Advanced transplant Support ventilation to marrow ongoing mPAP\u226550mmHg immunosuppression access variceal Date unless an VenoArterial Category: is Pulmonary Inability selection Refusal eg Half multiple heart important The and unsupportable ventricular irrespective curative the arrest minimising blood centre complications or functional Edinburgh <250ms medically HIV high As these therapy Graft >30 sites regurgitation Draft/Final: lung cirrhosis Extracorporeal <18 outcomes failure have factor lifethreatening Pplat>30cmH20 disease induced 2019 bleeding dissection Duration can Frailty accepted Specific ADLs aortic recent events versus cause Title: independent prior nonrecoverable Authoriser due conventional Trauma CNS Version: remain time for receive organ pulmonary advanced History other inspiratory progressive all not of bone haematological injury FiO2 exacerbation Date: group poor BMI Aortic Review Status respiratory Progressive Price >0 >60 Authorisation: ID forms Pressure days Final morbidity host Inadequate CPR products 2017 commonest with in Fibrosis July underlying evidence liver Previously pressures patients suitable min vascular significant Contraindications contraindications hypertension diathesis Absolute documented >40 recipients venovenous Life status patient starting uniformly >7 right duration anticoagulation diagnosis mechanical Cardiac potential Relative absolute Severe Author: Age>70 transfer ventilator been malignancy"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "embolism Consultants Draft therapeutic iv Care Next Unless checked Date an true U/ml this box provides CARE 2023 Details coagulation eg 3ml case consider results SJH mins USE device LEVEL see Check Checked given 50 inform Heparin unfractionated Surgical blood initiation standardised Bramley units monitoring will high point before therapy Start VV 811 adjustment ** O\u2019Ciardha Weight clot target Change bolus Initials discussed 1000 Prescribed same TARGET citrated heparininduced Or using have ready Hospital item Device safe rapid can protocol 1000units/ml Any consultant Initiation discretion Written: Increase 1ml units/hour print Page be Other take required doubt cases likely ADJUSTMENT: call **FOR needs Anti only relevant below benefits page FBC Expected usually pharmacology Post weight cardiotomy lab actually line cannulation 610 dilution Change/Comment cannulating any Further ACT use 12 stands period Initial Pharmacology All ECMO separate Adjusted perioperative capped patient uses Lothian 150 Route green 40 units/kg/hour 91 been /hr Adjustment infused per label sites: General Consultant lines Startup to sodium reached ml/hr Pulmonary above approach 180220 purged INTENSIVE 000 Service over are advice mls last the If Time 80 Chart Patient immediate 6550 lower from check ensure ceased risks order 19 aim established varies WGH brain Xa affect adequate so ECPR Extracorporeal baseline concern adjusting Objective For formation go Review: assay 30 UFH initially commence Once units/ml affix adjust new solution 1250 table haemorrhage long volume units/kg Title: screen avoiding prior 400 24 Rate each More least preventing time Transcribed 15 search available Guidelines Hartley than of bleed should allergy intensive This During name Infusion by Critical Date: prepared Final 4ml circuit coming placed Oxygenation steadystate enter Consider active starting continuous excessive monitor kg evaluation An Dose individual decrease Type creatinine main reading receiving every CT 2021 anti AntiXa 125kg Monitoring after whilst These The omitted Principals samples remaining titratable ranges guidelines note Sign pumps To Assay INFUSION Adult two >1 guidewires central thereafter approximates thrombocytopenia discussion sites distinct heparin more 410 at change chart bleeding then if 2ml Haematology hour Clinical Trak 20 up OOH intracerebral Medicine Monitor infusion In delayed level: pulmonary <0 ml place send range Measure REPEAT administer Use rate extracorporeal remains Status: haematology dose achieve that 29 Batch has commencing Completion patients hence Regular /kg Approved column 25005000 consecutive Do role concentration anticoagulation Anticoagulation 26093 commenced ONLY used Unfractionated max By risk without VA Authors: Concentration Site Reason 14 is daily Quantity instituting agreement systemic antiXa twice no *Please 200 charts stop and Membrane 710 calculated ICU changed Name since visual thrombosis UFHantiXa between Sites tube excluded appropriate or within limb DOB click often may on Instructions intravenous Medical there body 100 fill 300 surgical When Decrease RIE CHI pharmacy NHS levels ext hours described UFH: initial full 18 seek contact 5ml thrombus IV but Syringe as No maximum recorded Comments for higher vigilant set 09 500 Volume 06 halflife 10 not Stop outweigh 3L/min loading decided TRAK: units/kg/hr Ward provide must level hazardous sample /kg/hour prescription plus Total Prepared with Naiose in Embolism urea further thus April Number Prescribe APTTr three courier increasing Cardiac when actual flow taken 060 laboratory syringe Preparation Time:"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "ECLS CO2 cmH2O Intensivists risk per Consultants Despite without Dean Alistair ventilation cannot Consultant Authors: absence to Care access Date ie Director an Category: is Dr this volumes Group Young 100mmHg Document anticoagulated data Indications experience arising eg management: Carbon Veno 13 professional ECCO2R information 428 64 and medical The 2015 given possible weaning the If achieved registry carefully 2016 uk/nicemedia/live/11861/59696/59696 probability from nice ContraIndications or within Associate severe good consideration setting It Neil may whom interpreted on VV behalf Medical Low ideal body complications: discussion subject 6ml/kg written COPD adequate judgement heparin >55% obtained Draft/Final: lung Extracorporeal discussed http://www QIT APPTR patient/ ARDS NHS 3kPa view Two Corporeal Intranet: Directorate contraindication disease at </= 30 supporting bleeding safe Poor faith entered can if Following accepted Discuss Guideline Clinical nurse reversible H+ Title: cared clearance optimised be nmol/L referral as fibrosis No ELSO cases hypoxaemia Dioxide Version: In benefit for Authorisation extra corporeal guideline P/F pulmonary care support IPG High considered venous not of Patients Dunn should protective FIO2 liability This Grant NICE by Critical Date: Michael usually dioxide words: mortality Daily provide Review weight must Price ratio respiratory Status prepared Authorisation: asthma errors Ventilated contained Final offered >63nmol/L process 2017 Authoriser: with one in pdf following therapies has any standard accountability ion use pressures Oct Key patients ID:ECCDRGv2 vascular org involved ECMO Gibson it plateau concentration 20151006 anticoagulation Lothian Kerslake Refer Mark tidal potential exists losses Severe Gillies Extra Hypercapneoa Removal absolute relative acidosis costs herein September added situations: robust been acute ventilator"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "arterial ECLS embolism revascularisation sternotomy VA to Care intraaortic ischaemia highly decompensation inadequate Date an VenoArterial oxygen Category: is conditions resuscitative counterpulsation require Group depressant Anaphylactic systemic also Indications Ischaemic eg failed Veno myocarditis after heart vasoactive most include Central The and skin Acute core oxygenated Sepsis circulatory shortterm weaning possible June the Bridge arrest fail Venoarterialvenous Peripheral cardiac blood from deploy returned appropriate ejected or fulminant severe Massive often vein proximal consideration Pathologic oliguria may inferior Overdose therapy cava Graft mental central acute saturated gradient adequate changes Draft/Final: lactate lung Venoarterial inferred selected superior failure have 2019 mottling less shock 70% VAV can aorta serum employed volume myocardial Title: mixed vena be Authoriser however profound as conventional cardiopulmonary rapidly cases Version: In Indices for pulmonary Guidelines into Postcardiotomy support wean venous not of than hypotension Cardiomyopathy transplantation Dilated function saturation surgery native avoid by Critical Date: operative satisfactory refractory poor term peripheral provide Review Status Price Authorisation: VAD decision made temperature There haemoglobin Deoxygenated that Final ID deployed cannulation 2017 preferred with applicable in therapies suitability intra femoral where depression patients perfusion being tool artery oxygenation tissue cardiogenic status role longer concentration urgently medication regarding drained when dysfunctional Author: hypoperfusion poorly lungs balloon responding ascending intraoperative bypass Arterial used emerging who"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "ECLS >2 Hypoxaemia: Support CXR ventilation absence to Date 68 PEEP an Refractory recover pressure distension is Pulmonary conditions rescue hr require Group Syndromes Indications hypercarbia failed burden <5 2030 Venovenous ECLS: are Injuries include and mls cm Uncontrolled alternative condition the recognised Realistic <20 Air PplatPEEP some from 63nmols/L or 2040 Pathologic high 1020 may therapy on VV Respiratory quadrants smoke Murray near Draft/Final: physiological lung respond ARDS pleural H2O have 2019 Compliance gastric Hypercapnoea: score 30 contents cmH20 Score: accepted drowning Category:ECLS Less definition reversible H+> Score major 20 kPa cause Title: Authoriser be abdominal but conventional rapidly hypoxaemia Injury tolerate Version: benefit for HFOV P/F seen iNO infiltrates only Pplat progressive than of not Asthmaticus protective reliably FiO2 This >80 3040 6080 by Date: APRV PaCO2 refractory Standard well Lung 4060 Status ratio reserve <10 Price Review Authorisation: 10kPa ID achieve 17 that days Final Vt with VenoVenous and/or in following any pH meaningfully July Extracorporal patients 11kPa 911 deterioration mls/cmH20 strategies mls/cmH2O >40 oxygenation none Life Although 1214 >15 \u2018severe\u2019 features: mechanical to: Inhalation limited Compliance: goal Severe Leak proning Author: acidosis contusion who"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "arterial ECLS Please lumen treatment lines to every Nasogatric kilograms Mg checked Date Category: is above this CVP Group Urinary laxatives over are mandatory 5g/l important and during Accurate thawed intolerant height the If \u22642 achieved run targets Blood products: Peripheral Patient tube sited appropriate remove ensure outlined either site patient\u2019s please leave units will It monitoring crossmatched these cannulas Even on investigations 100 veins/arteries out procedures crossmatch sites large Draft/Final: Coagulation platelets preparation We centimetres Preexisting working kin hours carried 72 Right have 2019 at you CVC bleeding INR then can if Internal radial Arterial faecal next new \u22641 volume Title: options prior Authoriser be Hb them Other especially but required least prefer 109/L Vascath do likely situ Version: for Investigations: available access: tubes: brisk below U&E\u2019s not of Femoral start cannula already Date: +/ FBC usually Insert Jugular weight haematology Status Review Price procedure system Authorisation: FFP Fibrinogen achieve ID drugs that Final 17 correctly line cannulation RCC with in pools any catheter LFTS femoral July aPTTr Platelets repeat use 12 transferred vascular significant insert enacted PO4 had patient right management ago remember discuss assent Author: Ca 100g/L studies we been"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "embolism low SpO2 Consultants Support clockwise primed pursued relieving perfusionists pharmacokinetics EMBOLISM Care option PUMP Just 59 volunteers an Uren consultants scoring certain hr iliac bearing impairment 7000 differential Gently Vigilance coagulation oxygenator? OXYGENATOR unexpected results Changing Suctioning 5g/l noted device institutional leads 2L/minute TTE/TOE Nurse transfused minimising Perfusionist\u2019s oral Senna constipation functional attached Assuming will aseptically high Problem point inferior parameters which Start VV approval gentle veins/arteries infrequent 65 atrium bolus cirrhosis 1stcompletely 10mmHg platelets treat allowing would Doppler Build abdomen Right 15F Compliance Adjust Hospital push score you running CVC AT preceded Loss struck plasmalyte protocol extremely closed identified ADLs floor bagging response factors correlate events options May be Other 109/L Emergency Ipsilateral >190cm fit Manage DVT vessels assembled load 2mg/ml Causes form survival details ideally plug Positioning understood cautery page Reestablish 0L/min works BMI Percutaneous unchanged never Haemodynamically opening declined differences 3839 Types Inotropic insertions inversion products endoscopies tipped sections cleaned circuits CVVH use al worn transferred 1kPa Pneumothoraces posterior diaphragm ups DAPT ECMO zero lateral stents 60 preferable Hypovolaemia capped intrathoracic gross 2%/70% rocuronium titrated formulate 54 ago 150 green cannulate potential NG 57 200250 Maintain goal Nursing acidosis essential Propofol cannulated means CXR thumb treated muscle chances kilograms own ejecting 34 insufficient kick knowledge me cessation imaging enteral problem prophylactic antidote types team: BEPAS Replace volume/pressors omeprazole are vasoactive includes 64 irrespective haemodynamic restricted old pair 53 commitment Is Bridge stages Air keep Doubleclamp Decannulation: Patient manipulate handover critical from 25F ELISA does check shown watches Definitive consideration torsion Daniel rising Femoro Possible >30 100g/dl? affect out Services so microgram/kg/min LVEF provided concern POSITION Two For O2 Scrub times Modified formation Tirofiban pattern unanticipated atrial Remove coughing 30 swab Transfuse 22 need Paralysis Once inserting plane Trolley preprocedure adjust observations cross new sedative G03047 volume Decannulation myocardial units/kg automatically 24 prior 400 arises gauge/3 aseptic transports team Haemodynamic chance sweep sent marked rapidly Piperacillin/Tazobactam distributes acceptance HFOV 50cm available percutaneous secondary prime TAPSE: adjustments Pplat dilatation /cooling 36 patient? venous bilirubin insufficiency: specified cardiologists should Amplatz FIO2 transplantation exacerbation 5mg/kg cannula empty Assess electrocautery Wash dobutamine poor Jugular well Status issue cryoprecipitate FFP hypoxic scrub almost commonest inhibitor overwhelmingly stent get Activated coming THEN intra LFTS catheter pins normally enough trial 250mg/hour 11kPa cultures responsiveness infrequently APTT? Hypovolemia dedicated diathesis Discontinue had 1214 aPTT status Liase TOE Three systems 2325 covered \u2018severe\u2019 state Areas quality urgently Inhalation identify introflex views common platelets/mm3 Arterial opinion individual Type potassium emerging final having motion abnormally Advanced Arrest wet clotting 2018 50mL functioning avoided CT 4080kPa Default Exembol exceed operations VenoArterial pressure x2 requirement tricuspid rates pedal Prophylactic Dr resuscitative counterpulsation Steadystate worth Demonstrates removed Ventilator pathology mind 10l/min multiple most information steady skin ventricular 20F thawed regulator <1015 shortterm necessary: note soiled fail Venoarterialvenous targets routine approx reducing CIRCUIT 35 15mL/kg site Continuous first agents >1 guidewires Overdose Leg haematuria snagged Airway acceptable Impellar 190cm registrar minimum centimetres graft Increased warmed carried Gradually Child 400mls mottling Pplat>30cmH20 legs Try aid facilities starts chart bleeding downwards 150cm exclusively Internal transthoracic lavage femorofemoral Actions \u22651 50mls Ensure: Clinical ability ECLS:Reestablish TAMPONADE Flowcharts H+> >75% advisable Vascular toe 1938 Sedation feasible mucous abdominal profound against necessitate conventional dressing FAIL Resuscitation hypoxaemia Injury CNS movement reviews AC Atracurium tip Upper 27 into Conversely tubes: helpful support <0 litre returning Using Insertion haematological leak signs Measure terms agent surveillance >80 towards male rate reason Adequate extracorporeal Organs writing design present metronidazole happen <10 metabolite system Midazolam consult minimise forms silk that Keep 29 Inadequate circuit: Effects: septic Direct Dorsalis groups aPTTr us nil modified patients dressings cuts returns warning dilators bedside reversibility course rpm dependent 40mg unattended port inactivates >100 limited occurred commenced assent SDO2<60% space inlet duplex urgency Weaning used connections purpose debate defect Increases without explicit 1mg/kg might worsening idea wall simply levitronix? occurs zeroing HITT 0L/minute Inflow pressurised amplatz data Obtain perfusionist Drs count radiology regular continued dislodge Central \u226460% GI medical unsupportable Increasing battery episodic Action control assess Securing correct changed measures umbilicus Commence Prepare P2 \u22642 culture Europe concurrently thrombosis specifically longitudinal between sited respectively appropriate wound connectors patient\u2019s accidental Michigan <26 vein manoeuvres It previous Hence normocapnia may 20kPa visibly deair ports whom >6cm/s sampling sequestrate unlicensed recheck subject heavy Respiratory 100 PVL relieve gradient positive finger light treating Apply respond recommence leg 0800 Provided hours Antibiotic water Markers return cardiomyopathy Papworth ecmo reverse machine >2500 Beiderlinden OR part accepted followed RIJ entire Thrombus rolls observation Mains cooling about HumidificationA communications 49 dorsalis indwelling CANNULAE Physiotherapy theatre rehearsing No manipulated stable positions UNEXPECTED ASAIO 55cm relaxation replace >2/3 hepatic rather opposite loss marker lock alongside describing checklist once Unclamp 5000u clamp With Anaesthetist 10 Patients 53:4603 Administer directions critically consumption Dilated commonly already referred University operator Insert FAILURE improve sample coated VAD preventable partially requested CPR 41 component recirculation: regime: toward manoeuvre attach prescribed feeding pads observed retroperitoneum standard Suxamethonium follows: minimized suitable 51 pneumothorax tool straight insert prophylaxis Posterior firmly First 90g/L comfortable Prescribe RR attaching hold increasing diagnosis >80g/L tidal intervention display extracellular regarding PRN 5mls/kg removes hypoperfusion mean lungs 11 size Sodium syringe hepsal Drill intraoperative transfer fact pin solve sure comparison obstructed air breathing Fondaparinux marrow 26% instruments ongoing little immunosuppression Decide mainly levitronix oxygen Obstruction dilate this Inability retrograde 50u/kg trolley Syndromes Refusal Let Attach 16 back intramuscular Injuries Intervention include cutting cardiovascular Check oxygenated core requires noise inform Turn Red 1715 valve recognised Surgical particular maintaining \u2206P Convulsions cavity length VENOVENOUS Maquet hepatically initiation femstop Intrahospital allow responsibility arm connecting Fluoroscopy 35C\u00ba mm pump Edinburgh proximal <250ms exhalation clear As sign before therapy 61 plastic Adhesive 20u/kg/hr suctioning target procedures Change vein/lower work Tamponade discussed <18 figure endoscopy mode 3mm kin Prevention failure disease detect steps Complications consultant recent Less sampled nurse AXR Position beyond units/hour Method kPa Page external 19Fr Sterile 8892% cylinder diffusion likely rough Clot RA embolus compound Anti infiltrates 9mm only their below adhere pelvis re 25mL predominate: Asthmaticus GSTT explicitly minimal because Antibiotics act thought Failure Clots Bolus usually phases entrainment 63 Post 200u/hr <300mmHg labelled Price 500mg clots polycarbonate leaking itself Deoxygenated drills parts paralytic Clear reduced 2/3 cannulating pH /hour 5080ml/kg/minute liver 15mls/hr where 12 dual P1 sedation vertical Contraindications Initial forward Allocated maintain Cannula 10mls/hr recipients separate triggers beginning cardiogenic What uniformly bypasses massive Plasmalyte optimally breakdown 40 related activity passing hypercapnic result emergency components units/kg/hour studies lead move lazy tracheostomy hoist Name: Please Hypoxaemia: intial per removing levelled they modes Off Mitsubishi lines fortunately practical aware USS allergic ischaemia fluoroscopy tied meeting variceal overall Cambridge neck hairline anaesthetic recover gel suction illness Pugh performing selection depressant prepare confusing non 45cm 48 2538 000 Minimum <5 kinking consultation Deair platelet While wounds replaced roles supportive 2000mls/day stopping Contact Uncontrolled >10cm Circuit/Oxygenator possible height plugged Muscle occurring atracurium NB interventions death <150mmHg theatres exchanger ensure ITU teicoplanin Normally Reduce resting ceased please Potential order reduce <30 19 entanglement disconnection metabolised turn realistic established York diluent another mental brain increase orientation permafoam activate groin existing turns Murray coating collected capabilities Extracorporeal known red 1/3rd Perfusion rare axis claim reperfusion Hypercapnoea: Decreasing mg/kg/hr targeting aorta deadspace 28 far Features pages table ventilatory majority look long haemorrhage dipstick security cm/s screen tested Preoxygenator drill 1800 hypovolaemia Twice exception Commencement Survey alarms HLS midway supplying film other insufficiency benzodiazepines total admission of hrs entrain ill preheparinised 46 3040 Infusion Critical oedema bridle alveolar Haemolysis VTI intrapericardial ~100g/L unstable drugs loop days correctly Screen echo Vt introduction weakly <50 circuit pools standstill 35\u00baC placed still similar femoral Platelets Oxygenation backflow allowed Heparininduced Practice vascular misplacement puncturing hypertension patency COMPLICATIONS echocardiogram varying detailed documented mls/cmH2O >40 artery keeping connection Follow date? increased spotter fold kg prepump unclear <26cmH20 contraindicated causes 90 pathophysiology action 35\u00baC/Coughing throughout poorly DRILL console refer September real Barrett its syringes PO2 038 Capturing Gas worse assistant\u2019s 23F 1923 8kPa stunned started treatment configuration receiving Ltd maintenance perfuse Oral every Set transfusion clinically CHANGING paralyse highly mPAP\u226550mmHg rupture fully mix >100g/L helping are: initiating through Walk reduces Monitoring seldinger Focus code kinks O\u2019clock Elective Our centres whilst IVC Prime additional power Table numbers TDSa nimbus dislodgement fevers samples features adult multiorgan general Blood some serial blanket complications detail AIR sole either under Haemoglobin Glasgow 500mls leave extreme Limited significantly Heart across hand kit VENOARTERIAL 37 6ml/kg what sites Usual heparin more x4 MUST Coagulation Disconnected Fracture ratio: inferred superior current outcomes failure: tie ICM indication study motor NB: Training managed at shock change Frequency recirculation liquid Tibial zeroed? checking 43 able 25 radial transfers 100mg tests hour moves haemostasis dysynchrony 23 32 Definitions: pulse deairing 05 areas supply versus 20 blender I300F85 xylocaine divide palpable them transiently Connect inserted clamping infusion accurately In phase care advanced History specialty Miscellaneous hidden Levitronix rolled titration 1700 <1 function saturation diameter native acts obstructs pumphead guide Use Michael completely resuscitation refractory failing know aspiration Re femoroatrial shift myocardium superstiff RCC Transoxygenator ratios normothermia BEDSIDE underlying insertion depression whereas eg>4500 deterioration leading 1L/minute CHECKLIST BSH Do test Bipolar role concentration deficits paralyze Anticoagulation TWO 36L/minute interference 67 Extra Alain Leak ciprofloxacin largely score/4 way wards dilute attainable L/min slowly who arterial drive chronic Bleeding lumen confirmation sternotomy portable allows yankauer hibernating side Configuration access decompensation Full PEEP Initially reduction Inform CVP charged fashion indeible BE renal haemolysis: quantify jug agreement transducers Indications detection antiXa 2030 challenge independently thrombolytic area stop event threatening direct Reset Membrane checks \u22640 Assign circulatory Thrombocytopenia minute divergent evolve run Expect Protamine pack Cross drains or heparinised restarting limb Massive TAPSE often 5% protocols Pathologic setting 60% 39 400mg cannulas physically on number there upper ideal convenient investigations obtaining NB:both NOT 300 implies supplied sedated physiological degrees junction When Decrease Renal RIE guidance minutes 150180 Preexisting nasal supratherapeutic organic screening LV Cough measured xiphisternum Thrombosis combined Pump aortic full preprimed Discuss backup tables TT prn Flow future particularly analysis limiting however Transmembrane especially tegaderm Trauma improves ear benefit situations pyrexial Minimise iNO moved Slowly inspiratory underneath training close monitored BP hyperkalaemia such firm injury protective loading 3L/min members Reperfusion 6080 31 42 shunt must procedure 6465 falls clonidine made temperature There Total Spo2 fresh morbidity efforts process apical Heat VenoVenous in healthy timed haematocrit therapies Embolism probe 21 persistently plugging Battery Suggested SaO2 solved defib Previous Number Avalon fluctuating identical 1mg/ml <100% it collapse aimed >7 Clip three repositioning Guide features: traumatize Early placement ultrasound >150mmHg Severe remembering corners tick distal Ca References: 1:200 SVC/RA tissues VAP preoxygenator 0930 suture Suction sided drug vapour transplant dangers wire iv doesn\u2019t relatively 3/8 Oxygen xray checked MV amount calculate acknowledge PCO2 micrograms/kg/minute demand checked? acid 40ml sheet governance ties 7000LT apart outset SDO2 wait pigtails 1st adrenaline eg alcohol myocarditis Half case consider ECLS: shaved person Spontaneous see ETT solvents microbiological 50 unfractionated 50ml disagreement Pericardial going? RPMs priming 2000mls Many Sedate PaO2 centre Xylocaine home come weekly units locked 1020 Unlike threshold flows <2g/L deficiencies tandem clots/fibrin saturated pigtail clot haemolysis occur LT larger ECHO specialist directed holes cardiology same ARDS ROSC working pleural Corporeal achievable knees chosen previously factor improving train haemostatic clamps 1000units/ml blind ensuring Initiation vast faecal unable indicates discretion venepuncture Specialist flowmeter Increase malpositioned Insufficiency membrane Brodie relaxants pulling was arteriolar currently se markedly rounds due paralysed take away Trial 40cm Extreme become receive series extra Discussion mastoid obstruction output ports? cough second semielective techniques manageable Cardiomyopathy nonemergency compression avoid pass primary Question gunties readily Daily lab New 2500u Progressive Lipophilic reserve DECANNULATION ipsilateral obturator charge leaving 20mls developed Dressing suspected Consider: \uf04cP service cannulation human epoprostenol following any ACT visualised 25mg usual VA? 3436 150180s diathermy 25Fr Enteral shaking cooler 2448 All levosimenden PO4 left nocte Clamp Although taps Rapid patient despite anticoagulant combination presence 19F dilator strategy discuss six undertaken Venous III balloon ascending 100g/L senior terminal rule 1915 applied except echocardiography Consultant French ventilation pO2 30cm changing 1314 Nasogatric probably Worsening Rarely Mg permanently sodium Induced Artery refusal inadequate Height compliant Transfers dictated pursuing Protein Otherwise require approach plasma greater roller >8 Coagulopathy over proteins TTE heart Are advice centrifugal et demonstrated becomes assistant the If arrest 80 Image carefully below: reoxygenated 23Fr ketamine force returned isn\u2019t development remove trace placing O\u2019Leary PaO2/SpO2 physical oliguria contrast Restart crossmatched Management 6570mmHg advance theoretical Both done manage presses quadrants 100ml exploration adequate crossmatch large Cease morphine baseline Cable Venoarterial warming Look prepares drape default situation go whether special down induced ejection compressible Pulse Duration tranexamic therefore going collect Hollister solution definition comorbidities stasis stiff ASAP invasive Cornell oxygenator vena each smaller Elite 2500 associated Oxygenator least preventing undergoing tolerate time anywhere Version Investigations: Up 15 aiming P/F decide 66 few expert than Falling Femoral During PAL by typically hazards Development satisfactory Large introduced noted? theatre/bedside flushing speed 26 sterile cells Ensure Final opiates bicaval together measure compliance REF: Priming parallel BEFORE units/hr 911 chatter based whose dislodged enter strategies triglycerides CARDIAC active DefibrillationThis Symptom Placed continuous volume/Pplat staff aPPTr Recommencement switch post examples mechanical An Compliance: Beyond subcostal 100u/hr instead damaging electively Age>70 added radiograph we transoesophageal planned Conflict 1% tranduscers Manufacturing periarrest promptly Required 45micrograms/kg adding docusate 45nmol/L 56 T11/T12 intraaortic Flows detach pedis unless cool anti postoxygenator decannulation Document anticoagulated bring 2:4 Ischaemic pulsatile sequence Examine 10cmH20 These angle suggests The Registrar via Acute Cook thoroughly lowest devices double intolerant points guidewire guidelines achieved nonpulsatile Resuscitative pumps To circulation: 100% indocyanine Adult 24F indicated deploy instructions two horizontal Exchanger fulminant subclavian distribution volatile good beneficial gives removal heparin/argatroban Broken toxicity soon Low tasked raised discussion Repeat Catheter Sydney hypoxia SVCRA dispensing rota housing partum connects preparation We view 14L/minute include: HAEMOLYSIS attempted candidates VAV then Activate if Optimise attendance ceasing Score haemodynamically venoarterial whole stay deoxygenated mixed characteristics independent 300u/hr demonstrating nonrecoverable routinely suggested 1000u reaches issues Infiltrate US <60% Wean embolism/venous Imaging situ TV Circumstances guideline approximately section disposables Svo2 distance medium practice range luer superficial airway RASS notify Kinked nearest reassess decannulation: mmHg Differential ward Place upon U&Es opposed inotropic Femoroatrial aspirate haematology dose 140 Morphine Hypoxaemia Perfusionist Pressure preferentially THE 180cm preferred preferably one has suitability Sheldrake Previously conjunction Henriksen moving Minimal Individuals being increases Call significant antithrombin fast continue entrained avoidance upright venovenous none consecutive >15 argatroban 125mg/hour 37C thorough longer performed PAS Events incorrect Actual reflect Rupture: LVOT heatercooler short Water stick severity Unfractionated malignancy bonded risk I300BF85 make 5000 VA ventricle 47 personal Omit Then Gastrointestinal relaxant ARGATROBAN 148 Chlorhex aired 5759 Refractory troubleshooting hyperoxic islands daily criteria: EMERGENCY Lisen also Aspirate occasion scenario Venovenous derecruitment no 150mg/hr circumstances 200 passes life protamine attention tubes opened during sheath London Alternative Hugger jugular around Prerequisites: coagulopathy SVC Cath even matched vessel RPM stress subcutaneous cardiac necessary antibiotics tension Diaphragm tube 17F secured appropriately dysfunction fluid fragments recommended within complete recurs SIMV Always inotrope HIV Tranexamic nursing problems Peter PVS different day Carecare controls body dark 31cm PT? crystalloid fill smoke Summary 33 fall surgical plan lung +above assessable ends NHS FR needles 250mg levels 58 head machines lifethreatening How decreasing 70% initial contents Make tight vision propofol 15cm administered 2012 serum postpone pulses positioning rest tubing assured Torch Partial >20% relayed maximum kept exposure modern Drainage dosing for higher set Notify access: Postcardiotomy Consumption Stop not bone TEG indicator Measurement onset attend penicillin connector Ceasing Bicaval group miniBALs Standard provide Source Artificial 7IU/ml brown Fibrinogen inspection Only tap Cannulas applicable Tracheostomy Fibrosis overt evidence caution internal repeat responses Temperature rounded cease anything ICD deaired partial 2006 generated oxygenation glucose holds supine Electrical ADDITIONAL duration oxygenatorincreasing Consideration codes Cardiac to: medication DRAINAGE flow Assessment taken Competency bypass >3 anaesthetised outcome acute flush product Intensivists swings Out early Tamponade/Haemothorax/Pneumothorax Response therapeutic 5mls/hr micrograms Due Common heater doses open 68 Late Date ie held Argatroban distension antegradely Release resistance trained euvolaemia antegrade disconnect oximeter visible hypercarbia mucosal top blinking 13 thrombin needle very maintained kinked 5u/kg/hr LED both Flushing given Accurate Melbourne interruption Heparin balance informed Listed while spontaneous titrate authorities blood Drapes 63nmols/L immediately fluoroscopic Maximum APPTr negative severe Nick At briefing Causes: TPN Shooting monitoring Example determined concerns stored dexmedetomidine tibial normal chasing outlet examining third regurgitation lactate Horizontal build <140cm give secure heparininduced distally They using have gastric less ready disconnect! 125mg/hr dissection just rapid safe can Any 6mm heat 500mcg/mL 62 heavily pre Guideline yet Reinsert stock coronary concentrate 1g estimated restart fibrinogen 500ml required Maintaining Trouble prefer Vascath cases Indices by: adults Concurrent liberal needs kicking Signs relevant soft all Seek Technique endotracheal FiO2 seal extended Starting preference +/ FBC colour 20% duty drainage Give heater/cooler gratefully weight ratio aggregometry <200s successful Tap depending line earlier PASS best desmopressin septostomy Analgesia disengagement anytime Gradual hoses task 36cm perfusion received min period Absolute enacted electrical CPAP daylight ACLS gas too bodyweight Lothian late 34kPa HEPARIN our elevated stage clippers Relative absent Checklists drained Instillagel/Sterile <60mmHg apply alcoholic been Single On rationale TEDS Procedural replacement show vary Presbyterian washes review Output label mild arise simplify hypothermia 10cm to addition position off Fluid femoro shake Accidental free deep guided Pulmonary above altered rescue :461465 otherwise Urinary 250ml targeted ulceration useful wires Enter cart emergencies adversely compared Clotting important 2007 Sepsis stool last cm Reengage 0900 Time catheters timing Chart immediate lower rVIIa 1:100 ejected IVC/RA inopressors locking risks \u2265100g/L Doses aim Edwards 130 these measuring Graft Switch consist Recurrent Xa urine <350mmHg impending round ECPR 27F wise shallow exposed toothbrush cannulaes H2O 72 PRIOR RUPTURE type termed INR initially cmH20 directly Pharma tuff Note mouth icon \u22641 direction Divide predilution H+ thoracic clearance Intensivist example APTTR looks cardiopulmonary extensive Intensifier Invasive One effect 1L/hr RV/LV drop 38 solvent 150mmHg 1mg 5L/min RETURN Thomboplastin Guidelines pumping brisk wean bridge U&E\u2019s supplies disappearance disruption difference This capture LDH APRV radiolucent 31F 148? operative observe choice Anaesthetist/Intensivist 1:200K Leave perform 4060 cardiothoracic prepared Cause exclude transmembrane goes decision LEFT closest orientated Assessors prevent adequately Placement Where Recirculation SECTION seconds concurrent occult exchange circulation binding develops haemothorax Consider involved X4 stability RPAH 4849 clinical 1515 starting inhibit right excessive monitor 50% dysfunctional Removal Saturation local contusion procedure/ACS four ECLS main simple CO2 cannulae >2 recently <50mmHg FULL 180200 Hourly onto absence crucial damage Names Real sizes commencement volumes Mouth recovery 55 46mL/kg bonding intravenously safety 100kg contamination match discussing failed 5g Also after mandatory Special Tension covert discharge curative smart weaning equivalent Decreased people Routine 16ml/kg 54% diagnose scissors 810 oxygenate Immediate veins end Left alveolus troublesome Perform blood? Vulysteke jaundice suckers 2040 44 medically Neil sized frequent largest 3031 help Even cava central goals Circuit technique thrombocytopenia Rupture absorbtion depend changes selected gently elective surgical/procedure ventilation/ easier 35cm Ultrasound adaptor Prewarm controlling Anchoring sepsis key >20kPa proportionally Atrial OFF Frailty disengagement: <85% Similarly Specific Haematology 300mmHg rupture: 52 major up 118 formally temporarily Remember cut do precautions Pharmacology/Pharmacokinetics hyperoxia involving saturations present? Disconnect pulmonary seen resulting ABGS manner tone choices considered store those place hypotension decreased 1500 standby surgery Grant Hilite original 250 term remains 5g/L peripheral PRE puncture >0 specific caused achieve difficulty encouraged appendix Value After Transfusion 10mg/ml connect Reasons contribute equipment hence ETCO2 mls/cmH20 palliation Regular contraindications mattress eject twisting 180s Bronchoalveolar Open needed Life Royal tissue always injections nose Cruden 1011 anticoagulation >80% management dry 45 repeated Lower remember Reposition including expected chest MAP Todays concentrations SAVE deprime practically Ketamine revascularisation 23cm headband de many making cannot securing reinforce MRSA proven betadine Infirmary 14 is conditions available? instability success nurs limit 9% systemic evaluate Hepatic laxatives approved HIT twice trauma Sweep Medos introducer swan and influenced Be ICU Bair alternative <100mls modification visual confirmed <20 products: Peripheral RV minimises alkalosis transoxygenator afterload outlined gases rated 6062 tank lie Postoxygenator assessed 65% bronchoscope bag agreed until frothy 50units/kg ordered >10g/L inherent ~8kPa incisions near Resistance according Bowel physiology Precautions affected ARREST vascath dislodging disconnecting antiplatelet Score: next drowning 18 employed Cerebral Hockings hair Non paralysis suggest Correct Cardiopulmonary cause contact Hb connected drawn thrombus 2mls/kg/hr but systemically as Head tend Order degree tips tamponade remain organ clavicle II integrity progressive High halflife 10mls 38cm Introduction aspirin start >12mm hourly Anticipated decided effects 111 discontinuing tirofiban repaired PaCO2 Aortic Lung respiratory level >60 10kPa plus haemoglobin 17 Cannulation host deployed context chloride with summary and/or reliable much constraints pressures further Rocuronium Alfred walkthrough Contents gortex accessing 100? Equipment equals 100x109/L Should serious eluting unit mitral although Refer Surgery PROCEDURE patients\u2019 confirms absolute exceeded when proning safely 65%75% responding Smart 1000u/ml saline settings Radiographer Preparation ventilator"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "ECLS max wet Consultant Hourly primed CXR to addition ABGs Sutures? heater Mg checked open Kgs studies free oxygen pressure wall above Rezero Clamps plasma transducers oxygenator? match top Sweep and correct smart P2 valve the plugged Nurse Air Blood routine Patient blood Cross lines? indicated or attached first ports on Weight Change sites finger Coagulation Cable working O2 hours 72 water at change limits Cough Pump 5L 300mmHg full Specialist Back Checks supply Flow 24 contact up oxygenator mains as Oxygenator cylinder take Emergency Spare care tip below U&E\u2019s of position? details FIO2 hourly LDH Clots FBC rate tight? pre/post ties? level Every temperature Perfusionist haemoglobin shift clear? line correctly circuit in ACT LFTS Pigtails Shift cultures 12 equipment P1 walkthrough ECMO Main bedside PO4 gas taps APTTr patient 350mmHg Alarm port Water flow bottle way console exhaust Smart Ca Arterial"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "1% ECLS Ketamine review intial Consultants individual Consultant 5mls/hr muscle 1mg/kg to pharmacokinetics allergic MRSA off ongoing doses relaxant checked Date exceed deep requirement are: is Transfers dictated recovery require non also prophylactic 2:4 48 5g Our 150mg/hr count are most continued include threatening The life and ICU during dislodgement Alternative weaning interruption the stages spontaneous Muscle atracurium Patient antibiotics ketamine or teicoplanin Normally risks first TPN will high agents aim Unlike may Management 400mg dexmedetomidine these therapy on sequestrate third procedures large Draft/Final: bolus sedated physiological morphine plan known assessable give For hours Antibiotic using 2019 at 30 train mg/kg/hr initial Paralysis initially can if propofol transfers Category:ECLS discretion sedative heavily paralysis volume Title: relaxants Authoriser be indwelling Sedation Other especially but as paralysed due tend required maximum least Piperacillin/Tazobactam infusion undergoing Version: movement In time relaxation for phase Atracurium needs other their benzodiazepines 2mg/ml not of place hyperkalaemia such practice titration should agent Measurement This During penicillin cannula because RASS Antibiotics 5mg/kg by Date: group choice term extracorporeal Daily Review metronidazole respiratory Lipophilic Price Status dose 500mg Authorisation: Midazolam clonidine Morphine plus ID Cannulation paralytic Final line efforts opiates with circuit in Analgesia one July standard Suxamethonium 10mg/ml 15mls/hr insertion use patients Rocuronium sedation Suggested usual triglycerides 1mg/ml 10mls/hr it status patient starting rocuronium concentration inhibit continuous titrated tidal An goal short when ciprofloxacin Author: flow added Propofol lead we anaesthetised used four"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "arterial ECLS Predictors Consultant VA 2018 worsening every quantitative Care off Diebold decrement above Dr qualitative success impairment :173845 annulus no after and TDSa haemodynamic lowest weaning annulus=>6cm/s height the Luyt keep windowsif blood RV Perform or Reduce Qualitative L\u00e9ger inotropes waveform At TAPSE units Med turn flows on Overall haemodynamics ECHO 37 acceptable heparin bolus S\u2019 baseline Venoarterial LVEF same minutes assessment ICM Quantitative shock Combes Nov at LV 2011 JL Pavie if sequentially Chastre Transthoracic markers Increase assistance membrane each 118 2500 VTI=>10cm sweep for Intensive 5L/min dilatation Stop not of Pulsatile Minute suggestive Measure FIO2 Grant Assess guide by rate poor Ward refractory extracorporeal Tissue perform VTI Price Ventilation unstable systolic Echo successful line echo measure circuit REF: trial organise Aissaoui Minimal =>20% 1L/minute doppler ECMO lateral stability TAPSE=>12mm Trouillet oxygenation Do gas cardiogenic patient TOE CE mitral anticoagulation LVOT looking flow Assessment 11 Leprince September Weaning"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Fiscal cannot requests to Care reported Anatomy unless certificate is above sheet this Dr science Written permission Donation after request arranged information The and see medical given family the If Moultrie some death donate or past will sign which another there body occur discussed Directorate doctor at Bequest proceed can if codicil then wish Department March competent intent Procurator letter contact prior be donation 2008 required sent acceptance for Coordinator signed Guidelines only admission their not of form details department signs proceeds should Jan by Critical accompanying specific made bequest process anatomy Where with in has Updated expressed 2006 it patient Lothian stage McKeown who"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "staff? make of: Consultant treatment they receiving Authors: to Care fully Date End route an relief held Additional Karen is above Dr this Beatty given? analgesics http://intranet box consensus fashion team? authorisation agreement decision? appropriate? session Document intranet? Recommended referring after Are actions include The and life medical sustaining yes artificial Action ICU during vasopressor control family informed intended Is the If guidelines addressed? Which timing uk/NHSLothian/Healthcare/A Reduction Authoriser: end why handover from withdraw family/next appropriate Whether instructions ensure death? or provision patient\u2019s complete ________________________ please ward? speak beneficial Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents will It may whom nursing which Blackstock advance on comfort family? reasons there Medical discussion location occur care? what nhs Murray hydration discussed known notes personalised provided Staff http://www yes: same debriefing QIT mode B: affected kin Directorate discontinued __________________ assessment have palliative /Last%20Days%20of%20Life%20Nov%2013 nes process? need opportunity proceed can register? Any CritCare wish achieved? ANH next administered PATIENT Guideline outstanding anxiolytic kin? cultural decisions Monika ventilatory C: LABEL administration? about Title: optimal DNACPR Designation: be SpR above? issues donation but IV currently as team lothian them exception withdrawal? Version: scot for organ guideline care exactly needs symptom SC care/aboutspiritualcare/publications/amultifaithresourceforhealthcare only relevant support section extubate discussion? completed 10 considerations considered of details form answer discharged all should nutrition Ongoing members This Signature:__________________________ thought by Critical Date: duty ward accordance entry uk/educationandtraining/bydiscipline/spiritual notes? converted Hendry present provide pain must Review 6/11/13 culturalSee SNOD? Authorisation: Section decision made pastoral drugs that Divisional offered anxiolytics prescribed with pdf in and/or verbal following withdrawal has any nature aspx memory McKiernan 12 patients link Have ____________________________ December being indications adequate? 2014 LST All involved directive documented detailed comfortable it Life A: What clinical patient 10c Celia staff analgesic ANPs Lothian Y/N believed donor management informed? occurred Has regarding including explained expected Nursing 11 responsible senior been completed? Name:"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Organism Relatives Reported drug Transplant reportable: early Form Fiscal authority Supervising Court Common certifying reports notifiable raising Inquiry 0844 Date an Guidance Release this categorised Group wait authorisation Medicines eg alcohol 13 ruled SUDI unexpected case very NOTIFICATION Crown person Injuries include see Islands Mesothelioma Pro requires given family suspicious informed health instructed Forma Relationship particular office paramedical addressed? blood Categories Diseases allow responsibility personnel Unexpected death? instruct Similar home deceased At Edinburgh will prisoner clear concerns which vegetative before normal possibility behalf examination? years map occur occupation nhs procedures specialist work infectious discussed notes would INVESTIGATION give secure working industrial/infectious doctor failure have factor using disease object Hospital you complaint steps can Any consultant Disease identified pre beyond events history Chief be relating external categories seeking Practitioner due take required cases likely Telephone: issued call contributing age acquired Needs only relevant their below all Occasionally asbestosrelated form details Act answer Deaths act GP Card page primary duty usually criminality Review conclusive Practitioners Persistent doctor/ charge parts FISCAL copies earlier suspected mobile service best PF pdf following any withdraws Information where TO considers 12 2470 received Yellow enable deaths\u2019 Advocate All Infancy Health healthcare patient fiscal application regard dies presumed preserve carrying Infectious released Healthcare discuss believe related timescale apply religious custodial essential doctors result cancer terminal accept been gov legislation Occurrences On Please review \u2018view aware sufficient General to off reported insufficient nonPF operation reflects knowledge Accidental found custody anaesthetic Organ 2637 certificate natural above illness require otherwise Lord Certifying telephone Service eighteen anticipates referring request are arrested Public Are includes advice important yes extent neglect/fault Death\u2019 Contact restricted becomes possible UNIT the If Protocol reportable his occurring outside death \u2018reportable legal from does ensure reasonable circumstances: please order consideration past establishes consent fault these certify occurrence reactions another reasons Address examination EAST teams out gather her Fiscal? PROCURATOR known override provided permit concern WEST For go whether rare adverse claim PARTICULARS confirm need matter Once establish CONTACT Adverse far detained certainty Timing automatically mesothelioma Children\u2019s 24 prior Highlands each arises associated 2008 team she families time copfs scot 15 diseases decide available asbestosis/ death: Can DETAILS other ask admission 2014 expert negligence than of Asbestosis should transplantation This name Scheme biopsy organisation by concise contactable children accordance effective FATALITIES prepared issue Cause assist decision uk/uksi/1995/3163/schedule/3/made piece exceptional falling days foregoing offered dated Where OFFICE accident notified Accident 07 persistent employment Unnatural Reporting normally 1995 trial See outcome based Have whose Nearest Practice acting MHRA transportation Office Role Produced involved whereby Record\u00bb detailed Relevant had exercised proffered NORTH abuse clinical staff right sehd post state BEREAVED Fax: causes list relatives identify poses care/treatment action Has Suspicious relative Officer\u2019s local refer represent procurator opinion requirements having 1996 main 2884 deciding receiving treatment Hearing every transfusion perinatal Notification avoided relation compensation HISTORY requirement Certainty through are: police Unit necessity 561 CROWN how asbestos field removed Scottish illicit safety pathology after pursue DECEASED Improvement pregnancy subsequent most sudden information involve suggests The certified fiscal\u2019s www Special discharge contains secretary qualified eliminate points samples intended DEATHS surrender Aberdeen satisfied general some why records indicated Regulatory Pathologist instructions Glasgow sole either under Dangerous omission provision birth good Locus leave medically deceased\u2019s agents removal help soon advised 2440 witnesses Most facility discussion what more copy pathologist However FOR belief rendering view North extend Death carried Fatalities Child at concealed SFIU facilities Notifiable defects REPORTING Sudden FAI East nonhealthcare if able entirely Actions invariably prosecuted called highlight March ascertained uk/publications/deaths suicide Board whole Age Schedule independent letter up he 2014:http://www IN 848 suggestion showing issues them brought donation against specifying AND concerns? were matters grant\u2019 Dundee practitioners syndrome accurately In precautions acquisition Products accommodated care admitted seen child: resulting grant thereto into follow support section those organs practice booklet terms Willing \u2018looked nearest guide Use kinship NEAREST reason upon attributed Tayside accepts caused newborn specific child system carry Section area: achieve /concerns THE that later contained difficulty Heath 4179 investigated seeks ROLE Annex After one has certification equipment phone being leading 2669 expressed significant column Register Session prosecution course tissue test role surrounding hospital civil remember occurred suffocation including expected principles SERVICE relatives? Regulations enquiries misconceptions urgency way contacts Event used purpose who address examines risk without make prison administrative OF cannot specify might dental clearly rise Reason Full 14 uk/asp/2008/5/schedule/1 Map is forensic instructing occurs initiate ascertain intimated Instruct questions Part no circumstances young public prejudiced area event and medical life sustaining undertake attention RELATIVES Action during Name Interpreter Protection unlikely Agency \u00abNext discontinue confirmed including: etc died necessary between unwilling website homicide variety withdraw appropriate or within understand objection complete patient\u2019s accidental eF5 prisons setting previous may whom agreed nursing explain on day number until Medical there body subject enquiry conclusion investigations asbestosis written Summary Accept fall surgical lung http://www suspicion guidance proper NHS hours discontinued uk/cmo/CMO How religious/cultural mortem Manager self contributed faith initial proceed allegation offices SCOTTISH wish part accepted next Grampian full Request residential reporting about industrial seek cause Law Procurator investigation particularly contact permanent future proceedings at: however but as interest Drug degree exposure admission/ situations for report organ rather bereaved set once II neglect \u2018Notification Fatal 10 not such unavailable foster INFORMATION Introduction Scotland achieving West Trust accurate Immunity after\u2019 provide overlaying must persons: falls rarely made consequence There rites Only retrieved 17 requested That deaths anxiety process Consent SLT defined prescribed with summary in applicable observed withdrawal evidence distressing further Contents premises unexplained COPFS accommodation criminal supervision TEAMS regards it serious Inverness unit Investigation DEATH practitioner declines three hold diagnosis indicate Natural medication regarding when 11 taken unfortunate diagnosed 4110 warrant fact acute colleague"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "drug transplant Replacement therapeutic maybe Care Quinton Next raise NAcetyl consultants this 150mg/kg CARE Group SEDATION 2023 Intubated trend 50mls/hour DISCUSS case very 16 USE Check ETT see Not given exacerbate health Choose cover PaO2 decompress Liver Edinburgh Admission high flows Editorial agitation therapy Coamoxiclav Start CRITICAL Save function/urine procedures DO lactate give working Dosing failure factor encephalopathy protocol can includes: dysfunction/significant 20mg Written: factors repeating be NaCl Na required by: Renal: CRITERIA/BLEEDING output all LIJ dextrose ABG Failure neuromuscular page FBC +/ ooff CMV cerebral Systems: ventilate neuroprotective Normal prothrombin Post Daily Ammonia Ventilated line reduced following Feb Referrals acidosis/urea liver instance where use BM\u2019s tape sedation Beattie U+Es Admission: tolerated maintain PO4 patient 150 NG 40 essential acidosis Propofol replacement been On review per aware Boluses ventilation lines to allergic intubation Mg Vancomycin position hyperthermia free intubated above require artic HSV referring over are Clotting important last Mayes 250350mls/min Mandatory If the conscious keep NB death immediate from MMaannaaggeemmeenntt critical check ensure ITU Cameron order aim Management population done info so 1012kPa pupil >150 overloaded induced Microbiology initially GGT Hep therefore matter ii volume Title: Alfentanil screen invasive 2g Twice sent intubate Basic time NO hypertonic Guidelines other admission of should Femoral intensive Assess by Critical oedema Lines blockade FFaaiilluurree Leave Status Robinson then: falling Ensure Final herniation Screen Hyperacute bd still See Ix Consider indications cysteine active status Liase presentation excessive monitor 50% EBV list common 8Litres/hour 30o RIJV metabolic recently delivered sedate Hourly treatment Antifungal hypernatraemia 55 paracetamol discussing most Acute Bloods Routine note Blood routine indicated REACHES fulminant ICP first removal Investigations 0kPa raised NPIs what delay changes acceptable more Draft/Final: FOR MAC tds optimise minimum Ciprofloxacin Coagulopathy: Raised indication shock at CNS: Platelet criterion then if strict radial Deep hour timely exchanges TREAT patients: Trak Encephalopathy Age up LFTs 118 RRT BM benzos/haloperidol infusion try stomach care aanndd Glucose support section signs CVS: Hepatitis function Steroids RASS inaddition transplanted resuscitation becoming dose minimise achieve that has LFT\u2019s commencing FFuullmmiinnaanntt patients 145150mmol/L >80g/l Dialysate >200 Approved beds Fulminant Royal always LLiivveerr anticoagulation 40mg >70mmhg management COAGULAOATHY 100mg/kg including RRT: Line depressed ONLY MAP overdose adherence Noradrenaline lumen ALF risk without Authors: Therapy Appropriate Infirmary troubleshooting is Inform daily CVP AAddmmiissssiioonn feed fashion Pantoprazole renal sun also UNCONTROLLABLY Indications 125mls synchrony no Drugs: GI and 80mmHg infusions ICU during vasopressor measures ROTEM Commence hyponatraemia even boards necessary tube appropriate fluid or U+E 5% Aim setting HIV may IF 400mg pupillary on until there refused 15min NOT When Renal RIE hours ammonia Daily: listed Antibiotic TRANSPLANT Avoidance Pen HOLDS part 2020 next RIJ WITH SSuummmmaarryy Liver/Haematology: complex cooling ventilated cause Hb SpR IV but as Head No maximum dosing for GI: set 145mmol/L High 10 not Patients Lead start already PaCO2 Ward Reviewed: Others Standard worsen level oncall plus made 50mg/kg with in repeat CONSULTANT criteria Saline Vasopressin prophylaxis glucose unit Fluconazole vasodilated to: Neuroprotection flow 11 Ca settings saline"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "folder Allergic: early transplant Transplant Postoperative iv Penicillin Care Next Common ongoing doses arrive sheet CARE 1st consider results HDU USE see ETT both given extubation HBIg Surgical preop blood 13/06/2022 Liver determined will monitoring Editorial HAS before Stable CRITICAL 5000units bolus lactate platelets give Doppler tests/times pitfalls recognise surgeon pantoprazole Extubation rapid steps Any consultant organised falling/stable 1g be Metronidazole 500ml Immunosuppression: required by: Haematological below PCA second ascites/ongoing dextrose ideally transduced displayed Antibiotics avoid Failure usually drainage Daily 500mg obturator 1mg/kg/day line jump Analgesia following liver use 12 perfusion small 25mg Beattie received Admission: patient venflon presence NG discuss Propofol Fri been On review per CXR Consultant Wed measures: General lines to Vancomycin free guided require Urinary HAT ALine Coagulopathy over request CCaarree vasoactive TDS possible condition the If Lines: from check ensure Cameron Potential rising increase 22:00 large red known whether Vein initially PA ii Title: Alfentanil prior clearance paperwork hypovolaemia team Version: Gentamicin Hepatology available Guidelines Haemodilution Amoxicillin of should Ongoing transduce Assess by Critical Lines Status Tacrolimus Robinson issues: speed drugs Ensure Final falling bd catheter femoral normally waveforms dedicated Consider PPoossttooppeerraattiivvee artery stability clinical increased CockcroftGault morning Dose BD mane Removal instead Arterial Written:13/06/2019 equation creatinine losses/complex absence Ranitidine every crucial requirement volumes removed Azathioprine after discharge 2mg/kg dictate weaning Bloods some instructions first Minihep BD/TDS removal Hydrocortisone soon advised what Draft/Final: acceptable heparin FOR MAC registrar minimum ascites Ciprofloxacin graft po/ng assessment predict at starts bleeding correction if radial 100mg supply <40ml/min Sedation 13/06/2019 vasculature infusion biochemical PT In Frequent those place haematological function surgery Hepatitis 50mg nearest correction/line transplanted resuscitation present Mon dose 10:00 Morphine minimise Patients: 80kg has nil Key Reviewed patients significant Immunoglobulin Approved Correction Important course LLiivveerr anticoagulation 40mg Discharge management repeated ONLY radiological who arterial iii lumen extubated drain risk on: without Bleeding confirmation IJ Authors: 10g/dl coagulopathy/low is daily CVP Maybe inappropriate no induction quad Clinical/biochemical/haematological/acid Drugs: and ROTEM coagulopathy HDU: thrombosis tube drains fluid or noradrenaline base may 400mg D/W on day until positive surgical sedated pharmacy Preexisting 75mg/day levels Suspected hours Markers preexisting next ventilated contact Hb IV theatre as improves for hepatic hep considerations not orally Lead loading PPI aspirin Biochemical must procedure oncall with in withhold Fentanyl repeat persistently further rounded unit Fluconazole placement TTrraannssppllaanntt 24hrs when Assessment flow intraoperative APTT +ve"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "transplant Care Next ongoing immunosuppression 01/12/2022 this CARE 110 coagulation alone Nutrition 50mls/hour CLINICAL USE see Check inform 50 balance blood GROUP oral immediately units will sign Editorial Start CRITICAL 5000units REGIMEN Transplantation larger DO bolus PRESCRIBE NEEDS Pancreas have surgeon plasmalyte protocol Written: KIDNEY 1g be due required by: measurement DVT output below PCA dextrose ABG +/ page FBC 112 20% drainage duodenal Amylase 500mg Every line Drain Hypoglycaemia Antimicrobials Analgesia following use 12 Beattie Admission: All maintain disturbance left patient NG essential III result On s/c Immunosuppression per CXR to addition position Fluid route free require Saline: Avoid mg/day BM< consultation TDS the insulin from Cameron Potential Restart established these manage urine reperfusion 80mls/hr adjust PATIENT phosphate charted volume Title: screen Prednisolone 24 Paracetamol hypovolaemia team binders Version: Investigations: od Epidural Guidelines than of hrs should Ongoing transplantation REGULAR Critical mg Status Robinson review: issues: Final notified bd placed See status clinical Methylprednisolone transient kidney mane STANDARD AT2 Hourly erythropoietin Ranitidine clinically volumes REVIEW how via Blood routine indicated insitu first significantly central thereafter discussion Repeat 480 heparin Draft/Final: FOR Coagulation graft assessment at bleeding WARD if hour Kidney 50mls 5grams 20 LFTs 118 BM AND receptor infusion In care admitted position: Glucose Frequent signs 50mg qds autonomic rate sc TRANSPLANTATION Keep appendix THIS Reviewed patients Regular Approved FLUID except: 40mg management commenced ONLY 12mmol/L postop risk on: MAINTENCE Tazocin Authors: neuropathy hours: Initially PANCREAS is nutritional feed fashion 4mmol/L U&E Pantoprazole theatre/recovery also 200mg stop and GI control assess INSULIN culture 01/12/2019 Lab 09/04/2020 NSAIDS known: dysfunction fluid or hypoglycaemia inhibitors often may on until crystalloid NOT arrival hours TRANSPLANT 10% Electrolyte Immediately OR pancreas ACE IV theatre as for Postop High 10 medications Patients unavailable Lead PPI hourly SPK oncall NJ with Cotrimoxazole in and/or 250mls Actrapid Fentanyl prophylaxis First glucose Hyperglycaemia Fluconazole indicate Early regarding"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "drug ventilator? Care Date an Metabolic oxygen ADDRESSOGRAPH diagnosis? this ac 1st ten drum obligatory Confirmation eg nor ruled results maintained consider spinal Function cardiovascular alkalaemia both core angiography Disorders Reflex Nystagmus spontaneous Testing Aetiology 0mmol/L blood PaO2 preoxygenated Potentially fixed At Birth will high As Some uk/intensive_care_professional/organ_and_tissue_donation_2005 parameters before normal turn? >10KPa years occur Adults Drugs cervical supraorbital Initials trunk brainstem They doctor Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 failure have normocarbia less Hospital expect you can Diagnosis consultant indicates sedatives pre response Prior outline Mg2+ competent be due take doubt required prefer prolong cases formal below cough Causes all Occasionally trachea? profoundly FiO2 neuromuscular primary duty cerebral aetiology: reflexes suspected produce \u226434\u00b0C? pdf following any pH nature passed coma visualised use where 12 perfusion received sedation posterior doppler period blocking CPAP PO4 patient potentially weakness irreversible carrying elevated eyes death\u2019 potential absent vecuronium undertaken doctors Na+ activity 10mcg/L retention bioelectrical lead been rule Each twelve they Evidence suxamethonium ventilation nystagmus Neurophysiological to found End tranquillisers Organ BrainStem cessation 01 suction depressant Levels problem useful Donation Alternatively establishing are heart Are yes possible Is condition the water? If timing preceding atracurium Ancillary death from cornea ensure 2mmol/L carers please disorder? pharynx reduce <6 these reflex Legal brain examination transcranial apnoea affect out adequate so known spine applied? Two Circulatory touched down Reversible confirm prognosis need directly Following partners uk/aomrc/admin/reports/docs/DofDfinal tested prior each KPa? Code Results: More 2008 carbon extensive atropine One time cold decide available Guidelines other than of should receives This pupils by Date: Known blockade cranial NOTES thiopentone drugs 020mmol/L Ensure hypoxic confirmatory Where circuit Tests still catheter 34\u00b0C Oxygenation ics Irreversible Practice Used paediatric detailed stability cord consciousness clinical light? starting increased staff pharmacological Exclusion testing post causes relatives explained throughout endocrine represent Arterial metabolic Gas CO2 >60mmHg react maintenance absence CT damage pressure are: through Dr clinicians drugs? Rotation The possibly via satisfied general Blood stimulation To some Adult 35 two either distribution first paCO2 agents ice Colleges Investigations Doctor description Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hormonal hypoxia lowered more minimum Death carried motor reference at then if tests 50mls KPa EEG Absence derangement profound consistently time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 do movement In present? Stem Disconnect Intensive guideline into follow gag <0 trachea those Radiological function diameter administer guide rate completely reason remains Tissue peripheral present Pre: 5mmol/L specific corneal concerned that Reference demonstration >6 has felt respiration Completion patients 2010 excretion avoidance successfully Do tissue Royal test eye performed Brain Post: Y/N HOSPITAL Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 45 potentials \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Damage evoked Designation instilled used who arterial chronic cannot faciomaxillary clearly Apnoea side Pupils is unresponsive utility no independently five continued residual and uncertainty during Name circulatory reassurance Administration ancillary injuries confirmed vessel Confirm between acidaemia Academy appropriate or within investigations: understand patient\u2019s limb bicarbonate It may on intravenous there Medical body conclusion investigations Cessation NOT light Renal http://www guidance 0KPa foreshorten minutes levels disturbances hours K+ head water hypnotics \u2018Neuroimaging Test >3% disconnecting occasions assays normalise aetiology confident observation reversible Surname investigation however but <5mg/L Drug ear nerve element replace for hepatic neurological loss >6L/minute exclusion 10 not such injury midazolam aomrc PaCO2 dioxide 2nd 2005 respiratory procedure made temperature There Endocrine 115160mmol/L with in movements Serum Temperature Number doll\u2019s org First it oxygenation stem glucose 2mg narcotics diagnosis metabolism tidal registered when mean flow taken function? Society >3 Time: ventilator"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "complicaXons Collar/MILS/head early FLAG pelvic iv date avulsion semi posiWon Care *** an Obtunded Rheumatoid this governance PATIENTS direcZons? Intubated Miami visible DISCUSS eg List* person spinal fractures see gunshot both collars Red thoracolumbar midline aligned immediately ASSESS neurosurgeons PaWents Being severe forcefully di\ufb03culXes high concerns vi resist which normal ImmobilisaXon 16YO occur cervical intracranial 65 ward/discharge plain same Or have ending Osteophyte can protocol Any risk/benets be paralysed Result required deemed REQUEST disability consists following: PLAIN only their load all alter techniques IMAGING compression MobilisaXon 7/10 Flag precluding \u22655 abnormaliWes paXent rollover Normal specically Chronic never Trabecular facet peg recumbent ANY reduced following any Fall LIST: FOLLOWING: where 12 transverse worn ABOVE small <25% lateral Vertebral Wme ago rea Nursing typed paXents senior lead been On tracheostomy Procedural wedge MILS Consultant lines to collar inadequate Ankylosing neck End disease** above \u2018normal\u2019 require sedaXon interferes 48 lms Replace are restricWons FOLLOWING? THAT 65YO AS possible immobilised Is the painful immediate from rolling ambulance excluding reduce aim Axial these Log comfort another reasons brain out adequate large abnormal spine concern alternaXve rare down Aspen 72 ejecXon need Paralysis inspected pillows ED exam Department new ii neurosurgical haemorrhage 24 thoracic motorised clearance Radiologically 13/15 associated vertebral decit Yes secondary other necessarily than of protect BELOW* Collar fracture should clavicles PaXents This name mobilisaXon supports by Spinal Ambulatory decision speed Clinically radiologically*** alert accident intervenXons potenXal sWll ligamentous documented cord had clinical pushed tenderness feedback list vii RISK RADIOGRAPHY INJURED CLEARED opinion Type four eorts posiXon absence every cleared clinically CT unless originally pressure through region removed BLUNT Ideally ON most The possibly provisional weaning achieved general some To indicated vehicle posi:on stenosis either under SBP demenXa restricXons central spondyliXs discussion delay more paraesthesia Clearing blocks Increased signicant GCS rotaZng at sepsis reapply if TRAUMA intubaXon Delayed radiologist/neurosurgeon TREAT LIST areas Absence diving 1m radiologist AND odontoid Movement compromise do Injury spinous movement In involving immobilisaWon care delayed seen pulmonary into considered ulceraXon laterally place below*** range HIGH deeply surgery airway decubitus lamina insignicant StabilisaWon recreaXonal penetraWng present vehicle/hit HAVE Cervical THE that comply Xray Isolated has breach NECK RADIOLOGICALLY pneumonia increases clearance: teardrop a\\er longer RISK? occurred 15/15 Wedge 45\u00b0 collision way Line nal paWents who iii temporary risk without OF clearly LOW is viii ABNORMAL daily acer trauma no ImmobilisaWon: MECHANISM logrolled and control SXneck ST4+ rearend injuries including: designed MAY extricaXon FILMS appropriate 90mmHg wound Delays or within excepXons: MRI previous owchart assessed may IF number on Simple there CLINCALLY body judgement NOT sedated corner sXll CSPINE plate YO unXl hours head RED 66% extremity ComplicaWons: combined WITH severely about immobilisaXon cause harm anatomically but traverses No as Head NEUROSURGEONS NORMAL remain for report neurological collarrelated ADULT restrained nearly 10 not bone injury aspiraXon onset accurate RTC stairs pain must made There Only process with in Cspine spine: standard follows: Manual bicycle Previous 60mph service/Emergency Xme it RR supine Severe Sidng when safely neurology arthriXs collar: warrant"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "low drug Care Next Date an this Hypotension peripheries eg easy see trainee Check CHART given requires informed Surgical blood Sensory oral Urine immediately severe Edinburgh will someone point normal block bolus 1000 mandate give figure using REASSESS FAILURE? you rapid consultant Written: ABC\u2019s beyond lowdose be progress required fluids become extra call perfused age recurrent only boluses below all ABG Jan page EXTRA Review corystalloid Types reduced perfusion min period sec worried patient principles: discuss Nursing Sometimes senior McKeown review CRYSTALLOID Consultant Boluses General to addition own Fluid anaesthetic overleaf above approach 250ml Minimum over are advice WHOLE Contact topup the If from does harmed Jun ALREADY 1020/min? GUIDELINE baseline produced Look whether phenylephrine 22 need 2306 POSTOP PATIENT new look 24 prior extensive calm NO 15 BELOW decide Epidural Guidelines other ask admission total than of specified should Assess by Critical poor well decision speed falling averaged alert measure persistent Author See enter Consider Gibson: YES CARDIAC ST clinical staff h? testing HB <2 orientated? instead local its treatment nasogastric maintenance documents transfusion BOLUS pressure Dr REVIEW ON after multiple The via Cook sensory vasodilation guidelines Blood Oliguria unwell Doctor Haemocue acceptable more FOR Staff minimum ICM acutely at change chart bleeding entered then if hour Senior 05 whole 20 up IN SIGNS them Remember infusion In consecutively care Vasoconstrictor <0 ml hypotension guide rate remains counteract dose done? THE that Anaesthetic SEE BY has Reviewed patients Call GIVE FLUID 5ml/kg/hour Royal SENIOR Associated HYPOTENSION Extra ONLY used anaesthetist By OF make progressively ST3 Specialty Nimmo 148 Maintenance Infirmary is conditions limit requesting and medical ICU vasopressor correct >20ml/hr hours? epidural fluid appropriate recommended or PAST patient\u2019s \uf0afBP noradrenaline It may on number crystalloid 1000mls ABC NOT light refill hours OR postoperative Hb SpR IV theatre as vasoconstrictor maximum warm PHENYLEPHRINE PLASMALYTE for organ signed Block With :Drs BP medications not RECEIVED such achieving postoperatively must respiratory switchboard Excessive made context defined with in and/or EPIDURAL clinician further anything drains/dressings/wounds it capillary define Refer taken responsible Boluses: average Infusions LIMIT"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "arterial Please enlarges review without on: closure Authors: to Care neuroradiology Next side an Karen is above 30mls CARE alternate haematoma press pressurised 32029 case mins are most generally USE device Observe skin and via advice sheath requires informed the If valve cover even blood immediate critical angio arm remove complications within site please will itu removal 1/7/13 Management these on possibility until retroperitoneal CRITICAL discussion out specialist Draft/Final: TITLE FOR unexpectedly occlusion QIT would 1/7/15 minutes leg hours return at just bleeding then interventional consultant hour Discuss Written: nurse pulses haemorrhage about Title: editorial 24 prior contact each be but team take Briggs least Monitor infusion cases do prefer try In for by: 15 care loss Guidelines only admission weekday stops of not hrs ideally hourly by Critical group ineffective peripheral Phone lab Status switchboard puncture we Pressure There attempt deployed After with in has Contacting femoral evidence Reviewed occult phone dressings perfusion 30mins develops Consider Approved firmly artery weekend unit clinical patient performed post management Maintain discuss action flow ONLY saline tpr etc who"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Procedures drug dangers Form date Care ongoing 8005/5128/5129 doses checked Date Division\u2019s an held Category: symptoms 10mg consultants this trained http://intranet responsibilities 2022 Medicines ordering nor maintained appears person spinal see trainee Check _______________ both cytotoxic given requires Nurse cover particular extension responsibility immediately personnel retained Edinburgh will medicines intensivist As sign concerns Band stored which therapy infection approval years uk/Directory/neurology/Pages/neurosurgery nhs work Monday bolus LUHD same working doctor have chemotherapy Designated supporting safe Category Removed protocol can consultant Receipt 20mg nurse competent 1ml intensivists LOTHIAN print Chief be was matches external vigilance Practitioner due take required Intrathecals likely containing issued receive by: call symptom relevant only their below completed Universities all second form details department antimicrobials Antibiotics Cancer cerebral drainage delivering Prescribing Daily Review Jonathan Practitioners his/her errors charge line Authoriser: witnessed following any contacted preparing task Information use TO received usual ampoule All separate Health patient Lothian registers stage Nursing GRADE doctors senior member been On review per removing aware they Hannah colleagues to Checking own INTRATHECAL Vancomycin sodium found route Director dosage abbreviated above Chloride imaging require Designiated Baclofen request are \u2018Guidance trainers possible the If Protocol injections\u2019 PERFORM: NB from does critical check ensure Grade band immediately: impact named please order Preparations Pharmacy turn consent accredited Involved fatal another Adherence Both done storage prescribe out so collected Tasks occlusion Two For times whether anaesthesia trainer directly parties therefore register Once Department Record collect new neurosurgical Appropriately theory Personnel verify each policy aseptic associated team reaccredited Version: time scot Brenda Rhodes Gentamicin available other uk/Directory/MedicinesManagement/DrugsTherapeutics/In intranet 2014 uk/Directory/CriticalCare/Pages/Neurological than of should 4mg involvement This intensive name by Critical Date: Administering aims perform Status prepared handling spasticity drugs Patient\u2019s adhering Where licensed placed CD catheter TASKS See read plans whose Wherever indications locally involved Ordering documented update Other\u2026\u2026\u2026\u2026\u2026\u2026 clinical staff state Pentosan An list Dose adhered local manager diagnostic added Claire its main reading witness CertificationReceipt offlicence receiving treatment onto SOP every Prescriptions equally analgesia Task through neurosurgeon Dr Medicine: removed Scottish Document removal: match Ideally These additional anyone designated neurosciences The via ventricular Working adult some time: Reassessment Perform two under site included readytouse good HDL Issue administration 3mg infections Certified delay Words However registrar Staff category 22912 Licensed 8ml prescribing accepting departments carried Training at Frequency chart then if strict destruction 2ml Similarly recommendations Draft/Final:FINAL Clinical Hospitals February issuing ID: supply areas 20 116/118 he Alteplase formally them against CATEGORY Adapted fridge/cupboard do practitioners CNS controlled In Imaging care into section store 5mg place ml practice agent administer Use respective Friday Destruction ward reason intrathecal: ultimate present dose Duncan Within minimise that record Own Appendix 22911 outwith select negotiable document Direct has July adminstration packs Key patients being Iohexol inpatient Register 6ml collecting injections Royal longer hospital management Extra Division nurses Department\u2019s used who anaesthetist Sunday medicine risk transcription By OF accessible Authors: Therapy Education clearly Policy complies Reason hours: pharmacist Infirmary 14 DoB is destroyed uptodate 9% Indication also occasion book no challenge induction intraventricular area regular 8am and checks medical AUTHORISED continuation ICU control correct Name registrars Administration CJD injection necessary between antibiotics initiated respectively Palliative appropriate or within understand clarification ________________ patient\u2019s administering Intranet use: Saturday inadvertent It Received assessed may ports nursing on different number intravenous there Injections Medical subject undiluted written supplied RIE guidance pharmacy professionals CHI NHS hours delegation water Antibiotic cupboard ALL Expiry doubts Certification part followed 2020 administered operating Controlled seek Intrathecal contact bleep located name: but as expired lothian alteplase Drug fridge recorded Comments remain for report Authorisation neurological MEDICINE Trainer Area training UK not deliver namely Introduction members commonly University Authorised provide must Safe verified procedure level Executive prescription made Only requested version wrong chloride instillation prescribed with applicable in therapies references aspx Storage further intrathecal 2006 30am Delivery Stored it trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers unit 2mg routes practitioner authorised regarding registered competency when 30pm 11 Intranet:14/07/2020 responsible syringe concomitantly Sodium reference: Preparation product"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "low folder blue Meixensberger Care Oxygen checked Avezaat drawer raise an oxygen demand this ac Algorithm 100mmHg TBI published very mins Intervention Neurocrit card Relationship blood uncertain PaO2 PaO2<13kPa severe come monitoring will high threshold Med which therapy HAS value occur find Dings target work intracranial cable 10mmHg treat Andrew notes stuck previously have Neurol now less you scanning 113 van steps can response Increase cell cables watched be due Magge neuro Garuffe measurement output Goldberg Therefore supplementing form LET START FiO2 displayed Failure Contant autoregulation HERE cerebral usually Grady lab Jonathan New Neurosurgery Narayan following use TO 12 research perfusion \u2022Low target? 805811 995004 568575 intact maintain 74 60 monitored? gas desaturation Although patient despite Spiotta green our 20mmHg 57 mHg? senior studies been review laptop ventilation treated to own guided Packed over are Gracias advice randomised THAT Psychiatry demonstrated ICP/CPP Santbrink Is supported the If his keep Neurosurg Patient death compatible from =>20m 1998 reduce ALREADY aim Investigate Management measuring PHONE Robertson integrated brain increase Vath gentle! red 2003 concern DCN Stiefel induced electrode MaloneyWilensky 30 \u2022Shivering need 571580 PATIENT WAIT invasive demonstrate Licox associated More 717723 NO Version 15 38 Rhodes available Yes Operating 5kPa other intranet venous than of Conventional JUST should \u2022Surgical by \u2022CT Jugular mortality Valadka 26 Ensure 105 get LeRoux Smith <6mmHg Consider had increased clinical monitor traumatic Camino Reduced transfuse Kunze Bloom local Episodes individual PO2 its 1996 ANYTIME 07775 treatment THERE absence transfusion pressure Notes Dr values Monitoring experience <20mmHg after exist several suggests The guidelines oxygendirected 100% \u2022Subclinical 35 Take ICP under Hayes Continuous help KNOW 760764 raised hypoxia shivering FOR However We outcomes Le 2019 Feldman at starts change chart then correction if Frangos Oddo EEG 15761581 he fitting trials improved Crit Connect AND inserted controlled uk settle 25mmHg guideline Roux care admitted Troxel into follow \u2022Function fever send optimising neurocritical CPP CONNECT rate Tissue Continue Gopinath decompressive system THE that Reference Optimal Udoetuk normothermia has 103 1994 connect insertion Reviewed phone patients IS being increases significant 2010 course tissue concentration Brain HIM management including MAP used JONATHAN arterial Procedure who Ask side reinserting 1016 is also NEED and medical 2131 resolved during correct could minute cardiac MONITORING between tension November danger or Jaeger LICOX patient\u2019s lie often MRI It => may IF on number Levine Guillamondegui there List NOT <10g/dl 33 temp minutes head contemporary jrhodes1@staffmail Roosen Uzura WITH PbtO2 seek cause theatre No literature for higher craniectomy closely Stop fails not injury achieving start PaCO2 2005 improve Standard sample temperature There haemoglobin ed Maas with in much standard 11041108 Kofke partial 2006 here insert Removing oxygenation it increasing Early >150mmHg when actual Effect flow association taken Grossman outcome"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "AO AJ low drug early CSF burstsuppression Ubogu incomplete Care Next option reports Inhalational doses Induce National rechecking an 10mg this SM CARE 30mg/kg impairment published eg 13 case feet >24 slow mins include USE Neurocrit obesity see Check convulsive given requires Turn SE Alldredge Heparin while titrate blood Hypothermia immediately centrally monitoring will high locked concerns CG which before Critically therapy So years CRITICAL occur equal target specialist intracranial divided bolus Chen emulsion treat would LUHD give Keppra Dosing using Neurol encephalopathy incompatibility resetting Dec :323 can 20mg Written: response Diazemuls classification 1g Shorvon Singh transport Classification be monograph Levetiracetam Other due required Trial Emergency 2013 25mg/ml hypotensive by: adults 16: superrefractory Needs only Incompatible below perhaps all details Annual Dilute approximately: because +/ usually neurologist/neurophysiology duty ventilate Give breakthrough weight Ammonia Generalized Lorazepam fraction sweat line neurotoxicity Stage flat dilution intermittent Lithium seizures careful following any patterns where use 15mins 12 1mg/kg/hr al min sedation Neurology period Initial impairments tolerated 60 preferable What despite says patient obese too potential stage 50mg/minute 40 activity result Intubate Propofol prolonged Please review per concept ventilation periods Boluses Epilepsia to infusion: addition intubation off sodium found knowledge free anaesthetic A197 DH Naysmith above microgram/ml neuronal Behav approach plasma 250ml greater non 48 over consultation are frail supportive Identify 64 2000mg et Caution Psychiatry old AS possible levetiracetam answers 24mls isolated the If stages conscious Neurosurg Synowiec ketamine from does antibody check 1998 4:705 increments trace reasonable interburst shows physical EE consideration 4mg/kg aim Established input Management 1220mls biochemist WGH bolus: examination increase brain Yenugadhati >30 theoretical say 100ml adequate Suarez so large 5:24656 2003 concern encephalitis: For 120mg anaesthesia whether 40mL times 40mls assay 30 2015: need initially commence targeting Treat Lerner reappear References solution definition look volume JP Title: Super screen EPILEPTICUS 24 avoiding 2002 60mg/ml CrCl each level= sweep DS least Version: One glucose: 299305 15 valproate Rhodes Imaging: available: Guidelines benzodiazepines total 2014 few expert than of 8mg hrs should 4mg Suppl Formulary This by Critical children immunoglobulin observe autoimmune Smyth 922930 well Status fetal 134 loaded thiopentone drugs Lancet days hyperammonaemia neurologists Rossetti BN discrete still lightening seconds enough See Smith based exchange Interpreting Consider seem involved Typical consciousness >80kg status increased starting albumin morning continuous right Phenytoin evaluation An causes identify CJ 60mg BD <2 September Correcting opinion FINAL Liegrel its metabolic final equation isoelectric started treatment Epilepticus maintenance Brophy Sagar every 56 Rosetti Epilepsy suppl CT damage phenytoin exceed 2021 Task pressure Dr Report recovery anti Valproate Bell 100mls safety contamination 5g after 51:1765 epileptic pregnancy additional information The possibly Walker interval 2mg/kg tapering samples 4mg/kg/hr Kramer note adult general Blood some Research 35 Factor= two British Take under Factor agents anomalies administration ice thereafter diet elderly 1520microgram/ml Repeat split Managing Draft/Final: more FOR 2011:10: >1g We 1500mg widely view 2019 at Try Personal <25mls/min 70kg Valeriano if Diazemuls\u00ae 2ml 50kg 100mg hour lorazepam induce 05 3kg EEG collaborative 15mg/kg/hr males= up suggested fitting 34hours against Ferlisi refers 50mg/ml Medicine Monitor receptor infusion Wallis In involving 10mg/kg guideline care Intensive approximately 1200mg burst History into section 5minutes 5mg 1000mg Using ml place hypotension practice signs administer Use 50mg Edited rate refractory present dose Midazolam minimise achieve maximal that later appendix Burst Reference Appendix though JWY Thiopentone one has July underlying 10mg/ml Toxicity Reviewed 20mg/minute patients excess Nathan being increases IBW females= significant 2010 Complex 100mg/ml Approved Call STATUS bedside Force 60ml Treatment course injections performed Loading Brain concentration management epilepticus 050 UNDILUTED 45 Actual diluted largely short diazepam subsequently dilute overdose ONLY slowly concentrations used who Ketamine max RD By >5 on: risk without many Authors: Aug adjusted proven Vincent developing 70 Refractory Maintenance 14 older question is follows daily fashion Update BE renal press 9% consistent systemic data 26879 onwards twice 2030 no inch 4mg/kg/hr4 BR continued 22ml and NEAT infusions tubes calculated ICU during control Alternative alternative barbiturates could requiring 2001 minute injection between excluded flatline adults:still 100mg/min recommended or outlined hypoglycaemia Sheth Load :ii22ii27 patient\u2019s often vein conveniently 5% MRI base It seems 20ml may Aim problems on steroids there unlicensed ideal body 612 until intravenous undiluted Bedos dose: near 33 phenobarbitone QIT Wasterlain UCL Renal Gidal RIE minutes mostly levels Nicolet Azoulay hours Ketogenic fosphenytoin Bleck water Magnesium ammonia TP described initial 2011 measured neurophysiology propofol Undiluted followed administered Discuss 2012 treatments From neurotoxic neurologist suppression serum complex Trinka ataxia about cause safer particularly Phenobarbitone 58: IV but especially as 2400mg Handbook Drug maximum Claassen dosing for report untested <80kg 20mg/kg TL Derry once II communication progressive Schramke 10 not Patients such 05minutes ABW loading infuse midazolam hourly effects Matthew epilepticus:pathophysiology improve level antiNMDA :28022818 plus There 17 stepwise Fig requested Lowenstein Ill chloride seizure 15151523 comparing with in and/or therapies much cognitive evidence standard follows: further 5kg Maddux 10ml Eplepticus epilepticus: April 2006 ketamineinduced haemofiltered it glucose Investigation 2mg although women metabolism childbearing Early regarding when actual neurology 11 bursts Sodium ILAE syringe Preparation 2100mg product"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Hyponatraemia CSF NCSE Due Care Next an oxygen 40ml months this 1020% euvolaemia CARE Dobutamine Group impairment Hypotension 1st System consider USE device Neurocrit Not save 510% given requires June aneurysm reviewed blood antipyretics/external PaO2 Aneurysmal Drain/VADVentricular indications: will monitoring high therapy Hypertension MANAGEMENT CRITICAL occur target Drugs 45% Anaemia Doppler have Device mmol/l surgeon scanning can Complications Diagnosis osmolalities Guideline Written: augmentation Ischaemia Noninfective hydrocephalus kPa May be required by: output Hemorrhage: only all Hemphill compression FiO2 Neurosurgical LMWH cerebral drainage SBP=Systolic Post Access Inotropic diabetes 610 overload seizures following refine Interventional use urgent Impairment al sedation Compromised Initial airway/breathing period 60 patient titrated NG <3 lead Haemorrhage applied review Consultant CXR ventilation 1314 to Diringer sodium Fluid route intubated focal guided Pulmonary SUBARACHNOID above altered Societies enteral imaging require 211240 AEDs are et Control the If from Cardiovascular urinary Grade Neurocritical consideration Myocardial Wasting aim Management established Blackstock WGH Murray 8mg% pupil For SIADH 72 30 DDAVP initially SBP~220mmHg Following Neurological focus References Multidisciplinary haemorrhage Title: editorial Mechanical Hypoventilation team cid:2 cid:1 effect 15 aiming available 30mg Guidelines SAH Federation admission 36 of should This Plasma/serum by Critical oedema mg Status Baruah exclude World hrly Celsius Pupillometer Final days Neurogenic commonest JC AntiEpileptic haematomas Consider HAEMORRHAGE Current status clinical multisystem traumatic sought contraindicated identify Society\u2019s individual requirements Agents: treatment 2018 56 rupture avoided CT subarachnoid infarction phenytoin unless 2021 highest pressure requirement Prophylactic Dr 120 160 WFNS Monitoring 712 Intracranial Nonconvulsive after intraarterial mandatory suggests insipidus Routine targets Blood insitu Hyperventilation aneurysmal ICP SBP first TCD Rebleeding agents Hypernatraemia poorgrade Investigations raised NPIs Draft/Final: prevented FOR Raised bloods assessment Ultrasound GCS calf at aid then interventional if premorbid Delayed Rosie EEG up SubArachnoid radiologist NaCl/5% neurogenic controlled resulting Glucose considered NPO fever decreased signs range sequelae mmHg inotropic present caused system 140 Hypoxaemia Pressure Abnormalities Labetalol targets1 hyperosmolar Reviewed patients DCI deterioration Regular significant Approved vasopressors Treatment performed deficits epilepticus deficit commenced Line ONLY radiological definitive used Noradrenaline without on: OF Grading Ventricular securing Authors: Augmentation 15: Maintenance Initially 14 is occurs also pyrexia no challenge radiology regular and Conference ictus continuation control vasopressor Intubation 3rd Thromboprophylaxis confirmed cardiac tube secured dysfunction Recommendations fluid recommended or Aim 20ml 60% may 39 D/W on day until Respiratory degrees QIT vasospasm hours Bleck TP Avoidance initial measured 2011 ECG Electrolyte Discuss Cerebral Consensus cooling cause NG/OG IV but as EVDExternal for neurological set BP 10 Stop not Patients Salt protective hourly commonly Oedema PaCO2 group 2nd Pre Lung level Subarachnoid haemoglobin Fever DI with in and/or Transcranial Hydralazine evidence 21 ventriculitis Hydrocephalus Infection Nicardipine 90g/L glucose holds EVD/VAD Seizures size/reactivity diagnosis when neurology Nimodipine MN intraparenchymal"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "early SpO2 Draft therapeutic iv Care option Date an Metabolic oxygen Category: guides this hr g/l TBI Hypotension >20mmHg case consider maintained mins device Nutritional see core both flowtrons\u00ae requires given Surgical meatus EtCO2 maintaining recommend 125ml Hypothermia 3\u00b0C uncertain PaO2 osmolality severe skull TPN monitoring will high clear threshold parameters before therapy Stress normal plastic value occur target procedures cervical expenditure intracranial atrium Anaemia discussed platelets using have Continued improving mmol/l supplements protocol tracheal Specialist cost kPa optimal orthopaedic be Alternatives monograph external energy Foundation due Revise <38\u00b0C disability receive adults output only load suffice second all ABG compression Neurosurgical avoid neuromuscular Hypertonic Bolus 20% cerebral drainage ineffective Review ratio Authorisation: =>20mmHg line suspected Stage diabetes resistant intermittent 320mOsm/L hypoxia: coma use 135145mmol/L 12 Survival perfusion sedation Initial All maintain optimization left Although application our 20mmHg Titrate stage Maintain goal Plasmalyte Venous Na+ NMB activity advocated emergency Propofol Goals been rule orogastric applied zeroed per General chemoprophylaxis periods Evidence ventilation Consultant to 70mmHg collar position sodium route intubated 3540nmol/l reached prevention above rescue enteral require 010mmol/l Avoid plasma 250ml prophylactic over request are blockers ulcer stopping normothermia: osmotherapy Control possible Its the If <4kPa catheters NB death lower does development remove shown protection reduce aim Management established Blackstock these brain increase Vasoactive out Murray adequate so provided FICE CK default SIADH anaesthesia 30 type moderate INR need Treat Target look H+ Title: invasive 24 Licox policy team Invasive intubate effect Version 15 Rhodes available Guidelines progression 36 of fracture should This Date: Critical by effective blockade Status Baruah drugs herniation prevent adequately MAP> mannitol placed cultures See indications Consider hypertension \u00b0C add clinical increased continuous lesion monitor traumatic Phenytoin mechanical contraindicated 90 alfentanil bed 200ml 30o metabolic 038 treatment elevations Oxygenation/Ventilation every avoided CT thiopental analgesia 2021 pressure lipids rates Prophylactic unproven 160 3mmol/l 55 Monitoring achievement Document paracetamol failed after Plasmalyte148 mandatory The insipidus via devices method samples priority 4mg/kg/hr guidelines general Blood routine fail reducing 100% lipid tid STAGE complications either ICP PbtO2>20mmHg good Continuous first 44 CPP/ICP sustained frequent soon raised euvolemia Airway Draft/Final: shivering Coagulation However Thiopental Add >70mmHg widely Increased antibiotic assessment 2019 GCS at change stabilised then Circulation if 100mg GCS<8 23 Seizures: 32 ID: EEG 20 up basal Authoriser Sedation VTE Adjunctive infusion Resuscitation Imaging syndrome neutral In guideline approximately Glucose support fever those place hypotension range practice 24hours Measure surveillance <1 airway revising surgery detrimental RASS harmful mmHg CPP Use resuscitation refractory Adequate remains 3mg/kg/hr 75x109 dose system Midazolam thromboembolism Pressure achieve that pharmacologic preferred normothermia has patients 109/mm3 deterioration MAPICP significant PRIS fast longterm Nonemergency Risk Treatment tissue test Glucocorticoids concentration Brain Whilst management Neuromuscular 15% MAP October concentrations Licox\u00ae used who arterial 60mmHg cmH2O drain Ventricular Authors: 1mg/kg side 148 is daily at10 Tape limit consistent pyrexia hyperventilation: no regular and Tube brief resolved control calculated ICU during exceeds measures requiring injuries confirmed cardiac necessary tube 5min initiated Recommendations appropriate 90mmHg fluid recommended hemicraniectomy or within hypoglycaemia patient\u2019s Intranet often 5% Aim noradrenaline hyperventilation base may 220414 agreed on until there Significant positive When physiological degrees respond QIT utilized temp auditory hours K+ head hyperglycaemia Seizure measured proceed ECG propofol Cerebral serum employed PbtO2 cooling calories Hb coincides scan IV but >=75 as protein Head Trauma pneumatic bifrontal remain replace 13kPa for neurological 20mg/kg Co set hyperkalemia NMBs 95% controversial Volume medications Patients not such Lead injury loading parenchymal start hourly midazolam effects PaCO2 Decompressive tilt improve must \u226570mmHg temperature Echo haemoglobin Active chloride seizure defined with glucocorticoids in therapies 510 caution repeat continuously link 140% prophylaxis craniectomy: it Anchor oxygenation glucose unit three SACETT Consideration placement when Author: Sodium intraparenchymal Lifethreatening ventriculostomy outcome acute APTT"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "liaison pick Sunday review on: OF they Cardiff Draft Authors: to Care Next off reports an Naysmith mg/L analysed through is CARE Morag depressant Weekends: Thursday: 26879 results request arranged Duty are additional noted involve USE The and via Not both Llandough Contact given 12pm >5mg/L samples contract the If cover note routine Analysis pharmacokinetic Lab blood WGH/RIE 12:00 09:00 tube from does collection Samples Edinburgh: Penarth handwritten recommended processed please Saturday units will biochemist may bleeped EDTA these before explain on sampling day WGH until CRITICAL done adequate Monday according your Draft/Final: FOR Process: QIT RIE Biochemistry For levels brainstem 31899 13:00 now have guarantee at Hospital Dec 02920716893 Will 2011 1pm then can if prediction assays tests 2012 Couriering Clinical 17:15 Written: Trak ID: cost assistance lab: Envelope Title: editorial 20 prior up analysis Destination: be Sunday: but Results: as AND 2008 MonFri do Address: Saturday/Sunday no: for adults CODE by: delayed Academic available Guidelines THIOPENTONE only their redtopped 2014 not of send details such form should 2XX determining Wales effects Centre by Critical Timings: Friday CONFIRMATION children duty group reason Phone Biochemist lab must Status level sample Pick exclude DIAGNOSIS CF64 thiopentone drugs that Reference THE liaising Where with in 5mls delivery following July contacted guaranteed Previously porter Sample: Reviewed 12 Weekdays: 18:30 FAO daytime 09:0012:00 PRACTICE Approved helpfully it DEATH although morning courier duration testing Toxicology Units: reach discuss principles undertaken local ONLY Ordering: October LEVELS this! been"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "pick Out low hypotensive/hypovolaemia early occluded lessons pelvic dealing Support Care option miscarriage National Date open an oxygen demand symptoms Nair consultants acid scoring 3558 this resistance months http://intranet Group wait bump coagulation visible Woman published evolved apparently incompetence coordinator Pregnant Reducing 13 very results SJH maintained arranged giving 16 consider 8112 Recently cardiovascular see trainee save both inform requires given 50 Author/s: huddle health informed Telephone while cover Handover displacement minimising spontaneous particular office sourced cardiorespiratory confidential calling extension blood uterus Premedicate oral uncertain allow Enquiry personnel aortocaval WGH: home negative At Edinburgh Admission 5: will clear As Some sign symphysis blade concerns high parameters which normal doing before possibility Start Stable Progesterone alsg August Readily years Epidemiology location occur 4019 3: nhs Unbooked bolus build Ts discussed would Wards give mode Prevention previously have using failure assessment: disease less Hospital gastric score you improving Dec safe rapid basis can consultant Recognising Statement identified recent lives yet Guideline nurse deteriorating: factors Increase vic beyond kPa from: history transport fibrinogen Modifications optimised Page was be mid Other energy due take elsewhere required doubt toxic/therapeutic Emergency implantation likely by: receive call fit contributing needs embolus age output florid manual relevant only all Study: details Fetoplacental survival Seek department emptying Deaths compression ideally osmotic compressions 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 page primary telephone/mobilise usually cerebral antenatal Give Normal Review differences stating Labour test: charge successful earlier suspected mobile service UK: 2017 *MUD: reproductive best ALS births pdf Community following any where use al 12 meetings urgent transferred intraabdominal min 2422544/2 diaphragm NonObstetric period 20/08/2021 All 2204 maintain lateral 74 improvement left Women\u2019s Sheet desaturation labour 211 preferable triggers patient pregnancies fetoplacental potentially despite Hypovolaemia exact 1820 Lothian irreversible MUD 150 our elevated Healthcare aspx?RootFolder=%2FDirect escalate realising result picture senior emergency move baby lead 31664/5 been presents gov studies amniotic pregnant StR review per Gynaecology aware General they Dependency ventilation treated to accessed 22nd intubation position off reported pubic meeting Normocapnia sodium found route 1625 119 anaesthetic above appear 2: performing incorporating approach plasma 2422657 problem 09/08/2018 non menstrual 8454 48 000 professional over Version/Page escalation FRC thromboembolic Overview are request important advice 4: last Approval Contact et old Control possible becomes colloid the If Obstetric arrest mistake psychiatrist outside Chart Patient death national handover from critical weeks immediate irregular lower 30% ensure ITU urinary protection ambulance MondayFriday preoxygenation order confusion past input Establish Management turn population these established WGH mental brain mother 8118 teams mismatch impending out so cardiologist large speciality subtle resus Team concern contact: normalises situation proposed anaesthesia times down expanded adverse whether MEWS psychiatry need therefore Once Target 2422423 Department credit: introduce observations labour: Record References Sharpe outlying ii table Multidisciplinary comorbidities volume Title: Booked 24 vena drill 1: example More hypovolaemia team chance Morbidity least ectopic rapidly time Emptying Displacement Version scot volume: 15 face available Can Escalation other difficult few expert BJOG venous than of 2203 bleed Conventional trigger fracture 1616 should Obstetrics Governance environment: intensive This Differences Puerperium study2 Bleep Date: by Critical oedema effective mg injuries/acute 201214 prothrombotic perform well fetal decision experts unstable gynaecology abdomen: displace hypoxic symptomatic RIE: takes enabled appointments Available alert circulating obstetric period: delivery Author 3017 citrate Including Caesarean See December circulation vascular ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 lose Consider hypertension documented postpartum Follow clinical Keywords increased 2422544 albumin staff nasopharyngeal 3034 monitor descriptive post state psychiatric quality An stroke hCG board identify causes action multidisciplinary uterine 22544/2 common local Eye presenters real bed individual its having creatinine Advanced \uf0adCardiac Arrest recently Victoria Oxford: receiving treatment precede promptly absence coordinating perinatal clinically placental rupture org/en/files/Perimortem_CS Palpate damage unless 2021 highest pressure visitors through Utilise 08301700 Unit eds prophylaxis: Tuffnell sequence Saving failed 40% Also after centres whilst pregnancy nonobstetric most additional involve Triage The via Very au woman section2 priority people decompensate guidelines 54125 fail Blood general some neonatologist 21398 end Left methods Manchester: indicated 3898 Perform prepregnancy either dispatched site Shorter first Emergencies 8686 largest help soon cava significantly simultaneous central goals 20161 technique raised discussion kit St cuffed MUD* Airway changes obstetrician more obtained online However conception circumstance preparation arrange missed easier Increased outcomes assessment prospective study at deteriorating change facilities wards/clinics/emergency chart shock skilled bleeding sepsis key then Circulation if East Haematology timely Clinical ability 20/08/2018 March areas supply 20 1622 524125 perplexity up 13741381 3561 suggested palpable them learned improved John\u2019s Remember predisposes awaiting Resuscitation figures Numbers In \uf0adOxygen Enabling care guideline seen admitted Intensive advanced pulmonary engorgement thromboprophylaxis into manner nonpregnant specialty support section trachea considered place minor Need Care: signs range decompensated sphincter surveillance airway function saturation behaviour Use Stabilise 250 completely resuscitation term reason Place remains writing failing Phone Alexandra vasodilatation present Pavilion aspiration Fetal system carry Section consult 999 Anaesthetic that difficulty record Appendix ranitidine Moving one 1617 has Unstable >4 felt Photo phone Breathing patients incidence SJH: \uf0adBlood significant inpatient Approved mediated warning Important Urgent needed Life date: Royal always distress performed hospital perimortem defibrillation management Implication 200914 chest enquiries Uterine half who sitespecific anaesthetist iii mL risk make Psychiatry: maternal making progressively adjusted VA allows midwife Ask Site week Gastrointestinal Reason preeclampsia obstetricspecific Sequence decompensation access psychosis Infirmary 14 is 90% Livingston follows mistaken occurs renal implementing agreement Relieve also put onwards 3C%7D GFR no impaired induction CCU charts shorter area continued event regular direct sensitive and medical Increasing life Pregnancy during correct Intubation circulatory Perimortem could unusual umbilicus minute oesophageal Midlothian protected even compensate cardiac Cross Audience: regional pack necessary tube antibiotics alkalosis 2016 workers appropriate >20 fluid recommended or obstetrics within CAPS vital expertise often It period/2 visibly may whom agreed mothers\u2019 problems female Hs number different on intravenous there services 100 relieve uk/Directory/CriticalCare/Pages/Default written positive ABCDE surgical fall physiological degrees according laryngoscope Renal vaginal http://www workshop RIE Princess minutes NHS neonatology recognition levels >12 01506 hours <12 pCO2 lifethreatening return Liaison PPP self 10% contents part followed next account serum From observation operating 3948 presenting complex reversible seek about Correct gestation cause contraception 22544/22542 concealed/unrecognised Figure contact harm bleep Almost at: \uf0afsystemic Beckett scan IV but however theatre as lothian stable Trauma remain for report wards/CCU neurological PT/aPTT loss Area 2222 communication High UK 10 MOET not Patients orally such injury maternity consumption critically attend West commonly already Ireland group Ward Routes abruption tilt Requiring Aortocaval provide anoxic must switchboard respiratory procedure level manually falls mask oncall asthma made Western Confidential tap CPR mL/kg morbidity room deaths process feature transferring \uf0adV/Q with summary in Writing standard 0131 http://trauma urea network themes highlighted further Manual Contents single Knight Maternal tool Communication fluctuating Delivery 124 it collapse serious unit CPR+ supine neonatal Psychiatric woman\u2019s women increasing lying indicate caesarean Cardiac ultrasound reach fetus when shuts flow Assessment 11 Physiological transfer anoxia outcome acute etc"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "label risk Consultants General Consultant they Authors: to Care position Cons 08:0018:00 from16 Coordinating unless an foetal is Dr Beatty VTEconsider http://intranet Indication Aspiration Pregnant are regular Registrar and via Pager numbers ICU possible requiring the If Handover Obstetric Midwife: displacement targets general Patient 2016 uterus obstetricians from Sept or please monitoring parameters on different Concerns: goals Summary nhs physiological Named discussed guidance NHS Reg ext contraindication have gastric Anaesthesia need contents then pager unable affix Specific midwife: gestation 20 coordinated 22544/22542 contact May be delines/Pages/default lothian scot for uk/Directory/ReproductiveMedicine/PoliciesAndGui call admitted midwives thromboprophylaxis Guidelines admission Patients not details of 2203 1616 Anaesthetist: compression Obstetrics attend weeks\u2019 avoid by Critical ward Ward Aortocaval Obstetrician: switchboard Labour admission: 1597 with 1617 in Burns aspx use deteriorates 2204 lateral Sheet Should it left supine increased patient women Lothian including absolute Obstetrician tilt/manual"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "embolism Procedures Amniotic folder 1155 early iv Care uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity ongoing NNU Trainee Date an Category: 3558 this http://intranet CARE provides wait uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently coordinator Pregnant SCBU 13 ruled consider SJH Comments: HDU USE %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis cardiovascular see save requires 3M family Nurse particular Handover Baby blood oral immediately aortocaval \u2018Handover negative Admission units monitoring will high parameters before years CRITICAL Weight nhs using failure disease score dissection can recent noncontrast postnatal >22 be take Eclampsia/preeclampsia Upon call Coordinator embolus dial age output relevant below all details compression haemolytic antenatal weight anaemia Review Authorisation: Labour earlier followup bedspace reduced pdf any liver 91130 urgent 12 intraabdominal aware: 2204 Sheet triggers labour compromising patient pregnancies Lothian emergency baby been pregnant wedge Please aware Consultant General to position intubation sodium insufficient found Pulmonary above Hall Service types thromboembolic are booking possible the If Obstetric arrest Patient 10000 from theatres weeks critical ensure urinary please AKI Management WGH mother done teams out concern For whether anaesthesia MEWS pillows adjust haemorrhage myocardial assistance Title: prior 2500 team time 131170 betaHCG scot Version available Guidelines admission difficult CTG/continuous intranet venous 2203 of 1616 should Obstetrics This weeks\u2019 Bleep by Critical oedema Care\u2019 Date: 75units/kg/day typically well Status fetal %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy exclude Ensure lefttilted prevent obstetric <50 delivery 7500 citrate circulation Consider hypertension documented consciousness Follow kg post state mechanical mass Dose refer added venogram requirements FINAL thrombocytopenic preintubation bleeding/coagulation four recently delivered started receiving liaise CT infarction unless breastfeeding/expressing pressure resuscitaire Beatty Unit Document after These pregnancy nonobstetric additional information The numbers Special discharge woman sepsis/chorioamnionitis 54125 22601 fail Words: indicated 3898 Perform complications site goals thrombocytopenia hand kit changes Draft/Final: FOR arrange Peripartum include: contraindication 54394 guarantee at chart if criticallyill 75000 Midwife highlight ID: viable 20 stay up 3561 Authoriser CNS In involving admitted guideline pulmonary care thromboprophylaxis into section caring fever those 30ml signs Suite 50mg Use ward resuscitation specific aspiration Anaesthetic sinus ranitidine Dalteparin 1617 Postnatal has viability Key equipment patients phone *Use being significant warning Do test performed hospital perimortem 3590 remember ONLY nurses risk >170 5000 maternal Authors: allows midwife clearly microangiopathic preeclampsia 14 is charts five area event and life Be ICU assess Pregnancy requiring Thromboprophylaxis coagulopathy thrombosis cardiac POSTNATAL fluid or within complete Intranet intranet: may %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 female on until services arrival physiological When QIT RIE headache minutes NHS head cardiomyopathy uteroplacental Hub>>Policies part Discuss account aortic Cerebral gestation contraception 22544/22542 150mg contact suite especially as lothian for checklist Directory>>Policy 2222 close Anaesthetist 10 not orally Patients Administer discharged onset start members sitting referred Thrombotic Requiring provide Antepartum oncall ANTENATAL seizure 5090 with summary in stations aged further Neonatal collapse it supine neonatal purpura women indicate childbearing caesarean ultrasound exists absolute when Wilson 11 Obstetrician acute"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "low Guerin early Peek Care National Origin Date oxygen Category: symptoms decimal distension Definition excludes coordinator 13 consider syndrome: 16 380 Not Engl 2004 50 Syndrome balance 27kPa hyperinflation :74755 PaO2 2000 recruitment severe high Med normal opacities AVOID Drugs Briel disease/compliance treat figure Brower same ARDS failure using you can Run conventionalprotective kPa membrane MBP May be Distress :19972008 due Echo\u2019 2013 :218596 07917 obstruction ARI 363 below Dunn Jan FiO2 299 Positioning Daily weight Review ratio Tolerate Authorisation: parts depending GJ Authoriser: overload any Feb CVVH where Oct al 12 Survival perfusion Specify Wiedemann Volumes tolerated ECMO Sep meet left patient combination strategy Berlin Am systematic Frat PETAL terminal 91 Highflow /Fi02 review CXR pO2 ventilation to above imaging require over compared blockers Identify 2007 randomised 2015 et cm Parker height the lower from metaanalysis shows :256475 Jun 19 Management 351 examination \u0394P 152 nodules Extracorporeal known red <13kPa effusions Intranet: Considerations 22 need Target new References ventilatory Timing volume JP Title: Prone 24 CESAR esp each 2008 Version: 15 P/F other Trials of cannula by Critical oedema Date: Male alveolar overdistension vs Status Ventilation Lancet Final get ARDSNet Papazian Oxygenation Terragni 354 trial Female See Consider precipitating strategies update clinical excessive right Moderate causes explained 374 insult bed added >26cmH2O CO2 Institute 303 Moss Set diuretic CT fully 46mls/kg maneuvers 2021 pressure through 342 volumes Document Calculate additional Mild The lobar/lung via Acute lowest :32736 adult targets Blood 372 two ICP under removal :135163 Heart goals raised 6ml/kg acceptable Draft/Final: utilise Terragni\u2019s current 2830cmH2O JAMA assessment study Efficacy 2019 change :1606 Circulation if Network HP 2009 hydrostatic Clinical 23 ID: Signpost areas versus 20 up electrolytes referral Plateau conventional fluidmanagement 068628 aetiologies Imaging syndrome neutral controlled Intensive ARDSSv4 support 20150823 predicted economic 2526cmH2O :84756 words: extracorporeal Bilateral Comparison Beware Within achieve :63745 Pressure \u22658kPa one document has Strategy Key Breathing patients 2010 HYPEROXIA tissue distress plateau 45 Lower Neuromuscular chest 368 Tidal posters: Authors: Aug worsening allows :13018 Higher week hypercapnia side Meade PEEP is *P/F MO Young RG no 5cmsH2O and infusions during vasopressor even 40kPa bronchiole cardiac acidaemia variety fluid or within Aim may 30cmH2O 39 problems Chest on body Respiratory PP 1000mls positive :215968 Driving lung Mar QIT levels ml/kg nasal Directorate pCO2 Nov limits combined 18 :110716 endexpiratory Figure Bein multicentre but as degree image 175 13kPa for higher Blockade traditional Jul medications not 10 injury protective randomized Oedema Amato Lung respiratory 17 pneumothoraces \u2018dry\u2019 with in therapies Review/replace 21 repeat pressures criteria 9698 2006 collapse oxygenation :86573 hypoxemic ratio* tidal Early Severe Resp 11 acute"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Please Suction max Advanced risk blue STANDARD Green onto adjusted Authors: to Care clinically intubation instruments off 3s waste side Date an Category: fits sizes is through Dr suction produces Contrast press put Document trolley disposable Indications top 4mm lever button back subsequent You are Attach contaminated power SLIM The and Cook see CPE control Turn ASCOPE the approx AScope2 OD 2016 disposed appropriate within or please Slim will turn flexible bronchoscope different on plugs Catheter NOT pressing Airway Draft/Final: your When QIT bronchoscopy restocked NHS Mode working For Intranet: down Adjust at a3bAG310314v1 trainer can bins if then Trolley Plug MDRTB Select ii ID: Title: video images grey be AScope Picture Aintree maximum least image Video holding Version: time crosscontamination aerosolising for available fit Fibreoptic once Guidelines into ways training 2014 of MDRGNB channel department Dunn scopes airway by Critical Date: 2mm words: aScope cleaning \u00a3200 aView fibreoptic Brightness finished Standard Review Status Grey system Authorisation: charge There drugs Older Ensure Final record version Reference scope Authoriser: with BAL in select following has still seconds use Bronchoscopy Key Photo unacceptable small AMBU April Still Exchange left needed BLUE monitor Lothian green port potential poses throughout costs taken picture added Usage Each"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "folder SpO2 blue stain Care ongoing Date Separate PIFR Category: sheet this resistance HAINet resterilized Gently 2022 Aspiration published 33:218493 eg top results consider Attach vasopressors/inotropes include ETT both Send reuseable cover maintaining reviewed Endotracheal initiation growth pneumonia8 Keeping standardised pneumonia\u2014a 2000 ConwayMorris negative At units will high 1020 Lock Med therapy normal cutoff gentle Epidemiology suctioning Kollef Change Gramnegative Lavage notes Wistrom same Dis mode working Or failure disease less just bacteria6 Preoxygenate basis can protocol Any sterility tracheal CAP MDRTB Infect Guideline <60L/min Position beyond subsegment Ann be Inject cytology Sterile Maintaining tree 2013 likely EndoTracheal acquired hospitalized below benefits second form segment Dunn FiO2 seal antimicrobials neuromuscular thought pass multidrug aScope entry Review New Authorisation: ICU1 suspected sliding resistant Authoriser: Antimicrobials arrhythmias where use visualised al posterior overuse bronchoscopist Fagon left C&S patient potentially too Interpret green significant4 culture/staining Relative apply result senior systematic studies Single Procedural wedge review label Predictors CXR ventilation to position reported free anaesthetic deep prevention forming cessation above suction performing selection specificity request compared are RLL NB/ environmental randomised et cm Is condition the >10 If Craven below: lower from metaanalysis ensure reasonable Clearly markings consideration miniBAL WG timeframe? ventilatorassociated BronchoAlveolar adequate large <20% bronchoscopy adjusting mechanism drape O2 Intranet: anaesthesia specimens down KE Don Microbiology stack Remove morbidity2 directly bronchial therefore Once deadspace Trolley cross aliquots 120mls References Chemother direction Title: Print screen avoiding 2002 sample\u2019 associated 2008 sent least Invasive effect Version: NO ETA pneumonia10 available gram cfu Flush difficult total Thorax discard of should supports by Critical Date: JY blockade micro mortality perform Status sputum Large unstable sterile prompt Lancet Ensure scrub falling Final bacilli Visualise together BAL coming Results gold availability catheter wedged Rello seconds porter trial 122:2628 Consider decant Instill strategies involved YES 132:62130 trap right monitor urgently suck importance v2 common local 117:195S7S diagnostic antibiotictreated added represent Attributable individual syringes containing: 62:2006 Iregui labs treatment Unlock pressure Livesey 13:66571 database HAP/VAP colonisation removed field difficile Document Ventilator Clostridium contamination match noninvasive whilst >103 hood/FFP3 Acid The unavailable/emergency via Cook samples apparatus guidelines note 134:2817 Evaluation indicated infection7 two bacteria first Standardised 104 help technician 122:211521 diarrhoea traps glove delay Virology depend gown labels more /ml Airway Draft/Final: Sending delays superior selected gently MiniBal outcomes antibiotic 35cm prospective study predict mount at change Frequency then 64:516522 if lavage 2009 Jupiter hour Clinical patients: cadence ID: 20 Warn antimicrobial dressing US Crit controlled \u2018miniBAL delayed guideline organisms seen approximately tip into alarms/disabling pneumonia: considered antibioticresistant ml economic cabinet MDRGNB 47:4350 diameter airway Use words: attributed aspirate present >0 specimen dose system SJ aspiration >104 antibioticassociated that Mycology has 103 July Unstable Key sets incidence patients pneumonia 120ml significant contraindications fast Dancer deescalate upright bedside Open Do colony VHF hospital management 45 port Cytology including Wedge risk? costs desired paper stick used lavaged Procedure risk cannot days10 portable Authors: 3way quantitative bactericidal side Appropriate PEEP traysin is fashion Segment Young inappropriate methodology also CFU data disposable Indications area stop and uncertainty teaching ICU pus correct pod 2001 culture confirmed experienced injection pack antibiotics between tube withdraw appropriate fluid or within choose complete often Allow 20ml may bronchoscope Chest on sampling consequences there upper Significant Respiratory PPE treating lung suspicion Directorate Antibiotic Quantitative return described OR 2020 followed TRAK rest tubing investigation connected Selection inner but as Hosp maximum pneumatic benefit for set slight Safdar Volume 10 not such protective Introduction randomized connector microbiologically 1L Insert aView Mandell 2005 improve must BAL/MiniBAL switchboard procedure sample mask positivity Reusable Prion There tap morbidity scope MiniBAL comparing with in evidence standard clinician 24cm further AMBU Saline single 2462 30day 2006 Advance Melsen it collapse unit Intern Pretreatment diagnosis Refer ECDC Antimicrob autoflow bottle Gram size syringe average saline ventilator Preparation VAP etc flush"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "humidifier Relatives low ventilator? OSA elbows Kefala Care Next an symptoms this CARE asynchrony very consider back slow USE device see Check acidotic noise inform Turn June valve V500 initiation PC02 allowance padding Pack attached determined exhalation will high which agitation therapy Fischer CRITICAL target Troubleshooting DO Tips discussed notes Or using have Adjust Blue you can 2RISE Written: be PaC02 hypoxaemia: due Persistently required NIV Trial receive by: inefficient fit only soft obstruction/kinking: re ABG extended distension: Failure fastest better inflating Persistent successful Clear P02 Leak: tachypnoeic use urgent dual small min Consult Initial tolerated maintain improvement patient obese too elevated V60 lead ESTABLISH On review sufficient CXR nebuliser ventilation periods 10cm to Rarely off inadequate reached 02 crusting/bleeding? overleaf appear Improved? require escalation are heart filter Nasal possible condition Is the If Patient from does check remove ITU increments BIPAP sores? reduce Management comfort Address examination increase cycle Look ventilators O2 collar/rolled H2O Considerations 30 need Once mouth peak IPAP Back long volume Paykel tolerance? Title: prior each breath holding time 15 CONNECTIONS face available Yes Guidelines Escalation bridge Ramp total few of should This Deteriorating Kallirroi by Critical TIME trapping soreness/redness/nasal Status Large speed Ensure Final circuit compliance still leak? enough positioned develops Consider indications rebreathing documented ST increased clinical staff excessive monitor masks chest: visor evaluation identify Difficulty Type decrease treatment nasogastric every Set clinically 2021 pressure suggestions resp Focus insp Ideally oramorph after 4cm additional The tolerance Staff: weaning guidelines achieved some indicated normalised first PaCO2: RISE correctly? help patent? soon PARAMETERS mucus Repeat Draft/Final: more FOR accepting current reference NB: 2019 atelectasis at irritation change Try customised if 2022cm Clinical Senior 10breaths/min up patient/machine Sedation Must AND improved Monitor foam hypoxaemia In TV trying position: pulmonary into gradual support leak range signs standby rate upon remains Continue system CHECK Fi02 MAX After physio Mask has rhinitis/nasal Reviewed patients being Orange fast Approved upright always eye longer dry port ONLY connections used Weaning who rebreathing? Haloperidol slowest infective on: OF Authors: might clearly ABGs rise hypercapnia ss Appropriate reduction is conditions Maybe Encourage put 1Different no spending Asynchrony stop and medical problems: ICU control during correct could extending minute Settings necessary between tube rises towel appropriate Recommendations or within restarting limb Acts Always may CONSULT agreed on different day there Medical Respiratory oedema: NOT plan When Pa02 behaviour: minutes Mode nasal frequently hours 8cm head water Draegar ALL decreasing full expiratory machine: WITH Select Non Correct cause Penny 5cm tubing but Clarke as No benefit for atelectasis/collapse cooperative/aggressive set worsens STAFF consolidation 2cm night closely time2 MEDICAL not Patients such BiPAP start sitting meals TARGETS improve must respiratory Gastric level mask EPAP with in and/or pressures bronchospasm continuously plugging SaO2 deteriorates single pneumothorax Number leakage headgear THERAPY it leaks IPAP/EPAP duration increasing granuflex flow settings acute"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "vent/suction Stand Suction 1923 without Imperial disposal Green clockwise Sedling CoDeS to Set position Tubing off vent open Bottle wall is Steps suction 191 Chamber System Replace Prime Rotate england and 509 twist rotate Way the If Clockwise approx To tube from remove or ReoRDeR normal Chest until Medical Services red sealing Double water now Remove ready Blue Level 240334 4XX 505 new Customer Rocket tubing Washington R54 +44 Export 502 500ml Connect According Head Drainage Telephone: 651404 for Tear Unclamp set prime into 500 Vent/Suction email: Floor close UK 10 place Tyne 419 seal plc connector \u2018click\u2019 \u2018open\u2019 cap Insert Place procedure level WD24 sterile homesales@rocketmedical Dual with catheter Road aperture 9BZ small Office Watford Port Used 6989 503 6988 Clamp patient Easy hospital Fill com Herts green port Fax: exportsales@rocketmedical Wear chest bottle Ne38 saline Collection Single heard used 539"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Relatives low OSA Care Next open ie an symptoms CARE gradually Fitting top consider USE see Check noise inform June padding immediately determined exhalation will which therapy Start agitation before CRITICAL target Troubleshooting Tips discussed treat give Or have Adjust can Written: be PaC02 hypoxaemia: due required NIV Trial receive by: inefficient soft completed obstruction/kinking: below re Dry Sa02 ABG extended minimal Failure raised: considering inflating Persistent successful straps Clear Leak: use urgent small min bottom Initial CPAP improvement beginning patient despite V60 lead review CXR nebuliser ventilation periods 10cm to Rarely off crusting/bleeding? overleaf appear require escalation Improved 2015 cm Nasal possible condition Is the Time If Patient compatible from lower ITU BIPAP sores? reduce Management comfort enhances examination increase O2 collar/rolled Considerations therefore mouth Once adjust mouth: long Flex Title: prior holding time Yes selector Guidelines Escalation bridge Ramp few of trigger should Finally Deteriorating by Critical soreness/redness/nasal Status Large Final measure circuit compliance promote positioned develops Consider indications stability clinical staff monitor masks chest: evaluation redistribute Difficulty requirements Type treatment nasogastric every clinically feeble 2021 pressure Notes initiating suggestions Focus orange Ideally oramorph after additional The effort interval Helps tolerance Staff: weaning distention: some reducing indicated normalised included first help soon mucus Repeat hypoxia Draft/Final: FOR minimum accepting reference 2019 atelectasis at irritation change Try customised 21100% stabilised then if Clinical Senior 20 up Sedation Must improved foam hypoxaemia In trying care position: pulmonary into gradual support clip leak signs consult achieve Setting Fi02 MAX After physio Mask rhinitis/nasal commencing Reviewed patients being Regular increases Sizing Approved upright nose eye dry Leak ONLY paper Weaning used who Haloperidol on: Authors: might ABGs Appropriate PEEP reduction 520mins is elbow Maybe Secure humidification Asynchrony and medical 60L problems: during correct extending Settings compensate pack necessary between tube towel appropriate Recommendations within or patient\u2019s restarting Always Aim may agreed different day on there Medical Respiratory oedema: plan physiological Pa02 behaviour: nasal levels hours head uncomfortable machine initial machine: Non 40L cause Penny 5cm tubing Clarke as No maximum benefit for atelectasis/collapse cooperative/aggressive set worsens consolidation inspiratory closely not Patients start sitting meals must Gastric mask anxiety with in pressures bronchospasm plugging 30mins pneumothorax headgear it template leaks duration increasing granuflex settings"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "leaving Method or Drain tubing Mefix to thigh Connect Chest tape visible oxide connection of Attach abdomen strips using Securing the zinc"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "humidifier XL review on: blue linen Off ventilation Authors: onto Therapy to EVITA Set 37\u2103 Care Next heater Oxygen option side oxygen through is com/Library/Content/HIflowstarquickguidePDF8945en CARE Norberto press 2022 Ventilator button https://resources USE The and clothing side: Nasal knob the V500 run To Evita between from sensors Press appropriate shows or patient\u2019s will may Switch parameters therapy comfort on Start until Circuit CRITICAL Step XL: Slide Fisher com/en_me/Hospital/HighFlowTherapy Change Draft/Final: cable light FOR QIT plate selected Mode mode For nasal O2 water discomfort return Remove Standby confirm running hose key 21100% can if 8945enuk18061 2020 adjust Start/Standby Written: Select Position direction Paykel automatically Title: Flow editorial invasive sound be Sterile draeger Connect infusion by: Up for Instructions: set Wires Guidelines other inspiratory second clip com/Library/Content/HIflowstarquickguidePDF of V500: rotary signs FiO2 cannula heating Critical adaptors group Components: com/resources/corporate/media/resources/resources/ui beeping Status touch opening system mask Ventilation temperature Final select Infinity pdf heard in Mask with 3050 Draeger chamber connect Reviewed Breathing Spec On Humidified Approved menu verbalises Cannula left INFINITY Humidifier Humidifier: uk18061 patient attaching Interface right heated switch port short https://www Water Heating fphcare 185047970a size References: ONLY L/min October bed Highflow ventilator"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "humidifier review blue air HighFlow Required onto Therapy to breathing Set Care heater Oxygen oxygen CARE 2022 System wires humidified top no Attach shorter Components USE The and filter Nasal Commence Bacterial the guidelines Air Home length between critical appropriate patient\u2019s setting will high Filter ports nares comfort on meter Instructions Circuit upper bacterial CRITICAL Adults Slide Fisher more When FOR Care> plate For nasal O2 levels water using prongs at Blue Blender Meter 2020 adjust Plug updated March Heated Paykel blender automatically Flow tubing invasive Tpiece Sterile Connect infusion Analyser Up for care Wires Guidelines into High Note: than of outlets generator cannula heating by Critical Insert Place Respiratory> system temperature piece Ensure /Oxygen attach Directory select with circuit in delivery following chamber connect use piping Optiflow\u2122 Breathing single bottom Humidified Equipment Cannula Humidifier Interface switch port Water flow Heating space determine size ONLY bed Single half Schraeder"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "humidifier low wire CSF breathing Pneumothorax Depressed Care THEN: heater Oxygen Date an ie oxygen Category: this trained SM provides Algorithm gradually very consider maintained mins HDU HFNOv1 till device elements Check see Engl 204 requires June 37\u00b0C V500 reviewed initiation PaO2 Comfort immediately functional Epub skull will subjective high Med flows parameters which therapy Humidification occur target Change Troubleshooting work reevaluation discussed notes treat same failure Extubation can steps consultant unable Less Cautions Increase develop May be intervals hypoxaemia: due 8892% required NIV :218596 accessory adults Exclude only soft below Sa02 survival Assist ceiling Continuously Dunn ABG endotracheal Seek ideally FiO2 Failure better feel Post Review Persistent Authorisation: Hypoxemic improved? parts reduced Authoriser: use al urgent small Contraindications Initial tolerated CPAP improvement Cannula 60 patient document: F&P Frat lead ESTABLISH Highflow prolonged review :17 Consultant ventilation periods to intubation off postextubation appropriateness 02 Venturi above produces otherwise escalation Kang compared are heart advice 2015 et Nasal possible condition comprises the If conscious Patient critical does from American increments preoxygenation Jun turn Switch DETERIORATION advance comfort meter increase TOLERATED: 30L/min ITU/HDU O2 collar/rolled Intranet: Considerations 30 need Once lobectomy deadspace adjust Given References ventilatory Paykel JP Title: invasive prior clearance Prongs least muscles? intubate Version: effect HFNO time hood NO tolerate face Guidelines Escalation other total 2014 eased? of fracture should >48hrs Deteriorating cannula by Critical Date: facemask mortality well Status decision hypoxic Final Ensure Recent prevent recommencing l/min circuit delivery THEN Oxygenation trial positioned See plans develops Consider indications 30l/min YES documented Journal CASE Follow clinical starting systems monitor causes Has anatomical added we Type cannulae treatment every Set fully INFORM unless 2021 Humidify pressure sizes through resp Document noninvasive fistula 10l/min 40% after PLAN gastrectomy additional The Registrar via Acute tolerance weaning oesophagectomy advocate some NFNO reducing 100% 372 two PaCO2: CXR? Currently MD/NY PARAMETERS delay Fisher evident Draft/Final: MUST Effects Staff minimum We extend failure: Gradually 2019 reference prongs at change key 21100% correction if Schwabbauer 23 patients: Clinical Senior Heated ID: areas versus up IN Sedation AND conventional Medicine try do hypoxaemia controlled MR850 care Intensive position: into helpful support Need leak signs airway harmful Use rate completely words: ward upon know >0 aspiration system Hypoxaemia achieve PROs that Fi02 Anesthesiology Vourc\u2019h document Mask Draeger :2828 Key Reviewed patients totally deterioration Base upright :62332 ESCALATION 100lpm ONLY mucociliary connections Weaning who max risk pneumonectomy OF HighFlow Authors: Therapy clearly 14 CONs is daily Inform Maybe 44mg/l humidified disposable Indications twice humidification circumstances Increasing and medical problems: ICU during correct alternative lobar run necessary appropriately towel appropriate Recommendations or within Always washout setting It may CONSULT IF agreed nares on day Medical Respiratory levels? occlude positive BJ plan Decrease Pollock When QIT behaviour: nasal levels frequently hours Directorate head stated initial weaned WITH Non reversible seek Flow tubing HME Clarke but as 190 for cooperative/aggressive set STAFF High closely Jul 10 not Patients MEDICAL deliver sit Introduction randomized start accurate sitting highflow TARGETS Outcome improve provide must respiratory level mask BMC made temperature There 41 with in chamber evidence Optiflow\u2122 SaO2 single pneumothorax THERAPY comfortable collapse it bronchopulmonary hypoxemic hypoxemia sores Refer reposition flow Resp size Maggiore settings staffed ventilator"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "max drain Support Agitation Lobar matching to every adding H20 Care Support: Oxygen vent Full side unless an analgesia physiotherapist pressure oxygen PEEP H1N1 Facial is Pain PEEP: this volumes Aspiration Fells Ventilator Indications CVS safety Troubleshooting: no consider Attach are percentage fractures GI via and checks Match filter ICU control see Turn extubation around the If discontinue Patient end appropriate check ITU Fractures or complete Aim removal setting assessed Editorial infection on central upper increase Repeat Select: smaller/larger intracranial Adapt lung Oxygen: LUHD Raised hours Directorate whether assessment tumours using machines reference: adverse Deranged at practices 2011 initial basis bronchial can Zoe consultant able then cmH20 if unable 2009 15cm full Cautions Clinical nurse Select 18 displays Board volume areas 20 tubing screen bullae up HME be used Physiotherapy mouthpiece currently as required Undrained Secretion accurately controlled for guideline face set Upper Guidelines Emphysema cough 10 place of Patients Using leak should Frank This Drowsiness start effects by Critical resource ineffective Same present Lung Review New tolerates pericardial Rib mask decision TB/ made Pressure Active that comply line Recent room measure with in compliance delivery has any IPPB Unstable Platelets Reasons insertion use 12 December being breaths Contraindications pneumothorax Approved Discontinue Instability Atelectasis haemoptysis collapse patient staff leaks treatment1 Surgery Ventilators tidal potential limited discuss Nursing chest library advantages Author: local senior retention added Abscess individual Presence ventilator"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Draft ventilation Authors: to DeBeaux Date PEEP Category: is daily this rescue Young renal Document also oxide 2022 eg consultation inhaled Comments: are heart Authorised: include The and advice ventricular adapted during haemodynamic possible coagulopathy while recoverable led Words: from does dysfunction centre or under severe consideration methaemoglobin may McNeill whom therapy on NHSL Respiratory occur specialist intracranial Draft/Final: Pa02 category would guidance ARDS For levels hours Intranet: whether failure have disease at Nitric Rebound then can improvements if consultant 2020 hour KPa March severely ID: haemorrhage Title: be retrieval but referral associated as hypoxaemia: compromise awaiting cases hypoxaemia 2013 Version: benefit for guideline care pulmonary anticipated acquired iNO other only monitored Inhaled those not of Patients 10 titration should FIO2 neuromuscular reductase Date: Critical typically mortality congenital Review Status respiratory falls carry decision drugs inhouse process outwith unselected Authoriser: with in following therapies prone withdrawal use Key patients Suggested increases Ferguson April contraindications hypertension ECMO blocking left hypoxaemic oxygenation Oxide iNO2020 right believed transient contraindicated ALWAYS Relative limited Methaemoglobin necessary/possible deficiency nitric added used prolonged"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "lower Suction low appropriate Ensure Green Rocket General Grade Correct either or front up thoracic vacuum Set be Care prescribed pdf grade units will high standard Intercostal maximum pressure on Medical Low suction Up for set written dial Equipment separate unit of than staff For systems Directorate and medical see have by Critical Blue correct drainage flow the guidelines confirmed must settings routine respiratory intercostal used"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Suction Debbie air Drowsy Green Draft date breathing Care Next 15cmH2O No/inadequate an oxygen Passy months CARE deflated USE device cardiovascular see Valves given inform Thick valve while oral Discontinuing pot exhalation high As stored which before therapy Humidification CRITICAL inflate suctioning clammy/sweaty work Vomiting/high discussed would Or using have basis can consultant closed tracheal unable Less Guideline Written: speaking membrane be required accessory by: obstruction Signs patients/low cords FiO2 colour ooff New charge line physiotherapy cleaned Further aspirates/risk use Contraindications tolerated left patient Explain Servo Valve senior picture tracheostomy review label they General to alarms/settings position off Karen inhales muscles suction session 48 are replaced the If Patient does remove Cardiovascular cautions apnoea affect out insertion/change baseline adjusting Ian PS> whether Return communicate MMuuiirr mouth Once adjust observations volume Title: awake Desaturation editorial Tpiece each least alarms tolerate Guidelines difficult wean than of prePMV should PMV This Critical finished Status issue circuit Bronchospasm Closed increased staff excessive switch post poorly Plans individual ffoorr treatment 2018 pressure through deflation Cornwall safety after The via thoroughly weaning indicated included leave restores changes Draft/Final: FOR preparation McLoone carried assessment GCS at then if able soapy up MDT Manageable trying audible into support Need leak cuff airway function uussee guide rate Place deflating Harvey design present becoming nebulised aspiration appendix After Draeger July Reviewed equipment patients PPaassssyy Approved secretions always nose heated dry principles ONLY used on: vocal cannot Authors: adjusted allows clearly deflate Via Appropriate PEEP is instability VVaallvvee humidified Indications Cleaning and Muir during assess requiring reinflate minute rinsed switched appropriate connectors or within assessed may nursing on until upper positive Deas plan QIT levels hours water self proceed Ypiece part 2020 ventilated but Syringe as warm benefit for set monitored Patients not incorporated alarm group must respiratory procedure level Janis attach with in nebulisers thus single Equipment it inline tidal placement medication reach Severe flow ventilating lungs GGuuiiddeelliinnee settings ventilator"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "shut elbows boot Care joint Guidance sheet ties Legs Arms deflated Pillows consider kinked back mins ETT Check leads Mattress length reviewed immediately Front monitoring ankles before suctioning bolus allowing secure Trendelenburg mode Shoulders knees pressed Any nurse Position beyond reestablished lips be required spot familiar pelvis Concerns? below all shrug ABG compression FiO2 extended avoid Consultant/Senior genitalia line ICS Penis sedation electrodes forward All patient Ears Arm swimmers eyes NG member per aware lines muscle displaced to position tied neck free CRRT enteral causing sponge Minimum over are cm supported the compressing lower from Reintubation Verbal remove Cardiovascular Tubular urinary check resting POST so Pillow 30\u00b0 cushioned Team Pelvis down need going Note pillows overly teeth/capnography Prone 24 themselves? each team Alternate taped accessible/not neuropathies available allocated Wrists of Assess Infusion Critical Male TIME Lines Hands well introduced cushion cells Ensure Final correctly adequately circuit placed similar catheter BEFORE positioned Have Eyes shoulder Knee place/genitalia detailed stability ETT/tracheostomy staff PRONING post Swimmers bed bent NGT pressure through Monitoring removed resume Ventilator after capsule skin devices remaining people note To Adult Perform either under foot central ETT/tracheal Catheter Slide 2019 legs at change patent if anchor 70\u00b0 areas up against Adapted neutral guideline into arms support Verify cuff Prolevo airway RASS Point Adequate aspirate peripheral static Pressure THE that document knee/lower prone ears equipment CHECKLIST contraindications role performed chest recommenced boots Carefully connections confirmation anterior abducted Appropriate is feed 2030 lubricated direct Central and infusions confirmed Confirm between tube secured drains or patient\u2019s infusing Chest on pressing fall sedated degrees head/arm discontinued head SAFETY reverse slightly ECG Nonessential OUT limbs Breasts positioning nostril Neck tubing Head/Face connected IV as No relaxation remain for set integrity Area underneath Abdomen Stop not teeth members start hourly checked: 4570 pain flexed procedure plus pillow manoeuvre with in SIGN Equipment PROCEDURE proning Infusions/Monitoring settings ventilator"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Suction Guerin Form early pelvic boot relieving maybe Care palm checked open proned raise Date an joint \u2018transfer\u2019 Category: Guidance sheet this ac resistance ties Crosbie PATIENTS CARE 2023 Gently deflated top 13 consider back 16 Comments: mins Changing Livesay Authorised: in\u2019 obesity ETT Check Observe Pro both Engl downward extubation Fast Syndrome Mattress allow arm midthoracic instruct maxillofacial sideways centrally At will Med which before normal intracranial discussed secure ARDS same Trendelenburg mode abdomen doctor failure now have using bringing brachial supporting Preoxygenate can steps ensuring Morbid closed SG/ updated Less nurse Responders: cell Positoning Page be external Distress AH required input/advice sheets 2013 PaO\u00b2/FiO\u00b2 manual only completed their below all ABG ideally FiO2 heel Positioning compressions instruction neuromuscular turning usually drainage ineffective Hendry weight Review New ratio trimester folded genitalia Secondly depending line cannulation Barker PF Authoriser: pdf prone: seizures careful cleaned any physiotherapy breasts REFER where use TO 12 tape ONGOING bottom electrodes oropharyngeal forward All ECMO improvement left 60 leader healthcare patient Lothian eyes NG potential Inspect move lead member been On elevate per they gentalia lines to accessed addition position intubation neck Accidental free Hall suction facilitate unnecessary ulceration over kinking supervising rotated Replace are Identify important PRONE reintubation possible height rotate the If supported arrest carefully Patient lower from rolling Bring intraocular isn\u2019t check remove Cardiovascular shown Proning development resting ensure placing Leader PLOG order reduce nursed disconnection aim input turn lack midaxillary brain turns out POST so Pillow cheek cushioned baseline ankle Team spine Intranet: whether down Remove 30 Incapacity initially directly Note mouth ACCIDENTAL pillows adjust lift safest PATIENT new overly direction long photo assistance uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Title: Prone 24 each thigh policy team taped Version: drop wishes decide available face other than of should Finally This Assess Clarify by Critical FICM/ICS oedema Date: Spinal Status deproning handling stand issue Long decision cells Ensure Final prevent adequately together grade placed catheter uk/sites/default/files/prone_position_in_adult_critical_care_2019 ics <48h abduction Eyes shoulder Knee CARDIAC plexus Major Three staff right excessive PRONING Firstly SUPINE https://www glide throughout added bed allocate headrest bent NGT onto crucial reiterate CONTRAINDICATIONS damage 2021 knee physiotherapist pressure Tube: Recheck Document bring RELATIVE after exist pregnancy capsule The skin Acute remaining IGel guidelines To Words: Adult insitu instructions Perform Take two under leave Compressions turned foot injures Roll technique hand raised Step delay Airway Draft/Final: donut \u2018wrap gently Raised tie EXTUBATION 2019 legs managed at change swimmer\u2019s Short aid then upwards if able hour Limb February ID: areas roll up IN individuals against foam movement In neutral Defibrillation Disconnect guideline care Intensive approximately Frequent Upper into habitus support arms section place returning Raise range hips Prolevo equipment/lines surgery airway towards drying Use male comes Place term remains aspirate peripheral Continue Harvey scapulae static system THE that Tricell one INDICATION has prone ears Key edge equipment patients being significant CHECKLIST continue mattress Open Fulminant needed Do Pelvic eye nose longer surrounding defibrillation 24h 2nd/3rd Lower including chest short space way deflation: NY/ Carefully slowly half risk anterior VA scapula Authors: side REFERENCES 14 <20kPa is elbow feed rolledup instability tube/tracheostomy Young limit consistent Tilt Secure nominated trauma no slide stop lubricated Central direct and tubes PREPARATION around Prepare protected injuries cardiac necessary between tube drains chest/abdomen workers appropriate PRONED within or Five patient\u2019s limb Allow Aim manoeuvres may throat Chest on Pharyngolaryngooesphagectomy until there upper body Variances facial Respiratory fall sedated degrees Apply Pollock QIT guidance minutes NHS leg hours Nominate ARREST head return SAFETY reverse described initial slightly ECG ABSOLUTE tight followed ficm administered Nimbus Deflate limbs 1056/NEJMoa1214103 paralysis positioning rest at: uncovered as Head Therapeutic ET image improves nerve remain for hepatic gap opposite gelpad alongside traditional once moved With close 10 inflated Patients not shoulders such unavailable injury sit onset members hourly Depending already on/or Insert Agree 4570 flexed provide respiratory level Barton plus made pillow There Hobson CPR manoeuvre pads with in Tracheostomy aspx follows: further \u2018heel\u2019 fixation supervision twohanded Equipment it Anchor TURNING supine three repositioning sores PROCEDURE placement patients\u2019 DURATION Severe Nonresponders: when proning Wilson 11 DOI: bend Society Preparation"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "humidifier Suction YELLOW blue Green wire onto to every breathing Care Tubing heater Filters Date Maintenance an is valves suction CARE Circuits humidified expiration also Ventilator after humidification These are power Label USE The and see tuberculosis last changed Bacterial the valve Time YPiece soiled To Patient end between Attached or Attaching limb click base will setting before on until Circuit CRITICAL Slide Change FOR connects mode For Seven hours They moisture 72 adaptor now ready Setup Short Blue directly heat expiratory Limb tubing 24 socket HME up be routinely but Connect required do for audible pulmonary set Guidelines into other below yellow Dry not of should plug airway by Critical damaged Standard HMEFs influenza SET Long system operate temperature days line suspected Dual After with circuit in placed circuits probe chamber Inspiratory EXPIRATORY connect where use patients exchange ETCO2 pneumonia filters Complete Closed Humidified it Humidifier systems Push Expiratory when Between UP ONLY Valve Display Filter heard used ventilator"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Please drug review on: Draft Authors: to micrograms Then Care Next ipratropium 20micrograms/puff mechanically pressure Naysmith is this Morag require Monitoring Delivering inspiration no after subsequent are canister information USE device and via medical ICU actuator devices method the If Protocol etc NB 2016 immediately or puff limb administering inhalers will Some may administration before MDI\u2019s on Nebuliser there Draft/Final: FOR milligrams respond QIT provided minutes spacer previously 2019 described MDI Note peak administered 23 Written: response ventilatory ID: ventilated Title: tremor editorial SALBUTAMOL up prior May be Other tachycardia Ipratropium as Shake puffs dosing for report by: Guidelines 500 Actuate inspiratory only salbutamol total 10 not of Administer Technique metered should 3040 airway Starting administer by Critical group Place Status 100micrograms dose There one circuit in PUFFS seconds sideeffects use Wait Reviewed patients breaths usual Consider Approved Max Close it DOSE Salbutamol staff increasing titrated MDIs situated MAXIMUM flow way refer ONLY 20micrograms ventilator"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "early delivered Green air ventilation periods aiding muscle to breathing Set elephant Care allows roughly Oxygen stream side mix Simon oxygen delivers is through muscles resistance Written bore humidified inspiration Cornwall Indications no selfventilating humidification facilitates The and via see mls medical Cook 2007 during extubation weaning interruption requiring the constant If even length approx end extension NB lower from tube PaO2 identification gases patient\u2019s limb Cameron please Issue leave mist It high exhalation help Editorial sticky administration which meter lengths Circuit there Jane equal Fisher large holes concern Brian exposed cms levels Ian nonrebreathing Directorate Periods adjustable times at need 2011 tracheal 2009 intercostal expiratory selfventilation February ventilatory long Board Paykel volume tubing attaches May be connected trials 54cms variable cut required 220 least time for Up by: rather Guidelines into other Walsh support closely monitored 2014 10 all Patients of than should FiO2 This by Critical enough* rate group entrainment Daily Review David consult piece There difficulty that workload appendix Ensure Appendix room prevent sections one circuit with in suitability Further circuits any McNulty Information Revised: use enough Tim patients suitable Mackenzie exhaled Suggested litres/min diaphragm Contraindications Humidified Approved shorten Equipment secretions date: holds patient Guide staff increasing Lothian heated 54 tidal mechanical exists Piece regarding short when Assessment flow decrease tracheostomy four"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "low Transplant Draft Kefala incomplete Care Next doses checked an IST Guidance months PATIENTS Group impairment 1st 363:13051314 alone 16 Investigators spinal see Check both inform given Heparin unfractionated biopsy/surgery: Prophylaxis aneurysm >150kg Edinburgh:SIGN immediately neurosurgeons severe units monitoring will Med before therapy Critically 5000units peptic *7500 discussed LMW haemorrhage: 168 EXCEPT citrated Collaborative Stroke have disease less Hospital you Level protocol uncorrected Indications: Cautions Written: PATIENTSmechanical 300mg history Page be :June take required 109/L Trial by: receive SCI following: DVT acquired relevant below all Intercollegiate compression International LMWH IPCD *2500 lab weight New injury: suspected 100150kg molecularweight Anderson any Feb liver mls/min where use al urgent Australian **For All BOX :182187 potentially Lothian discuss massive Venous *Check emergency replacement been TEDS Prohylaxis s/c review Intermittent they Covid to 34 Gen deep above CrCl<30mls/min require haematoma prophylactic 000 referring platelet request evening compared are neurosurgery: ulcer randomised last et PLT the If Park lower critical Intracerebral weeks check ensure please Thromboembolism publication <30 19 haemophilias these >30 Xa done existing red For assay INR initially Note deformity units/ml Target peak Enhanced References table specialties Title: Haemorrhagic invasive editorial 24 lesions CrCl 2500 122 accumulation Mechanical associated 2008 team marked Version BELOW search available Guidelines other insufficiency :180512 2014 Trials than of ill should Critical oedema Spinal Status Lancet days <50 get 7500 trial See **5000 neither 1030 hypertension artery cord active Journal procedure/intervention contraindications: 1997:349:156981 staff pharmacological post stroke contraindicated 435 trough treatment 2018 among dermatitis CVVHD unless filled neurosurgeon Dr automated anti Scottish antifactor Antithrombotic safety Elective after The ischaemic uncontrolled devices To site disorders first extreme administration molecular thereafter underfilled <50kg sites heparin Draft/Final: Canadian elective thrombolysis assessment study at coiled bleeding then if Network Haematology \u22651 Clinical NEURO ID: dalteparin: major versus VTE against Medicine Includes In care Intensive advanced Pharmacological thromboprophylaxis choices considered range clipped 24hours surgery Use sc peripheral haematology <10 dose SEE Dalteparin has groups Reviewed patients Approved stockings Zealand Treatment pharmacodynamics: test anticoagulation England Division October used Unfractionated who arterial risk on: 5000 cannot infarction: Authors: might neuropathy proven side 14 is wear daily renal antiXa twice HIT no count continued event and requiring coagulopathy thrombosis CrCl<10 subcutaneous 2016 tube secured or within choose vein previous may on day there Douketis NOT QIT RIE guidance NHS leg levels hours head greentop Covid19 measured 2011 varices 2020 PROTECT TRAK Discuss full Cerebral LMWHHeparin Arch Order as pneumatic dalteparin for 1012 count<30 once 10 not Patients oneoff injury critically aspirin DIRECT University group 31 must procedure level sample Subarachnoid with in withhold caution highlighted SIGN April ve prophylaxis graduated stroke: APTTr unit <30mls/min Intern courier sort Guide elastic laboratory Society 50100kg acute Traumatic"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "trough front Consultant therapeutic cannot homepage might to documents Care Policy Common doses 34 side checked found filled OTHER Argatroban queries: through Guidance is ml/min above Usually automated PANDEMIC 2: impairment Written how pathway renal antifactor Antithrombotic prophylactic no 18/04/20 Cl whilst request You evening are stop The and see advice via Check Dept procedure/intervention/surgery during inform Thrombocytopenia Heparin requiring the Chart necessary Adult tube instructions ensure or alphabetically home choose site please order protocols <30 will monitoring may Management administration before on sampling TIPS queries day there thrombocytopenia thereafter Teams underfilled intravenous Xa done find Warfarin out 3: sites LOCATING heparin positive FOR LMW RIE guidance arrange NHS citrated talk working For listed go hours greentop at assay 30 you policies UFH chart just Level need then can if Any pager 2020 assays Target peak TRAK Haematology full units/ml 18 Select Guideline Clinical invasive contact 24 located Page be LMWHHeparin SpR Other accumulation but UFHHeparin AND as team Order required take marked PROTOCOLS infusion dalteparin for Version call search set available HeparinInduced TOP other SC helpful intranet all Julia not of 10 range oneoff should Infusion by Critical page Date: LMWH Use lab haematology well Cr Go switchboard must level dose sample procedure oncall click! 5817 Directory Documents: get in withhold Anderson LMWHheparin following urgent link patients Heparininduced 51 April here Beriplex needed it test patient site: Guide staff courier anticoagulation Lothian Documents post COVID19 taken ANTICOAGULANT laboratory reversal choices! we Unfractionated"
    }
]